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CHAPTER I 
GENERAL INTRODUCTION 
1. Historical overview. 
Serotonin (5-hydroxytryptamine, 5-HT) was first shown to be present within the 
central nervous system in 1953 by Twarog and Page. The compound itself was however 
for the first time detected outside the central nervous system. As early as 1933, 
Vially and Erspamer demonstrated by means of an argantophyl reaction the presence 
of an amine in the granules of the granulated cells in the gastrointestinal mucosa. 
In 1937 they detected it chemically in acetone and alcohol extracts of the same 
tissue, and in 1940 Erspamer stated that the substances extracted are biologically 
active. He called the active substance enteramine. The name enteramine is related 
to the specific storage product of the typical enterochromaffin cells of the 
gastrointestinal mucosa. Erspamer and Asero (1952) determined that the structure 
of enteramine is that of the heterocyclic amine 5-hydroxytryptamine. Kosterlitz 
and Robinson (1957) demonstrated that 5-HT stopped peristalsis when administered to 
the serosa of the guinea-pig ileum in vitro. Finally, Lembeck (1958) considered 
that the mode of action of 5-HT was to sentitize the afferent structures of the 
intestine to distension and regarded as a local tissue hormone. In that same time 
Rapport (1949) isolated a substance from ox blood, which could cause vasoconstriction, 
hence the name serotonin was related to that serum factor. Moreover, Rapport was 
able to determine the molecular structure as 5-hydroxytryptamine. Rand and Reid (1951) 
and Reid and Rand (1952) showed that the vasoconstrictor present within ox 
platelets was 5-HT or serotonin. 
From the foregoing it appears that one and the same compound, 5-hydroxytryptamine, 
was found to be present in both the gastrointestinal mucosa and in the blood platelets. 
As already mentioned the occurrence of 5-HT and its synthetizing enzymes, i.e. 
tryptophan hydroxylase and aromatic L-amino acid decarboxylase, was for the first 
time biochemically demonstrated by Twarog and Page (1953). Amin, Grawford and Gaddum 
(1954) and Zetler and Schlosser (1954) found 5-HT in the brain while studying the 
distribution of substance-P in that organ. Bogdansky, Pletcher, Brodie and Udenfriend 
(1956) confirmed fluorimetrically that serotonin is present in significant quantities 
in the central nervous system and that the concentrations of this compound shows 
considerable differences in the various parts of that organ. They found it in large 
quantities in the mesencephalon, and diencephalon especially in the hypothalamus. 
No 5-HT was demonstrated in the cerebellum, but an abundance of it appeared to be 
present in the area postrema. On the basis of these findings, the authors last 
mentioned, suggested that serotonin might be a neurotransmitter in the vertebrate 
brain. However, before discussing the functional role of serotonin, some background 
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information about the chemical synthesis of that substance has to be provided. 
2. Basics of brain serotonin. 
In the central nervous system (CNS), as elsewhere in the organism, the synthesis 
of serotonin requires two enzymatic steps. The natural precursor, the amino-acid 
L-tryptophan, is first hydroxylated by a specific enzyme, tryptophan hydroxylase 
(or tryptophan-5-mono-oxygenase, EC 1.14.16.4), with molecular oxygen and a 
reduced pterin as cosubstrates. The intermediate product, L-5-hydroxytryptophan, is 
then decarboxylated into 5-hydroxytryptamine by a pyridoxal phosphate-dependent 
enzyme, aromatic amino-acid decarboxylase (EC 4.11.28) (Figure 1). Studies on the 
respective characteristics of these two enzymes have led to the conclusion that the 
regulation of 5-HT synthesis preferentially involves the tryptophan hydroxylation 
step, which latter thus may be considered as the rate limiting step for 5-HT 
synthesis. Under normal physiological conditions this enzyme is not saturated. More­
over, it is known that serotoninergic neurons have a relatively high affinity 
uptake of L-tryptophan. 
The question as to whether serotonin acts as a neurotransmitter in the central 
nervous system can, of course, only be adequately answered after having presented 
beforehand a general definition of this group of substances. 
With Iversen (197Θ) I agree that neurotransmitters should fulfill the following four 
criteria: A) The compound is stored in neurons; B) It can be released after physio­
logical stimulation of the presynaptic structure, generally an axon or the cell soma, 
or even an electrical stimulation of afferent nerves. The transmitter is released 
from synaptic vesicles by a process of exocytosis. C) The substance is inactivated 
after its release and, D) Its effect can be blocked by appropriate antagonists. 
Ad A. Localization. Serotonin is present in neurons, and usually stored in high 
concentrations in presynaptic nerve terminals. This has been shown by several 
techniques, starting with the formaldehyde-induced fluorescence (Dahlström and 
Fuxe, 1964), later followed by autoradiography in combination with H-serotonin 
(Beaudet and Descarries, 1976; Chan-Palay, 1977) and finally by immunohistochemistry 
using antibodies to tryptophan hydroxylase (Pickel, Joh and Reis, 1976) or recently 
by the present author, using antibodies to serotonin itself (Steinbusch, Verhofstad 
and Joosten, 197Θ). 
Ad B. Release. Serotonin is released from nerve terminals in response to depolarizing 
stimuli, usually by a carrier dependent stimulus secretion coupling mechanism in­
volving exocytosis from storage vesicles. Indirect evidence for the release of 
serotonin from nerve terminals in response to electric stimulation of the mesence­
phalic raphe nuclei has been reported for the first time by Aghajanian, Rosecrans 
and Sheard (1967). They observed after stimulation of the nuclei mentioned a decrease 
of the endogenous levels of serotonin in the forebrain and an increase of the 
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exogenous levels of its major metabolite, 5-hydroxyindoleacetic acid (5-HIAA). 
Although the changes in serotonin concentration found in the forekrain after 
midbrain stimulation are generally explained in terms of a neurally mediated 
release of serotonin, a direct proof on the ultrastructural level for the presence 
of serotonin within vesicles has been given only recently (Pelletier, Steinbusch 
and Verhofstad, 1981). However, this study was also unable to unveil that serotonin 
is released after stimulation by exocytosis. Thus the exact cellular site of release 
cannot be ascertaid on the basis of the data obtained. 
However, it has been shown that exogenous tritiated serotonin injected into the 
cerebral ventricles is specifically taken up in areas rich in endogeneous serotonin 
(Parent, Descarries and Beaudet, 1981). Electronmicroscopic autoradiography has 
revealed that the tritiated serotonin is localized in relation to synaptic vesicles 
within these endings (Azmitia, 1981; Beaudet and Descarries, 1961). Baldessarini and 
Kopin (1966) showed that other tritiated monoamines, i.e. norepinephrine, dopamine 
and histamine, which accumulate in brain slices in vitro can be released by electrical 
stimulation. It seems likely that the endogeneous monoamines will be released by 
a common mechanism, i.e. exocytosis. 
Ad C. Inactlvatlon. Specific enzymatic or reuptake mechanisms are present for the 
inactivation of serotonin following its release. Serotonin, which is released upon 
nerve impulse into the synaptic cleft, may combine reversibly with receptors that 
exist not only postsynaptically but also presynaptically. The action of serotonin 
on synaptic receptors is terminated when it is dissociated from the receptor and 
pumped back into the nerve terminal, where it may either be stored in vesicles to 
be reutilized, or degraded enzymatically by monoamine oxidase into its major 
metabolite 5-HIAA (Fuller, 1980). 
Ad D. Pharmacological identity. The effects of serotonin can be blocked by appro-
priate antagonists. The serotonin antagonists most studied are metergoline (Fuxe, 
Ogren, Agnati and Jonsson, 1978), methysergide (Gyermek, 1961) and in particular 
lysergic acid diethylamide or LSD (Boakes, Bradley, Briggs and Dray, 1969). Like 
serotonin itself, these antagonistic drugs contain an indole nucleus. Haigler and 
Aghajanian (1974) demonstrated by the use of microiontophoresis (a technique which 
permits the direct application of small amounts of substances to single neurons) that 
LSD depresses the activity of serotoninergic neurons but has hardly any effect on 
non-serotoninergic neurons. 
On the basis of the findings reported above, it may be safely said that 
serotonin represents indeed a neurotransmitter in the vertebrate central nervous 
system. 
3. Alms and scope of the present investigations. 
The central serotoninergic neuron population is a phylogenetically ancient 
group of brain stem reticular neurons associated with the raphe nuclei. It shares 
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several organizational features with the group of noradrenergic neurons, sucl as a 
high degree of collaterallzation, multidirectionality of projections and considerable 
overlap in the regional distribution and density of axon terminait in e.g. the fore-
brain. However, the group of serotoninergic neurons shows other features that are 
unique. Thus its cell bodies may contain other transmitters or transmitter candidates 
such as GABA, substance P, enkephalin or thyrotrophin releasing hormone, its axons 
constitute an extensive supra-ependymal plexus and the terminals of some elements 
establish synaptic contacts with secretory ependymal cells as e.g. in the subcommiss-
ural organ. 
The major purpose of the present study is to contribute to our understanding 
of the nature, interrelationship and function of serotonin-containing neuronal 
elements in the central nervous system of the rat. 
Chapter II deals with the development of a technique for the localization 
of serotonin by immunofluorescence using antibodies to the neurotransmitter itself. 
The method was based upon coupling serotonin to bovine serum albumine, using 
formaldehyde as coupling agent. With regard to specificity and sensitivity this 
technique is superior to the procedures previously applied for the visualization 
of serotoninergic elements, such as formaldehyde-induced fluorescence, autoradio-
graphy or immunohistochemistry using antibodies to the enzymes tryptophan hydroxylase 
and aromatic amino-acid decarboxylase. 
In Chapter III the chemical background for the synthesis of three different 
serotonin-immunogens is described. The first of these three represents a further 
development of the one applied in chapter II. Just like the synthesis of the 
previous conjugate, the other two immunogenb are also based upon the coupling of 
serotonin to albumin, however instead of formaldehyde as the coupling reagent, 
isobutyIchloroformate or carbodiimide, both in combination with para-aminobenzoic-
acid, were utilized. The results achieved with these two antisera are of importance 
because they provide us with information regarding the cross reactivity of our 
antiserum towards beta-carbolines. 
In the same chapter we describe the application of our antiserum in the unlabeled 
peroxidase-anti-peroxidase method. The latter method in combination with vibratome 
sections appeared to be especially suitable for studies of serotoninergic perikarya 
and their dendritic pattern. 
Finally in the same chapter we provide evidence that our serotonin antibody 
can be used in members of different vertebrate classes in contrary to antibodies 
raised to purified mammalian enzymes. 
In Chapter IV the distribution of serotonin-immunoreactive cell bodies, fibres 
and terminals throughout the central nervous system of the rat is shown. The study 
reveals that the serotoninergic fibres and terminals are widely distributed and 
compared with other transmitter-specified arrangements are only equalled by the 
group of noradrenergic neurons. 
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In Chapter V the serotonin-immunoreactivity in the hypothalamus and the 
pituitary is dealt with in some detail. It was demonstrated that neither in untreated 
rats nor in rats in which the endogeneous levels of serotonin have been raised by 
loading with L-tryptophan or nialamide serotoninerglc cell bodies are demonstrable 
within the various hypothalamic nuclei. 
In Chapter VI we extend our observations by studying the brain area with tho 
largest number of serotoninerglc neurons, i.e. the nucleus raphe dorsalis. This 
nucleus has been studied in the following three ways, 1) The cell mass was subjected 
to a detailed cytoarchitectonic analysis, based upon Nissl- and Klüver-Barrera 
stained material. 2) Serotonin- as well as noradrenaline-immunoreactive neurons were 
plotted within and beyond the boundaries of this nucleus. 3) Following large in-
jections of the retrogradely transported fluorescent dye, propidium iodide, into 
the caudatoputamen complex, serotoninerglc as well as non-serotoninergic cells in 
the nucleus raphe dorsalis, which project upon the caudatoputamen could be visualized. 
The serotoninerglc as well as non-serotoninergic fibres appeared to arise from 
medium-sized neurons of the same cytoarchitectural appearance. 
In Chapter VII the results of a cytoarchitectonic and Immunol,istochemical 
analysis of the seven raphe nuclei are combined with data from the- literature. 
Special attention is paid to the dendritic patterns of the serotoninergic neurons 
within these nuclei, to their transmitter-specified and non-specified efferents and 
afférents and to the relation between serotoninergic neuronal elements on the one 
hand and glia and bloodvessels on the other hand. 
Finally, Chapter VIII summarizes our present day knowledge o' the physiological 
and behavioral effects of serotonin, with emphasis on data which < an be related to 
the serotoninergic pathways in the brain. The following eight topics are discussed: 
1) the central regulation of cardiovascular system and the pituitary; 2) depression; 
3) the relation between serotoninergic neurons and Parkinson's di*ease; 4) myoclonus; 
5) sleep; 6) thermoregulation; 7) pain and 8) locomotor activity. 
I H Tryptophan Ну^гожуfas* I 
5-HydroHytryptophan \ l] І Г * T 
Ч Л ^ ¿о 
1 ООН Decarboxylase (DOC I 
5-HydrcMytryptam.ne " T ( [ ψ0*!0"*"*! 
Fig.l. Biosynthetic pathway of serotonin. 
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LOCALIZATION OF SEROTONIN 
IN THE CENTRAL NERVOUS SYSTEM 
BY IMMUNOHISTOCHEMISTRY: DESCRIPTION OF A 
SPECIFIC AND SENSITIVE TECHNIQUE 
AND SOME APPLICATIONS 
H. W M STEINBUSCH, A. A. J. VERHOFSTAD and Η. W. J. JOOSTEN 
Department of Anatomy and Embryology, University of Nijmegen, 
Nijmegen, The Netherlands 
Abstract- A detailed description is given of an immunohistochemical technique for the localization 
of serotonin in the central nervous system of the rat In rabbits antibodies were raised against an 
antigen prepared by coupling serotonin to bovine serum albumin using formaldehyde as a coupling 
reagent In the antisera two types of antibodies, one against the bovine serum albumin-serotonin 
complex and another type directed to bovine serum albumin were demonstrated by Immunoelectro­
phoresis The antibodies to serum albumin could be removed by affinity chromatography. Brains and 
spinal cords of rats were fixed by perfusion with ice-cold 4% formaldehyde in 0 I м-sodium phosphate 
buffer (pH 7 3) and sectioned on a cryostat The sections were stained by the indirect immunofluores­
cence technique Immunofluorescence specific for serotonin was observed in cell bodies and fibre sys­
tems. The antisera could be diluted up to 1 .1024 provided a prolonged incubation at 4 С was employed 
The specificity of the antisera was examined by inhibition tests. From these tests it was estimated 
that in the central nervous system of the rat there might be a cross-reactivity of approximately 2"„ 
to 5-methoxytryptamine and dopamine and less than 1% to noradrenaline and adrenaline under the 
conditions which were used. 
Thus the procedure appears to be a specific and sensitive technique for the localization of serotonin 
in the central nervous system: it has the advantage that adjacent sections can be examined by the 
immunofluorescence method using antisera to a variety of antigens The application of this technique 
is some parts of the brain and spinal cord of the rat is demonstrated. 
T H E DISTRIBUTION of serotonin in the mammalian cen­
tral nervous system has been demonstrated by bio­
chemical and histochemical techniques (see e.g. 
TWAROG & PAGE, 1953; AMIN, CRAWFORD & G A D -
DUM, 1954; BOGDANSKI, PLETSCHER, BRODIE & U D E N -
FRIEND, 1956; BOGDANSKI, WEISSBACH & UDENFRIEND, 
1957; PAASONEN, MACLEAN & GIARMAN, 1957, 
K U N T Z M A N , SHORE, GOGDANSKI & BRODIE, 1961; 
PALKOVITS, BROWNSTEIN & SAAVEDRA, 1974; SAA­
VEDRA, BROWNSTEIN & PALKOVITS, 1974a; SAAVEDRA, 
PALKOvrrs, BROWNSTEIN & AXELROD, 1974Í?; H O L -
MAN, A N G W I N & BARCHAS, 1976; OLIVERAS, BOUR-
GOIN, HERY, BESSON & H A M O N , 1977; SAAVEDRA, 
1977; DAHLSTRÖM & F U X E , 1965α, b; A N D E N , D A H L -
STRÔM, F U X E , LARSSON, O L S O N & UNGERSTEDT, 1966; 
F U X E , HÖKFELT & UNGERSTEDT, 1968; UNGERSTEDT, 
1971; Loizou, 1972; F U X E & JONSSON, 1974). 
The morphological methods which have been used 
for the localization of serotonin in the central nervous 
system can be divided into three groups. The oldest 
procedure is based upon treatment of freeze-dried tis-
sue with formaldehyde vapour (FALCK, HILLARP, 
THIEME & TORP, 1962; FALCK, 1962; ERANKÓ, 1967). 
The original procedure is, however, considerably less 
Abbreviation • BSA. bovine serum albumin 
sensitive for serotonin than for catecholamines (see 
e.g. JONSSON, 1971; BJÖRKLUND, FALCK & LINDVALL, 
1975). Moreover, there is a rather marked photode-
composition (BJÖRKLUND, FALCK & STENEVI, 1971; 
JONSSON. 1971; BJÖRKLUND et ai, 1975). Attempts 
have been made to improve the sensitivity by meth-
odological modifications ( F U X E & JONSSON, 1967) and 
pharmacological manipulations (see e.g AGHAJANIAN, 
K U H A R & ROTH, 1973; F U X E & JONSSON, 1974). 
Recent methodological improvements which mark-
edly increases sensitivity for catecholamines (HÖKFELT 
& LJUNGDAHL, 1972; LINDVALL & BJÖRKLUND, 1974; 
BATTFNBERG & BLOOM, 1975; BLOOM & BATTENBERG. 
1976, LORÉN, BJÖRKLUND, FALCK & LINDVALL. 1976; 
AZMITIA & HENRIKSEN, 1976; N Y G R E N , 1976; DE LA 
TORRE & SURGEON, 1976; LORÉN, BJÖRKLUND & 
LINDVALL, 1977) do not, however, seem to represent 
any clear advance with regard to visualization of sero-
tonin. Another way of localizing serotonin is based 
upon autoradiography following monoamine oxidase 
inhibition and intraventricular application of [ J H ] -
serotonin (AGHAJANIAN & BLOOM, 1966; DESCARRIES, 
BEAUDET & WATKINS, 1975; C H A N - P A L A Y , 1977). In 
this case, however, the question may be raised if all 
serotonin-containing elements are reached by the in-
jected radioactive substance and, moreover, if the 
uptake mechanism is quite specific. Recently the ap-
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plication of immunohistochemical procedures have 
been described using antibodies to tryptophan hy-
droxylase and dopa decarboxylase (HÓKfrLT, F u x t 
& GoLDSTfciN, 1973; 1975; JOH. SHIKIMI, PicKrL & 
REIS, 1975; Р і с к ш JOH & R u s . 1976; H Ò K F E L T . 
LlLNGDAHL, STblNHUSCH. VERHOFSTAU, NlLSSON. Pi R-
Now & GoLDSTriN. 1978). These enzymes catalyse 
consecutive steps in the biosynthesis of serotonin. In 
spite of the impressive results which have been 
obtained with the latter techniques, they arc. of 
course, essentially indirect methods of demonstrating 
serotonin. Moreover, dopa decarboxylase is also in-
volved in the biosynthesis of catecholamines (CHRIS-
TENSON, DAIRMAN & UlM-NFRIFNI), 1972). 
This review of the presently available techniques 
makes it clear that a sensitive and specific procedure 
for the localization of serotonin itself is highly desir-
able. We therefore tried to prepare a specific anti-
serum to serotonin which could be used in an im-
munohistochemical approach. From the literature wc 
know that antisera to serotonin have been obtained 
by RANADIVE & SFHON (1967). PrsKAR & SPICTOR 
(1973), SPECTOR. BI.RKOWITZ. FLYNN & PTSKAR (1973) 
and GROTA & BROWN (1974) who. however, did not 
use their antisera for immunohistochemistry Since 
serotonin is too small a molecule to act as an antigen 
itself it needs to be coupled to an immunogenic car-
rier substance, as has been indicated by LANDSTEIMR 
(1947) and SPECTOR (1969) 
In the present paper the attempts to develop a 
specific and sensitive immunohistochemical procedure 
for serotonin is described. The preparation of the 
antiserum, its specificity and some applications in the 
brain and spinal cord of the rat are reported 
EXPERIMENTAL PROCEDURES 
Preparation of the antigen 
Serotonin was coupled lo bovine serum albumin (BSA) 
with formaldehyde. The procedure was based upon the de-
scriptions of RANADIVI & Si HON (1967) and GROTA & 
BROWN (1974) A quantity of 7 5 ml of a 12 м-sodium acet­
ate solution which contained 150 mg bovine scrum albu­
min (BSA) was mixed with 7 5 ml of a 12 м-sodium acetate 
solution in which 50 mg serotonin creatinine sulphate was 
dissolved. Then 15 ml of a 3°„ formaldehyde solution was 
added The reaction mixture (30 ml, pH 6 5) was incubated 
at room temperature After about 18 h the solution became 
opaque and a dense precipitate appeared The incubation 
was continued for 6 h and finally slopped by dialysis for 
3 days against running tap water at 4 С After centnfuga-
tion at 20,000 g
mn
 for 15 min the protein concentration 
was measured according to LOWRY. ROSEBROUGH, FARR 
& RANDALL (1951). Ultraviolet absorption spectra were 
determined in order to estimate the approximate amount 
of serotonin bound to BSA The antigen-containing solu­
tion was stored at - 2 0 С until immunization. 
Preparation of the antiserum 
Antibodies were raised in male New Zealand rabbits 
Each animal received an injection mixture prepared by 
emulsifying 0.5 ml of the antigen-containing solution (2 mg 
BSA-serotonin complex/ml) and 0 5 ml complete Frcund's 
adjuvant This mixture was administered intramuscularly 
Booster injections (incomplete Freund's adjuvant, other­
wise ihe same mixture) were given biweekly intramuscu­
larly (0 8 mg antigen) and subcutaneously (0 2 mg antigen) 
Serum was harvested by car puncture 8 days after the last 
booster inieclion Serum samples were tested by immuno­
diffusion according (o OICIFITRIONV (1967). Immunoelec­
trophoresis and immunofluorescence microscopy 
From these experiments il became obvious that the sera 
contained two types of antibodies, one directed against 
BSA and one directed against the BSA serotonin complex 
Therefore anlisera were purified from BSA antibodies b\ 
affinity chromatography 
Purification oj antiscra Jrom hot me serum alhwnm antibodies 
A two-step procedure was followed Antiscra were first 
shaken for 60 min al 37 С with BSA dissolved in phos­
phate buffered saline (1 4 vol vol. final concentration of 
BSA was 15 mg ml) followed by centrifugaron al 
20,000 jf
miv for 15 mm The composition of ihe phosphate 
buffered saline was 00lvi-Na phosphate buffer (pH73) 
containing 0 8"
n
 w ν NaCl and 0.2",, w ν KCl 
The partly cleared antiscra were then treated by affinily 
chromatography Albumin sepharose was prepared by 
adding 20 mg BSA (5 mg ml) dissolved in a 0 1 vt-sodium 
carbonaie buffer (pH9 0) lo 1 g of washed cyanogen bro­
mide Sepharose 4B The mixture was stirred gently for 
I h and left overnight at 4 С All the following steps were 
also performed at 4 С Sepharose 4B was sedimcnted by 
centrifugaron and 50 mmol of I vi-ethanolamine dis­
solved in a Ютм-sodium carbonate buffer (pH 8 0) per g 
of Sepharose 4B were added This mixture was left for 
6 h to allow a complete reaction with the remaining 
cyanogen bromide Sepharose After sedimentation and 
washing twice with a lOmvi-sodium phosphate buffer 
(pH 7.2). containing 0 9°,, NaCl. the complex was poured 
into a column (Pharmacia 09 χ 15cm) To remove non-
covalenlly bound albumin the column has to be washed 
with a sufficient amount of 0 1 м-sodium acetate buffer 
(pH4.8) containing 1 0 M-NaCl followed by washing with 
a 0 I M-sodium acetate buffer (pH7 4). containing 
ІОм-sodium chloride. After three washing cycles the 
column was equilibrated with a ІОтм-sodiiim phosphate 
buffer (pH 7.2). containing 0 9"
o
 NaCl Then the antiserum 
was applied The antiserum remained in contact with the 
complex for at least 30 min prior to elution with the 
column can be reused after washing with a 0 1 M-glycine 
buffer (pH2 2) 
Inhibition o) antihod\ actuit\ 
In order to investigate the specificity of the antisera in 
immunofluorescence microscopy, serum samples were in­
cubated with different concentrations of substances which 
might cross-react with the developed antibodies 
The sera were treated as follows. 
(1) sera, purified from BSA antibodies, were diluted 
1:512 with PBS, which contained 0 2"„ (v/v) Triton X-100 
(see immunofluorescence microscopy), 
(2) an equal volume of a solution containing the sub­
stance to be tested was added, 
(3) this mixture (antiserum dilution 1 1024, 0 1"„ Triton 
X-100) was shaken for 1 h at 37 С and then kept at 4 С 
for at least 18 h Before use the serum samples were cenlri-
fugated at 20,000 д
тл
, for 15 min to remove any precipitate 
HG. I. Photomicrographs showing specific immunofluorescence in the rat brain after incubation with 
a serotonin antiserum. (A) Nucleus caudatus. (B| Olfactory bulb. (C'l Supramammillarv/ region. (D) 
Nucleus raphe magnus. Magnification: 140 χ (В and D| and 350 χ (Λ and С). 
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FIG. 2. Photomicrographs showing specific immunofluorescence in the lumbar spinal cord of the rat 
after incubation with a serotonin antiserum. (A) Nerve terminals in the dorsal horn. (B) Fibre plexus 
in the ventral horn. (C) Higher magnification of an area indicated by rectangle in B. Magnification: 
140 χ (B) and 350 χ (A and C). 
- 22 -
Immunohistochemical localization of serotonin 
For detailed information about the substances and the 
concentrations which have been investigated, see Table 1 
I mmunofluorescence microscopy 
Male albino rats (body weight 125 175 g) were used The 
procedure was essentially that described by HOKF-H.T et 
ai (1973) The animals were anesthetized with sodium pen­
tobarbital (60mg/kg body weight) and perfused through 
the left heart ventricle for 15 min at a pressure of 
125 mmHg with 400 ml icecold 4"/„ paraformaldehyde dis­
solved in a 0 I M-sodium phosphate buffer (pH 7.3) (PE-ASI-. 
1962) The brains and the spinal cords were removed Tis­
sue pieces were dissected out and postfixed for 2 h at 4 С 
in the same fixative Finally they were rinsed at 4 С for 
at least 18 h in 5"„ (w/v) sucrose dissolved in a 
0 1 M-sodium phosphate buffer (pH 7.3). The tissue pieces 
were then frozen on cryostat chucks with powdered dry 
ice or with isopenlanc, cooled by liquid nitrogen. Sections 
(ΙΟμιτι) were cut on a cryostat (Dittes, Heidelberg. G F R ) 
at - 2 5 C and mounted on glass slides coated with chrome 
alum gelatin (0 5 g chrome alum and 0.5 gelatine in 100 ml 
H 2 0) . 
The sections were usually stored at —70 С for 24 h 
before staining The staining procedure was based upon 
the indirect immunofluorescence technique of COONS and 
co-workers (see COONS. 1958, NAIRN, 1976). The sections 
were first incubated in phosphate buffered saline al room 
temperature for 30 min Then they were incubated for 18 h 
with antiscra or pre-immune sera, diluted with phosphate 
buffered saline which contained Triton X-100 (the concen­
tration in the incubation medium was 0 l"„ v/v, the addi­
tion of Triton X-100 was suggested by HARTMAN, 1973) 
After careful rinsing in phosphate buffered saline for 
30 min at room temperature, the sections were treated with 
fluoresceinisolhiocyanate conjugated sheep anlirabbit im­
munoglobulins, diluted 1.4 with phosphate buffered saline 
which also contained Triton X-100 (concentration in the 
incubation medium was 0 075°-;,) After this final incubation 
for 30 min at room temperature, the sections were again 
rinsed in phosphate buffered saline (30 mm, room tempera­
ture) The sections were then mounted in a mixture of gly­
cerin and phosphate buffered saline (3 1, vol/vol) and 
examined in a Zeiss Universal microscope equipped for 
fluorescence with incident illumination Scopix RP 1 film 
(Gevaert. Belgium) was used for photomicrography. The 
slides were stored at - 2 0 С 
With the above procedure two kinds of experiments 
were performed 
(1) The spécifiai) of the anlisera were tested in compar-
able sections of the medulla oblongata of untreated rats, 
containing fluorescing cell bodies and fibre systems These 
sections were incubated with antiscra from which BSA 
antibodies had been removed, diluted I 1024 and treated 
with substances which might cross-react with the specific 
antibody (sec also preceding paragraph and Table I). Pre-
îmmune sera were used as control sera The degree of inhi-
bition was estimated semi-quantitatively 
(2) The upplicabüu\ of the antisera for localization 
studies was investigated in untreated rats Several parts 
of the brain and the spinal cord were examined with sera 
diluted 1 512 or 1 1024 
Reagents 
Sepharose 4B was obtained from Pharmacia Fine 
Chemical Inc., serotonin (5-hydroxytryptamme creaJinine 
sulphate), bovine scrum albumin, rat serum albumin. 5-
methoxylryptamine hydrochloride, dopamine (3-hydroxy-
tyramine hydrochloride), noradrenaline (L-norepinephnne 
bilartrale), adrenaline (L-epinephnne bitartrate) and Triton 
X-100 were purchased from Sigma Chemical Co ; fluores-
ceinisolhiocyanate conjugated sheep antirabbit immuno-
globulins were prepared by Statens Baktenologiska Labor-
atorium, SBL. Stockholm. Sweden All other chemicals 
were of analytical grade 
RESULTS 
Preparation of anti.sera 
With the coupling procedure described above a sol-
uble BSA serotonin complex was obtained as could 
be shown from the u.v absorption spectra. This 
observation confirms the descriptions of RANADivr & 
SCHON (1967) and GROTA & BROWN (1974). With this 
soluble BSA serotonin complex antibodies with high 
titres could be raised in rabbits. In the Ouchterlony 
immunodiffusion a single precipitation band was 
found with 7 μΐ of antiserum diluted up to 1 :128 
when tested against undiluted BSA-serolonin 
complex (2 mg/ml). Immunoelectrophoresis of the un­
diluted complex tested against the undiluted anti-
TAHLI 1 SUMMARY ot тнь RISI LTS OF ТНЬ INHIBITION ixprRiMfcNTS 
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Fluorescence intensity in comparable sections of the medulla oblongata after adding different concentrations of several 
substances to samples of a serotonin antiserum, which was separated from BSA-antibodies and diluted 1 1024 All 
sera contained 0 1°„ (v v) Triton X-100 
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serum revealed two precipitation lines: a heavy one, 
representing BSA antibodies and a weak one, repre-
senting antibodies directed against the complex. No 
precipitation could be found if BSA was replaced by 
albumins of other species, e.g rat serum albumin. 
Immunofluorescence studies 
The antibodies to BSA could be successfully 
removed by affinity chromatography. Purification led 
to a higher contrast in immunofluorescence micro-
scopy Moreover, the unwanted staining of blood ves-
sel walls, which sometimes was observed, could also 
be eliminated by purification of the antisera. How-
ever, it is noteworthy that even without purification 
very suitable immunofluorescence staining could be 
obtained. 
Characteristic fluorescent cell bodies and fibre sys-
tems could be visualized in several parts of the central 
nervous system after formaldehyde fixation. No fluor-
escence was obtained either in fresh frozen sections 
without fixation of after perfusion with 2% glu tar alde-
hyde in 0.1 M cacodylate buffer (pH 7.3). From these 
observations one may conclude that appropriate fixa-
tion is of the utmost importance. 
Since related antigens are also preserved by formal-
dehyde fixation (e.g. tryptophan hydroxylase, dopade-
car boxy lase, dopamine ^-hydroxylase) consecutive 
sections may be stained with different antisera for cor-
relation studies (HÖKFELT et ai, 1978). 
Specificity of antisera. The results of the inhibition 
experiments are summarized in Table I. From these 
test it may be concluded that the developed anti-
bodies have a very high affinity for serotonin and 
a much lower affinity for 5-methoxytryptamine and 
dopamine, while its binding capacity for noradrena-
line and adrenaline is very low. So there might be 
a cross-reactivity to 5-methoxytryptamine and dopa-
mine of approximately 2% and a cross-reactivity of 
less than 1% to noradrenaline and adrenaline in the 
central nervous system of the rat under the conditions 
which have been used for immunofluorescence micro-
scopy. 
After incubation with pre-immune sera only a very 
faint background fluorescence was observed. 
From these experiments it may be concluded that, 
at least in the rat, the developed antibodies reveal 
a highly specific immunoreactivity to serotonin in the 
central nervous system. 
Localization of serotonin in the central nervous sys-
tem of the rat. The applicability of the antisera for 
localization studies was tested in the brain and spinal 
cord of untreated rats. Some preliminary results are 
demonstrated in Figs ΙΑ-D and 2A-C. It should be 
emphasized thai in none of the brain regions known 
to contain the dopamine and noradrenaline cell 
groups originally described by DAHLSTRÖM & FUXE 
(1964) could cell bodies be found reacting with the 
present serotonin antisera (T. HÖKFELT, personal 
communication). Another application has been pub-
lished elsewhere (HÔKFFXT et a/., 1978). 
DISCUSSION 
The immunohistochemical procedure we have used 
is based upon the phenomenon that small molecules 
which by themselves arc completely devoid of anti-
genicity become immunogenic after coupling to u car-
rier protein (LANDSTEINER. 1947, SPFCTOR. 1969). If 
such a complex is used under appropriate conditions 
two types of antibodies are induced. One is directed 
against the earner, the other against the complex 
This latter antibody can also combine with the small 
molecule itself, unattached to any carrier 
This principle has already been used by RANADIVE 
& SEHON (1967), PESKAR & SPECTOR (1973), SPFCTOR 
et ai (1973) and GROTA & BROWN (1974) for the pro-
duction of serotonin antibodies. In all cases serotonin 
was linked to bovine serum albumin (BSA). Coupling 
was achieved either by the formaldehyde (RANADIVE 
& SEHON, 1967, GROTA & BROWN, 1974) or by the 
carbodiimidc (PESKAR & SPECTOR, 1973; SPFCTOR et 
al., 1973) reaction. In both techniques the carrier is 
linked to the indole nucleus of serotonin 
We also used formaldehyde as a coupling reagent 
and BSA as a earner. As could be expected, two anti-
bodies were raised, one directed against BSA and one 
directed to the BSA-serotonin complex. Both anti-
bodies could be detected by Immunoelectrophoresis. 
Because BSA antibodies sometimes gave rise to an 
unwanted staining of blood vessel walls they were 
removed by affinity chromatography. But, as men-
tioned in Results, even without purification of the 
antisera strongly fluorescent cell bodies and fibre sys-
tems in the brain and spinal cord could be demon-
strated. Their distribution is in good agreement with 
the distribution originally described by DAHLSTRÖM 
& FUXE (1964) and FUXE (1965a,b) on the basis of 
the formaldehyde fluorescence method. However, the 
terminal networks appear with a distinction and 
brightness which cannot be reached with formaldehy-
de-induced fluorescence. Furthermore, networks are 
easily observed in brain regions, such as the cerebral 
cortex, known to contain substantial amounts of sero-
tonin but where no serotonin nerve terminals could 
be seen with the formaldehyde-fluorescence tech-
nique. These findings indicate a considerable increase 
in sensitivity for visualization of serotonin compared 
with the older techniques. 
Specificity of the antiserum 
The main problem is the matter of specificity Since 
serotonin is coupled through the indole nucleus of 
the molecule the specificity of the wanted antibodies 
(i.e. antibodies against the BSA-serotonin complex) 
are mainly determined by the structure of the side 
chain (PESKAR & SPECTOR, 1973, SPECTOR et ai, 1973; 
GROTA & BROWN, 1974) In the reports of the latter 
authors specificity was estimated by radioimmunoas-
say. However, there is evidence that data obtained 
by radioimmunoassay might be of limited value in 
immunohistochemistry (PCTRUSZ. SAR, ORDRONNEAU 
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& DlMEo. 1976. L\RSSON & R F H F I L D . 1977). There­
fore we decided lo чье inhibition tests In these experi­
ments serum samples were mixed with several concen­
trations of serotonin. 5-methoxylryptamtne. dopa­
mine, noradrenaline or adrenaline The degree of inhi­
bition was estimated semi-quantiutively in sections 
of the medulla oblongata The choice of the sub­
stances used in the inhibition experiments was gov­
erned by two considerations, first most of the sero­
tonin analogues tested b) the previous authors, if 
present at all. are present in very low concentration 
in the central nervous system, and second, wc wanted 
to exclude with certainty a cross-reaction to catechol­
amines. 5-Methoxytrypiamine was included because 
of the high degree of cross-reactivity with serotonin 
antibodies as revealed by radioimmunoassay (PESKAR 
& SPFCTOR, 1973: S P I C T O R et al, 1973; G R O T A & 
B R O W N . 1974) and because of its fairly high concen­
tration in certain parts of the central nervous system 
( G R E F N , KOSLOW & COSTA. 1973: KOSLOW. 1974; 
1976; see also BJÓRKI UND et al., 1971, BJÓRKLUND, 
AxELSSON & FALCK. 1976) From the inhibition experi-
ments it can be concluded that antibodies to the 
BSA-serotonin complex might have a 2% cross-reac-
tivity to 5-methoxytryptamine and d o p a x i n e and less 
than l"„ cross-reactivity to noradrenaline .ind adrena-
line. However, there is a remarkable difference 
between the degree of cross-reactivity to 5-methoxy-
tryptamine in our experiments (2%) and those de-
scribed by G R O T A & BROWN (1974) (100%), who also 
used the formaldehyde coupling procedure. This dif-
ference might be due to the fact that the test condi-
tions are dissimilar (immunofluorescence microscopy 
versus radioimmunoassay). Recently the value of inhi-
bition experiments in tests of antibody specificity was 
criticized by SWAAH. POOL & VAN LEI UWEN (1977). 
However, there are additional observations which 
seem to establish the specificity towards serotonin of 
the antibodies we obtained. Thus, there ι«, a negative 
staining of cell bodies in areas known to contain 
dopamine-containing and noradrenalinc-containing 
cell bodies, as originally described by DAHLSTRÖM & 
FUXE (1964) on the basis of the formaldehyde fluor-
escence technique. Moreover, there is .in identity 
between serotonin-containing neurons as visualized 
with an antiserum raised to dopa decarboxylase and 
the fluorescent neurons seen with the present antisera 
(HOKFFLT et ai. 1978). In the latter stud) it was also 
demonstrated that no serotonin immunoreactivity 
could be observed after treatment of rats with reser-
pine and that treatment with the neurotoxins 5,6- and 
5,7-dihydroxytryptamine caused a complete disap-
pearance of serotonin immunoreactive nerve ter-
minals, eg . in the spinal cord. 
In conclusion, there is strong evidence that, at least 
in the rat, the immunohistochemical technique de-
scribed here may be considered as a specific pro-
cedure with a high sensitivity for the localization of 
serotonin in the central nervous system. The method 
is currently being used for a detailed mapping of the 
serotoninergic systems in the brain and spinal cord 
of the rat 
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ANTIBODIES TO SEROTONIN FOR NEUROIMMUNOCYTOCHEMICAL 
STUDIES ON THE CENTRAL NERVOUS SYSTEM 
Methodological aspects and applications 
INT RODUCTION 
The presence of serotonin (5-hydroxytryptamine, 5-HT) in the central nervous 
system of many species has been demonstrated by a variety of biochemical and 
histochemical methods. Serotonin belongs to the group of biogenic monoamines. It 
is known that one of the biosynthetic enzymes, i.e. aromatic dopadecarboxylase 
(ADDC) is also involved in the synthesis of closely related catecholamines like 
ι dopamine (DA), noradrenaline (NA) and adrenaline (A). 
Serotonin and its synthetizing enzymes have been demonstrated first bioche­
mically (2, 6, 47). The formaldehyde-induced fluorescence method introduced in the 
early sixties (II, 12, 13) brought up the possibility to visualize serotonin and 
catecholamines in histological sections of brain and spinal cord. Recently, many 
modifications of the original technique have been introduced such as: the use of 
glyoxylic acid instead of formaldehyde (4, 5, 15, 46), the combined use of glyoxylic 
acid and formaldehyde (29), the combination of formaldehyde and glutaraldehyde (16) 
and more recently, the aluminium-formaldehyde (ALFA) method (1, 27). However, in 
spite of all these improvements the induced fluorescence methods are rather 
insensitive with regard to serotonin. Moreover, its demonstration by e.g., photo­
micrography is complicated by the rapid fading of the fluorescence light. In 
addition, since serotonin and other monoamines like DA, NA and A are demonstrated 
at the same time, the induced fluorescence techniques are not quite specific. In 
fact, Micro-spectrofluorimetry and pharmacological manipulations, e.g. by enzyme 
inhibitors or by selective destruction of serotoninergic or catecholaminergic 
neurons with 5.7 dihydroxytryptamine (22) or 6-hydroxydopamine (45) respectively, 
are needed to improve sensitivity and specificity. 
The introduction of immunocytochemistry using specific antibodies to enzymes 
involved in the synthesis of serotonin opened new possibilities to overcome this 
lack in specificity. Both antibodies to tryptophan hydroxylas and ADDC have been 
used (19, 20, 32). However, this approach suffers from several limitations. Firstly, 
isolation of these enzymes is time-consuming and needs expensive technical 
equipment. Secondly, antibodies to these enzymes are rather species-specific which 
means that a certain antibody can only be used for immunocytochemical purposes 
in a limited number of species. Thirdly, another, although minor disadvantage is, 
that localizing an enzyme by immunocytochemistry does not provide information 
about the question whether the enzyme studied is in its active of inactive state. 
In this chapter we want to report on a different immunocytochemical approach 
using antibodies to serotonin. Since the serotonin molecule is too small to be 
antigenic itself it needs to be coupled to a carrier protein like bovine serum 
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albumin (BSA). In the past several studies have been published about the 
production of antibodies to serotonin (14, 18, 23, 31, 33, 35). However, the anti­
bodies raised were only used in immunodiffusion tests or in radioimmunoassay. In 
this report different procedures for coupling of serotonin to BSA will be 
described. It will be demonstrated that antibodies to such conjugates can be used 
in immunocytochemical studies on the central nervous system. Findings with regard to 
specificity and applicability in different species will be presented. 
MATERIALS AND METHODS 
Preparation of the inmunogens 
Three different types of serotonin-immunogens were synthesized. In all cases 
BSA was used as the carrier protein. 
1. Serotonin-immnogen A was prepared according to the Mannich reaction using 
formaldehyde as a coupling reagent. In brief, 9.2 mg serotonin-creatinine sulphate 
(Sigma) in 1 ml aquadest was mixed with 28.1 mg BSA (Sigma) also dissolved in 1 ml 
aquadest, 1 ml 3 M sodium acetate buffer and 1 ml 7.5% formaldehyde (Merck). In 
order to study the influence of the pH on the coupling reaction sodium acetate 
buffers with different pH were used. The reaction mixture was incubated at room 
temperature in a shake water-bath. The pH was readjusted after 30 min. Incubation 
was continued for an additional 18 hrs. The reaction was then stopped by dialysis 
for 3 days against running tap water at 4 C. The precipitate was removed by 
centrifugation at 20.000 g. The protein concentration was measured according to 
Lowry et al. (28). Ultraviolet absorption spectra were determined in order to 
estimate the molar ratio of BSA and serotonin. The immunogen-containing solution 
was stored at -20 C. 
2. Serotonin-irmriunogen 5 was synthesized via a mixed anhydride reaction as has 
been described by Wurtzburger et al. (48) for the preparation of a melatonin 
ішшипоgen. The coupling procedure consists of three steps. First, diazotation of 
para-aminobenzoic acid (PABA) : '. mmol PABA (Sigma) was lissolved in 5 ml 1.0 N HCL 
at room temperature; 1 mmol sodium nitrite was dissolved in 1 ml aquadest and 
added dropwise to the PABA-solution. After an incubation for 20 min at 4 C, the 
reaction was stopped by adding 0.5 M ammonium sulphamate. Second, coupling of the 
diazotated PABA to serotonin: 1 mmol serotonin creatinine sulphate was dissolved 
in 1 ml 0.1 N NaOH at room temperature. The solution was adjusted to pH 1.0. The 
diazotated PABA (+ 6 ml) was added dropwise and the reaction was continued for 
2 hrs at 4 C. The precipitate was removed by centrifugation at 12.000 g and washed 
several times with aquadest. The precipitate was lyophilized until further use. 
Third, conjugation to BSA: 0.26 mmol PABA-serotonin was dissolved in 2 ml dry 
dioxane, obtained by purifying this solution over a basic aluminium oxide column. 
Then 0.26 mmol triethylamine (Merck) at 8 -J0° С was added to the PABA-5-HT 
solution followed by 0.26 mmol isobutylchloroformate (Sigma).. The reaction was 
continuted for 20 min at 8°-J0° С 300 jng BSA was dissolved in 1.0 ml aquadest at 
room temperature, after which 8 ml dry dioxane was added dropwise. The pH was 
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readjusted to 9.0 with 0.1 N NaOH and the mixed anhydride s o l u t i o n was added. The 
r e a c t i o n mixture was kept for 30 min a t 8 -10 C, under constant s t i r r i n g and then 
f u r t h e r s tored overnight a t 4 С The s o l u t i o n was dialyzed for 3 days against 
dioxane-water (1:1) and f i n a l l y for one day against aquadest. The immunogen was 
lyophi l ized u n t i l fu r ther use. The molar r a t i o s of BSA to serotonin were est imated 
from u l t r a v i o l e t absorption s p e c t r a . 
3. Serotorcin-imnunogen С was prepared by means of a carbodiimide reac t ion 
previously described by Holloway e t a l . (21) for the conjugation of melatonin to 
BSA. The f i r s t s teps in the p r e p a r a t i o n of immunogen С are s i m i l a r to the f i r s t 
and second p a r t of the procedure followed for immunogen B. However, the f ina l e t e p , 
i . e . conjugation to BSA, i s d i f f e r e n t : 200 mg PABA-serotonin in 10 ml 10 mM PBS 
buffer, pH 6.5, was mixed with 400 mg BSA in 10 ml 10 mM PBS buffer and 200 mg 
l - e t h y l - 3 (3-dimethylaminopropyl)-carbodiimide HCL (ECDI; Sigma) in 10 ml 10 mM 
PBS buffer. The r e a c t i o n was heavi ly s t i r r e d for 4 hrs a t room temperature. Then 
the r e a c t i o n mixture was dialyzed for 3 days aga ins t running tap water . The 
immunogen was lyophi l i zed u n t i l f u r t h e r use. The molar r a t i o of BSA to serotonin 
was also est imated from u l t r a v i o l e t absorpt ion s p e c t r a . 
P r e p a r a t i o n of the a n t i s e r a 
Antibodies were r a i s e d in r a b b i t s . Each animal received 0.5 ml of an incnunogen-
containing s o l u t i o n (2 mg protein/ml) emulsif ied in 0.5 ml complete Freund's 
adjuvant (Difco) in t racutaneous ly a t e i g h t d i f f e r e n t s i d e s . Booster i n j e c t i o n s with 
incomplete Freund's adjuvant were given threeweekly intramuscular ly in the hind 
limb a t four s i d e s . 
Serum samples were taken j u s t before immunization (pre-immune serum) and e i g h t 
days a f t e r the boos ter i n j e c t i o n s These samples were t e s t e d by immunodiffusion 
according to Ouchterlony (30), Immunoelectrophoresis and immunofluorescence 
microscopy. Since ant ibodies with a high a f f i n i t y to BSA caused unwanted s t a i n i n g 
of co l lagen-r ich t i s s u e s , as i . e . blood vesse l w a l l s , a l l se ra to be used for 
immunofluorescence or immunoperoxidase s t a i n i n g were previously p u r i f i e d by l i q u i d 
phase absorption with BSA (3-5 mg/ml) or by s o l i d phase absorption using a 
Sepharose 4B-CNBr-activated BSA-column. 
Immunocytochemical s t a i n i n g procedures 
Two d i f f e r e n t immunocytochemical s t a i n i n g techniques have been p r a c t i s e d . 
F i r s t l y , the i n d i r e c t immunofluorescence s t a i n i n g according to Coons (8) on 
c r y o s t a t sec t ions and secondly, the Peroxydase anti-peroxydase (PAP) method 
described by Sternberger and co-workers (43) on Vibratome s e c t i o n s . Mostly, b ra ins 
and s p i n a l cords of unt rea ted animals were used. However, in s p e c i a l cases, e .g . 
i f c e l l bodies or dendr i te s were s t u d i e d , animals were p r e t r e a t e d with the mono­
amine oxydase i n h i b i t o r Nialamide (Sigma; 100 mg/kg bodyweight; i n t r a p e r i t o n e a l l y , 
2 hrs before s a c r i f i c i n g ) . Male a lb ino r a t s (Vistar s t r a i n ) were anaesthet ized with 
sodium p e n t o b a r b i t a l (60 mg/kg bodyweight, in jected i n t r a p e r i t o n e a l l y ) . Trouts 
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Salmo gairdneri) ant' lampreys (Lampetra fluviatilis) were anaesthetized by adding 
MS-222 (Sandoz) to the water in which they were kept. All animals were perfused 
through the heart with 50 ml icecold oxygen-enriched, Ca free Tyrode's buffer, 
followed by 250 ml icecold 4% paraformaldehyde dissolved in 0.1 M .sodium phosphate 
buffer, pH 7.3, in 30 min at a pressure of 50 mm Hg. The brains and the spinal cords 
were rapidly removed and postfixed in the same fixative for 2 hrs at 4 C. Tissue 
pieces were rinsed in 5% sucrose dissolved in 0.1 M sodium phosphate buffer, pH 
7.3, for 24 hrs at 4 С if they were studied by immunofluorescence. This step needed 
not to be included in case Vibratome section was processed with the PAP-technique. 
1. Immimofluorescence staining of cryostat sections 
Cryostat sections, 10 um thick, were processed for immunofluorescence as 
described elsewhere (36, 40). 
2. Immunoperoxydase staining of Vibratome sections 
Vibratome sections, 50 or 100 pm thick, were processed for immunohistochemistry 
as described elsewhere (42). 
Experiments 
Three types of experiments were performed. 
1. Using the indirect immunofluorescence technique antisera raised with the immuno-
gens А, В and С were tested on cryostat sections of rat brains. 
2. The specificity of the antisera obtained after immunization with inmunogen A 
was investigated by indirect immunofluorescence on cryostat sections of rat brain 
tissue. Several tests were performed. First, consecutive sections were incubated 
with either immune or pre-immune sera. Second, serum samples, previously absorbed 
with BSA, were incubated with increasing concentrations of serotonin, 5-methoxy-
tryptamine (5-MT), DA, NA, A, octopamine (OCT), synephrine (SYN), or histamine 
(HIST). These samples were first incubated for 1 h at 37 С and then kept at 4 С 
overnight. Third, with a similar procedure serum samples were absorbed with 
different immunogens, viz. BSA-5HT (immunogen A), BSA-5MT, BSA-DA, BSA-NA and 
BSA-A. 
3. Finally, to prove that antibodies to serotonin can be used for neurocytochemical 
purposes irrespective of the species studied, brains of the lamprey (Lampetra 
fluviatilis), the trout (Salmo gairdneri) and the rat were investigated by the 
indirect immunofluorescence or PAP-technique on cryostat or Vibratome sections 
respectively. In these experiments only antibodies to immunogen A were used. 
RESULTS AND DISCUSSION 
Serotonin itself is not immunogenic. However, from the work of Landsteiner (26) 
we know that such molecules might become immunogenic after linkage to proteins. In 
fact, this principle was adopted by those who reported on the preparation of 
antibodies against serotonin previously (14, 18, 23, 31, 33, 35). These authors 
characterized their antisera by immunoprecipitation tests or radioimmunoassays 
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only, However, we were able to show that these antibodies can be used for immuno-
histochemical localization of serotonin on the central nervous system (36). 
In the next part of this section special attention will be given to the 
following items: (1) the preparation of three types of serotonin-immunogens and 
some immunohistochemical characteristics of the antibodies raised by them; (2) 
specificity tests and (3) some applications of serotonin antibodies in neuro-
immunocytochemis t ry. 
Preparation of three types of eerotonin-imnunogens and antibodies raised by them. 
Serotonin was linked to BSA either directly or indirectly via PABA as a spacer 
molecule. Direct linkage (serotonin-immunogen A) was achieved by the Mannich 
reaction with formaldehyde as a coupling reagent. The highest molar ratio of about 
54 was obtained at pH 6.8. It is most likely that with the procedure followed 
serotonin is coupled through the nitrogen atom of its indole nucleus to lysine or 
tyrosine residues of BSA (Fig. 1). Serotonin-immunogens В and С were prepared 
differently using PABA as a spacer molecule (indirect linkage). For serotonin-
immunogens В the mixed anhydride method was adopted, isobutylchloroformate serving 
as a coupling reagent. Maximal molar ratios were of about 24. Probably, in this 
case serotonin is conjugated to BSA through its aromatic ring (Figs. 2A,B; ЗА). In 
preparing serotonin-immunogen С coupling was achieved with a carbodiimide reagent. 
The highest molar ratio obtained was about 60. Most probably, serotonin-immunogens 
В and С have similar structures (Figs. 2A,B; 3B). 
Antibodies raised by the immunogens А, В and С were tested by immunofluorescence 
on cryostat sections of rat brain. Antibodies to the immunogens A and В showed a 
similar distribution of immunoreactive cell bodies, nerve fibres and nerve 
terminals after fixation by 4% paraformaldehyde dissolved in 0.1 M sodium 
phosphate buffer, pH 7.3. Antibodies to immunogen A were also tested under other 
fixation conditions. Thus it was established that addition of a small amount of 
glutaraldehyde (0.5%) caused a decrease in the immunofluorescence intensity. 
Moreover, no fluorescence was obtained either in fresh frozen tissue without 
fixation or after perfusion with 25! glutaraldehyde in 0.1 M cacodylate buffer, pH 
7.3. Apparently, fixation is of utmost importance. The fixation efficiency of 4% 
paraformaldehyde was further demonstrated by Schipper et al. (34). Using rat brain 
tissue and a non-biological model system, both incubated with radioactive serotonin, 
they showed that about 50Z of the radioactivity was retained after fixation and 
several rinsing steps. These data together with our findings with regard to the 
antibodies raised by the immunogens A and В seem to support our supposition that 
antibodies to serotonin-immunogen A, first described in 1978 (36), are 
demonstrating serotonin rather than its ß-carboline derivate. 
No immunofluorescence was obtained with antibodies to immunogen С employing 
4% paraformaldehyde fixation. 
Recently, the application of antibodies to serotonin in immunohistochemistry 
was reported by two other groups. In both cases antibodies were raised by an 
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immunogen prepared according to Peskar and Spector (31). This immunogen, very much 
resembling our serotonin-immunogen C, was prepared by coupling of serotonin to a 
diazotated conjugate of BSA and aminophenylalanine. One group (7) reported on 
studies in the rat brain and spinal cord. Immunoreactive nerve axons and terminals ·, 
as well as immunoreactive cell bodies were observed after fixation with 2% 
glutaraldehyde or 2% glutaraldehyde plus 0.2% picric acid, both buffered at pH 7. 
However, the distribution of immunoreactive material differs from those obtained 
with antibodies to the presently described serotonin-immunogen A and B. A second 
group (10) found immunostained cells in the gastrointestinal epithelium of several 
species employing p-benzoquinone vapour fixation of freeze-dried material. In both 
eases no staining was seen after fixation by formaldehyde which is in agreement 
with our findings. 
If one assumes that the serotonin-immunogens В and С have similar structures 
the absence of inmunostaining by antibodies to immunogen С in formaldehyde-fixed 
tissues is hardly to explain. One explanation might be a different steric 
configuration of the immunogens В and С due to the different coupling reactions 
used. Apparently, antibodies to serotonin-immunogen С do not recognize 
•erotoninergic structures as do antibodies to the immunogens A and B. Further, if 
serotonin-immunogen С is indeed resembling the serotonin-immunogen used by 3uffa 
and co-workers (7) one might suggest that the immunoreactivity they demonstrated 
in sections of rat brain and spinal cord is due to a different compound. Obviously, 
auch antibodies are able to bind serotonin in a radioimmunoassay performance. 
Specificity testa 
Antibodies to the immunogens В and С were obtained recently, whereas anti­
bodies, against serotonin-immunogen A have been used widely since 1978 (36). Hence, 
this paragraph will be devoted to the specificity of antibodies to immunogen A 
only. Using indirect immunofluorescence several tests were performed on cryostat 
sections of rat brain fixed by 4% paraformaldehyde. The results of these tests can 
be summarized as follows: 
|. Immunofluorescence could only be achieved with immune sera. No staining was 
seen using pre-immune sera. 
2. Serum samples incubated with increasing concentrations of different substances 
revealed that antibodies can be blocked by 5-MT and to a lesser extent also by 
DA. From these data it may be concluded that there is a cross-reactivity of 2-3% 
to 5-MT and of less than 0.25% to DA in rat brain tissue under the conditions used 
for immunofluorescence microscopy. Cross-reactivity to the other compounds tested 
seems to be neglectable. 
3. Immunofluorescence staining disappeared completely after absorption of the 
antiserum with serotonin-immunogen A. On the contrary, no reduction of 
fluorescence intensity was observed after absorption with immunogens to NA (BSA-NA) 
and A (BSA-A). These findings indicate once more that there is a neglectable 
degree of cross-reactivity to NA and A, if any. 
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There are additional observations relevant to the matter of specificity. Thus, 
immunofluorescence staining in rat brain sections could be abolished or strongly 
reduced by treatment with the Serotonin neurotoxins 5.7 dihydroxytryptamine (20, 
25) and parachloroamphefamine (25) or by treatment with reserpine. Further, in the 
rat there is a close correlation between the distribution of serotonin-immuno-
reactivity as revealed by antibodies to inmunogen A and observations obtained by 
other histochemical methods, e.g. immunofluorescence microscopy using antibodies 
to ADDC (17, 20) and the induced fluorescence techniques (9). 
Although the value of each single parameter might be questioned, the combined 
use of the presented data strongly support the conclusion that antibodies to 
serotonin-immunogen A are highly specific tools for demonstrating serotoninergic 
neuronal structures of the rat brain and spinal cord. It seems reasonable to 
assume that a similar degree of specificity applies other species as well, 
especially if there is a good correspondence between immunohistochemical findings 
and previous observations made e.g. by the induced fluorescence techniques. 
ι 
Applications of eerotonirt-antibodiee in neuroinriunoaytoaheTTiietry 
Innnunoreactivity of antibodies to synthesizing enzymes is mostly species-
specific. Apparently, proteins with similar enzymatic functions may have 
different immunogenic properties. Therefore, application of these antibodies in 
immunohistochemistry is often limited to certain species. However, it may be 
expected that antibodies to small molecular substances like serotonin can be used 
irrespective of the species studied. In order to test this assumption the central 
nervous system of three species, viz. lamprey, trout and rat were examined 
employing antibodies to the serotonin-immunogen A. Immunoreactive leuronal 
structures could be demonstrated clearly in all species, either by immuno­
fluorescence on cryostat sections or by immunoperoxydase staining of Vibratome 
sections (Figs. 4A,B,C,D). In general, the distribution of the innnunoreactivity 
corresponds well with earlier observations made by e.g. induced fluorescence 
techniques in the lamprey (3), the trout (44) and the rat (9). In addition, cell 
bodies, nerve fibres and nerve terminals were observed in other, hitherto 
undescribed areas as well, indicating the high sensitivity of the presented method. 
The matter of sensitivity was investigated recently by Schipper and co-workers 
(34). Using model preparations (see: first paragraph of this section) it was 
estimated that the presently described immunofluorescence method for serotonin is 
approximately 1000 times as sensitive as the formaldehyde-induced fluorescence 
technique. Detailed descriptions of the serotonin-innnunoreactivity in the species 
studied have been published elsewhere (20, 24, 25, 36, 37, 38, 40, 41, 49). 
In the present study both immunofluorescence staining of cryostat sections and 
immunoperoxydase staining of Vibratome sections were used. Immunofluorescence 
turned out to be a convenient and reliable method for the demonstration of 
serotoninergic neurons in general and serotoninergic fibres and terminals in 
particular. Moreover, it can be easily combined with the fluorescent retrograde 
axonal labelling technique (39, 42). On the other hand, immunoperoxydase-stained 
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Vibratome sections are especially suited for morphological studies on nerve 
processes such as examining the spatial orientation and the branching pattern of 
dendrites. 
Virtually, due to the high sensitivity of the immunohistochemical method for 
serotonin no pharmacological treatment of the animals examined is needed. However, 
the demonstration of cell bodies and dendrites is facilitated by raising the 
endogenous serotonin concentration, e.g. by monoamine oxydase inhibitors. 
CONCLUSIONS 
1. Antibodies raised by the serotonin-immunogen A appeared to be well-suited 
for neuroimmunocytochemical studies on the central nervous system after fixation 
with 4% paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.3. Serotonin-
immunoreactivity could be demonstrated in the three species examined, namely the 
lamprey, the trout and the rat. Thus, the applicability of these antibodies seems 
not to be limited to certain species as is the case with antibodies to synthesizing 
enzymes. 
2. Antibodies to the serotonin-immunogen A appeared to be rather specific. 
Blocking experiments showed that there might be a cross-reactivity of about 2-3Z 
to 5-methoxytryptamine and less than 0.25% to dopamine. Cross-reactivity to the 
other substances tested, viz. noradrenaline, adrenaline, octopamine, synephrine 
and histamine seemed to be neglectable. Moreover, there was a good correspondence 
with previously reported histochemical data concerning the distribution of 
serotonin. Therefore, it is concluded that the immunoreactivity demonstrated is 
indeed due to serotonin. 
3. In the three species studied immunoreactivity was observed also in areas 
where earlier histochemical techniques failed to so, indicating the high 
sensitivity of the presented method. This supposition seems to be supported by 
recent experiments using model preparations. These experiments showed that the 
presently reported immunohistochemical procedure is about 1000 times as sensitive 
as the classical formaldehyde-induced fluorescence technique. 
4. Both immunofluorescence on cryostat sections and immunoperoxydase staining 
of Vibratome sections could be used. Immu.nofluorescence on cryostat sections 
appeared to be a convenient and reliable method for the visualization of 
serotoninergic neurons, in particular serotoninergic fibres and terminals. Immuro— 
peroxydase--stained Vibratome sections were especially suited for examining the 
dendrites of serotoninergic neurons. 
5. Besides serotonin-immunogen A, two other immunogens (B and C) were 
synthesized both containing PABA as a spacer molecule. Serotonin-immunogen В was 
prepared via a mixed anhydride reaction. For serotonin-immunogen С a carbodiimide 
reaction was used for coupling the FABA-serotonin complex to BSA. Probably both 
immunogens have a similar structure. In spite of this, immunoreactivity could only 
be revealed with antibodies to the serotonin-immunogen B. This unexpected 
observation might indicate differences in the steric configuration of the immunogens 
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В and С, probably due to the different coupling reactions used. A similar 
distribution of JLnnnunoreactivity was observed employing antibodies to the 
serotonin-immunogens A and B. From this one might infer that antibodies to the 
immunogen A, currently used since our first report (36), are demonstrating serotonin 
rather than its ß-carboline derivate. 
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Fig. A Photomicrographs of transversal, immunoperoxidase-stained Vibratome 
sections through the brain of the trout (Salmo gairdneri) (A,B) and 
transversal cryostat sections stained by immunofluorescence through 
the brain of the lamprey (Lampetra fluviatilis) (C,D) incubated with 
antibodies to serotonin-immunogen A. Note in A serotoninergic cell bodies 
in the raphe region and serotonin-positive terminals in the nucleus 
interpeduncularis (n. interp.). Note in В small cell bodies in the nucleus 
tuberis inferior, (n. tub. inf.), which give rise to ventrolaterally 
oriented fibres (ree. 1: recessus lateralis; η. lob. 1.: nucleus lobis 
lateralis). Note in С and D liquor-contacting neurons situated in the pars 
ventralis thalami. Bars indicate 50,um. 
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Abstract—The localization and distribution of serotonin (5-hydroxytryptamine, 5-HT) has been studied 
with the indirect immunofluorescence technique using a highly specific and well-characterized antibody 
to 5-HT. In neuron systems 5-HT was found to be primarily present with a distribution similar to that 
observed in basic mappings carried out with the formaldehyde-induced fluorescence method. In addition 
to the nine areas originally described, several other areas in the mesencephalon and rhombencephalon 
appeared to contain widely distributed 5-HT-positive perikarya. In the median eminence 5-HT fluor­
escent mast cells could be visualized No 5-HT-positive nerve cell bodies could be observed either in the 
telencephalon or diencephalon. 
Our results also demonstrate a widespread occurrence of 5-HT-positive nerve terminals throughout 
the central nervous system Dense populations of serotonin-immunoreactive nerve terminals are present 
in the following areas, from rostral to caudal: various parts of the medial forebrain bundle; the ventro­
medial part of the nucleus suprachiasmaticus; the most ventrolateral part of the caudatus-putamen 
complex; an area between the rostral part of the nucleus reumens and the fornix· at that same level of 
the latter area, a region just ventral of the fornix; the dorsolateral part of the nucleus periventricular^ 
thalami; an area lateral of the claustrum, close to the cortex piriformis; the nucleus amygdaloideus 
basalis; the dorsomedial part of the nucleus mediahs thalami pars medialis, only in the rostral part; the 
inner part of the nucleus ventromedial hypothalami; the ventral part of the nucleus mamillaris 
mediahs, the radiatio thalami superior; the nucleus subthalamicus; the caudal part of the nucleus 
amygdaloideus mediahs posterior; the area pretectalis radialis; the dorsal part of the nucleus ventrahs 
corporis geniculati lateralis; the ventromedial part of the substantia nigra reticularis; an area ventral of 
the decussatio supramammillaris, the substantia nigra pars lateralis; the dorsolateral part of the nucleus 
reticularis pontis oralis; some parts of the nucleus origines nervi trigemini; the ventromedial part of the 
nucleus origines nervi facialis; the medial part of the nucleus tractus solitanus and the medial part of the 
cornu ventrale of the spinal cord. There are only a few areas where no serotonin-immunoreactivity could 
be found. Within several areas, as, e.g., hippocampus, nucleus caudatus, medial forebrain bundle, the 
density of serotoninergic fibers appeared to show considerable local differences. Within the same nuclei 
or area the amount can differ considerably 
This immunohistochemical procedure makes it possible to study the distribution of serotonin-contain­
ing nerves and their processes in considerable detail. The finding that serotonin-containing neurons are 
present in many nuclei that also include catecholamine-containing neurons makes it necessary to recon­
sider the terminology of the monoaminergic cell groups. 
T H E PRESENCE of serotonin (5-HT) in the central ner­
vous system was first demonstrated biochemically by 
TWAROG & PAGE (1953). Their findings were subse­
quently confined fluorimelncally by BOGDANSKY, 
PLETSCHER, BRODIE & UDENFRIEND (1956). Evidence 
that serotonin is localized within neurons was made 
possible by the development of the formaldehyde-
induced fluorescence (FIF) technique (FALCK, H I L -
LARP, THIEME & T O R P , 1962; DAHLSTRÖM & FUXE, 
1964; FUXE, 1965; ERÄNKÖ, 1967). This technique has 
one major drawback: the fluorescent product of 
5-HT, the /î-carboline, is extremely sensitive to ultra-
Abbreviattons BSA, bovine serum albumin ; FIF, formal-
dehyde-induced fluorescence; FLM, fasciculus longitudin-
ali s mediahs; 5-HT, 5-hydroxylryptamine; PBS, phos-
phate-buffered salines. 
violet light. This results in a rapid decomposition and 
fading of the yellow fluorescence product. A second-
ary problem is the bad histological condition of the 
section; this is a result of freeze-drying the tissue, 
prior to sectioning The basic mapping of the central 
monoamine neurons at the light microscopic level has 
been carried out using the FIF-technique (DAHL-
STRÖM & FUXE, 1964; DAHLSTRÖM, HÄGGENDAL & 
ATACK, 1974; FUXE, HÖKFELT, NILSSON & REINIUS, 
1966). Recent methodological modifications markedly 
increase its sensitivity for catecholamines but do not 
seem to provide any clear improvement with regard 
to the visualization of serotonin (FUXE & JONSSON, 
1967; BJÖRKLUND, LINDVALL & SVENSSON, 1972; 
HÖKFELT & LJUNGDAHL, 1972; AZMITZIA & HENRIK-
SEN, 1976; LOREN, BJÖRKLUND, FALCK & LINDVALL, 
1976; NYGREN, 1976; DE LA TORRE & SURGEON, 1976; 
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FuRNESS, COSTA & WILSON, 1977). In order to localize 
serotonin more precisely, other indirect techniques 
have been developed. These include: (A) the selective 
destruction of monoamine-neurons by pharmacologi-
cal manipulations with such chemicals as 5,6-dihy-
droxytryplamine (AGHAJANIAN, KUHAR & ROTH, 1973; 
FUXE & JONSSON, 1974; KAWA, ARIYAMA, TANIGUCHI, 
KAMISAKI & K.ANEHISA, 1978), 5,7-dihydroxytryp-
tamine (BAUMGARTEN & LACHENMAYER, 1972, 1974; 
DALY, FUXE & JONSSON, 1974; FUXE & JONSSON, 
1974; SACHS & JONSSON, 1975; JONSSON, POLLARE, 
HALLMAN & SACHS, 1978), or p-chloroamphetamine 
(MASSARI, TEZABI, GOTTESFELD & JACOBOWITZ, 1978). 
(B) Autoradiographic demonstration of [3H]seroto-
nin (CALAS, ALONSO, ARNAULD & VINCENT, 1974; 
DESCARRIES, BEAUDFT & WATKINS, 1975; BEAUDET & 
DESCARRIES, 1976; CALAS, BESSON, GAUCHY, ALONSO, 
GLOWINSKI & CHERAMY, 1976; CALAS, 1977; CHAN-
PALAY, 1977; HALASZ, LJUNGDAHL & HÓKFELT, 1978; 
see also. PARENT, DESCARRIES & BEAUDET, 1981, Ed.). 
(C) Immunohislochemistry using antibodies to trypto-
phan hydroxylase and/or aromatic aminoacid 
decarboxylase as markers for serotonin: tryptophan 
hydroxylase converts tryptophan into 5-hydroxytryp-
tophan, whereas the decarboxylase converts 5-hy-
droxytryptophan into 5-hydroxytryptamine. More-
over, aromatic aminoacid decarboxylase is also 
involved in the synthesis of catecholamines (HÖKFELT, 
FUXE & GoLDSTriN, 1973; JOH, SHIKIMI, PICKEL & 
REIS, 1975; REIS, PICKFL, SHIKIMI & JOH, 1975; 
PICKEL, JOH & REIS, 1976, 1977). The fourth and most 
recently developed technique has been radiolabelhng 
with [3H]reserpine (RICHARDS, D A PRADA, WÚRSCH, 
LOREZ & PIERI, 1979). For the localization of sero-
tonin, chemical lesions of catecholamine-containing 
pathways with 6-hydroxydopamine are necessary 
(THOENEN & TRANZER, 1973). The present studies util-
ize a further developed antibody to serotonin, which 
has been raised to a new antigen with a higher molar 
ratio between serotonin and bovine serum albumin 
(BSA), for the direct localization of the putative 
neurotransmitters (STIINBUSCH & NIEUWENHUYS, 
1980). The aim of this paper is to provide a detailed 
mapping of the serotonin system in the central ner-
vous system of the rat. The relation of fluorescent and 
лоп-fluorescent cell bodies in the raphe nuclei and the 
dendritic pattern of these centers will be presented in 
future papers. A preliminary report was presented at 
the Third European Neuroscience Meeting (Rome, 
September 1979). 
EXPERIMENTAL PROCEDURE 
Preparation of the serotomn-antiserum 
Serotonin was coupled to bovine serum albumin (BSA) 
with formaldehyde as previously described (STEINBUSCH, 
VERHOFSTAD & JOOSTFN, 1978). The procedure of preparing 
the antigen has been modified so as to receive a conjugate 
with a maximum molar ratio of BSA to serotonin of 1:26. 
The modified procedure is as follows an incubation sol­
ution consisting of 1 ml 3 M sodium acetate buffer, pH 6 8, 
1 ml 7 5% formaldehyde solution (v/v), 1 ml distilled water 
in which 9 2 mg serotonin creatinine sulphate was dis­
solved and 1 ml distilled water in which 28 1 mg BSA was 
dissolved The reaction mixture was incubated at room 
temperature in a shaking water bath for 2 h. The pH was 
then adjusted to 6 8 and the reaction was continued for an 
additional 18 h The procedure continued with a dialysis 
and centnfugation step. A more detailed description of this 
procedure has been published elsewhere (STEINBUSCH & 
NIEUWENHUYS, 1980) Antibodies to the conjugate were de­
veloped in rabbits. Control pre-immune serum was 
obtained from each rabbit before immunization The con­
jugate was emulsified with an equal amount of complete 
Freund's adjuvant and injected intramuscularly at four dif­
ferent sites Booster injections with incomplete Freund's 
adjuvant were given subcutaneously at three weekly inter­
vals at multiple sites along the mammilary line Anlisera 
were purified from nonspecific BSA antibodies by precipi­
tation and affinity chromatography using a Sepharose-4B-
CNBR-activaled BSA column. Antisera were tested by 
immunodiffusion according to OUCHTERLONY (1967), by Im­
munoelectrophoresis and by immunohislochemistry. In 
order to investigate the specificity of the purified antiserum 
in immunofluorescence microscopy, serum samples were 
incubated with different concentrations of substances 
which would cross-react with the serotonin-antibody 
Characterization of the antisera revealed that there was a 
cross-reactivity of less than 2% to 5-methoxytryptamine 
and dopamine, less than 0.5% to noradrenaline and less 
than 0.1% to adrenaline under the conditions used 
Tissue preparation 
Male albino rats were used Some rats were pretrealed 
with an intraventricular (75/jg/20^l) or a subcutaneous 
injection of colchicine (1.2 mg/kg body weight). Intraventri­
cular injections were made into the lateral ventricle and 
into the third ventricle. All injections were given 24 h prior 
to perfusion as described by HÒKFELT & DAHLSTRÓM 
(1971). 
The animals were anesthetized with sodium pentobarbi-
tal (Nembutal, 60 mg/kg bodyweight, intraperitoneal) and 
perfused through the left ventricle. The blood was washed 
out with cold, oxygen enriched, Ca2 +-free Tyrode's buffer 
(50 ml at 4°C) followed by 500 ml ice-cold 4% (w/v) para-
formaldehyde in 0.1 M sodium phosphate buffer, pH 7.3 
(PEASE, 1962) for 30 mm at a pressure of 70 mm Hg The 
brains and the spinal cords were quickly removed and 
soaked for 90 min in fresh fixative at 4°C. After fixation, 
they were rinsed in 5% sucrose dissolved in 0.1 M sodium 
phosphate buffer (pH 7.3) at 4°C for at least 1 day. Tissue 
pieces were then frozen on cryostat with powdered dry ice 
Sections, 10 μτη thick, were cut on a cryostat (Dittes, 
Heidelberg, FRG) at -25°C and subsequently mounted on 
glass slides coated with chrome alum gelatine to prevent 
detachment of the sections during the incubation pro­
cedure. In addition, sagittal sections were cut from a few 
brains. The sections were immediately processed for 
immunohistochemislry 
Immunofluorescence procedure 
The indirect immunohistochemical procedure of COONS 
(1958) and HOKFELT, ELDE, FUXE, JOHANSSON, LJUNGDAHL, 
GOLDSTEIN, LUFT, EFENDIC, WILSSON, TERENIUS, GANTEN, 
JfcFFCOATE, R E H F F L D , SAID, PEREZ DE LA MORA, POSSANl, 
TAPIA, TERAN & PALACIOS (1978) was used with minor 
modifications 
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The sections were first incubated in 0.1 M phosphate 
buffered saline (PBS) (pH 7.3) at room temperature for 
10-30 min. They were then incubated at 4°C for 18 h with 
5-HT antiserum (76 mg/mi) or pre-immune serum that had 
been diluted 1.500 or 1:1000 with PBS containing 01°;, 
Triton X-100 (HARTMAN, 1973; SCHLIEPER & DE ROBERTIS, 
1977) After rinsing in PBS for 30 min at room tempera-
ture, the sections were treated with fluorescein îsothiocyan-
ate conjugated sheep anti-rabbit immuno-y-globulin 
diluted 1 · 16 with PBS containing 0 l0/0 Tnton-X-100. After 
this final incubation of 30 min at room temperature, the 
sections were rinsed once again in PBS for 30 min and 
mounted under a covershp in a mixture of glycerme-PBS 
(3:1, v/v) The sections were examined in a Zeiss Universal 
microscope equipped with incident illumination for fluor-
escence Kodak Tri-X film was used for photomicrography 
having exposure times between 5 s and 20 s. Alternate 
sections were mounted on separate slides and stained with 
cresyl violet. The latter sections were photographed on 
Ilford Pan-F film. 60 χ 40 cm photomontages were used 
for the mapping 
Evaluation and presentation of results 
The specificity of the immunoreaction was controlled by 
comparing sections incubated with either 5-HT antiserum 
or pre-immuneserum. Specific 5-HT stained structures are 
called 5-HT-immunoreactive. For the description of the 
5-HT-positive cell, groups of the designations Β,-Β, as 
introduced by DAHLSTRÓM & FUXE (1964) were employed 
The distribution, number and density of 5-HT-positive cell 
bodies and terminals are presented on schematic drawings 
of transversal sections The densities have been divided 
into six categories: (a) no fluorescence (0); (b) single fibers 
( + ); (c) low density (1); (d) medium density (2), (e) high 
density (3), and (0 very high density (4) The estimates of 
the densities were based on at least six different series of 
sections The number of 5-HT-positive cell bodies per 
section in a certain area or nucleus were studied in colchi-
cine-treated rats and indicated by different types of sym-
bols denoting 1-3 cells, 3-10 cells, 10-20 cells and more 
than 20 cells per section. The symbols for the serotonin-
positive cell bodies have only been placed in the figures 
where serotoninergic neurons were present The schematic 
drawings are principally the same as those used by LJUNG-
DAHL, HÓKFELT & NiLSSON (1978) They are lased upon 
the aliases of KÖNIG & KLIPPEL (1963), JACOBOWITZ & 
PALKOVITS (1974) and PALKOVITS & JACOBOWITZ (1974) 
and were chosen to facilitate comparison with the map-
pings of other putative neurotransmitters as e g. LJUNG-
DAHL, HOKFELT & NiLSSON (1978). 
RESULTS 
Serotonin-positive cell bodies, fibers and terminals 
were present in most parts of the central nervous sys-
tem. Their morphological appearance and distribu-
tion strongly suggested that they were neuronal. 
Specific serotonin-immunoreactivity was found in the 
glial elements of the infundibulum (Figs 36A,B.) In the 
median eminence some serotonin-positive tanycytes 
(Fig. 36C) and mast cells were localized (Figs 24B,C). 
The results will be described under the headings cell 
bodies and nerve fibers and terminals. The distribu-
tion patterns are illustrated in schematic drawings 
(Figs 1-14), a table (Table 1) and photomicrographs 
(Figs 15-38). 
Serotomn-imrmmoreactive cell bodies 
For the localization of serotonin-positive cell 
bodies, untreated, as well as colchicine pre-treated. 
rats were used. Serotonin-containing neurons primar-
ily appeared in the same area in the untreated rats as 
in the colchicine pre-treated rats. However, in the col-
chicine pre-treated rats, (a) the intensity of the fluor-
escence of the cell bodies was higher, and, (b) the 
number of fluorescent cell bodies was significantly 
greater than in untreated rats. Serotonin-immuno-
reactive cell bodies could be observed in the following 
areas from caudal to rostral. 
FIGS 1-14. The schematic transversal drawings are based upon the atlases of KÖNIG & KLIPPEL (1963), 
JACOBOWITZ & PALKOVITS (1974) and PALKOVITS & JACOBOWITZ (1974) The variation of densities were 
estimated subjectively in non-colchicine-treated rats according to the following symbols 4+ : very high 
density, 3 + : high density; 2+ : medium density; I + : low density; - : single fibers and no fluorescence. 
The number of serotonin-positive cell bodies per section were revealed in colchicine-treated rats and 
indicated by four different types of symbols denoting more than 20 cells; between 10 and 20 cells, 
between 3 and 10 cells, and finally, between 1 and 3 cells per section The symbols for the serotonin-
positive cell bodies have only been placed in the figures where serotoninergic neurons were present 
Abbreviations used m the Figures 
a nucleus accumbens 
aa area amygdaloidea anterior 
ab nucleus amygdaloideus basalis 
abp nucleus amygdaloideus basalis posterior 
AC aquaductus cerebri 
ac nucleus amygdaloideus centralis 
aco nucleus amygdaloideus corticahs 
aD nucleus accessonus Darkschewitsch 
AL ansa lenticularis 
al nucleus amygdaloideus lateralis 
ah nucleus amygdaloideus lateralis inferior 
am nucleus amygdaloideus medialis 
amb nucleus ambiguus 
amp nucleus amygdaloideus medialis posterior 
ap area postrema 
apm area pretectalis medialis 
apo nucleus amygdaloideus posterior 
atv area tegmentalis ventralis Tsai 
BCI brachium colliculi inférions 
с nucleus caudatus 
CA commissura anterior 
ca nucleus interslilialis commissurae antenons 
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CAE capsula externa 
CAI capsula interna 
CC crus cerebri 
CCA corpus callosum 
ccgm nucleus centralis corporis geniculati medialis 
CCS commissura colliculorum supenorum 
cd cornu dorsale 
ce cortex entorhinahs 
CFD commissura formas dorsalis 
CFV commissura fornicis ventralis 
CH commissura habenularum 
ci colliculus inferior 
cl claustrum 
cla cornu laterale 
cm nucleus centromedianus thalami 
CO chiasma opticum 
cod nucleus cochlearis dorsalis 
cov nucleus cochlearis ventralis 
cp nucleus caudatus putamen 
CP commissura posterior 
CSDD commissura supraoptica dorsalis, pars dorsalis 
(Ganser) 
CSDV commissura supraoptica dorsalis, pars ventralis 
(Meynert) 
CT corpus trapezoideum 
et nucleus corporis trapezoidei 
cu nucleus cuneatus 
cul nucleus cuneatus lateralis 
cv cornu ventrale 
dgel nucleus dorsalis corporis geniculati lateralis 
DP decussatio pyramidis 
DPCS decussatio peduneuh cerebellarium superiorum 
DT decussationes tegmenti 
ep nucleus entopeduncularis 
F fornix 
FC fasciculus cuneatus 
FD funiculus dorsalis 
FG fasciculus gracilis 
FH fimbria hippocampi 
FI funiculus lateralis 
FLM fasciculus longitudinale medialis 
FMI forceps minor 
FMT fasciculus mammillothalamicus 
FMTG fasciculus mamillotegmentalis 
FR fasciculus retroflexus 
FS forceps superior 
FV funiculus ventralis 
g nucleus gelatinosus thalami 
GD gyrus dentatus 
gp globus pallidus 
gr nucleus gracilis 
HI hippocampus 
HIA hippocampus anterior 
hi nucleus habenulae lateralis 
hm nucleus habenulae medialis 
hl Forel HI 
h2 Forel H2 
ic nucleus interstitialis Cajal 
iC insulae Callejae 
iCm insulae Callejae magna 
ю nucleus olivaris inferior 
ïod nucleus accessonus olivaris dorsalis 
ю т nucleus accessonus olivaris medialis 
ip nucleus interpeduncular^ 
lc locus coeruleus 
LG lamina glomerulosa bulbi olfactorii 
LGA lamina glomerulosa bulbi olfactorii accessoru 
LGR lamina granulans bulbi olfactorii 
LL lemniscus lateralis 
lid nucleus lemnisci lateralis dorsalis 
Mr nucleus lemnisci lateralis rostralis 
11 ν nucleus lemnisci lateralis ventralis 
LM lemniscus medialis 
LMA lamina cellularum milralium bulbi olfactorii 
accessorii 
LMIO lamina medullans interna bulbi olfactorii 
LNO lamina nervi olfactorii 
LP lamina plexiformis externa bulbi olfactorii 
megm nucleus marginalia corporis geniculati medialis 
ME median eminence 
MFB medial forebram bundle (fasciculus medialis pro-
sencephali) 
mi massae intercalatae 
na nucleus arcuatus 
nbi nucleus basilans internus Cajal 
nco nucleus commissurahs 
ncs nucleus centralis superior 
net nucleus conterminahs 
neu nucleus cuneiformis 
ndm nucleus dorsomedialis hypothalami 
nE nucleus Edinger-Weslphal 
nha nucleus hypothalamicus anterior 
nhp nucleus hypothalamicus posterior 
nie nucleus intercalatus 
nicf nucleus interstitialis commissurae fornicis 
nich nucleus interstitialis traclus corticohabenularis 
medialis 
nish nucleus interstitialis tractus septohabenulans 
nism nucleus interstitialis striae medullans 
nist nucleus interstitialis striae terminahs 
nistd nucleus interstitialis striae terminahs pars dorsalis 
nistv nucleus interstitialis striae terminahs pars ven­
tralis 
nie nucleus linearis caudalis 
nlo nucleus linearis oralis 
nml nucleus mamillans lateralis 
nmm nucleus mamillans medialis 
np nucleus parabrachiahs ventralis 
npd nucleus parabrachiahs dorsalis 
npe nucleus periventricular^ hypothalami 
npf nucleus penfornicahs 
npl nucleus prelaleralis mamillans 
npmd nucleus premamillans dorsalis 
npmv nucleus premamillans ventralis 
npv nucleus paraventricular^ hypothalami 
npV nucleus principalis nervi trigemini 
nrd nucleus reticularis medullae oblongatae pars dor­
salis 
nrp nucleus reticularis paramedianus 
nrv nucleus reticularis medullae oblongatae pars ven­
tralis 
nsc nucleus suprachiasmaticus 
nso nucleus supraoplicus 
ntd nucleus tegmenti dorsalis (Gudden) 
ntdl nucleus tegmenti dorsalis lateralis 
ntm nucleus tractus mesencephah 
nts nucleus tractus solitari! 
ntv nucleus tegmenti ventralis (Gudden) 
ntV nucleus tractus spinalis nervi trigemini 
ntVd nucleus tractus spinalis nervi trigemini pars dorso­
medialis 
nvm nucleus ventromedials hypothalami 
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nvma nucleus ventromediahs anterior SGCv 
nlll nucleus motonus nervi oculomotoni sgm 
nIV nucleus motonus nervi trochlears sgp 
nV nucleus motonus nervi trigemini sgs 
nVI nucleus nervi abducentis sgV 
nVIII nucleus nervi facialis si 
nX nucleus dorsalis nervi vagi SM 
nXII nucleus nervi hypoglossi sm 
oad nucleus olfactonus anterior pars dorsalis snc 
oal nucleus olfactonus anterior pars lateralis snl 
oam nucleus olfactonus anterior pars medialis snr 
oap nucleus olfactonus anterior pars posterior SO 
OC tractus olivocerebellar« spf 
ol nucleus tractus olfactorn lateralis ST 
ope nucleus preolivans externus st 
os nucleus olivans superior SUM 
osa nucleus accessonus olivans superior sut 
osp nucleus parolivans superior tad 
Ρ tractus corticospinal« tarn 
ρ nucleus pretectal« tav 
PCI pedunculus cerebellar« inferior TCHL 
PCM pedunculus cerebellar« médius TCL 
PCMA pedunculus corporis mamillar« TCM 
PCS pedunculus cerebellar« superior Id 
PF polus frontal« tl 
pf nucleus parafascicular« tip 
ph nucleus preposilus hypoglossi TM 
pi cortex piriform« tm 
po nucleus pont« tml 
pol nucleus preopticus lateral« tmm 
pom nucleus preopticus medial« TO 
pop nucleus preopticus periventricular« TOI 
pos nucleus preopticus suprachiasmaticus TOL 
ps nucleus parasolitanus tol 
pt nucleus paratenial« TOM 
pv nucleus periventricular« thalami torn 
r nucleus ruber tpm 
re area retrochiasmatica tpo 
rd nucleus raphe dorsal« tr 
re nucleus reuniens TRS 
rgi nucleus reticular« gigantocellular« TS 
rh nucleus rhomboideus TSC 
ri nucleus reticularis lateral« TSH 
rm nucleus raphe magnus TSHT 
ro nucleus raphe obscurus TSTH 
rp nucleus raphe pallidus TSV 
rpc nucleus reticularis parvocellular« TT 
rpo nucleus raphe pont« tu 
rpoc nucleus reticular« pont« caudal« tv 
rpoo nucleus reticularis pont« oral« tvd 
RTI radatio thalami inferior tvm 
rtp nucleus reticular« tegmenti pont« 
RTS radatio thalami superior vcgl 
S subiculum vl 
s nucleus suprageniculatus vm 
SA striae acuslicae VO 
sa nucleus salivatonus VIII 
SAM stratum album mediale colhculi superior« VIV 
sd nucleus dorsal« septi VL 
sdì nucleus dorsal« septi pars intermedia vs 
sdl nucleus dorsalis septi pars lateralis vsp 
sf nucleus fìmbrial« septi zi 
sfo subfornical organ V 
sg nucleus suprageniculatus facialis VII 
SGC substantia grísea central« IX 
SGCd substantia gnsea central« dorsal« X 
substantia gnsea central« ventral« 
stratum griseum mediale colhculi superior« 
stratum griseum profundum colhculi superior« 
stratum griseum superficiale colhculi superior« 
substantia gelatinosa trigemini 
nucleus lateral« septi 
striae medullar« thalami 
nucleus medial« septi 
substantia nigra zona compacta 
substantia nigra pars lateral« 
substantia nigra zona reticular« 
stratum opticum colhculi superior« 
nucleus subparafasciculans 
striae terminal« 
nucleus triangular« septi 
decussatio supramamillar« 
nucleus subthalamicus 
nucleus anterior dorsal« thalami 
nucleus anterior medial« thalami 
nucleus anterior ventral« thalami 
tractus corticohabenulans lateral« 
tractus corticohypothalamicus lateral« 
tractus diagonal« Broca 
nucleus tractus diagonal« Broca 
nucleus lateralis thalami 
nucleus lateral« posterior thalami 
tractus mesencephahcus nervi trigemini 
nucleus medial« thalami 
nucleus medial« thalami pars lateral« 
nucleus medial« thalami pars medial« 
tractus opticus 
tractus olfactonus intermedius 
tractus olfactonus lateralis 
nucleus tractus optici pars lateralis 
tractus olfactonus medial« 
nucleus tractus optici pars medial« 
nucleus posteromedianus thalami 
nucleus posterior thalami 
nucleus reticular« thalami 
tractus rubrospinal« 
tractus solitanus 
tractus septocortical« 
tractus septohabenular« 
tractus septohypolhalamicus 
tractus stnohypothalamicus 
tractus spinal« nervi trigemini 
tractus tectospinal« 
tuberculum olfactonum 
nucleus ventral« thalami 
nucleus ventral« thalami pars dorsal« 
nucleus ventral« medial« thalami pars magnocel-
lulans 
nucleus ventral« corporis geniculati lateralis 
nucleus vestibularis lateral« 
nucleus vestibular« medial« 
ventnculus olfactonus 
third ventricle 
fourth ventricle 
lateral ventricle 
nucleus vestibular« superior 
nucleus vestibular« spinal« 
zona incerta 
nervus trigeminus 
nervus facial« 
nervus glossopharyngeus 
nervus vagus 
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Group В,. In the caudal part of the medulla oblon­
gata some fluorescent cells were seen from level Ρ 
8000 to level Ρ 7000, in the area dorsal to the nucleus 
accessorius olivaris dorsalis and between the nucleus 
reticularis medullae oblongatae, pars ventralis and the 
nucleus reticularis paramedianus. Some cells were 
also present ventromedial to the nucleus reticularis 
lateralis. The vast majority of the cells just described 
appeared to be situated within the nucleus raphe pal-
lidus which corresponds to group B, of DAHLSTRÓM 
& FUXE (1964) (Figs 13C,D,E, 33B and 34A,B). 
Group B2. Most of the serotoninergic neurons of 
this group have been found within the confines of the 
nucleus raphe obscurus. In addition some cells are 
localized within the most caudal part of the nucleus 
reticularis paramedianus, level Ρ 7400 The group 
extends from level Ρ 8000 to level Ρ 7000 and ends in 
an area of scattered cells at level Ρ 8000. This cell 
group is surrounded by the nucleus olivaris inferior, 
the nucleus reticularis medullae oblongatae, pars ven­
tralis and the decussatio pyramidis. Since the major 
part of this group is situated within the confines of the 
nucleus raphe obscurus, it corresponds to group B2 of 
DAHLSTRÖM & FUXE (1964); (Figs 12C; 13A,B,C,D,E; 
33A, В and 34B). 
Group Bj. Starting from the rostral part of the nu­
cleus raphe magnus, some cells are scattered between 
the nucleus raphe magnus and the lateral part of the 
tractus corticospinalis. At this level, between 10 and 
20 cells have been counted per section; the number of 
cells decreases the more caudal the area is. Serotonin-
positive cell bodies were found over the whole length 
of the corpus trapezoideum, level Ρ 3400 until Ρ 2000. 
The highest concentrations, more than 20 cell bodies 
per section, were found in the rostral and caudal part 
ofthat region. Cell bodies were not visualized close to 
the midline but were mainly found in the ventro­
lateral part of the corpus trapezoideum, close to the 
lemniscus medialis. Some cells, 10-20 per section, 
were found more laterally m an area, level Ρ 2800, 
surrounded by the tractus corticospinalis, the nucleus 
parolivans superior and the nucleus corporis trape-
zoidei. This same area is more negative the more ros­
tral it lies, but caudally some cells were observed dor­
sal and lateral from the nucleus olivaris superior. 
However, most cells of this group are present within 
the nucleus raphe magnus and in the corpus trapezoi­
deum. It is a massive cell group with more than 20 
cells per section from level Ρ 5000 to level Ρ 3900. 
The nucleus raphe magnus corresponds to the group 
B3 of DAHLSTRÓM & FUXE (1964); (Figs I2B,C,D and 
31A,B,C). 
Group B4. This is a small cell group situated in the 
vicinity of the lateral part of the nucleus vestibularis 
medialis close to the midline where 3-10 cells per 
section were demonstrated These cells lie dorsal to 
the nucleus prepositus hypoglossi No special com-
parison with a raphe nucleus is possible. This group, 
especially the cells in the midline corresponds to the 
B4-group of DAHLSTRÖM & FUXE (1964); (Fig 12C). 
Group Bs. The main portion of this group was 
present in the intermediate part of the nucleus raphe 
pontis. The most rostral and caudal parts of this nu-
cleus did not contain any serotoninergic cell bodies. 
However, according to our observations, this group 
additionally comprises a number of cells situated 
more dorsally, at level Ρ 2300 until Ρ 1500, between 
both medial longitudinal fascicles The serotoninergic 
neurons in the nucleus raphe pontis were related to 
the B5 group of the Swedish investigators (Figs 11A. 
B,C). 
Group Bb In the area Trom Ρ 3400 to Ρ 2000 some 
concentrations of cells were demonstrated close to 
and in the midline beneath the rostral part of the 
fourth ventricle in the area dorsomedial to the nu­
cleus tegmenti dorsalis (of Gudden). The fluorescent 
intensity of these cells was very high, and was easily 
comparable to the also intense serotoninergic inner­
vation of that same area. Within the area outlined, 
distinct concentrations of serotoninergic cells were 
observed at levels Ρ 2000 and Ρ 2800 This cell group 
can be seen either as a separate entity or as a caudal 
extension of the nucleus raphe dorsalis, the B7-group 
Its cells do not belong to a special raphe nucleus and 
have been designated by DAHLSTRÓM & FUXE (1964) 
as the B6-group; (Figs 11B,C,D and 12A) 
Group B-, The serotoninergic neurons belonging to 
this group comprise a large number of cells, located 
within the confines of the nucleus raphe dorsalis and 
some scattered cells situated dorsolateral to the nu-
cleus raphe dorsalis. close to the aquaductus cerebri, 
and within or ventral to the fasciculus longitudinale 
medialis (FLM). 
The serotoninergic penkarya of the nucleus raphe 
dorsalis could be divided into three groups: dorso-
median, ventromedial and lateral. Most of the sero-
toninergic cells were localized in the ventromedial 
part of this nucleus, just dorsal to the FLM. The 
dorsomedian group is, as its name implies, strictly 
situated in the midline 
The lateral group, rostrally observed until level Ρ 
200, consists of only a small number of cells. 
The scattered serotonin-immunoreactive neurons, 
situated dorsolalcrally to the nucleus raphe dorsalis. 
were observed from level Ρ 1200 to A 1000. These 
cells were fluorescent, but not with the same intensity 
as the elements situated in the medial pari of the 
nucleus raphe dorsalis. The scattered serotonin­
ergic cells located within the FLM were observed 
from level Ρ 1000 to A 100. those located ventro­
medial to the FLM were found from level Ρ 1000 to 
A 1400. 
The serotoninergic penkarya localized within the 
confines of the nucleus raphe dorsalis correspond to 
the group B7 of DAHLSTRÓM & FUXE (1964); 
(Figs 9C.D; 10 A.B.C.D; 27 and 28). 
Group Bs. This group is coextensive with the nu-
cleus centralis superior from level Ρ 1000 to A 500. 
However, some additional cells have been found in: 
(a) the medial parts of the tegmental decussations. 
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level A 1800; (b) the medial parts of the area dorsal to 
the nucleus linearis oralis, level A 1400; (c) the rostral 
part of the decussation of the brachium conjunctivum, 
level A 500. Some cells of the B
e
-group are confined 
to the nucleus centralis superior. Most of them are, 
however, lying outside the borders of this nucleus. 
The Swedish investigators related their B9-group to 
the nucleus centralis superior and partly to the nu­
cleus linearis (Figs 9 A,B,C,D; 10 A,B,C,D and 27). 
Group B9. This group is mostly confined to seroto­
nin-positive perikarya in and around the lemniscus 
medialis. However, in addition we have found scat­
tered serotomnergic neurons in the area dorsal to the 
lemniscus medialis. 
The major part of group B9 is situated from level Ρ 
1200 to A 1600. Starting caudally at level Ρ 1200 we 
observed that all serotonin-positive cells were situated 
in the ventral part of the lemniscus medialis and in 
the zone between the tractus corticospinals and the 
lemniscus medialis. The medial part of this accumu­
lation of cells contains a much larger number of sero-
tonin-immunoreactive cells than the lateral part. 
More rostrally, the serotoninergic perikarya belong­
ing to the medial part of the cell cluster just described, 
spread out into the whole medial part of the lem­
niscus medialis. Two cell groups have been visualized 
in the lateral parts, a larger ventrolateral and a 
smaller dorsolateral group. The first group reached its 
maximum at level A 900, at which more than 20 cells 
per section could be counted 
Besides the groups mentioned above, some sero­
toninergic neurons, probably belonging to the 
Bq-group, have been found in the ventromedial part 
of the nucleus ruber (level A 1400) and, more caudally 
in the lateral parts of an area bordered by the nucleus 
cuneiformis, the tractus lectospinalis. the lemniscus 
medialis, the pedunculus cerebellans superior and the 
tractus rubrospinalis 
In summary, we can say that the B9-group is com­
posed of an accumulation of cells within the bounds 
of the lemniscus medialis in the mesencephalon The 
neurons belong to the B9-cell group originally de­
scribed by DAHLSTRÖM & FUXE (1964); (Figs 9C,D; 
10A,B,C,D and 27). 
Other groups of serotonin-positive tell bodies 
Finally, in addition to the nine areas described, we 
were able with our current procedure to demonstrate 
the presence of five additional groups of serotonin-
ergic cells: (a) A compact group of relatively small. 
monopolar cells was found in the area postrema 
(Figs 13C; 37 A,B). (b) Serotoninergic neurons have 
been seen in the ventrocaudal part of the locus coeru-
leus and in the caudal part of an area described as the 
subcoeruleus area, at level Ρ 2800. These cells are 
smaller than the noradrenergic cells present in that 
same nucleus (Figs 1 ID; 38 A,B) (c) Serotonin-posit­
ive cells have been observed in the region between the 
locus coeruleus and the midline at levels Ρ 2000 to 
Ρ 1500. These cells surround the nucleus tegmentalis 
dorsalis and are structurally distinctly different from 
the serotoninergic cells of the midline which belong to 
the nucleus raphe dorsalis. The cells of the latter 
group are small, round and multipolar, while the cells 
in the border zone of the nucleus tegmentalis dorsalis 
appear to be more elongated and tripolar. They are 
arranged in a plane perpendicular to the midline 
(Fig. IIB), (d) Serotoninergic perikarya have been 
seen in the wing-like structures surrounding the nu­
cleus interpedunculans and in the area tegmentalis 
ventralis (of Tsai); (Fig. 9B). These cells show a fusi­
form shape and are oriented perpendicular to the 
midline (Figs 37 C,D). (e) An accumulation of seroto­
nin-positive neurons is localized in the dorsomedial 
part of the nucleus interpedunculans. Their perikarya 
are round or bipolar (Figs 9C; 37C). 
Scrotonin-unmunoreaitive nerve jihers unci terminals 
In the brain and spinal cord widespread networks 
of serotonin-positive fibers are present The following 
three types of serotoninergic fibers have been ob­
served. 
{a) Fibers without any or only a few varicosities. 
These fibers are long and small (0 2-0.5 μτη in diam­
eter) and preferentially oriented in a rostro-caudal di­
rection Two examples of these elements are: fibers in 
the cingulum bundle (Figs 16A,B,D) and fibers 
belonging to the ventral serotoninergic bundle, which 
fibers arise from the nucleus raphe dorsalis (Figs 27, 
28) and spread out in the medial forebrain bundle 
(Figs 21 C,D). The latter fibers show in addition the 
phenomenon that the fibers are clustered. 
{b) Fibers with varicosities. They are thinner than 
the fibers described under (a), and show in general no 
special direction However, in the area dorsal to the 
rhombencephalic section of the tractus cortico-spi-
nalis a substantial amount of rostro-caudally oriented 
fibers of this type were observed 
(e) Vaniovties without clear inlervaricose connec­
tions This type was found preferentially in very 
densely (4 + ) innervated regions, i.e.. the nucleus 
suprachiasmaticus (Figs 19C.D) or the locus coeruleus 
(Figs 29A.B) In these areas, we have observed in ad­
dition an increase of the background fluorescence 
probably due lo a leaking out of serotonin from the 
terminals. There were notable differences between 
varicose interconnections in the rhombencephalon/ 
mesencephalon and those in the telencephalon. The 
distances between the varicosities are greater in the 
rostral areas as, eg, cortex (Fig. 23B) or nucleus cau-
dalus (Fig 17D) than in such caudal regions, as, e.g., 
the substantia nigra No systematic attempt has been 
made to classify varicosities in different brain areas 
with regard to their size The distribution and extent 
of serotoninergic nerve fibers and terminals in various 
parts of the brains of non-colchicine-treated rats have 
been summarized in Table 1 and shown in Figs 1-14. 
The variations in densities were estimated subjectively 
and divided in a range of six levels. 
Very high (4 + ) concentrations of serotonin-immu-
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noreactive nerve terminals were found in the follow­
ing areas, listed from rostral to caudal : 
Rhinencephalon. In the rhinencephalon no 4+ den­
sity was observed. Only the lamina glomerulosa bulbi 
olfactorii receives a high (3 + ) innervation of seroto-
nin-immunoreactive fibers (Figs 15A,B,C,D). 
Telencephalon. If we proceed from rostral to caudal, 
the insula Callejae magna is the first area showing a 
very high serotonin-positive density At that same 
level (A 8620), a 4+ density has been observed in the 
ventromedial part of the nucleus caudatus. The fluor­
escence continues into the ventrolateral parts of the 
nucleus accumbens. The same degree of fluorescence 
is also present in the area medial and dorsal to the 
medial forebrain bundle, and in the zone between the 
nucleus of the diagonal band of Broca and the tuber­
osum olfactorium, pars corticalis, lamina plexiformis 
In a more caudal location, at level A 7890. we per­
ceived a shift of the 4+ density from the insula Calle­
jae magna to an area lying mostly within the tractus 
septo-hypothalamicus, ventrally to the nucleus later­
alis septi and medially to the nucleus accumbens 
(Fig. 16C). At that same level, a 4 + density is ob­
served in the medial part of the medial forebrain 
bundle. It shifts to a medioventral direction until the 
tuberculum olfactorium (Fig. 3D). A long area of very 
high serotonin-innervation commences in the dorsola­
teral part of the nucleus interstitialis commissurae 
anterioris (Fig. 4D). This area is localized caudally in 
the ventrolateral part of the caudato-putamen and 
terminates in a region dorsal to the massae intercala-
tae. The dorsal part of the nucleus caudatus contains 
a low density of weakly immunofluorescent fine fibers 
(Figs 17C,D). Medially to the caudatoputamen 
complex, the globus pallidus receives a medium (2 + ) 
density (Figs 20A,B). Within the nucleus amygdaloi-
deus basalis, particularly the rostral and medial parts, 
an extensive, very densely-innervated region was ob­
served. More caudal, at the bifurcation of the nucleus 
amygdaloideus basalis into its medial and lateral 
parts, we noticed a decrease of the density to low and 
medium A high (3 + ) density was seen in the nucleus 
amygdaloideus lateralis (Figs 22C.D). In the most 
caudal part of the amygdala complex a 4+ density 
was confined to the nucleus amygdaloideus mediahs 
posterior and to the medial and lateral part of the 
nucleus amygdaloideus posterior. At that same level, 
the density in the ventral part of the hippocampus 
increased greatly. In the neocortex (Figs 23A.B), a 
small area receives very high innervation with seroto­
nin-positive fibers. This region extends to a length of 
approximately 300/jm and is confined to an area 
adjacent to the sulcus rhinalis, lateral to the claus-
trum and dorsal to the cortex piriformis, level A 
6360-A 6060 (Fig. 18). 
Diencephalon. In the diencephalon, the nucleus 
suprachiasmaticus is the most rostral group receiving 
a 4+ serotonin-positive innervation This density was 
observed throughout the entire ventral part of this 
nucleus (Figs 19C.D). Close to level A 6060, two other 
very highly dense groups emerge: a region in the dor­
solateral part of the nucleus periventncularis thalami, 
and an area ventral to the fornix and medial to the 
stria medullaris thalami The 4+ density level of the 
nucleus periventncularis thalami initially decreases 
caudally to medium and high levels (Figs 19A,B), but 
increases again to very high levels in the most caudal 
area of the nucleus periventriculans thalami. Along­
side the nucleus periventriculans thalami. a very high 
density was observed in the rostral part of the nucleus 
medialis thalami. pars mediahs. The medial forebrain 
bundle in the diencephalon is also an area which 
receives a 4+ innervation but only the dorsomedial 
part and the area adjacent to the fornix have this very 
high density The overall part of the medial forebrain 
bundle shows a medium to high density (Figs 21 
A.B.C.D). The nucleus subthalamicus, which is adja­
cent to the posterior hypothalamus is densely inner­
vated caudally. A very high density has been found in 
the central part of the nucleus ventromedialis hypo­
thalami. A high 3 + innervation was present in the 
rostroventral and caudoventral part of this nucleus. 
In the caudal part of the hypothalamus a very high 
density was seen in the ventral part of the nucleus 
marni llaris mediahs. 
In the caudal part of the thalamus, two areas with a 
very high density of serotonin-immunoreactivity 
stand out: the radiado thalami superior and the 
medial part of the nucleus ventrahs corporis genicu-
lati lateralis (Figs 26A.B). This 4+ innervation ter­
minates in the dorsal part of the latter nucleus 
(Figs 22A,B). 
Mesencephalon. In the mesencephalon, only three 
areas have a very high density: the rostral part of the 
nucleus tractus optici, pars medialis; the rostral part 
of the substantia nigra, pars reticularis and the sub­
stantia nigra, pars lateralis The nucleus inlerpedun-
culans receives in its dorsal part a 3 + serotonin-
positive innervation (Figs 26C,D). 
Rhombeiu ephalon. A very high 4 + density of sero­
tonin-positive fibers was observed in the lateral parts 
of the reticular formation, more precisely in the dor­
solateral part of the nucleus reticularis ponlis oralis, 
which is located ventral to the pedunculus cerebellans 
superior and ventrolateral to the nucleus parabra-
chialis ventrahs This 4+ density extends into the nu­
cleus motonus nervi trigemini, decreasing caudally to 
3+ levels. The 4+ density is maintained in the 
mediolateral part of the nucleus motonus nervi tri­
gemini and is confined at level Ρ 2800 to the overall 
part of the latter nucleus (Figs 29C.D). In the caudal 
part of the rhombencephalon, there is another cranial 
nerve nucleus which receives a very high innervation 
of serotonin-positive fibers: the nucleus nervi facialis. 
It arises in the medial part (level Ρ 3900, Figs 30C,D) 
and continues into the ventral part of this nucleus. 
More caudally this density rapidly decreases to 
medium and low levels. At level Ρ 4500, a small 
region within the dorsolateral part of the nucleus 
tractus spinalis nervi trigemini, shows a very high 
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density level (Fig. 32B). The last cranial nerve nucleus 
which shows a 4+ density is the caudal part of the 
nucleus tractus solitarn (Fig. 32C). 
Spinal cord. For the description of the different 
areas of the spinal cord which are serotonin-immu-
noreactive, the nomenclature of REXED (1954) is used. 
Striking quantitative differences have been found 
between the serotonin-innervalion densities of the 
white and grey matter at cervical, thoracic, lumbar 
and sacral levels. 
In the white matter, some single fibers were ob-
served at all levels. These single fibers were mostly 
localized in the funiculus ventrahs, in the region adja-
cent to the nucleus commissurahs in lamina VIII. In 
the functions lateralis serotonin-positive fibers and 
terminals have been demonstrated at the cervical, 
thoracic and lumbar levels; no serotonin-immuno-
reactivity was localized at the sacral and coccygal 
levels At cervical levels, serotonin-positive fibers were 
seen in the area opposite to lamina III, IV and V of 
the grey matter; at thoracic levels, single serotonin-
immunoreactive fibers could be detected in a region 
adjacent to the nucleus intermedio-laterahs in lamina 
VII; at lumbar levels, some single fibers were found 
close to lamina IX. The funiculus dorsalis did not 
contain any serotonin-immunoreactive fibers. 
Within the grey matter, the degree of Serotonin-
innervation varied considerably. High (3 + ) to very 
high (4 + ) densities were visualized at all levels. At 
cervical levels, a very high density was found in the 
medial part of lamina VIII, which includes the nu-
cleus commissurahs and the nucleus ventromedial of 
lamina IX At thoracic levels, a 4+ innervation was 
demonstrated in the area corresponding to the nu-
cleus intermedio-lateralis of lamina VII. At lumbar 
levels, a very high serotonin-positive innervation was 
seen in both the medial part of lamina VIII and the 
nucleus ventromedialis of lamina IX. At sacral and 
coccygal levels, this same density was observed in the 
medial part of lamina VIII, which comprises the nu-
cleus commissurahs. 
High (3 + ) to medium (2 + ) density was found at all 
levels of the cornu dorsale in lamina II and III; low 
density (1 + ) to single fibers ( —) was confined to 
lamina V, VI and all levels of the dorsal part of VII. 
All levels of the peri-ependymal region revealed high 
serotonin concentrations. No serotonin-negative areas 
in the grey matter of the spinal cord were detected 
(Figs 35A,B,C). 
Supra-ependymal plexus. The presence of cerebro-
spinal fluid contacting, 5-HT-positive, nerve fibers 
projecting through or lying on the cerebral ventricu-
lar ependyma was observed in all ventricles. The dis-
tribution of this ventricular supra-ependymal plexus 
is not shown on the transversal sections of the atlas. 
This plexus can be divided into two parts: (a) a 
strongly fluorescent plexus on the ventricular surface 
of the rhombencephalon, in the entire aquaductus 
cerebri, and in the whole lateral ventricles 
(Figs 17A,B; 19A,B; 28; 29A,B; 30A,B; 32A); (b) a 
moderately fluorescent plexus in the dorsal part of the 
third ventricle (Figs 20C,D: 25A,B). No serotonin-
positive fluorescence was observed in the ventral part 
of the third ventricle, e.g., the zone adjacent to the 
hypothalamus (Figs 24A,B,C; 25C,D). 
DISCUSSION 
The immunohistochemical staining of serotonin in 
the central nervous system of the rat shows an exten-
sive distribution of serotonin-immunoreactive cell 
bodies, fibers and terminals. The specificity of the im-
munofluorescence method used in the present investi-
gation has been discussed at length in previous papers 
(STEINBUSCH et ai, 1978; STEINBUSCH & VERHOFSTAD, 
1979; STEINBUSCH & NIEUWENHUYS, 1980; STEIN-
BuscH, VERHOFSTAD, PENKE, VARGA & JOOSTEN, 1980) 
In this paper, I have used five criteria to test the 
specificity of the antiserum: 1. control experiments, 
using immune as well as pre-immune sera in serial 
sections; 2. inhibition experiments, using substances 
which might cross-react and confined the existence of 
low cross-reactivity; 3. absorption tests with conju-
gates to serotonin, noradrenaline and adrenaline 
which could add a minor cross-reactivity to the anti-
body^, pharmacological treatments: negative seroto-
nin-immunoreactivity was found after degeneration of 
the serotoninergic system following administration of 
5,7-dihydroxytryptamine (T. HÖKFELT, personal com-
munication); 5. comparison with data obtained with 
other histochemical techniques, e.g., the formalde-
hyde-induced-fluorescence technique and an immuno-
histochemical method. The latter procedure showed a 
conformity between perikarya visualized with anti-
dopadecarboxylase and those visualized with anti-
serotonin (T. HÖKFELT, personal communication). 
Moreover, the sections incubated with anti-dopa 
decarboxylase demonstrated numerous dopaminergic 
and noradrenergic neurons. 
Serotonin-immunoreactive perikarya 
The use of colchicine increased the fluorescence 
intensity in those cells already visualized in untreated 
rats; moreover, neurons which in untreated rats had a 
fluorescence not greater than background fluor-
escence could then be seen. The fluorescence intensity 
of the latter group was, however, not equal to that of 
the former. Colchicine treatment inhibits axonal 
transport of proteins and particles and thereby causes 
an accumulation of serotonin in the perikarya. 
In general, the observations regarding the distribu-
tion of serotonin-immunoreactive perikarya are in 
agreement with those of DAHLSTRÖM & FUXE (1964). 
However, we observed in all of the nine B-groups, 
except for B4 and B6, an expansion of serotonin-posi-
tive cells into the lateral parts of the raphe nuclei. 
LEVITT & MOORE (1978) suggested on the basis of 
their ontogenetic study of the raphe serotonin neu-
rons that the scattered serotonin-positive neurons 
present external to the raphe groups in mesencephalic 
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FIG. 15. (А, В) Olfactory bulb, saggilal section, (C, D) Olfactory bulb (level A 12580) transversal section 
after incubation with 5-hydroxytryptamine antiserum. Single ( - ) 5-HT positive fibers can be observed in 
all layers of the bulb with highest innervation in the lamina glomerulosa bulbi olfactoni (LG, level A 
12580, Fig 1A; Bars. 50μπι) 
FIG. 16 (A, B, D) Cingulum bundle in sagittal sections, (C) area ventromedial^ to corpus callosum (level 
A 9650, Fig. 2C) in transversal section of colchicine treated rats after incubation with 5-hydroxytryp-
lamine antiserum. No fluorescence is seen within the corpus callosum (Bars: 50μπι). 
FIG. 17. (A, B) Nucleus lateralis septi in transversal section (si, level A 7190, Fig. 4B), (C, D) nucleus 
caudatus in transversal section (c, level A 7190, Fig 4B) after incubation with 5-hydroxylryptamine 
antiserum. (A, B) A high density of 5-HT positive nerve terminals is seen in the nucleus lateralis septi. No 
fluorescence is observed in the ependyma. A strong 5-HT positive supraependymal plexus is present. 
(C, D) The dorsal part of the nucleus caudatus contains a low density of weakly immunofluorescent fine 
fibers (Bars1 50 μπ\). 
FIG. 18. A photomontage of a transversal section of a very high dense plexus in an area lateral of the 
claustrum, dorsal of the cortex piriformis and opposite of the sulcus rhinahs (SR). More medially the 
density of the 5-HT-positive fibers rapidly decrease to low levels (level A 6360, Fig 5A, Bar: 50 μπι). 
FIG 19. (A, B) nucleus periventricular^ thalami (pv, level A 5780, Fig 5D) and (C, D) nucleus supra-
chiasmaticus (sc, level A 6280, Fig 5B) in transversal sections after incubation with 5-hydroxytryplamine 
antiserum (A. B) Within the nucleus periventriculans thalami a very high (4 + ) density has been found in 
the dorsal part The ventricular surface shows a strong 5-HT positive supra-ependymal plexus. (C, D) 
The ventromedial part of the nucleus suprachiasmaticus shows a very high density In the rest of the 
nucleus suprachiasmaticus and the nucleus hypothalamics anterior a low density of 5-HT positive 
terminals was seen. In the third ventricle a 5-HT positive supraependymal plexus is absent (Bars· 50μπι). 
FIG. 20. (A, B) globus palhdus (gp, level A 5660, Fig 6A) and nucleus paraventricularis hypothalami 
(npv, level A 5660, Fig. 6A) in transversal sections after incubation* with 5-hydroxytryptamine antiserum. 
(A, B) A medium density was seen throughout the whole gp. At that level the density of the innervation 
was equal to that in the ventral part of the cp. (C, D) Single fibers were seen in the npv. The ependymal 
layer was negative and a very faint 5-HT positive supraependymal plexus was observed Dorsal of the 
npv a medium density was observed, which appeared to continue into the nucleus reuniens The fornix 
was completely negative (Bars: 50μτη). 
FIG. 21. (A. B) Medial forebrain bundle (MFB, level A 4620, Fig. 6D), ( C D ) medial forebrain bundle 
(MFB, level A 2580, Fig. 8C) in transversal section after incubation with 5-hydroxytryptamine anti­
serum. (A, B) in the dorsomedial part of the MFB small bundles of fibers extending beyond the boun­
daries of that bundle, the fornix has no fluorescence (C, D) The whole MFB has a high density. Long, 
small axons, with only very few varicosities, are running into the decussatio supramamillans. The 
fasciculus mamillotegmentalis is negative (Bars: 50μπι) 
FIG 22. (A, B) Nucleus dorsalis corporis geniculati lateralis (dgcl, level A 3750, Fig. 7C) and (C, D) 
nucleus amygdaloideus lateralis (al, level A 4620, Fig. 6D) in transversal section after incubation with 
5-hydroxytryptamine antiserum (A, B) A high density of 5-HT positive fibers was observed in the dgcl. 
More laterally a low density has been observed in the fimbria hippocampi, and medially to the dgcl, 
there was a low density in the nucleus lateralis posterior thalami. (C, D) A high density was seen in the 
al. More laterally and ventrally a decrease to low density has been observed (Bars: 50 μπι). 
FIG. 23. (A, B) Transversal section through the neocortex at level A 6670, Fig 4D A medium high (2 + ) 
innervation has been found in layer I Some single ( — ) fibers have been seen in layer II Layer III, IV, V 
and VI show only a sparse innervation (Bars· 50μπι). 
FIG 24. (A) Median eminence and part of the nucleus arcuatus (ME and na, level A 3750, Fig. 7C) and 
(B, C) median eminence (ME, level A 3750, Fig. 7C) in transversal section after incubation with 5-hy­
droxytryptamine antiserum. (A) A general view is shown of the ventral part of the ventricle. A low density 
in the' na and ME is seen In this part of the third ventricle no 5-HT positive supraependymal plexus is 
present. (B, C) Many strongly fluorescent mast cells are present in the medial external layer (Bars· 
50 μπι) 
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FIG. 25 (A, B) Dorsal part of the third ventricle and (C, D) ventral part of the third ventricle (level A 
3430, Fig. 7D) in transversal section after incubation with serotonin antiserum The difference is shown, 
between a 5-HT-positive supraependymal plexus in the dorsal part (B) and the non-existence of this 
plexus in the ventral part (D). (A, B) A medium density is seen in the nucleus hypothalamicus posterior 
The ependymal layer surrounding the ventricle is negative. (C, D) In the nucleus arcuatus some single 
fibers are visible. More dorsally there is an increase in density which continues in a medium density of 
the nucleus hypothalamicus anterior The ependymal layer is here negative (Bars. 50μπι) 
FIG. 26. (A, B) Nucleus ventrahs corporis geniculati lateralis (vgcl, level A 2580, Fig 8C) and (C, D) 
nucleus interpeduncular (ip, level A 1800, Fig. 9B) in transversal section after incubation with 5-hy-
droxytryptamine antiserum. (A, B) A very high density has been localized in the dorsal part of the vgcl, 
more ventrally the intensity decreases to the dense innervation of the vgcl. More laterally we can see a 
low density in the hippocampus (C, D) Within the ip there are two densities: in the dorsal part a high 
density, in the ventral part a low density region The decussationes tegmenti (DT) and the area tegmen-
talis ventrahs Tsai (atv) show only a low density (Bars: 50μπι). 
FIG. 27. Nucleus raphe dorsahs, nucleus centralis superior and lemniscus medialis (rd, ncs and LM. level 
A 500, Fig 10A) in colchicine-treated rats after incubation with 5-hydroxytryplamine antiserum Many 
cell bodies were seen in the rd (B7), some in the ncs (B8) and LM (B9) The rd and ncs also show a dense 
innervation Some cell bodies are seen just ventrally to the fasciculus longitudinale medialis and within 
the decussatio pedunculi cerebellanum supenorum (Bars. 50/<m). 
FIG 28. Nucleus raphe dorsahs (rd, level A 500, Fig 10A) in a transversal section of colchicine-treated 
rats after incubation with 5-hydroxytryptamine antiserum The rd can be divided in three fluorescent 
cellgroups Two densely packed cellgroups within the dorsomedian and ventromedial part and lateral 
some cells which are more widely distributed Dorsolateral of the rd, close to the aquaductus cerebri 
some 5-HT-posilive cells are localized Long serotonin-positive processes are running through the fasci­
culus longitudinahs medialis (FLM). Some cells were visualized in the ventromedial part of the FLM 
(Bars: 50pm). 
FIG 29. (A, B) Locus coeruleus (LC, level Ρ 2300, Fig 11С) and (C, D) nucleus molonus nervi trigemini 
(nV. level Ρ 2800, Fig. 1 ID) in transversal section after incubation with 5-hydroxylryplamine antiserum 
(A, B) A high density is seen in the LC, laterally to the LC a decrease to medium and low density is 
observed in the nucleus tractus mesencephah and the traclus mesencephahcus nervi trigemini A strong 
fluorescent 5-HT-positive supraependymal plexus is present at the dorsolateral and ventral part of the 
fourth ventricle At this level all the cells in the LC are 5-HT negative (C, D) A very high density is seen 
within the nV The 5-HT positive fibers are particularly coarse here and it appears, that there is an 
increase in the number of varicosities. More medially there is a decrease to low density into the reticular 
formation and more laterally a decrease to medium density into the nucleus tractus spinalis nervi 
trigemini (Bars: 50μπι). 
FIG. 30. (Α. Β) Fasciculus longitudinahs medialis and nucleus vestibularis medialis (FLM and vm, level 
Ρ 3900, Fig 12B) and (C, D) nucleus nervi facialis (nVII, level Ρ 3900, Fig. 12D) in transversal sections 
after incubation with 5-hydroxytryptamine antiserum. (A, B) A very high density is seen in the periventri­
cular central grey matter under the fourth ventricle. The FLM and the vm show only a low density. (B) 
Note long serotonin-positive dendritic bundles, running along the midline. (C, D) The nVII shows three 
different densities, passing from medial to lateral we see first a medium density, then a very high density 
and finally a high density. More laterally we can see the negative tractus spinalis nervi trigemini 
Ventrally to the nVII is the negative area of the pedunculus cerebellans inferior (Bars: 50 μιτι) 
FIG 31 (A, B, C) Nucleus raphe magnus (B3) (rm, level Ρ 3900, Fig 12B) in transversal sections of 
colchicine-treated rats after incubation with 5-hydroxytryptamine antiserum. (A) 5-HT positive cells arc 
seen in the rm and in the nucleus reticularis giganlocellulans overlying the tractus pyramidalis The area 
in which the cell bodies are lying itself has a medium density. Some fibers arc running into the nucleus 
interfascicular^ hypoglossi The dendritic pattern of the cells is perpendicular to the midline Just a few 
cells are located in the midline itself. (Bars. 50μπι) 
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FIG 32. (A) Nucleus vestibularis mediahs (vm, level Ρ 4500, Fig. 12C) and (B) nucleus tractus spinalis 
nervi trigemini, pars dorso-medialis (ntVd, level Ρ 4500, Fig. 12C) in transversal section and (C) sagittal 
section through the nucleus tractus solitanus (nts) in (A) colchicine-trealed and (B, C) untreated rats after 
incubation with 5-hydroxytryptamine antiserum. (A) Some 5-HT positive cells are seen within the 
periventricular grey matter Those cells belong to the rostral part οΓ the B4 serotoninergic group At this 
level the medial part of the vm has a medium density, which goes over in the lateral part on low density 
The cells are much smaller than those in the raphe area (Fig 17B). (B) An area with very high density is 
seen within the ntVd, more laterally some fibers are passing through the tractus spinalis nervi trigemini, 
a tractus which itself is 5-HT negative. The largest part of the ntVd is more medium densely innervated. 
(C) The nts is a densely innervated region, which is surrounded by only low density areas like the 
nucleus vestibularis spinalis. More ventrally a decrease in density can be observed (Bars: 50μπι). 
FIG 33 (A, B) Nucleus raphe obscurus, nucleus raphe palhdus (ro, rp, level Ρ 6500, Fig 13B) in 
transversal section of colchicine treated rats after incubation with 5-hydroxytryptamine antiserum (A, B) 
5-HT positive cells are seen within the ro and rp. Two cell groups in which the rp belongs to the 
Bl-group and the ro to the B2-group. Some cells of the B2-group are lying in the nucleus reticularis 
paramedianus. Those cells are much larger, than those localized in the midline. Some cells were seen 
ventrolateral^ to the inferior olive complex. The nucleus reticularis paramedianus and the oliva inferior 
show plexuses with a low density. The tractus corticospinalis is completely negative (Bars: 50μπι). 
FIG. 34. (A) Nucleus raphe pallidus, (rp, level Ρ 6500, Fig. 13B) (B) nucleus raphe obscurus (ro, level Ρ 
6500, Fig. 13B) and (С) cells situated ventrolateral^ to the inferior olive complex (level Ρ 6500, Fig. 13B) 
in transversal sections of colchicine-treated rats after incubation with 5-hydroxytryplamine antiserum 
(A, B) The cells of the rp and ro are located near the midline, but these two groups are not fused. In the 
midline itself there are only serotonin-positive dendrites running parallel to the midline. (C) The area 
between the nucleus reticularis lateralis and the nucleus olivaris inferior shows medium density sero­
toninergic innervation (Bars: 50μτη). 
FIG 35 (A, B, C) Cornu laterale and cornu ventrale (eia and cv, level Th5, Fig. 14B) in transversal 
section after incubation with 5-hydroxylryptamine antiserum. (A) A small very high density area is seen 
in the cornu laterale in the nucleus intermediolaterahs according to the terminology of RE-XED, 1954. 
Some fibers extends into the funiculus lateralis. Dorsal there is a decrease of density to only single fibers 
and ventral to low density. (C) A high density is seen in the cornu ventrale, especially in lamina VIII 
The rest of the cornu ventrale shows a medium density (Bars: 50 μπι). 
FIG 36. (A, B) Infundibulum stalk and nucleus arcualus (I and na) in sagittal section and (C) median 
eminence (ME) in horizontal section after incubation with serotonin-anliserum. (A, B) In the infundibu­
lum stalk weakly fluoresccent glia cells were observed. (A) The nucleus arcuatus shows only a low 
density of serolomn-immunoreactive fibers (C) A rich 5-HT positive innervation was demonstrated in 
the median eminence Arrows indicate a tanycyte which reaches from the recessus ìnfundibularis until 
the portal system (Bars: 50μπι). 
FIG. 37 (A, B) Area postrema and nucleus tractus solitarn (ap and nts) in sagittal section and (C, D) 
nucleus interpeduncular^ and lemniscus mediahs (ìp and LM; level A 1600) in transversal section after 
incubation with serolonin-antiserum. (A, B) A compact group of small cells can be seen in the area 
postrema. (A) Ventrally to the area postrema a 4+ density has been found in the nucleus tractus 
solitari!. (С, D) Serotoninergic perikarya were demonstrated in the wing-like structures between the 
nucleus interpeduncular^ and the lemniscus mediahs (C) Serotonin-positive neurons are situated in the 
dorsomedial part of the nucleus interpeduncular^ (Bars: 50 μπι) 
FIG. 38. (A, B) Locus coeruleus (V: fourth ventricle, level Ρ 2800, Fig. 1 ID) in transversal section after 
incubation with serotonin-antiserum, (C, D) Locus coeruleus (level Ρ 2800, Fig. 11D) in transversal 
section after incubation with noradrenaline-antiserum. (A, B) Some serotonin-positive cell bodies were 
visualized in the ventral part of the locus coeruleus and the subcoeruleus area. (C, D) Using an antibody 
to noradrenaline with a different fixation procedure as described elsewhere (STEINBUSCH, VERHOFSTAD, 
PENKE, VARGA & JOOSTEN., 1980; VERHOFSTAD et α/., 1980) the present author was able to localize 
NA-positive perikarya in the same area. This result reveals that in this region serotonin- and noradrena-
hne-neurons are intermingled (Bars: 50μπι). 
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and pontine reticular formation represent elements 
which have not 'migrated properly during embryo-
genesis'. Only three of the nine cell groups identified, 
Bu B2 and B7, are located as fused structures within 
the midline raphe nuclei. 
There were five additional areas in which seroto-
nin-positive perikarya could be observed by the 
present procedure, in which animals were not pre-
treated with a monoamine oxidase inhibitor: 
(a) In the caudal part of the rhombencephalon I 
have found a compact group of small serotonin-posit-
ive cells in the area postrema (Figs 37A,B). These peri-
karya have also been described by FUXE & OWMAN 
(1965), using the FIF-technique. However, they visua-
lized those cells only after treatment of the animals 
with a monoamine oxidase inhibitor. 
(b) A few serotonin-positive perikarya were seen in 
the ventrocaudal part of the locus coeruleus and in 
the dorsomcdial part of the subcoeruleus area 
(Figs 38A,B). The cells are bipolar and localized in a 
rostro-caudal direction. SLADEK & WALKER (1977) 
using the FIF-technique in primates, LÉGER & DES-
CARRIES (1978) using autoradiography in rats, and 
LÉGER, WIKLUND, DESCARRIES & PERSSON (1979) in a 
fluorescence-histochemical and autoradiographic 
study in the cat, have also demonstrated the presence 
of serotonin-positive cell bodies in the locus coeruleus 
and subcoeruleus area. However, LÉGER et al. (1979) 
stated that indolaminergic cell bodies occur in all sub-
divisions of the locus coeruleus complex. In addition, 
they found that, due to a similarity in size, the indol-
aminergic and noradrenergic cells of the locus coeru-
leus are cytoarchitectonically indistinguishable in 
Nissl-stained material. SLADEK & WALKER (1977) sug-
gested that these elements have not migrated toward 
the raphe during ontogenesis. 
(c) I have described some serotoninergic neurons 
surrounding the nucleus tegmentalis dorsahs. Their 
morphology is different from the serotonin-containing 
perikarya which lie medial to the region of the locus 
coeruleus or from those arranged medially in the cau-
dal extension of the nucleus raphe dorsahs. Some of 
the cells were observed by SLADEK & WALKER (1977) 
and LÉGER et al. (1979). However, the former authors 
did not distinguish between different cell types and 
classified them all as a lateral part of the nucleus 
raphe dorsahs They described the indolaminergic 
cells in and ventral to the periventricular grey matter 
as linking the locus coeruleus proper to the nucleus 
raphe dorsalis. 
(d) The serotonin-positive cells arranged in the 
wing-like structures surrounding the nucleus interpe-
duncularis have not been described by other authors. 
The shape of the cells is fusiform and they are 
arranged perpendicular to the midline. It is important 
to note that these cells are clearly different from those 
in group B9. 
(e) The small population of serotoninergic neurons 
detected in the dorsocaudal part of the nucleus ìnter-
peduncularis should be considered as a subsystem of 
the B8 cell group (Fig. 37C). Moreover, the shape of 
the perikarya is similar to those of the serotonin-
immunoreactive cells in the nucleus centralis superior. 
As far as I know, these cells have not been observed 
by other authors. 
Several authors have found serotonin-positive neu-
rons in the diencephalon and in the olfactory bulb 
The presented results are in contrast to the studies of 
CHAN-PALAY (1977), KENT & SLADEK (1978) and 
BEAUDET & DESCARRIES (1979) CHAN-PALAY (1977), 
using autoradiography, reported the presence of sero-
tonin-containing nerve cell bodies in several hypo-
thalamic nuclei, among which the nucleus ventro-
medialis hypothalami, the nucleus dorsomediahs 
hypothalami and the nucleus paraventriculans 
hypothalami. KENT & SLADEK (1978), using the FIF-
technique, demonstrated yellow fluorescence in the 
nucleus arcuatus; BEAUDET & DESCARRIES (1979) using 
autoradiography, reported serotonin-positive peri-
karya only in the nucleus hypothalamicus dorsome-
diahs, pars ventralis. The latter authors have used not 
only a rather low concentration of [3H]serotonin in 
combination with a monoamine oxidase inhibitor, but 
in addition they have made an attempt to raise the 
specificity of the procedure. For this purpose they 
have added to the perfusate non-radioactive nor-
adrenaline or they injected the same concentration 
[3H]noradrenaline instead of [3H]serotonin 
However, I remain unable to confirm their findings. 
Regarding these autoradiographic findings it should 
be mentioned that according to the work of LICH-
TENSTEIGER, MUTZNER & LANGEMANN (1967), the pres-
ence of a high concentration of [3H]serotonin leads 
to a build-up of serotonin in the tubero-infundibulum 
dopaminergic neurons. The investigations of FUXE & 
UNGERSTEDT (1968) demonstrated that amines 
injected into the cerebral ventricles only reach a 
limited zone, about 300 μτη wide, surrounding the 
ventricles and the ventral part of the subarachnoidal 
space. They also demonstrated that the specificity of 
autoradiography is concentration-dependent. It is my 
impression that the disparity between the results 
obtained with autoradiography and immunofluores­
cence can be interpreted as follows: [3H]serotonin-
containing cell bodies in the hypothalamus do not 
contain serotonin but are rather dopaminergic There 
could have been a nonspecific uptake of serotonin in 
these dopaminergic neurons due to the high concen­
tration of [3H]serotonin used by the authors cited 
above. Another possibility could be the presence of 
another indolamine in the hypothalamus. Another 
indolamine, which could be 5-melhoxytryptamine. 
tryptamine or melatonin, has been described biochem­
ically by GREEN, KOSLOW & COSTA (1972) and by 
BJÖRKLUND, AXELSSON & FALCK (1976), using micro-
spectrofluorometry in combination with pharmaco-
logical experiments. Biochemically, 5-methoxytrypt-
amine, tryptamine and melatonin appear to be 
unevenly distributed in the central nervous system 
5-methoxytryptamine is preferentially found in the 
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hypothalamus, tryptamine in the spinal cord and 
melatonin in the pineal gland. However, BOSIN, 
JONSSON & BECK (1979) using a highly sensitive gas-
chromatography mass spectrometric method remained 
unable to detect any 5-methoxytryptamine in the cen-
tral nervous system of the rat. In addition, it has to be 
kept in mind that our antiserum shows a cross-reac-
tivity of less than 2% to 5-methoxytryptamine, which 
means, that by using this serotonin antiserum it 
would not be possible to localize 5-methoxytryp-
tamine, whether or not is is present. The presence of 
5-methoxytryptamine in the hypothalamus could be 
solved by using immunofluorescence with an anti-
body to 5-methoxytryptamine. Studies to test this are 
in progress. 
Serotonin-containing neurons in areas where catecho-
lamine-containing neurons occur. In this study I have 
found areas where serotoninergjc and catecholamin-
ergic neurons coincide: 1. Some serotonin-positive 
cell bodies have been found in the locus coeruleus 
(Figs 38A.B). This area, which is often denoted as 
the A6 group, contains noradrenergic neurons 
(Figs 38C,D). 2. In the region lateral to the nucleus 
interpedunculans and ventral to the lemniscus 
medialis serotonin-positive cells have been observed. 
This region forms part of the area tegmentalis of Tsai, 
which is known to contain large numbers of 
dopaminergic cells. The latter constitute together the 
AIO group of DAHLSTRÖM & Fuxfc (1964). 3. Some 
noradrenergic as well as dopaminergic neurons have 
been found in the very uniform serotonin-positive nu-
cleus raphe dorsalis. The noradrenergic cells have 
been described as belonging to the most rostral part 
of the A6 cell group by G R Z A N N A & MOLLIVER (1980), 
using a homologous antibody to dopamine-beta-hy-
droxylase. These findings have been confirmed by using 
an antibody to noradrenaline (STEINBUSCH, NIEUWEN-
HUYS, VERHOFSTAD & VAN DER Κοογ, 1981). The 
neurons in question are situated in the caudolateral 
part of the nucleus raphe dorsalis. Dopamine-contain-
ìng neurons in the midbrain raphe nuclei have been 
described by O C H I & SHIMIZU (1978) using the FIF-
procedure with an improved filter system. Those cells 
were situated near the midline between the fasciculus 
longitudinahs medialis of both sides and medial to the 
nucleus oculomotorius and the nucleus trochleans. 
However, the present author, using a primary cate-
cholamine antibody, which stains dopamine as well as 
noradrenaline-containing perikarya, remained unable 
to detect these elements (STEINBUSCH, VAN DER KOOY, 
VERHOFSTAD & PELLEGRINO, 1980; VFRHOFSTAD, 
STEINBUSCH, PENKE, VARGA & JOOSTEN, 1980). 
From the above, it will be clear that it is necessary 
to reconsider the use of terms A1-A10 and B1-B9. 
Rather than adding new symbols, it may well be 
advisable to use the old nomenclature again. The 
nomenclature of the Swedish investigators was based 
on the supposition that all cells in each of the groups 
distinguished contain one transmitter. This suppo-
sition appears to be incorrect, however In a forth-
coming paper this problem will be discussed in some 
detail. 
Serotomn-immunoreactive nerve fibers and terminals 
The present report has described the distribution of 
serotonin-positive fibers and nerve terminals in the 
central nervous system of the rat. Serotonin-contain-
ing pathways will be discussed in a forthcoming 
paper. Two major mappings of the serotoninergic sys-
tem in the rat have already been published : one from 
FUXE (1965), who used the formaldehyde-induced-
fluorescence technique and the other by CHAN-PALAY 
(1977) who used autoradiography with [3H]serotonin. 
A smaller, but still comprehensive, study regarding 
the serotonin innervation of the hypothalamus, has 
been presented by DESCARRIES & BEAUDET (1978). (See 
also PARENT et al, 1981; Ed.) These authors used 
autoradiography with [3H]serotonin. A determi-
nation of serotonin by biochemistry in the central 
nervous system of the rat was presented by SAAVEDRA 
(1977). A comparison of our immunofluorescenl 
results with the initial findings of FUXE (1965) and the 
more recent paper findings of CHAN-PALAY (1977) has 
been included in Table 1. Also included are the bio-
chemical data of SAAVEDRA, PALKOVITS, BROWNSTEIN 
& AXELROD (1974) and the findings of DESCARRIES & 
BEAUDET (1978). From this comparison, it may be 
concluded that in general there is a good correlation 
between our results and those of the authors men-
tioned. However, in comparison with the results of 
FUXE (1965), I have found significantly more seroto-
nin-positive fiber systems and nuclei. In areas where 
both methods reveal positive results, the immunohis-
tochemical method shows higher concentrations of 
serotonin. This mainly reflects differences in sensi-
tivity of both techniques: immunofluorescence using 
an antibody to serotonin can be considered superior 
to the FIF-technique. With autoradiography more 
areas appear serotonin-positive than with the FIF-
technique, but not as many as those observed with 
our immunofluorescence method. 
We have to divide the autoradiographic findings 
into two parts: the results of CHAN-PALAY (1977) and 
those from DESCARRIES & BEAUDET (1978). Compar-
ing the results obtained by both groups, we have to 
conclude that the findings of DESCARRIES & BEAUDET 
(1978) are fairly similar to our own results in the 
hypothalamus. Striking differences between the im-
munofluorescence results achieved by the presently-
used method and those obtained by DESCARRIES & 
BEAUDET (1978) using radioautography, have been 
found in the following nuclei: higher concentrations 
of serotonin were observed by autoradiography in the 
nucleus arcuatus, the nucleus dorsomediahs hypotha-
lami and the nucleus preopticus periventricular^; 
lower concentrations of serotonin with autoradi-
ography compared to immunofluorescence have been 
found in the nucleus hypotha lamics posterior, the 
nucleus mamillans lateralis, the nucleus perifornicahs, 
the nucleus ventromedialis hypothalami and the nu-
cleus preopticus lateralis. A detailed description and 
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TABLE 1 COMPARATIVE DATA ON THE SEROTONIN INNERVATION OF THE CENTRAL NERVOUS SYSTEM 
0 
3 
1 
1 
2 
0 
0 
+ 
0 
0 
0 
1 
0 
1-2 
1-2 
+ .2 
2 
0 
1 
1-2 
1 
0 
1 
1 
0-4 
+-2 
1 
1 
0-+ 
1 
1-4 
1 
1 
1 
1 
1 
1. Rhinencephalon, olfactory bulb. 
FMI forceps minor 
LG lamina glomerulosa bulbi olfactorii 
LGA lamina glomerulosa bulbi olfactorii accessorii 
LGR lamina granularis bulbi olfactorii 
LMA lamina cellularim mitralium bulbi olfactorii accessorii 
LMIO lamina medullaris interna bulbi olfactorii 
LNO lamina nervi olfactorii 
LP lamina plexiformis externa bulbi olfactorii 
TOI tractus olfactorius intermedius 
TOL tractus olfactorius lateralis 
TOM tractus olfactorius medialis 
tu tuberculum olfactorium 
VO ventriculus olfactorius 
oad nucleus olfactorius anterior pars dorsalis 
oal nucleus olfactorius anterior pars lateralis 
oam nucleus olfactorius anterior pars medialis 
oap nucleus olfactorius anterior pars posterior 
2. Telencephalon. 
a. Neocortex and Lobus Piriformis. 
CAI capsula interna 
ce cortex entorhinalis 
cl claustrum 
pi cortex piriformis 
b. Hippocampus and Septum. 
CAE capsula externa 
FH fimbria hippocampi 
GD gyrus dentatus 
HI hippocampus 
HIA hippocampus anterior 
ST stria terminalis 
TSC tractus septocorticalis 
TSH tractus septohabenularis 
a nucleus accumbens 
ca nucleus interstitialis commissurae anterioris 
nicf nucleus interstitialis commissurae fornicis 
nich nucleus interstitialis tractus corticohabenularis medialis 
nish nucleus interstitialis tractus septohabenularis 
nism nucleus interstitialis striae medullaris 
nist nucleus interstitialis striae terminalis 
(continued) 
610 H. W. M. STEINBUSCH 
TABLE 1 {contd) 
A 
0 
0 
+ 
0 
0 
+ 
1-2 
0 
0 
0 
0 
0-+ 
1 
в 
2 
1 
1 
1 
2 
2 
2 
2 
2 
2 
3 
2 
2 
3 
2 
2 
2 
2 
2 
2 
2 
1 
2 
С 
1 
2 
1 
1 
2 
1 
1 
1 
1 
1 
2 
1 
1 
1 
1 
1 
1 
2 
L 
4 
D E 
1 
1 
+-1 
+-1 
+-2 
+ 
1-3 
+-2 
1 
1 
1-3 
0 
0 
1-4 
1-4 
+ 
1-2 
1-3 
1 
* - l 
+-4 
1 
1-3 
1-3 
+-1 
1-3 
1 
0 
1 
1 
1,3-4 
1 
1 
1 
+ 
+ 
1-2 
+ 
+ - 2 , 4 
1 
+ 
+ 
0 
1-2 
nistd nucleus interstitialis striae terminalis, pars dorsalis 
nistv nucleus interstitialis striae terminalis, pars ventralis 
sd nucleus dorsalis septi 
sdi nucleus dorsalis septi, pars intermedia 
sdì nucleus dorsalis septi, pars lateralis 
sf nucleus fimbrialis septi 
si nucleus lateralis septi 
sm nucleus medialis septi 
st nucleus triangularis septi 
td nucleus tractus diagonalis Broca 
c. Basal ganglia: striatum and amygdala complex. 
aa area amygdaloidea anterior 
AL ansa lenticularis 
CA conimi s sura anterior 
ab nucleus amygdaloideus basalis 
abp nucleus amygdaloideus basalis posterior 
ac nucleus amygdaloideus centralis 
aco nucleus amygdaloideus corticalis 
al nucleus amygdaloideus lateralis 
ali nucleus amygdaloideus lateralis inferior 
am nucleus amygdaloideus medialis 
amp nucleus amygdaloideus medialis posterior 
apo nucleus amygdaloideus posterior 
С nucleus caudatus 
cp nucleus caudatus + putamen 
ep nucleus ento~eduncularis 
gp globus pallidus 
ol nucleus tractus olfactorii lateralis 
d. Remaining telencephalic areas. 
CCA corpus callosum 
CFD commissura fornicis dorsalis 
1С insula Callejae 
ICm insula Callejae magna 
mi massae intercalatae 
PF polus frontalis 
S subiculum 
sfo subfornical organ 
TCHL tractus corticohabenularis lateralis 
TCL tractus corticohypothalamicus lateralis 
TCM tractus diagonalis Broca 
TSHT tractus septohypothalamicus 
3. Diencephalon. 
a. Epithalamus. 
CH commissura habenularum 
FR fasciculus retroflexus 
SM stria medullaris thalami 
hi nucleus habenulae lateralis 
hm nucleus habenulae medialis 
(continued) 
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TABU- 1 (contd) 
A 
+-2 
+ 
1 
+ 
+ 
+ 
1 
0 
0 
0 
0 
0 
+-1 
в 
1 
1 
2 
2 
2 
2-4 
2 
С 
2 
3 
3 
2 
2 
2 
3 
2 
1 
1 
3 
3 
1 
1 
D 
2 
2 
E 
1 
3-4 
1 
+ 
2-3 
1 
+-2 
2 
3-4 
1-2 
2 
2 
0-+ 
+ 
1 
1 
3 
+-2 
1-2 
I 
+ 
+-1,4 
1 
+-1 
+ 
+ 
+ 
+ 
2-4 
1 
1 
2 
1-4 
0 
2 
+ 
0 
1 
+ 
1 
2-4 
+ 
2 
0 
b. Thalamus. 
RTI 
RTS 
ccgm 
cm 
dgcl 
g 
mgcra 
pt 
pv 
re 
rh 
s 
sf 
spf 
tad 
Cam 
tav 
tl 
tip 
tm 
tml 
tmm 
tpm 
tpo 
tr 
tv 
tvd 
tvm 
vgcl 
radatio 
radatio 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
centralis corporis geniculati medialis 
centromedianus thalami 
dorsalis corporis geniculati lateralis 
gelatinosi™ thalami 
parafasсicuiaris 
parataenialis 
periventricularis thalami 
reuniens 
rhomboideus 
suprageniculatus 
fimbrialis septi 
subparafascicularis 
anterior dorsalis thalami 
anterior medialis thalami 
ante"ior ventralis thalami 
lateralis thalami 
lateralis posterior thalami 
medialis thalami 
medialis thalami, pars lateralis 
medialis thalami, pars medialis 
posteromedianus thalami 
posterior thalami 
reticularis thalami 
ventralis thalami 
ventralis thalami, pars dorsalis 
ventralis medialis thalami, pars magnocellularis 
ventralis corporis geniculati lateralis 
Subthalamus. 
Hi 
H2 
zi 
iield Hl of Forel 
field H2 of Forel 
zona incerta 
sut nucleus subthalamicus 
d. Hypothalamus. 
CO chiasma opticum 
CSDD commissura supraoptica dorsalis, pars dorsalis (Ganser) 
CSDV commissura supraoptica dorsalis, pars ventralis (Meynert) 
F fornix 
FMT fasciculus mamillothalamicus 
FS fornix superior 
ME median eminence 
MFB medial forebrain bundle 
PCMA pedunculus corporis mamillaris 
RC area retrochiasmatica 
SUM decussatio supramamillaris 
TO tractus opticus 
(continued) 
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TABLE I (contd) 
E 
з"~і 
4 1-2 
1 1 
2-3 
1 3 
3 2,4 
3 1-2 
1 
I 
2 1 
1-2 
3 1-2 
4 1,4 
1 
2-4 
1 
1-2 
3 1-2 
3 + 
1-3 
1-2 
1 
+ 
0 
I 
1 
1 
2 
1-2 
1 
2,4 
1 
1 
0 
0-1 
1-2 
1-2 
1 
1-4 
4 
2-3 
1 
1 
1 
1 
1-4 
3 
3 
na nucleus arcuatus 
ndm nucleus dorsomedialis hypothalami 
nha nucleus hypothalamicus anterior 
nhp nucleus hypothlamicus posterior 
nml nucleus mamillaris lateralis 
пшт nucleus mamillaris medialis 
npe nucleus periventricularis hypothalami 
npf nucleus perifornicalis 
npl nucleus mamillaris prelateralis 
npmd nucleus premamillaris dorsalis 
npmv nucleus premamillaris ventralis 
npv nucleus paraventricularis hypothalami 
nsc nucleus suprachiasmaticus 
nso nucleus supraopticus 
nvm nucleus ventromedialis hypothalami 
nvma nucleus ventromedialis anterior hypothalami 
pol nucleus preopticus lateralis 
pom nucleus preopticus medialis 
pop nucleus preopticus periventricularis 
pos nucleus preopticus suprachiasmaticus 
4. Mesencephalon. 
a. Tectum. 
BCI brachium colliculi inferioris 
CCS commissure colliculorum superiorum 
ci colliculus inferior 
CP commissura posterior 
SAM stratum album mediale colliculi superioris 
sgm stratum griseum mediale colliculi inferioris 
sgp stratum griseum profundum colliculi inferioris 
sgs stratum griseum superficiale colliculi inferioris 
SO stratum opticum colliculi inferioris 
tol nucleus tractus optici, pars lateralis 
torn nucleus tractus optici, pars medialis 
b. Tegmentum. 
atv area tegmentalis ventralis Tsai 
DT decussationes tegmenti 
FMTG fasciculus mamillotegmentalis 
LM lemniscus medialis 
SGC substantia grisea centralis 
SGCd substantia grisea centralis dorsalis 
SGCv substantia grisea centralis ventralis 
snc substantia nigra zona compacta 
snl substantia nigra zona lateralis 
snr substantia nigra zona reticularis 
TM tractus mesencephalic nervi trigemini 
TT tractus tectospinalis 
aD nucleus Darkschewitsch 
ic nucleus interstitialis Cajal 
ip nucleus interpeduncularis 
lid nucleus lemnisci lateralis dorsalis 
llr nucleus lemnisci lateralis rostralis 
(continued) 
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TABLE 1 (contd) 
С 
1 
0 
0 
4 
1 
1 
1 
2 
1 
4 
4 
4 
1 
0 
4 
3 
3 
3 
3 
3 
2 
3 
3 
D 
2 
1 
4 
2 
1 
0 
E 
0 
+-2 
2 
+-2 
1 
0 
1 
1-2 
2-3 
1-2 
2-4 
1-3 
1-4 
2 
1-4 
1-2 
+-1 
1 
1 
1 
1 
1 
1 
1 
1 
0-+ 
+ 
3-4 
+-2 
+ 
2 
1-2 
1-2 
2 
1 
1-4 
1 
1 
1 
1 
llv nucleus lemnisci lateralis ventralis 
nlll nucleus motorius nervi oculomotorii 
nE nucleus Edinger-Westphal 
ntm nucleus tractus mesencephali 
г nucleus ruber 
c. Remaining mesencephalic nerve. 
apm area pretectalis medialis 
CC crus cerebri 
ρ nucleus pretectalis 
5. Rhombencephalon. 
a. Cranial nerve nuclei. 
ambiguus 
commissuralis 
sensorius principalis nervi trigemini 
tractus solitarius 
tractus spinalis i trigemini 
motorius nervi trigemini 
nervi abducentis 
nervi facialis 
dorsalis nervi vagi 
nervi hypoglossi 
salivatorius 
vestibularis lateralis 
vestibularis medialis 
vestibularis superior 
vestibularis spinalis 
amb 
nco 
npV 
nts 
ntV 
nV 
nVI 
nVIII 
nX 
nXII 
sa 
vi 
vm 
vs 
vsp 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
b. Reticular and raphe nuclei. 
nbi 
nrd 
nrp 
nrv 
ntv 
rd 
rgi 
rl 
rm 
ro 
rp 
rpc 
rpo 
rpoc 
rpoo 
rtp 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
nucleus 
basilaris internus Cajal 
reticularis medullae oblongatae, pars dorsalis 
reticularis paramedianus 
reticularis medullae oblongatae, pars ventralis 
tegmenti ventralis (Gudden) 
raphe dorsalis 
reticularis gigantocellularis 
reticularis lateralis 
raphe magnus 
raphe obscurus 
raphe pallidus 
reticularis parvocellularis 
raphe pontis 
reticularis pontis caudalis 
reticularis pontis oralis 
reticularis tegmenti pontis 
c. Remaining rhombencephalic nuclei. 
cu nucleus cuneatus 
cui nucleus cuneatus lateralis 
io nucleus olivaris inferior 
iod nucleus accessorius olivaris dorsalis 
(continued) 
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+-1 
2 
1-3 
1.3 
1 
2 
2 
1-2 
2-3 
1-2 
2-3 
2 
+-1 
1 
1-2 
1,3 
1 
1-3 
1 
о 
1 
0-+ 
2 
1-2 
О 
О 
О 
О 
0,1 
0-2 
I 
0,2,3 
1 
1 
о 
о 
о 
о 
о 
1-3 
+ ,1,4 
1-4 
о 
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TABLF 1 (conta) 
iom nucleus accessorius olivaris medialis 
gr nucleus gracilis 
le locus coeruleus 
nes nucleus centralis superior 
nie nucleus intercalatus 
nie nucleus linearis caudalis 
nlo nucleus linearis oralis 
np nucleus parabrachialis ventralis 
npd nucleus parabrachialis dorsalis 
ntd nucleus tegmenti dorsalis (Gudden) 
ntdl nucleus tegmenti dorsalis lateralis 
ope nucleus preolivaris externus 
os nucleus olivaris superior 
osa nucleus accessorius olivaris superior 
osp nucleus parolivaris superior 
ph nucleus prepositus hypoglossi 
po nucleus pontis 
ps nucleus parasolitarius 
d. Rhombencephalic fibre systems. 
ap area postrema 
CT corpus trapezoideum 
DP decussatio pyramidis 
DPCS decussatio pedunculi cerebellarum superiorum 
FC fasciculus cuneatus 
FG fasciculus gracilis 
FLM fasciculus longitudinales medialis 
LL lemniscus lateralis 
OC tractus olivocerebellaris 
Ρ tractus corticospinalis 
PCI pedunculus cerebellaris inferior 
PCM pedunculus cerebellaris médius 
PCS pedunculus cerebellaris superior 
SA striae acusticae 
sgV substantia gelatinosa trigemini 
TRS tractus rubrospinalis 
TS tractus solitarius 
TSV tractus spinalis nervi trigemini 
V nervus trigeminus 
VII nervus facialis 
IX nervus glossopharyngeus 
X nervus vagus 
i. Spinal cord. 
cd cornu dorsale 
eia cornu laterale 
cv cornu ventrale 
FO funiculus dorsalis 
FC funiculus lateralis 
FV funiculus ventralis 
The variations of densities were estimated subjectively according to the following symbols 
0 no fluorescence 
+ single fibers 
1 low density 
2 medium density 
3 high density 
4 very high density 
If there is an increase in density within a certain area it will be described with the symbol ( —), for instance 1-3 
shows, that 1, 2 and 3 is present in that area 1, 3 shows that only 1 and 3 is present (A) Density of yellow 
fluorescent terminals in adult rats pretreated with monoamine oxidase inhibitor, from Fbxc (1965) (B) Concen-
trations of serotonin measured by biochemical methods according to SAAVEDRA (1977) The original values, 
given in ng/mg protein have been converted to a semi-quantitative scale 1 <10, 2 10-20, 3 20-30 and 4 
30-40 (C) Indolamine plexuses in rats pretreated with clorgyhne localized by autoradiography according to 
CHAN-PALAY (1977) (D) Number of varicosities visualized in rats pretreated with a monoamine oxidase 
inhibitor according to DFSCARRIES and BEAUDET (1978) (E) Concentrations of serotonin immunoreactivity in 
untreated rats, based on the present study 
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discussion of the serotoninergic system in the hypo-
thalamus and pituitary have been presented elsewhere 
(STEINBUSCH & NIEUWENHUYS, 1980). 
Finally, in comparing the immunofluorescence 
results with the biochemical data of SAAVEDRA et al. 
(1974), I have found that the following fiber systems 
and nuclei have higher, semi-quantitative, concen-
trations than those obtained biochemically, see 
Table IB and E. The data are arranged from rostral 
to caudal: in the telencephalon—the tuberculum olfac-
torium, the nucleus accumbens, the nucleus ìntersti-
tialis striae terminalis, the nucleus interstitialis striae 
medullans, the nucleus septi triangularis, the nucleus 
tractus diagonalis Broca, the nucleus amygdaloideus 
centralis, the nucleus amygdaloideus mediahs, the nu-
cleus amygdaloideus posterior and the nucleus tractus 
olfactoni lateralis; in the diencephalon—the median 
eminence, the area retrochiasmatica, the nucleus 
arcuatus, the nucleus perifomicahs and the nucleus 
premamillans dorsahs; in the mesencephalon—the 
area tegmentalis ventralis Tsai and the substantia grí-
sea centralis ventralis, in the rhombencephalon—the 
nucleus linearis caudalis, the nucleus linearis oralis 
and the area postrema. 
Conversely, only a single nucleus has been shown 
to have a serotonin concentration which is lower in 
the biochemical method than in the presently-used 
immunofluorescence method, namely, in the rhomb-
encephalon; the nucleus tractus soltani. 
From the above, it is clear that the major differ-
ences quantitative, as well as qualitative, have been 
observed in the telencephalon. Most of the areas de-
scribed above occupy only small areas in transversely 
cut slices. In small areas, it is difficult to make 
punches which are strictly confined to that area. Only 
in large regions as, e.g., the nucleus caudatus with a 
rather uniform serotoninergic innervation, can re-
liable and reproducible biochemical results be 
achieved. However, in small areas as, e.g., the nucleus 
arcuatus, it is conceivable that the punch, especially in 
the border-zones, is not only limited to that nucleus. 
In the vicinity of these small regions, groups with high 
to very high innervations have been located. So, if 
there is a difference in innervation between the sur-
rounding areas and the nucleus in question, the bio-
chemical results are not reproducible. 
An additional advantage in using immunohisto-
chemical mapping of serotonin in the central nervous 
system over the F IF or the autoradiographic method 
is that it is not necessary to pretreat the animals with 
a monoamine oxidase inhibitor. In omitting this step, 
the in vwo situation is more closely approached. 
According to FUXE (1965), it is necessary, for visualiz-
ing serotonin with the FIF-technique, to pretreat the 
animals with, for example, reserpine. By this means, 
the catecholaminergic systems wil be depleted of 
amines. Without reserpine, it was not possible for him 
to localize many of the areas in the rhinencephalon, 
telencephalon and diencephalon, known to contain 
serotonin Such a pharmacological manipulation is, of 
course, not necessary for localizing serotomn-immu-
noreactive nerve terminals 
Spinal cord. The results I have obtained concerning 
the distribution of serotonin-positive fibers in the spi-
nal cord are to some extent in conformity with those 
of OLIVERAS, BOURGOIN, HERY, BESSON & HAMON 
(1977) and SEGU & CALAS (1978) Within the white 
matter, it was not possible for us to detect any fluor-
escence in the funiculus dorsahs. This finding tallies 
with the results of SEGU & CALAS (1978), but not with 
those of OLIVERAS et al. (1977). In the remaining parts 
of the white matter, the highest densities were local-
ized at all levels in the medial part of the funiculus 
ventralis. The fluorescent fibers were longitudinally 
oriented. No fluorescence was observed in the ventral 
part of the funiculus lateralis or in the lateral part of 
the funiculus lateralis. These findings are contrary to 
those of OLIVERAS et al. (1977) and SEGU & CALAS 
(1978), who both measured serotonin in the whole 
funiculus lateralis and funiculus ventralis. 
Within the grey matter, the results of the present 
study are not identical with those of either OLIVERAS 
et al. (1977) or SEGU & CALAS (1978) I found high 
densities within the ventrolateral part of the cornu 
\entrale at all levels; very high density in the medial 
part of the cornu ventrale at cervical, lumbar and 
sacral levels and in the cornu laterale at thoracal 
levels. By contrast, the highest concentrations ob-
served by the above cited authors were located within 
the peri-ependymal region, the lateral column, the 
whole dorsal horn and the motor neuron area of the 
ventral horn 
The ventricular supra-ependymal plexus. Our obser-
vations on the innervation of the ventricle walls are 
not in agreement with the findings of AGHAJANIAN, 
BLOOM, LOWELL, SHEARD & FREEDMAN (1966) and 
CHAN-PALAY (1976). Using autoradiography, they 
found a serotonin plexus in all ventricles. However, 
the findings of the present study are in harmony with 
the observations of RICHARDS, LOREZ & TRANZER 
(1973) and LOREZ & RICHARDS (1975), who showed an 
innervation of the ventricular surface of the rhomb-
encephalon, using histofluorescence. I could not con-
firm a serotonin-positive plexus in the ventral part of 
the third ventricle, as described by CHAN-PALAY 
(1977), and found only a weak fluorescent supra-epen-
dymal plexus in the dorsal part of the third ventricle, 
compared to the strongly fluorescent supra-ependy-
mal plexus in the fourth and lateral ventricles. 
CONCLUSIONS 
Immunohistochemistry has provided us with a 
technique by which the serotoninergic system can be 
explored in much greater detail than with any other 
presently available method as, e.g., the FIF-technique 
or autoradiography The intermingling of serotonin-
ergic and catecholaminergic neurons in many nuclei 
makes a critical re-evaluation of the terminology of 
the monoaminergic cell groups, which we are 
presently using, very urgently needed. 
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ABSTRACT 
The localization and distribution of serotonin (5-HT) has in the 
rat brain been studied with the indirect immunofluorescence technique 
of Coons (1958 )using a newly developed, specific antibody to 5-HT. 
This paper contains a detailed description of the distribution of 
5-HT in the hypothalamus and hypophyis and a brief report on the 
localization of 5-HT containing cell bodies. Principally, 5-HT peri-
karya were present in neuron systems with a distribution similar to 
that revealed by the mapping of Dahl ström & Fuxe (1964) with the 
formaldehyde-induced-fluorescence technique (FIF). However, in addi-
tion to the nine areas originally described, several other areas in 
the mesencephalon and rhombencephalon appeared to contain 5-HT cell 
bodies. In the hypothalamus no 5-HT positive neuronal perikarya could 
be observed. However, in'the infundibulum and in the median eminence 
some 5-HT positive tanycytes and mast cells were observed. Serotoner-
gic fibers and terminals are present throughout the hypothalamus . 
Particularly dense plexus of the fibers and terminals have been ob-
served in the lateral hypothalamic area, nucleus mamillaris medialis, 
the nucleus perifornicalis, the nucleus suprachiasmaticus and the 
nucleus ventromedialis hypothalami. All remaining hypothalamic areas 
demonstrate various densities of 5-HT immunoreactive nerve fibers. 
In the pituitary 5-HT-like immunoreactivity have been found in the 
pars nervosa. 
INTRODUCTION 
The presence of serotonin (5-hydroxy tryptamine), in the central 
nervous system was first demonstrated by Twarog and Page (1953) with 
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biochemical methods. Their findings were confirmed fluorimetrically 
'by Bogdansky, Pletscher, Brodie and Udenfriend (1956). Evidence that 
serotonin was localized within the neurons was made possible by the 
development of the formaldehyde-induced fluorescence technique (FIF) 
Falck and Oxman (1952) DahlstrSm & Fuxe (1964) Fuxe 1965; Eränkö 
(1967)'jnfortunately, this method, demonstrating catecholamines as 
well, has a low sensitivety to serotonin. Moreover, the fluorescent 
product formed, the B-carboline, is highly sensitive to irradiation 
resulting in a rapid fading of the fluorescence. Another matter of 
great difficulty is the bad quality of the sections, due to the 
crackforming during freeze-drying of the tissue. The basic mapping 
of the central monaminergic system at the light microscopic level 
has been carried out with the FIF-technique Dahlström 4 Fuxe (1964) 
Dahlström, Haggendal & Atack and Hokfelt, 1966; Fuxe, Hokfelt, 
Nilsson & Reinius (1966).Recent methodological modifications of the 
FIF-technique markedly increased the sensitivity for catecholamines 
but do not seem to represent any clear advantage with regard to the 
visualization of serotonin (Björklund, Lindvall & Svensson, 1972; 
Hökfelt & Ljungdahl, 1972; Fuxe & Jonsson, 1974; Loren, Björklund, 
Falck & Lindvall, 1976; Nygren, 1976 and Furness, Heath & Costa, 
1978).In order to localize serotonin more precisely other, indirect 
techniques were developed. These included: A. The selective destruc-
tion of indolamine neurons by pharmacological manipulations, e.g. 
with 5, 6-dihydroxytryptamine (Fuxe & Joneeon, 1967; Aghajanian, 
Kuhar & Roth, 1973; Kawa, Ariyama, Taniguchi, Kamisaki & Kanehisa, 
1978), 5, 7-dihydroxytryptamine (Baumgarten 4 Lachenmayer, 1972; 
Daly, Fuxe & Jonsson, 1974; Sachs and Jonsson, 1975; Jonsson, 
Pollare, Hallman & Sachs, 1978) or p-chloroamphetamine (Massari, 
Tizabi, Gottesfeld & Jacobowitz, 1978). B. Autoradiographic demon-
stration of •'H-serotonin uptake after injection into the brain ven-
tricles (Calas, Alonso, Arnauld & Vincent, 1974; Descarries, Beaudet 
& Watkins, 1975; Chan-Palay, 1977). С Immunohistochemistry using 
antibodies to the enzymes tryptophan hydroxylase (TrH) and dopade-
carboxylase (DDC) as markers for serotonin (Hokfelt, Fuxe & Gold­
stein, 1973; Joh, Shikimi, Pickel & Reis, 1975; Pickel, Joh & Reis, 
1976). Both enzymes are involved in the biosynthesis of serotonin. 
TrH will catalyze the first step specific, i.e. the conversion of 
tryptamine to 5-hydroxy tryptophan, DDC converts DOPA into dopamine, 
but is also involved in the biosynthesis of the indolamine. D. The 
fourth and most recent technique is based on the combined use of 
labelled ^H -reserpine (Richards, Da Prada, Würsch, Lorez & Pieri, 
1979). For the localization of serotonin with 3H-reserpine chemical 
lesions of catecholaminergic cells with 6-hydroxydopamine are 
necessary (Thoenen & Tranzer, 1973). In the present study a newly 
developed antibody to serotonin for the direct localization of the 
neurotransmitter in the brain is utilized. The aim of this paper is 
to present a detailed description of the localization of serotonin 
in the hypothalamus and hypophysis and a brief summary of the dis-
tribution of serotonin positive cell bodies in the rat brain. 
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A detailed description of the serotonergic perikarya and nerve ter­
minals throughout the central nervous system of the rat will be pub­
lished in a subsequent paper (Steinbusch, in preparation). 
METHODOLOGY 
Preparation of the serotonin-antibodies 
The production of antibodies to serotonin for immunohistochemi-
cal purposes has been described by Steinbusch, Verhofstad & Joosten 
(1978) and Steinbusch 4 Verhofstad (1979). Since the development of 
this technique the following modifications to obtain a conjugate with 
a maximum molar-ratio of bovine serum albumin (BSA)-serotonin have 
been introduced. Serotonin was coupled to BSA with formaldehyde. The 
incubation procedure consisted of 1 ml aquadest in which 9,2 mg sero-
tonin-creatinine-sulphate was dissolved; 28.1 mg BSA in 1 ml aquadest 
1 ml 3M sodium-acetate, pH 6.8 and 1 ml 7.5% formaldehyde. The reac­
tion mixture was incubated at room temperature in a shake water bath 
for 2 hours. Then the pH was adjusted to 6.8 and the incubation was 
continued for an additional 18 hours. The reaction was stopped by 
dialysis against tapwater for 3 days at 4° C. The precipitate was re­
moved by centrifugation at 20000 g. Protein concentration was meas­
ured according to Lowry (1951). Ultraviolet absorption spectra were 
estimated in order to determine the molar-ratio BSA-5-HT. The antigen 
was stored at -20° С until immunization. Antibodies to this conjugate 
were raised in rabbits. Pre-immune serum was obtained from each rab­
bit before the immunization was started. The conjugate was emulsified 
with an equal amount of complete Freund's adjuvant and injected 
intramuscularly at four different sites. Booster doses with incom­
plete Freund's adjuvant were given subcutaneously along the mamil­
lary line at multiple sites at three weekly intervals. Antisera were 
tested by immunodiffusion, Immunoelectrophoresis, and immuno­
fluorescence microscopy. Antisera were purified from non-specific 
BSA antibodies by precipitation and by affinity chromatography using 
a Sepharose-4B-activated BSA column. Albino rats, wistar strain, 
were used, partly untreated, partly after injection of colchicine, 
(either as an intraventricular (20 μ1/75 pg) or as an subcutaneously 
injection (1,2 mg /kg bodyweight) 24 hours before sacrificing. 
Cryostat sections of the brain were incubated according to the in­
direct immunofluorescence technique of Coons (1958). Preparation of 
the tissue and immunofluorescence procedure have been described in 
detail elsewhere (Steinbusch et al., 1978). 
Presentation of results 
The specificity of the immunoreaction was controlled by com­
paring sections incubated with 5-HT antiserum or pre-immuen serum. 
Specific 5-HT stained structures were called 5-HT- immunoreactive. 
For the description of 5-HT positive cell bodies the terminology of 
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Dahlström & Fuxe (1964), using the designations Bl - B9 was used. 
The distribution of 5-HT positive cell bodies are presented on 
schematic drawings of transversel sections through the brain stem. 
The same procedure was used in the hypothalamus. The density of the 
immuno reactive nerve fibers were classified in six categories: a) 
'no fluorescence (o); b) single fibers (+); c) low density (1); 
d) medium density (2); e) high density (3) and f) very high density 
(4). The density as indicated in the fig. 3 are based on at least 
six different series of sections. The number of 5-HT positive cell 
bodies in a certain area or nucleus, are revealed in colchicine-
treated rats and indicated by different symbols denoting 3-10 cells 
and 10-20 cells. The schematic drawings are essentially the same as 
those used by Ljungdahl, Hökfelt & Nilsson (1978). They are based 
upon the atlasses of König & Klippel (1963), Jacobowitz & Palkovits 
(1974) and Palkovits 4 Jacobowitz (1974). 
RESULTS 
Specificity of the immunoreaction 
In order to investigate the specificity of the newly purified 
antiserum against serotonin in immunofluorescence microscopy serum 
samples were incubated with different concentrations of substances 
which might cross-react with the serotonin antibody, fig. 1. These 
experiments revealed, that there is a cross-reactivity of less than 
2% to 5-MT and DA, less than 0.5% to NA and less than 0.1% to A 
under the conditions used. 
As already mentioned in the Methodology section, the procedure 
for preparing the antigen has been modified. Experiments showed that 
several conditions are necessary to fulfill to obtain a maximum 
molar-ratio of BSA-serotonin. These include : 1. a ratio of BSA : 
5-HT of 6 : 1; 2. a pH between 6.6 and 6.8; 3. a final concentration 
of BSA of 6.5 mg/ml and 4. an incubation time of between 20 and 24 
hours. Fig. 2 show the relation between variance of the -H and the 
coupling of 5-HT to BSA. It can be seen that at pH 6,8 the differ-
ence between &28o/^55 r e a c n e s his maximum. 
The results of the serotonin-like imminoreactivity will be discussed 
under the following headings: 
1. Detailed description of the distribution of serotonin in the 
hypothalamus and hypophysis, and 11. Brief review of the serotoner-
gic perikarya in the brain. 
1. Detailed description of the distribution of serotonin in the 
hypothalamus and hypophysis 
General remarks 
In the hypothalamus no 5-HT-immuno reactive perikarya could be found. 
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Fig. 1. Schematic illustration of inhibition experiments. A serie 
of consecutive sections of the medullae oblongatae was incubated, 
with an antiserum to serotonin. Diluted 1 : 500. Increasing con-
centration of 5-hydroxytryptamine, 5-methoxytryptamine, dopamine, 
noradrenaline and adrenaline have been used. The coded sections were 
examined independently by two observers. Fluorescence intensity of 
the nerve terminals was rated to the scale 0, +(weak), ++ (medium), 
and +++ (strong). 
Only nerve fibers were observed. The density of the nerve fibers 
differs in the various parts of the hypothalamus. A H hypothalamic 
nuclei seem to contain at least some 5-HT-immuno reactive nerve 
fibers. The only stained cells are reprensenting either glia cells 
in the infundibulum or tanycytes and mast cells in the median 
eminence, see fig. 6c. 
5-HT-like immunoreactive fibre structures in the hypothalamohypo-
physeal complex. 
The fibre structures may represent axons or nerve terminals. 
A summary of the results has been presented in Table 1. In the 
description of the serotonin-positive innervation of the hypo-
thalamus three areas: lateral, medial and infundibular will be dis-
tinguished. Within the hypothalamus there are no negative nuclei. 
a. Lateral hypothalamus. High to very high concentrations have been 
found in the following areas. In the medial part of the medial 
forebrain bundle (MFB) at level A 6860. This density extends into 
the lateral zone of the nucleus preopticus medialis, see fig. 3. 
In the intermediate part of the lateral hypothalamus the MFB shows 
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Fig. 2. Influence of the pH on the formation of the BSA-serotonin 
conjugate. 
only a medium density. Caudally, we observed high to very high den-
sity in the dorsomedial and lateral part of the MFB, i.e., the part 
adjacent to the fornix, see fig. 4a. Besides of this part there is 
medium to high density in the ventrolateral to lateral part of MFB. 
In the posterior hypothalamus only the dorsomedial concentration is 
present. In the intermediate and rostral part of the lateral hypo-
thalamus we have observed a large area of to very high density. In 
the dorsal part of this area is the MFB situated. The rest of this 
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Table 1. 
Hypothalamus 
0 CO chiasma opticum 
2 CSDD commissura supraoptica dorsalis, pars dorsalis (Ganser) 
0 - I CSDV commessura supraoptica dorsalis, pars ventralis Meynert 
0 F fornix 
1 FMT fasciculus mamillothalamicus 
0 - 1 FS fornix superior 
1 ME median eminence 
2 - 4 MFB medial forebrain bundle 
2 PCMA pedunculus corporis mamillaris 
0 - 1 RC area retrochiasmatica 
2 SUM decussatio supramamillaris 
0 TO tractus opticus 
na 
ndm 
nha 
nhp 
nml 
1 
1 - 2 
1 
2 - 3 
3 
2 and 4nmm 
1 - 2 npe 
4 
1 
1 
1 - 2 
1 - 2 
npf 
npl 
npmd 
npmv 
npv 
I and 4nsc 
nso 
nvm 
nvma 
pol 
pom 
pop 
pos 
1 
2 - 4 
1 
1 - 2 
1 - 2 
0 - I 
1 - 3 
nucleus arcuatus 
nucleus dorsomedialis hypothalami 
nucleus hypothalamicus anterior 
nucleus hypothalamicus posterior 
nucleus mamillaris lateralis 
nucleus mamillaris medialis 
nucleus periventricularis hypothalami 
nucleus perifornicalis 
nucleus mamillaris prelateralis 
nucleus premamillaris dorsalis 
nucleus premamillaris ventralis 
nucleus paraventricularis hypothalami 
nucleus suprachiasmaticus 
nucleus supraopticus 
nucleus ventromedialis hypothalami 
nucleus ventromedialis anterior hypothalami 
nucleus preopticus lateralis 
nucleus preopticus medialis 
nucleus preopticus periventricularis 
nucleus preopticus suprachiasmaticus 
Different concentrations of serotonin-like immunoreactivity in the 
hypothalamus of non-colchicine-treated rats. The variation in den-
sities were estimated subjectively according to the following sym-
bols: 
0 no fluorescence; 1 low density; 2 medium density; 3 high density; 
4 very high density. 
area expands to the basal surface and to the tractus opticus. In the 
caudal part of the lateral hypothalamus we have observed long 
fibers, which are leaving the MFB pass medialy to the ventricle, 
above the tractus opticus. 
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Figure 3. Serotonin-like immunoreactivity in the hypothalamus 
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Fig. 4. Medial forebrain bundle (MFB, level A 4620), (B) MFB, (le-
vel A 2580) in untreated rats after incubation with 5-HT antiserum. 
(A) In the dorsomedial part of the MFB small bundles of fibers ex-
tending out the bundle, the fornix has no fluorescence. (B) The 
whole MFB has a high density. Long, small axons, with only very few 
varicosities, are running into the decussatio supramamillaris. Bars 
indicate 50 ym. 
b. Medial Hypothalamus. In the rostral part of the medial hypotha-
lamus every highly innervated region is observed in the ventro-
lateral part of the nucleus preopticus suprachiasmaticus, which con-
tinues in the caudoventral part of the nucleus preopticus supra-
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Fig. 5. (A,В) nucleus suprachiasmaticus (sc, level A 6280) in trans­
versal and (С) in sagital sections of untreated rats after incu­
bation with 5-HT antiserum. (A,B) The ventromedial part of the 
nucleus suprachiasmaticus shows a very high density. Bars indicate 
50 um. 
chiasmaticus and further in the nucleus suprachiasmaticus itself, 
see fig. 5a, b, c. Very high density has been found in the central 
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pert of the nucleus ventromedialis hypothalami. A high innervation 
has been observed in the roetroventral and caudoventral part of this 
nucleus. In the caudal part of the medial hypothalamus a high den­
sity has been seen at level A 3750 in the region between the nucleus 
arcuatus and the nucleus ρremami11aris dorsalis and the premamillaris 
ventralis. In the posterior hypothalamus three areas with a very high 
density of serotonin-like immunoreactivity are localized: first, the 
caudal part of the nucleus hypothalamics posterior; second, a very 
high innervation of the whole ventral part of the nucleus mamillaris 
medialiβ and third, a region at level A 2790, between the fasciculus 
mamillothalamicus and the fasciculus mamillotegmentalis. 
с Infundibular region. The fluorescence intensity of the median 
eminence is low. The fibers, which are localized in the lateral part 
of the external zone of that structure are not ramified and pass to 
the portal system of the pituitary complex, see fig. 6b. In the ros­
tral part of the median eminence the fibers appeared to be more nu­
merous than in the caudal part. Rostral those fibers are running 
near the ventral surface in the direction of the nucleus arcuatus. 
In the medial part of the infundibulum we have localized some weak­
ly fluorescent cells, the elongated cell bodies,which are situated 
close to the ventricular surface. Their radially arranged processes 
extend into the external zone of the median eminence. Most probably, 
these elements represent tanycytes, see fig. 7a,b. In the pituitary 
we have observed serotonin-positive fibers in the pars nervosa of 
posterior lobe, with the highest concentration in the zone adjacent 
to the pars intermedia. No fluorescence was observed in the pars 
intermedia and the pars distaile, see fig. 6a. 
II. Brief review of the serotonergic perikarya in the brain 
For the localization of S-HT positive cell bodies, untreated and 
colchicine pre-treated rats were used. It appeared that in the col­
chicine pre-treated rats a) the intensity of the fluorescence of the 
cellbodies is higher, and b) the number of fluorescent cellbodies is 
significantly larger than in untreated rats. For the description of 
the cellgroups we will use the terminology, Bl - B9, as allready 
mentioned in Methodology. The localization of the serotonin-positive 
cellbodies has been presented in fig. 8 and 9. 
Bl. The vast majority of cells of this group is situated within the 
nucleus raphe pallidus. Some cells have been found dorsal to the 
nucleus accessorius olivaris dorsalis and between the nucleus reti­
cularis medullae oblongatae, pars ventralis and the nucleus reticu­
laris paramedianus. Some cells were present ventrol medial o.f the 
nucleus reticularis lateralis, see figure 10a, b, c, d; level Ρ 7400. 
B2. Most elements of this group are situated within the confines of 
the nucleus raphe obscurus. Some cells within the nucleus reticula­
ris paramedianus and in the area, which is bordered by the nucleus 
olivaris inferior; the nucleus reticularis medullae oblongatae, pars 
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Figure 8. Localization of serotonin-positive cell bodies in the 
brainstem 
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Figure 9. Serotonin-positive ce l l bodies in the 
brainstem 
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Fig.6. (A) Horizontal section through the pars nervosa (pn), pars 
intermedia (pi) and pars distalis (pd) of the pituitary, (В,С) the 
median eminence (ME) in untreated rats after incubation with 5-H1 
antiserum. (A) Serotonin positive fibers have been only observed in 
the pars nervosa. (B,C) A rich 5-HT positive innervation has been 
found in the ME, (C). A tanycyte reaches from the recessus infundi-
bularis until the portal system. Bars indicate 50 urn. 
Fig.7. (A,B) Sagittal section through the infundibulum stalk. Un­
treated rats after incubation with a 5-HT antiserum. In the infun­
dibulum stalk weakly fluorescent glia cells have been observed. Bars 
indicate 50 ym. 
Fig.10. (A,B) Nucleus raphe obscurus, nucleus raphe pallidus (ro.rp; 
level Ρ 6000) and (C,D) inferior olive complex (io; level Ρ 6000) 
in colchicine treated rats after incubation with 5-HT antiserum. 
(A,B) 5-HT positive cells are seen within the ro and rp. Two cell-
groups in which the ro belongs to the B2 group and the rp to the Bl-
group. (C,D) Some cells were seen ventrolateral of the inferior olive 
complex. The tractus corticospinalis is complete negative. Bars 
indicate 50 ym. 
Fig.11. Consecutive sections of colchicine treated rats through the 
nucleus raphe dorsalis and nucleus centralis superior, (rd, ncs; 
level Ρ 100) (A) was counterstained with cresyl-violet, (B) was in­
cubated with an 5-HT antiserum. Some 5-HT positive cells have been 
visualized in the dorsomedial part of the FLM. In the ncs only a 
small percentage of all cells has been serotonergic. Bars indicate 
50 ym. 
ventralis and the decussation pyramidis should also be considered as 
belonging to this group, level Ρ 6000. 
B3. Most cells of this group are localized in the nucleus raphe mag-
nus and in the corpus trapezoideum. Some cells have been found in an 
area surrounded by the tractus corticospinalis; the nucleus paroli-
varis superior and the nucleus corporis trapezoidei, level Ρ 4500. 
B4 is a small cell group, situated close to the lateral part of the 
nucleus vestibularis medialis, level Ρ 4500. 
B5. The main group is present in the nucleus raphe pontis. However, 
according to our observations this group comprises in addition a 
number of cells situated more dorsally between both medial longitu­
dinal fascicles, level Ρ 2000. 
B6. Serotonergic cells have been seen in the periventricular gray 
under the rostral part of the fourth ventricle, level Ρ 2000. 
B7. The vast majority of the cells of this group are localized with­
in the nucleus raphe dorsalis. A few cells appeared to be present 
in an area directly lateral to the nucleus nervi trochlearis, see 
fig. lla,b;level Ρ 1000 - A 900. 
B8. This group is largely coextensive with the nucleus centralis 
superior. However, some additional cells have been found within the 
tegmental decussations, the nucleus interpeduncularis and the dor­
sal part of the nucleus linearis oralis. The ventral part of the 
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latter nucleus ie entirely composed of non-eerotonergic cells, see 
fig. lla.b and 12; level Ρ 1000-Ρ 100. 
B9 is formed by a group of cells localized in and around the lemnis­
cus medialis in the mesencephalon from level Ρ 1000 to A 1400. Some 
celle have been found in the nucleus ruber, the pedunculus marni11a-
ris, the area tegmentalis ventralis Tsai and the area bordered by 
the nucleus cuneiformia, the tractus rubrospinalis, the lemniscus 
medialis, the pedunculus cerebellaris superior and the tractus tec-
tospinalis. Finally, some S-HT positive cells were observed in the 
ventral part of the locus coeruleus and in the so-called subcoeru-
leus area, level Ρ 2800. 
DISCUSSION 
The specificity of the Immunofluorescence method used In the 
present investigation has been discussed at length in previous pa­
pers (Steinbusch, Verhofstad 4 Jóosten, 1978; Steinbusch & Verhof-
stad, 1979). Briefly, it may be stated that 1. The inhibition ex-
periments demonstrated the presence of a certain degree of cross 
reactivity of the antiserum. 2. There is a negative staining in 
areas known to contain DA and NA cell bodies, for instance the locus 
coeruleus, see fig. 13; 3. There is a good correspondence between 
the neurons visualized with anti-DDC and those visualized with 
anti-5-НТ. Treatment of consecutive sections with an antiserum to 
5-HT and to DDC shows, that the same neurone observed in the pre­
parations treated with anti-5-НТ are also present in those treated 
with anti-DDC. However, in the preparations treated with the latter 
serum, in addition numerous catecholaminergic neurons have been ob­
served. 4. Negative immunoreactivity has been found after treatment 
with 5,6-dihydroxytryptamine. 
Serotonergic nerve terminals in the hypothalamus and pituitary 
The serotonergic innervation of the hypothalamus have been pre­
viously described by Fuxe (1965), Ungeretedt (1971) and more recent­
ly by Kent & Sladek (1978). Fuxe confined himself to stating that 
hypothalamus receives a rich 5-HT innervation. These observations 
were based on the FIF-technique. Our results are in agreement with 
the findings of Ungerstedt (1971) who described a major system of 
5-HT containing fibers ascending by way of the MFB. The density of 
serotonergic fibers within that bundle varries from medial density 
to very high density. The highest density has been found in the 
dorsomedial part of the MFB, the zone adjacent to the fornix. Our 
results are conform the findings of Saavedra, Palkovits, Brownstein 
4 Axelrod (1974). They reported the presence of serotonin concentra­
tions in allmost all hypothalamic nuclei, using an enzymatic-isoto-
pic technique. However, it was not possible for him to determine 
local differences in concentrations within the nuclei. In general 
our results are in agreement with those of Saavedra, 1977. However, 
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Fig. 13. (A,B) Immunofluorescence photomicrographs through the locus 
coeruleus. (A) after incubation with 5-HT-antiserum, (B) after incu-
bation with an antiserum against Noradrenaline. In the locus coerulus 
a high density has been observed of serotonin-positive nerve termi-
nals. (B) Many NA-positive perikarya were located. Bars indicate 50 
um. 
the immunofluorescence technique enabled us to detect local differ-
ences, which was not possible with the punch-technique of Saavedra, 
1977. First: we have found in the whole hypothalamus no negative 
nuclei and only three negative areas: the chiasma opticum, the for-
nix and the tractus opticus. Kent & Sladek (1978) studied the dis-
tribution of the serotonergic innervation of the hypothalamus using 
the FIF-technique. Using this procedure they did not find any sero-
tonergic fibers in the nucleus hypothalamicus anterior, the nucleus 
ventromedialis hypothalami and the nucleus dorsomedialis hypothala-
mi, three of the major medial hypothalamic nuclei. Since it was 
possible for us to detect a low density in these nuclei and since 
there results are conform biochemical measurements we have to consi-
der that our method a more sensitive. The area in which we have 
found striking differences with other authors is the nucleus arcua-
tus. We have observed in that nucleus single fibers to low density. 
However, Saavedra et al. (1974) reported on the basis of a biochemi-
cal analysis of specific nuclei by microdissection-punch technique a 
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high concentration of serotonin in the nucleus arcuatus. Kent & Sla-
dek (1978) using the FIF-technique also observed high serotonin con-
centrations. We have to realize that these techniques cannot differ 
between the different indolamines with their technique. These differ-
ences between our findings and those of the authors mentioned could 
be explained by the low crossreactivity of our antiserum to other 
tryptamines. It is well known, that with the FIF-procedure a differ-
entiation between different indolamines cannot be made. Our results 
show, that especially the hypothalamus is one of the highest seroto-
nin-innervated areas within the central nervous system. As regards 
the localization of serotonin in the pituitary our findings differ 
in some respects from those of Saavedra, Palkovits, Brownstein and 
Axelrod, 1975. According to our observations serotonin is only pre-
sent in the posterior lobe, with highest concentrations in the zone 
adjacent to the intermediate lobe. Saavedra et al. (1975) reported 
only high concentrations in the posterior lobe, but also medium and 
low activity in the intermediate and anterior lobes, respectively. 
Our results are also in contrast to the findings of Bjorklund & 
Falck (1969) who, using the FIF-technique, have found serotonin in 
the pituitary with highest concentrations in the intermediate and 
posterior lobe. But again this may be explained by the impossibility 
to distinguish between the different indolamines using the FIF-pro-
cedure. Bjorklund and Falck (1969) reported already the presence of 
tryptamine-like indoleamines in the anterior pituitary. However, our 
technique has almost no cross-reactivity to the tryptamines, as for 
instance 5-methoxy-tryptamine. Thus in our case we are not localizing 
any other compound as 5-HT in the pituitary. Using antibodies to 
other indolamines could solve this problem. 
The localization of serotonergic fibers in the posterior lobe, 
situated in the borderzone between the pars nervosa and the pars in-
termedia suggests, that serotonergic mechanisms are involved in the 
regulation of the activity of peptidergic cells in the pars inter-
media. The peptide with the highest concentration within the pars 
intermedia is ot-MSH. There has been evidence obtained by ultraetruc-
tural studies in the eel (Olivereau and 01ivereau, 1979) and bioche-
mical data on Anolis carolinensis that 5-HT induce ot-MSH releaee and 
darken green lizards (Thronton and Geschwind, 1975). Those regula-
tion could be a non-synaptic intercellular diffusion of serotonin 
and caused in that way a 5-HT release promoting factor. 
Serotonin - positive cellbodies 
The use of colchicine treated rats permitted the detection of 
certain serotonin - positive perikarya, which have not been de-
scribed so far previously in untreated rats. Colchicine treatment 
inhibits axonal transport and thereby enhances an increase in fluor-
escence intensity within the cell bodies. In the broad outline our 
observations concerning the distribution of 5-HT positive cell bo-
dies are in harmony with those of Dahlström & Fuxe, 1964. However, 
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we observed that the cells of seven of the nine B-groups are more 
widely distributed than indicated in the description of Dahlström & 
Fuxe (1964) The investigations of Levitt and Moore,(1978), demonstra-
ted that the scattered serotonergic neurons, occuring in the mesen-
cephalic and pontine reticular formation, have failed to migrate pro-
perly during embryogenesis. 
Besides of the described areas we were able to localize in the 
ventromedial part of the locus coeruleus and in the dorsal part of 
the subcoeruleus 5-HT positive perikarya. These cells have not been 
described by Dahlström & Fuxe (1964) using the FIF - technique 
nor by Pickel, Joh and Reis (1977) using immunohistochemistry. 
Pickel et al. (1977) postulated, that no neuronal perikarya in the 
locus coeruleus contained TrH. Sladek & Walker, (1977) who also have 
used the FIF-procedure in a primate and Léger & Descarries (1978) 
using autoradiography could also demonstrate the existence of 5-HT 
positive cellbodies in the locus coeruleus and subcoeruleus. Sladek 
& Walker, (1977) held that these elements have probably failed to 
migrate toward the raphe during ontogenesis. 
In the hypothalamus we have not found any 5-HT positive cell 
bodies. This negative result is in contrast with the study of Chan-
Palay (1977) using autoradiography. She reported the presence of 
5-HT nerve cell bodies in several hypothalamic nuclei. Beaudet and 
Descarrie? (1979 J also using autoradiography reported 5-HT perikarya 
in the nucleus hypothalamics dorsomedialis, pars ventralis and Kent 
& Sladek (1978) using the FIF-technique demonstrated yellow fluor-
escence in the nucleus arcuatus. It should be emphasised that at high 
concentrations of serotonin 5-HT can accumulate in tubero-infundibu-
lar dopaminergic neurons (Lichtensteiger, Mutzner & Langemann, 1967). 
The study of Fuxe & Ungerstedt (1968) showed that amines injected into 
the cerebral ventricles only reach a limited zone around 300 um wide 
surrounding the ventricles and the ventral part of the subarachnoi-
dal space. They also demonstrated, that the specificity of autoradio-
graphy is concentration dependent. We have only described high inner-
vations of 5-HT-immunoreactivity in the autoradiographic mentioned 
hypothalamic nuclei. In our opinion the difference between autora-
diographic studies and our technique can be explained in two differ-
ent ways. Either Η-serotonin containing cell bodies do not contain 
serotonin, but are dopaminergic. There could be a non-specific up­
take of serotonin in dopaminergic neurons, due to the high concen­
trations of Η-serotonin, which are used by the above cited authors, 
or another indolamine could be involved in the hypothalamus, which 
has been described by Björklund, Axelsson & Falck (1976)and Green, 
Koslow and Costa (1972^ Further experiments will be necessary to 
prove, that the 5-HT-accumulating hypothalamic neurons are containing 
no other type of indolamine. Studies in this field are in progress. 
CONCLUSION 
We have presented a further development of the immunofluorescence 
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technique using antibodies directed against eertonin. The specifi-
city and sensitivity of the reaction has been increased. The sero-
tonin-containing system has the widest distribution of the yet known 
neurotransmitters within the whole central nervous system, even when 
wiï compare it with the noradrenergic system, mapped by Swanson & 
Hartman (1975), Jacobowitz & Palkovits (1974) and Palkovits & Jacobo-
witz, 1974, or the Substance-P system, mapped by Ljungdahl et. al. 
(1978). 
ABBREVIATIONS 
atv area tegmentalis ventralis Tsai 
CAI capsula interna 
CC crus cerebri 
cm nucleus centromedianus thalami 
CO chiasma opticum 
CSDV comraissura supraoptica dorsalis, pare ventralie (Meynert) 
CT corpus trapezoideum 
DT decussationes tegnenti 
ер nucleus entopeduncularis 
F fornix 
FLM fasciculus longitudinalis medialis 
FHT fasciculus mamillothalamicus 
FR fasciculus retroflexus 
g nucleus gelatinosus thalami 
iom nucleus accessories olivaría mediali· 
ip nucleus interpeduncularis 
LM lemniscus medialis 
ME median eminence 
MFB medial forebrain bundle (fasciculus medialis prosencephala) 
na nucleus arcuatus 
nee nucleus centralis superior 
ndm nucleus dorsomedialis hypothalami 
nha nucleus hypothalamicus anterior 
nhp nucleus hypothalamicus posterior 
nist nucleus interstitialis' striae terminalis 
nmm nucleus mamillaris medialis 
npc nucleus periventricularis hypothalami 
npf nucleus perifornicalis 
npmd nucleus premamillaris dorsalis 
npmv nucleus premamillaris ventralis 
nrp nucleus reticularis paramedianus 
nsc nucleus suprachiasmaticus 
neo nucleus supraopticus 
ntd nucleus tegmenti dorsalis (Gudden) 
ntv nucleus tegmenti ventralis (Gudden) 
nvm nucleus ventromedialis hypothalami 
nvma nucleus ventromedialis anterior 
η IV nucleus motorius nervi trochlearis 
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η VII nucleus nervi facialis 
PCS pedunculus cerebellaris superior 
pol nucleus preopticus lateralis 
pom nucleus preopticus medialis 
pop nucleus preopticus periventricularis 
pos nucleus preopticus suprachiasmaticus 
rd nucleus raphe dorsalis 
re nucleus reuniens 
rh nucleus rhomboideus 
ro nucleus raphe obscurus 
rp nucleus raphe pallidus 
RTI radatio thalami inferior 
SM striae medullar!s thalami 
spf nucleus subparafascicularis 
ST striae terminalis 
sut nucleus subthalamicus 
TCHL tractus corticohabenularis lateralis 
TO tractus opticus 
tpm nucleus posteromedianus thalami 
tv nucleus ventralis thalami 
tvm nucleus ventralis medialis thalami pars magnocellularis 
zi zona incerta 
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SUMMARY · 
The nucleus raphe dorsalis of the albino rat has been 
studied in the following three ways : (I) the cell mass was 
subjected to a detailed cytoarchitectonic analysis, based upon 
Nissl-stained material ; (2) serotonin — as well as the 
noradrenaline — immunoreactive neurons present in the area 
of the nucleus raphe dorsalis were plotted ; (3) following large 
injections of the fluorescent dye propidium iodide into the 
caudatoputamen complex, the cells in the nucleus raphe 
dorsalis projecting to this complex were labeled and 
subsequently stained with an antibody against serotonin. 
Cytoarchitectonic analysis showed that three cell types are 
present within the confines of the nucleus raphe dorsalis : 
small, medium and large. Moreover, differences in concentra­
tions of cell bodies made it possible to subdivide the nucleus 
raphe dorsalis into four regions. Immunochistochemical 
analysis showed that the borders of the serotoninergic cell 
groups B6 and B7 of DAHLSTRÖM and FUXE do not coincide 
with those of the nucleus raphe dorsalis. Serotonin-immuno-
reaclive penkarya in the nucleus raphe dorsalis were cat-
egorized as medium and large neurons ; noradrenaline-
immunoreactive neurons in the nucleus raphe dorsalis do all 
belong to the category — large neurons. With the combined 
use of immunofluorescence and fluorescent retrograde 
tracing, it was found that the projection from the nucleus 
raphe dorsalis to the caudatoputamen complex originates 
from serotoninergic as well as non-serotoninergic cells, both 
of which can be categorized as being medium-sized neurons. 
The data presented in this paper provides a guide for 
further studies of alferent and efferent connections ol 
the nucleus raphe dorsalis and for electrophysiological 
experiments on its constituent neurons. 
Key-words : Nucleus raphe dorsalis. Serotonin. Noradrenaline. 
* Reçu en premiere lecture le IS septembre I960, en deuxième lecture le 
7 novembre 1980 
Ί his work was partly supported by the Netherlands Organization lor the 
Advancement of Pure Research (Z W.O ) 
INTRODUCTION 
The nucleus raphe dorsalis (NRD) is a large, 
distinct cell mass situated in the tegmentum of the 
mesencephalon and pons. Before the development of 
the formaldehyde-induced fluorescence (F1F) technique, 
which allows microscopic visualization of monoamines 
in freeze-dned tissues (FALCK et al., 1962), little was 
known about this cell group and its projections. With 
the aid of the above mentioned technique and later 
modifications ( D A H L S T R Ö M and F U X E , 1964 ; F U X E 
and JONSSON, 1967 ; BJÖRKLUND el al., 1971 ; F U X E 
and JONSSON, 1974 ; JONSSON el al., 1975 ; AZMITZIA 
and HENRIKSEN, 1976 ; BJÖRKLUND el al., 1976 ; 
LOREN et al., 1976 ; SMIALOWSKA, 1979) it has been 
shown that the nucleus raphe dorsalis contains 
numerous serotonin-synthesizing cells which give rise to 
both ascending and descending fibres The ascending 
fibres constitute two bundles, known respectively as the 
dorsal and ventral serotoninergic bundles. The fibres of 
the dorsal bundle terminate mainly in the caudatus-
putamen complex, whereas those of the ventral bundle, 
al tei having traversed the medial torebrain bundle, 
innervale a considerable number of other telencephalic 
and diencephalic centres. The descending libres of the 
nucleus raphe dorsalis are distributed to the cerebellum, 
the lower brain stem and the spinal cord. The presence 
of the projection, just mentioned, has also recently 
been demonstrated with (non-transmitter-specific) 
anterograde and retrograde tracer t echn iques 
(BOBILLIER et al., 1976 ; CONRAD et al., 1976 ; DRAY 
et al., 1976 ; GEYER et al., 1976 ; HALARIS et al., 
1976 ; FlBlGER and MILLER, 1977 ; A G H A J A N I A N et 
al., 1978 ; AZMITZIA and S E G A L , 1978 ; GALLAGER 
and P E R T , 1978 ; JACOBS et αι., 1978 ; M O O R E el al.. 
1978 ; VAN DER KAR and LORENS, 1979 ; T O H Y A M A et 
al., 1980 ; VEEN1NG el al., 1980). Although the studies 
clarified the distribution of the efferents of the nucleus 
raphe dorsalis to a considerable extent, many questions 
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concerning the structural organization of the nucleus 
itself remained unresolved. Thus, DAHLSTRÖM and 
FUXE (1964) reported the presence of two groups of 
indolaminergic cell bodies in the area of the nucleus 
which they initially labeled B6 and B7. However, the 
exact relationship between these two cell groups and the 
nucleus raphe dorsalis as a cytoarchitectonic entity has 
not been assessed so far. Moreover, it has been 
established that in the area of the nucleus raphe 
dorsalis, in addition to serotoninergic neurons, cells 
containing several putative transmitters, do occur i.e. 
dopamine (OCHI and SHIMIZU, 1978 ; NAGATSU et al., 
1979), noradrenaline (GRZANNA and MOLLIVER, 1980), 
gamma-aminobutyric acid (GABA) (NANOPOULOS et 
al., 1980), enkephalin (UHL et ai, 1979 ; HÖKFELT et 
al., 1979) and vasoactive intestinal polypeptide (VIP) 
(SIMS et al., 1980). However, again the relationship 
between these neurons and the cytoarchitectonic entity 
nucleus raphe dorsalis remains to be established. This 
observation that the nucleus raphe dorsalis is not 
exclusively composed of serotoninergic neurons calls 
for a specification of the efferent fibres in terms of the 
transmitter carried by them. 
The aim of the present study is threefold : firstly, 
to subject the nucleus raphe dorsalis to a detailed 
cytoarchitectonic analysis ; second, to describe the size, 
shape and position ot the serotonin- and noradrenaline-
immunoreactive perikarya within the nucleus raphe 
dorsalis ; third, to obtain evidence concerning the 
relative number of serotoninergic cell bodies in the 
nucleus raphe dorsalis, projecting to the caudate-
putamen complex, and to consider the question whether 
these neurons have a preferential position within that 
nucleus. For this purpose, immunofluorescent staining 
of serotonin-containing cells was combined with 
fluorescent retrograde tracing by propidium iodide. 
MATERIAL AND METHODS 
For this study, adult male albino rats (160-180 g) were used. 
Some animals were fixed by perfusion with 4 Щ formaldehyde. 
Brains were dissected, dehydrated and embedded in paraffin. 
Transverse and saggital sections of IS Mm thickness were cut on a 
rotary microtome and stained with cresyl violet (Nissl), or according 
to the technique of KLÜVER and BARRERA (1953) 
In order to visualize serotoninergic and noradrenergic neurons, 
the peroxidase-anti-peroxidase (PAP) technique of STERNBERGER el 
al. (1970), as applied by GRZANNA el al. (1978), was used 
Animals were pretreated wiih Nialamide (SIGMA), used as a 
monoamine-oxidase inhibitor, 100-200 mg/kg body weight All 
injections were given 2 h before perfusion intrapentoneally. 
The animals were anaesthetized with sodium pentobarbital 
(Nembutal, 60 mg/kg body weight, intraperitoneal) and perfused 
through the left ventnele of the heart with 40 ml icecold Ca* *-free 
Tyrodc's solution This solution was saturated with a mixture of 
95 % 0 2 and 5 % C 0 2 gas one hour pnor to perfusion. This pre-
Journal de Physiologie 
perfusion was followed by 400 ml, icecold, 4 0^ (w/v) para-
lormalüehyde dissolved in 0 Ι M sodium phosphate buffer, pH 7 3 
(Pi \м , 1962) lor serotonin staining, or 4 Ч'о (w/v) para­
formaldehyde - 0.5 % (v/v) glutaraldehydc in the same buffer for 
noradrenaline staining, lor 20 mm at a pressure ot 50 mm Hg. 
Brains were promptly removed and cui into 5*8 mm slabs in 
either the transverse, sagittal or horizontal directions. The tissue 
pieces were posi-fixed for 90 mm at 4 °C in the same fixative and 
washed for at least 4 h in a mixture of 5 % sucrose dissolved in 0.1 M 
sodium phosphate buffer, pH 7 3, at 4 °C. Tissue pieces were 
mounted on the Vibratome stage with a cyanoacrylale adhesive. After 
a dry period of 5 min, the tissue slices were kept in icecold 0.1 M 
sodium phosphate buffer, pH 7.3 Serial sections of 50-100 um 
thickness were cut, and collected in counting tubes 
The sections were first incubated overnight at 4 °C with a rabbn 
antiserum to serotonin (76 mg/m I ; STEINBLSCH and NIEUWENHUVS, 
1980) or pre-immununeserum, diluted 1 -1000 with phosphate-buffered 
saline (PBS), which contained 0 2 % (νΛ) Triton Х-ІО0 Alter­
natively, on transverse sections an antibody raised in sheep against 
a BSA noradrenaline conjugate was used (SIEINBUSCH el al, 1981 ; 
VERIIOI-SIAU el al, 1980) at a dilution of I . 500 All subsequent steps 
were carried out at room temperature Sections were washed for 10 min 
with PBS containing 0 I la Triton X I 0 0 , followed by a wash in PBS, 
also lor 10 mm. Then, they were incubated with a 1 • 30 dilution of a 
goat-anti-rabbit antiserum (1 mg/ml) for ihe seroionin antibody, or 
swine-ann-sheep antiserum, for the noradrenaline antibody, in PBS for 
two hours (goal antirabbit lgG/Fc-specific, Nordic, Tilburg, The 
Netherlands , swine-anti-sheep IgG, Capei Laboratories, U.S A ). 
hollowing two 10 mm washes in PBS, a rabbit peroxidase-anti-
peroxidase complex (PAP) (Dakopatts, Denmark) or a sheep-PAP 
complex (Capel Laboratories, U.S.A.) were applied in a dilution of 
I 60 in PBS. Aller 1 hour incubation, sections were washed two times 
for 10 mm with PBS Then, they were put in a solution containing 3.3-
diaminobenzidme-HCI (SII.MA, 0.75 mg/ml) and CaCI2 (120 /iM) in 
50 mM Tns-HCI, pH 7 7 ; after 10 mm H 2 0 2 was added in a final 
concentration of 0.003 "A and the reaction was earned out for an 
additional 15 min Sections were briefly rinsed in PBS and floated on 
glass slides, coated with chrome alum gelatine. They were then air dried 
over night Sections were postfixed with 2 % glutaraldehyde in PBS. 
For permanent storage, sections were dehydrated and mounted in 
DePeX (Gurr) 
For retrograde axonal tracing, the fluorescent dye propidium 
iodide (KUYPERS el al. 1979 ; VAN OER KOOI and STEINBUSCH, 1981) 
was employed. Under pentobarbital anaesthesia, 0.6 μΐ 5 Щ 
propidium iodide (PI) dissolved in distilled water was injected 
unilaterally into the caudate-putamen complex of six animals The 
size οΓ the injections was determined by sectioning the whole 
torebrain and counterstaining according to KLUVEH and BARRERA. 
The non-injected contralateral side served as a control. It appeared 
that on the side of the injection, more than 80 <?· of the total area of 
the caudatoputamen was infiltrated with propidium iodide Two 
penetrations were done, each over a two minute period. We have used 
the following stereotaxic coordinates for the injection side . 
A P. +• 1.8 mm from bregma, lateral 2 6 and 3.4 mm from the 
midline and 5.0 mm down from the dura After a survival time of 2 
to 4 days, the animals were perfused with 4 Щ paraformaldehyde 
(w/v) 0.1 M sodium phosphate buffer, pH 7.3 Cryostat sections 
10 urn thick through the nucleus raphe dorsalis were processed for 
immunofluorescence as described elsewhere (STEINBUSCH et al.. 1978). 
The sections were examined ш a Zeiss Universal microscope equipped 
for epifluorescence. Red (Pl-labeled) cell bodies were studied by 
selective green excitation light (BP 546 ; FT 580 ; LP 590) 
(STEINBUSCH el al., 1980). The green (FITC-labeled) serotonin-
immunoreaclive cells were examined with a filter system providing 
blue excitation light of 455-490 nm (BP 455-490 ; FT 510) In this 
way, the faint red PI fluorescence, which sometimes shines through 
the FlTC-barriers-filler commonly used, was completely suppressed. 
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The size of Ihe tell bodies was studied in normal histological as 
well as in immunohistochemical Vibralome material. The diameter ot 
the penkaryj was determined as follows * in nine equall) spaced 
transverse as well as sagittal sections through the nucleus raphe 
dorsahs, approximately 200 cells were drawn al a magnification of 
500 limes, using a Zeiss drawing prism In these drawings, the 
diameter of the somala were determined The arithmetical average of 
the data obtained Irom the 1 800 individual cells have been used for a 
classification ol the cell types 
RESULTS 
The nucleus raphe dorsalis (NRD) is confined lo 
ihe mesencephalon and pons. Our results will be 
described under the following two headings : A) cell 
bodies and B) the projection from the NRD to the 
caudato-putamen complex. 
A) Cell bodies 
1) CYTOARCHITECTURE. 
The nucleus raphe dorsalis is a large, distinct 
nucleus situated in the caudal part of the tegmentum 
mesencephali and the rostral part of the tegmentum 
ponlis. It extends from level A 1200 to level Ρ 2000, 
in the atlas of KÖNIG and KLIPPEL (1963). The nucleus 
is confined roslrally to the nucleus Edinger-Westphal, 
and caudally to the rostral extent of the nucleus 
tegmentahs dorsalis (GUDDEN) . The caudalmost 
neurons of the nucleus raphe dorsalis were localized in 
the midline between the dorsal tegmental nucleus and 
the fasciculus longitudinalis medialis (FLM) (Fig. 1). 
Rostral to the level of the nucleus tegmentalis dorsalis, 
the dorsal part of the nucleus raphe dorsalis fans out 
laterally, forming at the level of the trochlear nucleus 
two midline groups and bilateral wings of cells (Fig. 2). 
The most rostral part of the nucleus raphe dorsalis is 
strictly confined to the midline (Fig. 3). In most places, 
the boundaries of the nucleus raphe dorsalis are 
distinct. At some places, however, this cell mass fuses 
with other groups of cells, thus making its delimination 
arbitrary. This happens to be the case at the border 
zone between the ventral part of the NRD and the 
brachium conjunctivum and at the dorsal borders of 
the bilateral wings of the NRD, which are situated 
rostrally to the nucleus tegmentalis ventralis (GUDDEN). 
Four high cell density areas could be defined in the 
nucleus raphe dorsalis : one in the caudal rhom-
bencephalic part (pars caudalis), and three in the 
rostral mesencephalic part. The latter are designated as 
dorsomedian, ventromedial and lateral (Figs. 1, 2, 3). 
The dorsomedian part of the nucleus raphe dorsalis can 
be seen as a spherical cluster, which has the highest cell 
density within the nucleus. 
Three types ol neurons could be observed trom 
combining the results of the transverse and sagittal 
sections of the NRD : small-round, medium-sized-
lusitorm and largo-mulltpolar neurons. The small cells 
has a diameter ol 10 ± 3 μιτι ; the medium-sized cells 
were oriented in a rostrocaudal direction with an 
average length of 24 ± 6 μιη and a diameter of 
20 ± 3 μπι ; the large neurons showed no special 
orientation and had a diameter ol 35 ± 4 μιη. 
In nine equally spaced sections ol the NRD, we 
have counted approximately 2 000 cells, about 800 of 
which were small, I 100 medium-sized and 100 large. 
The small cells appeared to be pai ticularly numerous in 
the lateral pans ot the NRD. The medium-sized cells 
were equally distributed over the four areas of the 
NRD. They frequently occurred in pairs. A special 
orientation of the medium-sized-fusiform cells was 
observed only in the narrow area between both medial 
longitudinal fascicles. In this area, they were mostly 
lying in a dorsoventral direction, with their nucleus 
acentric in the ventral part ot their cell body. The large 
cells were only situated in the lateral part of the nucleus 
raphe dorsalis. 
2 ) S E R O T O N I N - A N D C A T E C H O L A M I N E - I M M U N O -
REACT1VE CELL BODIES. 
The Vibratome sections, processed for immuno-
histochemistry, with antibodies to serotonin or 
noradrenaline, yielded the lollowing results. The 
serotoninergic neurons were not confined to the NRD 
only. In addition to the serotonin-immunoreaclive 
penkarya in the NRD, as defined in the Nissl-material, 
we observed serotonin-positive cells in the peri-
aquaductal gray, and within and around the FLM. The 
catecholamine-immunoreactive neurons were situated in 
the lateral portion of the periventricular gray, partly 
within and partly beyond the boundaries of the NRD. 
Those serotoninergic and catecholaminergic neu­
rons in which a nucleolus was visible were plotted in 
our atlas, which was drawn from Nissl- and Kluver-
Barrera material (bigs. 1, 2, 3). The 10 to 15 % defer­
ence in size between the parafi in- and Vibratome 
sections was eliminated by using such standard 
relercnce-poinls as the aquaduclus cerebri, the fas­
ciculus longitudinalis medialis, the lemniscus medialis 
and the basal surface of the section. 
In this article, we will only deal with the 
serotoninergic and catecholaminergic cells which are 
confined to the Nissl-borders ot the NRD. 
a) Serotoninergic cell bodies. 
Cell bodies in the dorsomedian mesencephalic part 
of the nucleus raphe dorsalis are generally oriented in a 
- 150 
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rostrocaudal direction. Their appearance is lusilorin, or 
sometimes bipolar, with an average length ol 24 t 4 μιτι 
and a diameter ol' 19 ± 2 μπ\ (Figs. 4, 5 A, 5 B). 
The serotonin-positive cell bodies in the ventro­
medial mesencephalic part of the NRD are not 
distributed equally over this region. The highest con­
centration of these neurons was lound in the area 
between the fasciculi longitudinale medialis and in the 
ventrolateral part of this compartment. Two types of cell 
bodies were found : small neurons which are round or 
oval with an average diameter of 18 ± 2 μιτι, and 
medium-sized cell bodies of a more fusiform type, 
orientated in a rostrocaudal extent, with an average 
length of 31 ± 2 μτπ and a diameter of 18 ± 2 μτη. The 
latter medium-sized cell bodies are confined to the 
midline and are few in number. We observed about 
5 times as many smaller cell bodies as medium-sized 
ones (Fig. 4). 
In the lateral mesencephalic parts of the NRD, only 
one type of cell body was identified : elements with large 
perikarya with an average diameter of 39 ± 5 urn. These 
cells are multipolar and do not show any special direction 
(Figs. 4, 5 A, 5 C). 
The shape of the serotonin-positive cell bodies in the 
caudal rhombencephalic part of the NRD resembles that 
of the perikarya in the dorsomedian mesencephalic part. 
The cell bodies have a fusiform shape and are mostly 
oriented in a dorsoventral direction, with an average 
length of approximately 25 ± 2 μιτι and a diameter of 
20 ± 2 urn. 
b) Catecholaminergic cell bodies. 
Catecholamine-immunoreactive perikarya, localized 
in 100 /im thick Vibratome sections, have been included 
in our atlas based upon paraffin Nissl-stained material 
(Figs. 1, 2). The cells are multipolar, with an average 
diameter of 35 ± 4 μΐη and no special orientation. 
Within the nucleus raphe dorsalis, these elements are 
only found caudally in the lateral mesencephalic portion 
of that nucleus. They form part of a group of nor­
adrenergic perikarya which extends laterally over the 
mesencephalic periaquaductal grey. The entire group has 
been mentioned by some authors (GRZANNA and MOL-
LlVER, 1980) as a rostral extension of the locus coeruleus 
(Fig. 6). 
B) The projection from the nucleus raphe dorsalis (o the 
caudato putamen complex 
In order to determine which of the serotoninergic 
cells in the nucleus raphe dorsalis project to the caudato-
putamen complex, a combination of immuno­
fluorescence and fluorescent retrograde tracing has been 
used. 
Journal de Physiologie 
A large injection of the red lluorescenl dye, 
propidium iodide, was given unilaterally into the 
caudate-pulamen complex. The non-injected con­
trollerai side served as a control (Fig. 7). 
After a survival time of four days, numerous red 
(Pl-posilive) fluorescent cells were observed in the NRD 
and in the substantia nigra. It may be added that the 
substantia nigra, which has a substantial projection upon 
the caudato-putamen complen, also contained numerous 
Pl-labeled neurons (Figs. 10 A, 10 B, 11 C, Il D). Only 
neuronal cell bodies were found ; no Pl-labeled glia cells 
were observed. While the Pl-labeled cells were most 
heavily concentrated on the ipsilateral side of the NRD, 
contralateral^ labeled cells were often encountered. The 
frequency of such labeling was inversely related to 
distance from the midline (Fig. 8 B). Most ol' the Pl-
labeled cells were seen in the dorsomedian and ventro­
medial parts of the ipsilateral NRD. Only at level Ρ 200, 
a rather small number of Pl-labeled cells was found in 
the lateral part of the NRD. Relatively few labeled 
perikarya were observed in the most rostral and caudal 
parts оГ the NRD. 
In all experiments, most of the sections containing 
Pl-labeled cells were processed for immunofluorescence. 
However, some sections were kept unstained in order to 
investigate whether the immunofluorescence procedure 
influences the intensity of the Pl-fluorescence intensity. 
No evidence for such an influence was found. By the 
combined method just indicated, it was possible to 
demonstrate serotonin-immunoreaclive neurons and Pl-
labeled perikarya simultaneously in the same section ol 
the nucleus raphe dorsalis. 
Three categories of fluorescent neurons were tound 
in the NRD : the major portion (59 %) ot all fluorescent 
neurons were only serotonin-immunoreaclive ; 33 % of 
the fluorescent cells appeared to contain serotonin as 
well as PI ; while a number (8 97o) only showed a Pl-
labeling, and thus were apparently non-serotoninergic 
(Figs. 8, 9). These three cell categories have been 
plotted in the outline drawings of the eleven sections 
which comprise our atlas of the nucleus raphe dorsalis 
(Figs. 1, 2, 3). It appears that about 33 % of the 
serotoninergic neurons in the NRD of the rat project to 
the caudate-putamen complex, an area which receives a 
medium to high serotonin innervation (STEINBUSCH, 
1981). Moreover, these results indicate that, in spite of 
extensive axon collateralization of neurons from the 
NRD, 59 % of the serotoninergic neurons in that 
nucleus have axons that do not extend into the caudate-
putamen complex. The material further reveals the 
existence of a small population (8 %) of non-
serotoninergic neurons in the NRD projecting to the 
caudate-putamen complex. Most of these non-sero­
toninergic perikarya are lying caudally in the 
ventromedial and dorsomedian parts of the NRD. 
в 
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Fie. 4. — Photomicrographs of a transversal, 50 μτη thick Vibratome section through ihe nucleus raphe 
dorsalis (level A 300) incubated with an antibody to serotonin. 
Note in (A) and (B) the high innervation ot the ventricle walls by a serotonin-positive supraependymal 
plexus. This plexus partly originates from cell bodies situated in the roslrolateral parts of the NRD. (C) 
Serotoninergic axon bundles arises from the NRD and run ventrolateral^ to the medial torebrain bundle. 
Bars indicate 75 μηι. 
с I 
* • · ^ . 
tí' 
# 4 . 
mV 
% « 
FlG. 5. — Photomicrographs of a horizontal, WO μΐη thick Vibratome section through the nucleus raphe 
dorsalis incubated with an antibody to serotonin. 
Note in (A) that especially in the lateral parts the processes are directed eaudally. Note in {B> the strong 
serotoninergic bupraepcndymal plexus. Note in (C) large multipolar cells. Note in (D) the pairning oi' 
ьегоюпіп-immunoreactive cell bodies (c : caudal ; r : rostral). Bars indicate 75 μηι. 
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Fio. 6. — 'Photomicrographs of a transversal, 
100 mn. thick Víbrateme section (level I' 600) 
through the nucleus raphe tlorsalis incubated 
with an antibody to noradrenaline. 
Note the presence of the noradrenaline-
immunoreactive cell bodies in the lateral parts 
of the nucleus raphe dorsalis and near the 
lateral corner of the periaquaductal grey. The 
perikarya are of the category large neurons. 
Bars indicate 75 μηι. 
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Fio. 7. — Schematic drawing of the projections of the NRD to the caudate-putamen complex. 
The mesencephalic pan ol the NRD has been divided inio three FLM : fasciculus longiiudinalis medialis ; gp : globus pallidus ; LL : 
subgroups : dorsomedian, ventromedial and lateral. In the lemniscus lateralis ; LM : lemniscus medialis ; MFB : medial lorebrain 
dorsomedian and ventromedial subgroup, three fluorescent cell types bundle ; ncs : nucleus centralis superior ; nist : nucleus mierstuialis 
were observed after a combined use ol immunofluorescence staining striae terminalis ; np : nucleus parabrachialis ventralis ; npd : nucleus 
for serotonin and injection of propidium iodide in the parabrachialis dorsalis ; nrd : nucleus raphe dorsalis ; Ρ : tractus 
caudatoputamen : + only 5-HT positive, · 5-HT as well as PI-positive corticospinalis ; PCS : pedunculus cerebellaris superior ; pi : cortex 
ando only Pi-positive. From our results, we can conclude that there are piriformis ; po : nucleus pontis ; pol : nucleus preopticus lateralis ; 
at least two projections from the NRD to the CP : a serotonin-positive pom : nucleus preopticus medialis ; rpoo : nucleus reticularis pontis 
and a serotonin-negative. oralis ; rtp : nucleus reticularis tegmenti pontis ; st : nucleus 
(aa : area amygdaloidea anterior ; AC : aquaductus cerebri ; CA : triangularis sepli ; ST : striae terminalis and TT : tractus tectospinalis). 
commissura anterior ; cp : nucleus caudatus-putamen ; F : fornix ; 
Fio. Й. — Photomicrographs of a transversal section (level Ρ 300) through the NRD after a combined use of 
immunofluorescence staining for serotonin and injection of PI in the caudatoputamen. 
(A) Numerous serotonin-immunofluorescent perikarya are seen. (B) The same section photographed 
with a filter combination specific for PI ; labeled cells are preferentially distributed in the ipsilateral 
ventromedial division of the nucleus raphe dorsalis. Bars indicate 75 μπι. 

а О С -г-
з э 3 > 
ft: О 
η 9- 0 -
ft! Χ (Κ (re 
- ^ 3" 3 сл£ „. 
η ζ 5- 5 
a:
 rt
 s; 
— в. CL 5 
° " Í w 
"Ç о s* E. 
— 3 В" о η
 
υ
Γ
 
a
 d 
ly
 
Ρ
 
-
р
о
ы
 
se
n
 
iffei 
1-po 
live 
·-- с -
w ¿ = o 
ю < η 
- ¡ fï —ι —-
"> · 3-" э 
í>«f 
S'il i 
s i l i 
1 i Ig 
з з o ρ 
Ρ σ" 3 ί (Τ) . <τ> 
Ο Ό СГ 
—i ρ Π) 
& 3 
П. Г. 3 
ί ° 5-
Ο "* <τ 
c 2 w 
Ξ л, Ζ 
? с" 5-OV 
С
 0 ι 3 3 Τ3 
O r O 
3 ί* й-
* *. "** 
η > < 
s es g'S i 
с з £ 
з 1 « 
S f f S " 
0 <TJ 
!ÏS 
i l * =
 ~ 3 
£ l o 
</- ^ p -
з α. α 
Я 5 < 
=-£ g. 
EL3 • 
" Ρ £ 
ë 
S. ο Η 
3 зг <- — <Τ) 
m Ρ 
3 Ξ" Ш 
з5*э 
5* _ 
ir 
s
- c 
Й » 
» ο 
^ ;; 
- S 
δ; гу 
ГЗ ft »0 
л 5' 
3 ? 
: < 
Q β 
Ξ 's 
— > Í с 
' ΐ 'j·. 
ч ? 
5 s 
^ 5 5-
аЗ 
- -
~ '= 5 а-
г -
e s-(Í Ιΐ 
i 
Ss О-í« Co 
g ^ 
Ξ 2 
~ C; 
Ч э 
fci 
S Ьг | ¿ 
5 Q 
s
 1 
1:1 
s s 
С Ц 
Ol 
- . С" 
5! S: 
5- с 
t ч 
ft з 
5 о 
1 "i Cl 
S S 
• C i 
t 
• 
щ 
' ι-
к " • I 
. 
*" ι ' VU 
К ι .. •' ' 
У"
4 
\_J* 
-
r 
(f"¿i;· 
Χ · 
. ? . 
% "Η * 
-
г Ч. " 
». » 
» 4 
— — _ 
FIG. 11. — Photomicrographs of sagittal sections through the brain stem after a combined use of 
immunofluorescence staining for serotonin and injection of PI in the caudatoputamen. 
(A) 5-HT-posiiive n,eurons can be seen in the caudal part of the brain stem ; the cells arc situated in or 
close to the FLM. (B) The same section photographed with a different filter combination for PI-
fluorescence. Arrows indicate a neuron which is only serotonin-positive. (C) A dense innervation by 
serotonm-immunoreactive fibers was found in the substantia nigra (SN). (D) The same section with a 
different filter combination shows a large number of neurons, which are only Pi-positive, demonstrating 
the striato-nigral pathwav. Bars indicate 75 urn 
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DISCUSSION 
This paper presents a comprehensive atlas of the 
nucleus raphe dorsalis of the rat. The dorsal raphe 
nuclei of the cat ( T A B E R et al., I960 ; B E R M A N , 1968), 
man (BRAAK, 1970) and rabbit (FELTEN and Сим-
MiNGS, 1979) were previously described within the 
general frame of studies on the raphe nuclei. However, 
information on this cell mass in the rat, the most 
commonly used experimental animal, is lacking in the 
literature. This study was principally based upon Nissl-
and Klüver-Barrera-stained material. In this material 
we have determined the borders ol the nucleus and 
studied its constituent cells. In addition, using immuno-
hislochemisiry, we were able to plot serotonin-immuno-
reactive and noradrenaline-immunoreactive cell bodies 
present within and around the nucleus raphe dorsalis. 
Further, by combining immunofluorescence and 
fluorescent retrograde tracing, we determined numbers 
and positions of serotoninergic and non-serotoninergic 
neurons in the nucleus raphe dorsalis. 
1) Cell bodies. 
DAHLSTRÖM and FUXE (1964) studied mono-
aminergic cell bodies in the brain stem ol the rat with 
the FIF-technique. They found nine groups of indol-
aminergic cell bodies, all located in or near the raphe, 
which they subsequently labeled Β,-Β.,. Although two 
of these, B 6 and B7, are almost entirely situated within 
the confines ol the nucleus raphe dorsalis, DAHLSTRÖM 
and FUXE did not relate their findings to the cyto-
archilecture ol' the brain stem. Neither in the area of 
the nucleus raphe dorsalis, nor in the more caudal 
portions of the brain stem (STEINBUSCH and NIEU-
WENHUYS, in prep.) do we see any reason for 
maintaining the labels introduced by DAHLSTRÖM and 
FUXE. 
With regard to size and shape of the cell bodies, 
our results are in general agreement with other studies 
on the nucleus raphe dorsalis ( T A B E R el al., I960 ; 
DAHLSTRÖM and F U X E , 1964 ; H U B B A R D and Di 
C A R L O , 1974). From our results, it is obvious that the 
serotonin-immunoreactive neurons closely resemble the 
medium-sized-fusiform and the large-muhipolar neurons 
observed in the normal material. Noradrenaline-immuno-
reactive neurons, which are only situated in the lateral 
parts of the NRD, do all belong to the category of large 
cells. Thus, in the lateral parts, the serotonin- and 
noradrenaline-immunoreactive penkarya are not rep-
resented by cytoarchitectionally distinguishable cell 
types. 
2) The dorsal ascending pathway oj the nucleus raphe 
dorsalis. 
I he two most important projections derived trom 
the nucleus raphe dorsalis are the dorsal and the ventral 
ascending pathways. The ventral pathway passes ros-
tral^ through the medial lorebrain bundle, whereas the 
dorsal pathway is situated laterally to that bundle. The 
venirci ascending pathway lies in the ventrolateral 
aspeci ol that same bundle. The pathways have been 
localized by analyzing results obiained from bio-
chemical work (UfcYER e/ al.. 1976 , TbRNAUX el al., 
1977), and studies using the FIF-method ( A N D E N et al., 
1966), retrograde transport (ЫВ1Ы R and MllLER, 
1977) as well as anterograde tracer techniques (BOBIL-
LIER el al., 1976). 
Studies employing lormaldchyde-induced serotonin 
fluorescence ( A N D E N et al., 1966 ; F I X E and JONSSON, 
1967), and especially those employing serotonin-
immunolluorescence (Lmov et al., 1980 ; STEINBUSCH, 
1981), have shown an impressive collaleralizalion ol 
serotonin axons in many areas ol the lorebrain. 
However, these techniques cannot reveal the extent ol 
the axonal systems of single NRD cells, nor can they 
demonstrate the exact topography of the NRD cells 
projecting to the various lorebrain areas. 
Several aspects ol the NRD projections deserve 
special attention. These include the projections to the 
basal ganglia, the laterality ot the projections, the 
possibility ot recurrent NRD axon collaterals, and the 
transmitter involved. 
First, with respect to basal ganglia innervation, it 
was lound that fluorescent tracer injections into the 
caudate-pulamen and substantia nigra produced retro­
grade double labeling ol the majority ol neuronal cell 
bodies (VAN DER KOOY and HATTORI, 1980 a) in the 
dorsal portion of the NRD. Thus, single NRD neurons 
are in a position to exert control over both ends of the 
massive nigro-striatal and slriato-mgral projections 
( N A U T A and DOMESICK, 1979). 
Secondly, retrograde axonal transport studies have 
shown that injecting the lorebrain with various isotopes 
labeled NRD neurons both ipsilateral and, to a lesser 
extent, contralateral to the injection site ( J A C O B S et al., 
1978 ; M I I L E R et al., 1975 ; VAN DER KOOY, 1979). 
Given the extensive ipsilateral axon collateralization of 
NRD neurons described above, it would seem probable 
that single NRD neurons would have bilateral forebrain 
axon collaterals. In contrast to this supposition, 
bilateral injections of retrograde tracers into the 
caudate-putamen, Irontal cortex, or substantia nigra 
never produced retrogradely double labeled NRD 
neurons (VAN DER KOOY and HATTORI, 1980 b). Thus, 
regardless ot the lateral positioning of a NRD cell 
body, its extensive axonal projection is only unilateral. 
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The third issue deserving attention is the possibility 
that, in addition to their forebrain axon collaterals, 
NRD neurons may also possess recurrent axon 
collaterals within the NRD. The most convincing 
evidence for this supposition comes from combined 
physiological and pharmacological studies which dem-
onstrated that activation of NRD neurons produces a 
short-latency, apparently serotonin-mediated, inhibition 
of those same NRD cells (WANG and AGHAJANIAN, 
1978 ; AGHAJANIAN et al., 1978). However, these 
studies cannot rule out the possibility that dendro-
dendntic interactions between NRD neurons mediate 
the effects observed (MOSKO el al., 1977). Moreover, 
the experiments cited above have not established that 
the NRD neurons studied are serotoninergic. For this 
purpose, a detailed examination of the NRD projec-
tions to the caudate-putamen was undertaken, which 
employed a combination of immunofluorescence, using 
an antibody to serotonin, and retrograde fluorescent 
tracing, using propidium iodide. 
It was assumed, especially by the workers using the 
FIF-technique (ANDÉN et αι., 1966), that the dorsal 
ascending pathway, which arises from the nucleus 
raphe dorsalis and passes into the caudate-putamen 
complex, is a serotoninergic pathway. From our results, 
it may be concluded that approximately 80 % of this 
pathway does arise from serotoninergic neurons in the 
NRD ; however, a substantial amount appears to 
originate from non-serotoninergic cells within the 
NRD. 
In addition to serotonin, cells containing five other 
neurotransmitters have been claimed in the NRD of the 
rat : i.e., dopamine, noradrenaline, GABA, enkephalin 
and VIP. 
Using a histofluorescence method, OCHI and 
SHIMIZU (1978) observed dopaminergic perikarya only 
in the midline of the ventromedial part of the NRD. 
NAGATSU et al. (1979) have described immunohisto-
chemically, using antibodies to tyrosine hydroxylase 
and dopamine-ß-hydroxylase (DBH), the presence of 
dopaminergic neurons in the part just above and medial 
to the FLM. GRZANNA and MOLLlVER (1980) 
demonstrated that noradrenergic cells are present in the 
lateral parts of the NRD. This was done immunohisto-
chemically, using an homologous antibody to dop-
amine-ß-hydroxylase. Yet, when we used" an antibody 
which visualizes the noradrenergic neurons of the locus 
coeruleus as well as the dopaminergic perikarya in the 
substantia nigra, only immunohistochemical staining 
was observed in the lateral part of the NRD. These 
observations seem to confirm the presence of nor-
adrenergic cells in the latter described area. With regard 
to the ventromedial part, our results are in contrast 
with the findings of OCHI and SHIMIZU (1978) and 
NAGATSU et al. (1979) ; therefore, the presence of 
dopaminergic neurons in the NRD needs further 
investigation. 
Enkephalin-containing cell bodies in the dorsal 
region ot the bilateral parts of the NRD have been 
described by UHL et al. (1979) and HÖKFELT et al. 
(1977 a, 1977 b, 1979). However, in these both areas no 
5-HT negative and Pi-positive perikarya were observed. 
VlP-containing neurons have been localized by 
SIMS et al. (1980) in the caudal and the dorsomedian 
part of the NRD. No data were available concerning 
the exact localization and number of VIP-neurons in 
the central gray. However, the authors stated that the 
localization of the VIP-cells in the central gray of the 
midbrain shows a distribution similar to that shown by 
enkephalin-containing neurons. From the data reviewed 
above, it may be concluded that only a certain 
proportion of the non-serotonergic neurons, projecting 
to the caudato-putamen complex may contain GABA, 
i.e., those cells situated in the ventrolateral area of the 
ventromedial part of the NRD. Therefore, most of the 
non-serotonergic neurons, which are primarily situated 
in the dorsomedian and ventromedial part of the 
nucleus raphe dorsalis, must contain hitherto unknown 
transmitter substances. Cytoarchitectonically, we have 
stated that serotonin-immunoreactive neurons strictly 
resemble the medium-sized and large cells which we 
found in the paraffin Nissl-stained material. With this 
point in mind, it is worth mentioning that, with regard 
to size as well as diameter, no cytoarchitectural differ-
ences were observed between the two cell types which 
project to the caudate-putamen complex. 
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I. INTRODUCTION 
Since the monoamine serotonin (5-hydroxytryptamine, 5-HT) was found biochemi-
cally in the brain by Twarog and Page (310) and Bogdansky et al. (39), and its 
intraneuronal localization was first demonstrated histochemically by Falck (84), 
Falck et al. (85), and Falck and Owman (86, 87), numerous studies on the organization 
of the central serotoninergic neuron populations have been performed. With the aid of 
the formaldehyde-induced fluorescence (FIF) technique and/or immunocytochemistry 
serotonin-containing neurons have been demonstrated in a variety of invertebrate 
(e.g. the cockroach, Feriplaneta americana: Pandey and Habibulla, 223; the flatworms, 
Planaria: Dugesia tigrina, Phagocata oregonensis and Procotyla fluviatilis: Welsh 
and Williams, 333) and vertebrate species (e.g. the lamprey, Lampetra fluviatilis: 
Baumgarten, 20; Steinbusch and Nieuwenhuys, 285; Steinbusch et al., 290; the 
lizard, Lacerta siccula and Lacerta muralis: Marschall, 188; the rat: Fuxe, 100; 
Steinbusch, 284; cat: Pin et al., 237; Wiklund et al., 337; man: Nyström et al., 
215). 
Unfortunately, the FIF-method has a low sensitivity towards serotonin. Moreover, 
ß-carboline, the yellow fluorescent product formed,is highly sensitive to irradiation, 
resulting in a rapid fading of the fluorescence (Schofield and Wreford, 263). Another 
complication is the bad quality of the sections, due to the freeze-drying of the 
tissue. 
The basic mapping of the central monoaminergic system of the rat has been carried out 
with the FIF-technique by Dahlström and Fuxe (69). During recent years several 
modifications of the FIF-technique have been introduced, such as the use of 
glyoxylic acid (Björklund et al., 29; Bloom and Battenberg, 336; Furness and Costa, 
97; Lindvall and Björklund, 171; Lorén et al., 178; Maeda et al., 186; Nygren, 214; 
de la Torre and Surgeon, 309; Watson and Barchas, 329), the employement of hypertonic 
formaldehyde perfusion (Azmitzia and Henrickson, 14), the application of magnesium 
ions (Lorén et al., 179, 180), the combination of formaldehyde and glutaraldehyde 
(Furness et al., 98;99) and recently the aluminium-formaldehyde (ALFA) method (Ajelis 
et al., 7; Lorén et al., 181). However, although these methodological modifications 
of the FIF-technique markedly increase the sensitivity for catecholamines, they do 
not seem to represent any clear advantage with regard to the visualization of 
serotonin. However, during the last years several other methods have been found 
highly usefuls for neuroanatomical studies on central serotoninergic neurons. These 
techniques include: 
A. Autoradiographic demonstration of Η-serotonin uptake after injection into 
the brain ventricles (Calas et al., 54; Calas and Segu, 56; Chan-Palay, 59, 60, 61; 
Descarries et al., 73; Kellum and Jaffe, 148; Léger et al., 164 ; Léger and 
Descarries, 162 ; Segu and Calas, 268). 
B. Immunocytochemistry using antibodies to the enzymes tryptophan hydroxylase 
(TrH) and dopadecarboxylase (DDC) as markers for serotonin (Hokfelt et al., 124; 
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Joh et al., 140; Pickel et al., 235), see Figure 1. 
C. The selective destruction of indolamine-containing neurons by pharmacological 
manipulations, e.g. with 5,6-dihydroxytryptamine (Kawa et al., 144; Nakamura and 
Fukushima, 206), 5,7-dihydroxytryptamine (Baumgarten and Lachenmayer, 21; Daly et 
al., 71; Jonsson et al., 142; M^llgard et al., 199; Sachs and Jonsson, 252), or 
p-chloroamphetamine (Aghajanian et al., 3; Massari et al., 190; Steranka et al., 
292) or the use of selective serotonin uptake inhibitors (Lemberger et al., 166). 
D. Biochemical determination of serotonin and/or the rate-limiting enzyme of 
the synthesis for serotonin (tryptophan hydroxylase) in minute amounts of tissue 
(Douay and Kamoun, 77; Kizer et al., 150; Marini et al., 187; Metcalf, 195; 
Oliveras et al., 217; Saavedra, 251; Seiler, 269; Suzuki et al., 295; Ternaux et 
al., 303; Tong and Kaufman, 308; Widmer et al., 335). 
In this chapter the present knowledge of the organization of serotoninergic 
neurons in the brain of the rat will be summarized with emphasis on our own 
investigations. These investigations are based on an immunocytochemical technique 
with the aid of which serotonin can be directly localized. 
The localization of the serotonin-immunoreactive cell bodies in the 
rhombencephalon and mesencephalon of the rat have already been dealt with in two 
previous papers. The first of these (Steinbusch and Nieuwenhuys, 286) was mainly 
devoted to the serotoninergic innervation of the hypothalamo-hypophyseal system. 
In the second (Steinbusch, 284) a comprehensive mapping of serotoninergic cell 
bodies and terminal fibers throughout the central nervous system of the rat was 
presented. These two studies were based upon 10 ym thick cryostate sections, which 
were stained for immunofluorescence. In the present work the following two 
experimental modifications have been applied. A: In preceding experiments we have 
pretreated the animals only with intraventricular injections of colchicine. However, 
it appeared to be favorable to visualize serotonin-immunoreactive neurons in 
vibratome sections achieved from animals which were pharmacologically treated with 
either Nialamide or L-tryptophane. B: In the mapping paper we have used schematic 
drawings in which we indicated with symbols the density of serotonin-positive 
neurons within a certain area. In the present study vibratome sections, in which 
the serotonin-containing neurons were visualized, were counterstained with cresyl 
violet. This procedure enabled us to delineate in our sections the seven raphe 
nuclei as cytoarchitectonic entities and, hence, to determine exactly which 
serotonin-p°siti\e cells were localized within and which of these elements were 
located beyond the boundaries of these nuclei. The relation between serotonin-
immunoreactive neurons and other transmitter-specified elements, cell bodies as 
well as fibers, will be discussed in some detail and summarized in five tables. 
A preliminary report of this work was presented at the Fourth European Neuroscience 
Meeting (Brighton, September 1980). 
2. METHOJOLOGY 
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2.1 Preparation of the antiserum 
The preparation of the immunogen for serotonin has been described previously 
(Steinbusch, 284; Steinbusch and Verhofstad, 289). The serotonin antigen has been 
modified to yield a higher molar ratio between serotonin and its carrier protein (BSA) 
as has been described by Steinbusch and Nieuwenhuys (286), and Steinbusch et al. (291). 
The antibody to tyrosine-hydroxylase was a generous 31ft of Dr. M. Goldstein. 
2.2 Preparation of tissues 
The animals were pharmacologically pretreate.d according to five different 
procedures: 
I.an intraventricular injection of colchicine (Sigma, St. Louis, Mo..U.S.A.) (60.ug/ 
20,ul 0.9% sodiumchloride) into the lateral ventricles 24 hrs prior to sacrifice. 
2.an intraperitoneal injection with Nialamide (Sigma, St. Louis, Mo., U.S.A.) 
(150 mg / kg bodyweight) 2 hrs before death. 
З.ап intraperitoneal injection with Nialamide and subsequently 60 minutes before 
perfusion an intraperitoneal injection with L-Tryptophan (100 mg / kg bodyweight). 
4.an intraperitoneal injection with reserpine (10 mg / kg bodyweight) 4 hrs prior to 
perfusion. 
5.an intracerebral injection of 5,7-dihydroxytryptamine creatinine sulphate (Sigma) 
(10,ug) with a survival time of 20-25 days. 
Adult male albino rats (160-180 g) were anaesthetized with sodium pentobarbital 
(Nembutal; 60 mg / kg bodyweight, intraperitoneal). Because it is known that the 
serotonin concentration in the central nervous system of the rat shows a circadian 
rhythm (Brammer and Binkley, 42; Kan et al., 143; Quay et al., 241) we sacrificed 
the animals always at the same time of the day. 
In order to visualize serotonin-immunoreactive cell bodies and dendrites the 
peroxidase-anti-peroxidase (PAP) technique of Sternberger et al. (293) as applied by 
Grzanna et al. (116) was used. Animals were perfused through the left ventricle of 
the heart with 40 ml icecold Ca -free Tyrode's solution. This solution was 
saturated with a mixture of 95% 0- -5% CO2 -gas, starting one hour before perfusion. 
The preperfusion was followed by 400 ml, icecold 4% (w/v) paraformaldehyde, dissolved 
in 0.1 M sodium phosphate buffer, pH 7.3, during 20 min at a pressure of 50 mm Hg. 
Brains were promptly removed and cut into 5-8 mm slabs in either transverse, 
sagittal or horizontal directions. The tissue pieces were postfixed for 90 min at 
4° С in the same fixative and washed for at least 4 hrs in a 5% sucrose, dissolved 
in 0.J M sodium-phosphate buffer, at 4 С It should be noted, that after the 
fixation procedure followed by us 50% of the serotonin is still present. This 
3 
appeared from biochemical measurements, using Η-serotonin (Schipper et al., 262). 
This percentage is considerably higher than the 3% serotonin which was detected 
after the FIF-procedure. 
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2.3 Inimunocytochemical procedures: immunofluorescence and immunohistochemistry 
Immunofluorescence procedure. This procedure has been described in depth 
recently (Steinbusch, 284). 
Immunohistochemical procedure. Tissue pieces were mounted onto chucks of a 
Vibratome stage with a cyanoacrylate adhesive. After a dry period of 5 min the tissue 
slices were kept in icecold, 0.1 M sodium phosphate buffer, pH 7.3 until they were 
sectioned. Serial sections of 50 or 100 ,um thickness were cut Λ. a vibration rate oí 
8-9 scale units and a feeding speed of 2-4 scale units, and collected in counting 
tubes, filled with the same buffer (Hökfelt and Ljungdahl, 128). 
The sections were first incubated overnight in the refrigirator with a rabbit 
anti-serotonin serum (Steinbusch and Nieuwenhuys 286; Steinbusch et al., 291) 
(76 mg / ml) or pre-immuneserum, diluted 1:1500 with phosphate-buffered saline (PBS), 
which contained 0.2% (v/v) Triton-X-100. All subsequent steps were carried out at 
room temperature. Sections were washed for 10 min with PBS containing 0.2% Triton-X-
100, followed by a wash for 10 min in PBS with 0.1% Triton-X-100 and finally for an 
additional 10 min wash in PBS, alone. Then they were incubated with goat-anti-rabbit 
antiserum (1 mg/ml) 1:30 diluted with PBS during 2 hrs (goat-anti-rabbit / IgG 
(Fc-specific) (Nordic, Tilburg, The Netherlands). Following a two times 10 min wash 
in PBS, the rabbit PAP-complex (DAKOpatts, Denmark) was applied in a dilution of 
1:90 in PBS. After 1 hr incubation the sections were washed two times for 10 min 
vifh PBS. Then they were put in a solution containing 3,3-diaminobenzidine -HCL 
(Sigma 0.75 mg/ml) and CaCl2 (120.uM) in 50 mM Tris-HCL, pH 7.7; after 10 min H 20 2 
was added to yield a final concentration of 0.003% and the reaction was 
carried out for an additional 15 min. Sections were briefly rinsed in PBS and 
floated on glass slides coated with chrome alum gelatine. They were then air dried 
over the night. Sections were postfixed with 2% glutaraldehyde in PBS. For permanent 
storage, sections were dehydrated and coverslipped with DePeX (Gurr). 
In order to study the cytoarchitecture of the brain some animals were fixed 
with 4% paraformaldehyde. Brains were dissected, dehydrated and embedded in 
paraffin. Transverse and sagittal sections of 15,urn thickness were cut on a rotary 
microtome and stained with cresyl violet, or according to the technique of Klüver 
and Barrera. 
The boundaries of the seven raphe nuclei were determined principally in 
cresyl-violet stained 50,urn thick Vibratome sections. Serotonin-immunoreactive neurons 
have been visualized in 50.urn thick Vibratome sections. The size of the cell bodies 
within the confines of the raphe nuclei was studied in Nissl- and Klüver-Barrera 
stained paraffine material as well as in Vibratome sections processed for immuno-
histochemistry. Their diameters were determined from drawings at a magnification 
of 800 times, using a Zeiss drawing prism, by averaging the lengths measured in two 
directions perpendicular to each other. The arithmetical averages of the data 
obtained have been used for a classification of the cell t._pes. 
The length of the processes of the serotonin-immunoreactive cells was determined 
in 100.um thick Vibratome sections, with the aid of a semi-automatic system for 
measuring cellular tree structures in three dimensions, as described by Overdijk et 
al. (221) and Uylings (315). 
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3. RESULTS 
In this chapter the cytoarchitecture of the raphe nuclei and the serotoninergic 
neurons present in the brain stem of the rat will be described. The description 
of the serotonin-immunoreactive perikarya and their dendrites, present in each of 
the seven raphe nuclei are based on Vibratome sections, immunohistochemically 
stained with an antibody against serotonin. Nomenclature and definitions of the 
raphe nuclei are based upon the atlasses of König and Klippel (156), Meesen 
and Olszewski (194), Wünscher et al. (340), and the descriptions of Braak (41), 
Feiten and Cummings (89) and Taber et al. (300). The localization of the cell 
bodies is indicated in 21 representative sections through the brain stem (Figs. 
2-12). The dimensions of the serotoninergic cell bodies appeared to be 
significantly larger than the sizes of the cells observed in the Nissl-stained 
paraffin sections. The measurements of the dendritic patterns of these neurons, 
which were obtained with a semi-automatical measuring system have to be regarded as 
preliminary. For a detailed description of serotonin-immunoreactive fibers and 
terminals we refer to a previous paper (Steinbusch, 284). 
Although serotoninergic neurons are confined to the rhombencephalon and the 
tegmentum of the midbrain, serotonin-positive fibers and terminals appeared to be 
present in practically all parts of the central nervous system. In the diencephalon 
the following types of non-neuronal cells showed a specific serotonin-imrauno-
reactivity: 1) pinealocytes, 2) pinealocyte-like elements in the epithaiamiс lamina 
intercalaris (Figs. I6A,B,C,D), 3) tanycytes and other glia elements in the 
infundibular region, and 4) mast cells in the median eminence. In the rhombencephalon 
superficial situated glia cells were demonstrated at the basal surface of the 
brain stem (Fig. 14). 
3.1 The raphe nuclei 
3.1.1 Nucleus raphe obscurus 
Cy toarchi teoture 
The nucleus raphe obscurus is a small nucleus situated in the caudal part 
of the rhombencephalon. It extends from level Ρ 7000 to Ρ 5250 in our atlas 
(Figs. 3B; 4A,B). The nucleus is situated dorsal to the nucleus raphe pallidus 
and ventral to the fasciculus longitudinalie medialis. It extends rostral to the 
caudal pole of the nucleus raphe magnus and caudal to the level of the decussatio 
pyramidis. The nucleus is confined to a narrow median and paramedian zone. At its 
caudal side it is laterally bordered by the nucleus reticularis paramedianus. 
Rostrally the nucleus raphe obscurus is flanked by the inferior olive complex. In 
most places the boundaries of the nucleus are distinct. The cellular density is 
small, especially in its dorsal region. 
The nucleus raphe obscurus contains two types of neurons, which may be 
designated as small and lsr"e, respectively< 18.um and 28-36 .ч·0· The small elements 
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have a spherical shape and a diamter of 17+2.um. The large neurons are bipolar or 
tripolar. Their length and diameter measure 29+3.um and 26+2,urn, respectively. 
Both cell types are present equally and distributed evenly within the nucleus. 
Serotonin-immunoreaative perikarya and dendrites 
Perikarya 
Serotonin-positive cell bodies can be found throughout the nucleus raphe 
obscurus, with highest concentrations in the intermediate part of its 
rostrocaudal extension. The serotoninergic neurons form here two parallel, vertical 
laminae, adjacent to the midline (Fig. 14). 
Two types of cell bodies were identified: medium-sized and large, respectively 
18-27,um and 28-36,um. The medium-sized elements are round with an elongated shape. 
Their length and diameter measure 27+5,um and 18+3,urn, respectively. The large 
neurons are multipolar with a length and diameter of 32+4,um and 23+Э.шп, 
respectively. The medium-sized cells were predominantly found in the dorsal parts 
of the nucleus, the large cell type more ventrally. 
Comparison of the results obtained from the normal and the immunohistochemical 
material rendered it likely, that the two serotonin-positive cell types probably 
corresponds both with the medium-sized cells observed in the Nissl-material. 
Dendrites 
Both types of serotonin-immunoreactive neurons in the nucleus raphe obscurus 
have three to four dendrites, which are mainly oriented in a dorsolateral direction 
(Figs. 19; 20B). Their average length is between 40 and 100,um. 
3.1.2 Nucleus raphe pallidus 
Cytoarohitecture 
The nucleus raphe pallidus is one of the two caudal components of the raphe 
nuclear group. It extends from level Ρ 7000 to Ρ 5250 in oar atlas (Figs. 3B; 
4A,B). The nucleus is situated ventral to the nucleus raphe obscurus. Its ventral 
border touches the basal surface of the brain. The nucleus has approximately the 
same longitudinal extent as the nucleus raphe obscurus. Both nuclei are separated 
from each by transversely running fibers. The nucleus raphe pallidus, is a mass of 
relatively densely packed cells, situated in the median region adjoining the 
dorsomedial edges of the pyramidal tracts. The caudal part of the nucleus is 
laterally well delineated by the nucleus reticularis paramedianus. The medial and 
rostral part of the nucleus raphe pallidus are flanked by the nucleus reticularis 
gigantocellularis, medullae oblongatae. In this area the borders of the nucleus are 
ill-delined. 
The nucleus raphe pallidus contains two cell types: small and very large, 
respectively < 18,um and >36.um. The medium-sized elements are round or oval with 
a diameter of 17+3,urn. The large neurons are fusiform or elongated. Their length 
and diameter measure 37+6,um and 27.+_6.um, respectively. The highest proportion of 
cells belongs to the medium-sized cell type. These cells are predominantly present 
in the ventral part of the nucleus raphe pallidus. The large cells were evenly 
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Serotonin-immunoreaative perikarya and dendrites 
Ретікагуа 
Serotoninergic cell bodies were found throughout the nucleus raphe pallidus, 
with highest concentrations in the ventrocaudal, ventrointermediate and the 
entire rostral part (Fig. 14). 
Two cell types were observed: medium and large. The medium-sized cells have 
an oval shape with a length and diameter of 24+5 ,um and 16+4 .um, respectively. The 
large neurons are multipolar with a length and diameter of 36+5,urn and 30+5.urn, 
respectively. The medium-sized perikarya are predominantly found ventrally, where 
almost no large cells were detected. In the dorsal part of the nucleus both cell 
types were present in about equal numbers. 
Comparison of the cell bodies in the normal, Nissl material and in the 
immunohistochemical material reveals, that there is a good correspondence between 
the two cell types described. 
Dendrites 
The two types of serotoninergic cells are different with regard to both the 
number and the preferential direction of their dendrites. The medium-sized cells 
have two or three main dendrites, while the large neurons have four or five 
dendrites. The direction of their dendrites varies with their position within the 
nucleus. The direction of the dendrites, arising from the cells, situated medially, 
is hard to determine, because of the high density of these elements. The processes 
of the cells situated in the dorsal part of the nucleus raphe pallidus were 
directed dorsally or ventrolaterally (Fig. 14). 
3.1.3 Nucleus raphe magnus 
Cytoarahiteature 
The nucleus raphe magnus is a large cell group situated in the rostral part 
of the medulla oblongata. It extends from level Ρ 5000 to level Ρ 3900 in our 
atlas (Figs. 5A,B). It is localized dorsal to the lemniscus medialis and ventral 
to the fasciculus longitudinal is medialis. The nucleus extends rostrally to the 
level of the caudal pole of the nucleus corporis trapezoidii and caudally to the 
caudal pole of the nucleus nervi facialis and the nucleus raphe obscurus. The 
caudal part of the nucleus grades into the rostral pole of the nucleus raphe 
pallidus. Caudally the nucleus raphe magnus expands laterally to the nucleus nervi 
facialis. Rostrally, the nucleus narrows to a thin median sheet bordered on 
either side by the lemniscus medialis. The delimitation of the ventral, lateral 
and dorsorostral borders of the nucleus are arbitrary. 
The nucleus raphe magnus can be distinguished from the surrounding reticular 
formation by having a greater cell density. The nucleus contains two types of 
neurons: medium-sized and large. The medium-sized cells are multipolar, with 
an oval shape. Their length and diameter are 21+4 .urn and 18+3. um, respectively. 
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The large cells are fusiform with a length and diameter of 35+5,um and 23+5,urn, 
respectively. Both cell types were found equally and were distributed uniformly 
within the nucleus raphe magnus. 
Serotonin-immunoreactive perikarya and dendrites 
Perikarya 
Serotonin-positive cell bodies are not equally distributed over the 
nucleus. The neurons are mainly localized in its ventrocaudal part. 
In the dorsal part of the nucleus raphe magnus only a small number of 
serotoninergic cells appeared to be present. The cells are oriented perpendicular 
to the midline. 
One type of cell body could be demonstrated: polygonal with a dimension of 
34+5,um. This cell type resembles the large neurons observed in the Nissl-stained 
material. 
Dendrites 
The serotoninergic cell bodies of the nucleus raphe magnus have four to eight 
dendrites with only a few branches. The average length of these dendrites is 
between 150-450,um. They are predominantly oriented perpendicular to the midline. 
The processes of the cells, which are located adjacent to the midline are passing 
this area and then arch back to extend dorsally or ventrally. The dendrites, which 
are directed laterally, extend into the reticular formation over a distance of 
350 to 700 .urn. 
3.1.4 Nucleus raphe pontis 
Cil toara hitecture 
The nucleus raphe pontis is a vertically oriented and elongated cell mass 
which, as its name implies,is situated in the pons. It can be observed from 
level Ρ 2600 to level Ρ 1500 in our atlas (Figs. 7A,B; 8A). The nucleus is 
situated dorsal to the lemniscus medial is and ventral to the fasciculus 
longitudinalis medialis. Rostrally it extends to the level of the nucleus 
reticularis pontis oralis and the locus coeruleus. Caudally, the cells of the 
nucleus raphe pontis are situated immediately dorsal to the lemniscus medialis, at 
the level of the rostral pole of the nucleus reticularis pontis caudalis. From 
caudal to rostral the nucleus shifts gradually from a ventral to a more dorsal 
position. 
The dorsal and ventral borders are distinct, however the lateral aspects are 
not sharp. 
Three types of cell bodies were demonstrated: small, medium-sized and large. 
The small cells are ellipsoid. Their length and diameter measure 15+3.um and 
13+3 ym, respectively. The medium-sized cells have a multipolar appearance, with 
a dimension of 21+4 ym. The large neurons are bi- or sometimes multipolar, with a 
length and diameter of 27+4.urn and 22+4,um, respectively. The small, medium-sized 
and large cell types were equally present and distributed evenly over the nucleus 
raphe pontis. 
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Serotonin-immunoreaative perikarya and dendrites 
Perikarya 
The serotonin-positive neurons are scattered throughout the nucleus with their 
highest concentration caudally. However, it should be mentioned, that the total 
number of serotoninergic neurons is relatively small. Moreover, no immunoreactive 
cells were found in the median plane. 
Three cell types were observed: A) medium-sized, B) large-fusiform and 
C) large-multipolar. The medium-sized perikarya have an oval or bipolar shape with 
a diameter of 22+3 ,um. The large-fusiform cells are oriented perpendicular to the 
midline. Their length and diameter measure 29+4 ,um and 23+3,um, respectively. 
The large-multipolar cells are situated with their long axis parallel to the 
median plane. Their length and diameter are 29+4 .urn and 24+3,um, respectively. Cell 
type В is equally dispersed over the nucleus raphe pontis. Cell type С is mainly 
found caudally in the vicinity of the midline, while cell type A was observed in 
the ventrorostral part of the nucleus, close to the median plane. 
The three serotoninergic cell types correspond to the medium-sized and large 
cell types in the normal histological material, 
Dendrites 
With regard to their dendrites neurons of type A show two characteristics: At 
their medial side, there is one long, unbranched process, which can be followed 
over a distance of 77+9,um. Laterally these neurons have small, highly branched 
processes. The long process reaches the midline and continues dorsally. We found 
that the processes arising from neurons situated rostrolaterally are much longer 
(115+20,urn) than those of the elements situated in the remainder of the nucleus. 
The dendrites of the multipolar cell type B, do not show any special 
direction. They can be followed over a distance of 40-80,um. 
The dendrites of cell type С resemble the ones of cell type A with only one 
difference and that is that the long, medially oriented process, during its course 
to the midline, gives rise to many ventrally oriented ramifications. 
3.1.5 Nucleus raphe dorsalis 
Cutoarahiteature 
The nucleus raphe dorsalis is the largest raphe nucleus. It is located in 
the rostral part of the tegmentum pontis and in the caudal part of the tegmentum 
mesencephali. It extends from level Ρ 2000 to level A 1400 in our atlas (Figs. 7A, 
Β; 8A,B; 9A,B; 10A.B). The nucleus is situated dorsal to the fasciculus 
longitudinalis medialis and ventral to the rostral part of the fourth ventricle 
and the aquaductus cerebri. It is rostrally bordered to the nucleus 
Edinger-Westphal. Caudally, the nucleus extends to the level of the rostral pole of 
the nucleus tegmental is dorsalis of Gudden. The dorsal part of the nucleus fans out 
laterally, forming at the level of the nucleus nervi trochlearis, a ventromedial 
group, a dorsomedian group and two bilateral wings of cells. The most rostral part 
of the nucleus is a cluster of cells situated close to the median plane. In most 
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places its boundaries are distinct. At some places, however, this cell mass fuses 
with other groups of cells, thus making its delineation arbitrary. This happens 
to be the case at the border zone between the ventral part of the nucleus and the 
brachium conjunctivum and at the dorsal borders of its bilateral wings. In the latter 
region the cell mass under discussion grades into the substantia grisea centralis. 
Four areas with a particularly high cell density were defined in the nucleus 
raphe dorsalis: one in the caudal, rhombencephalic part (pars caudalis), and three 
in the rostral, mesencephalic part. The latter are designated as: dorsomedian, 
ventromedial and lateral. The dorsomedian part of the nucleus can be seen as the 
spherical cluster, which has the highest cell density within the nucleus. 
Three types of neurons were observed: small, medium and large. The small cells 
are spherical and have a diameter of 14+3,um. The median cells are of a fusiform 
shape; they are generally oriented in a rostrocaudal direction. Their length and 
diameter are 24+6.um and 20+3.um, respectively. The large cells are multipolar, 
with a diameter of 35+4.urn. The small cells appeared to be particularly numerous 
in the lateral parts of the nucleus. The medium-sized cells were equally distributed. 
They frequently occurred in pairs. A special orientation of the medium-sized cells 
was observed in the narrow area between both medial longitudinal fascicles. In this 
region they were mostly lying dorsoventrally. The large cells were only found in the 
bilateral wings of the nucleus raphe dorsalis. 
Serotonin-immunoreactive perikarya and dendrites 
Perikarya 
Serotonin-positive cell bodies are not equally distributed over the nucleus. 
Most of these neurons were demonstrated in its dorsomedian and ventromedial, 
mesencephalic part. Moreover, a substantial number of serotoninergic cell bodies was 
observed in the caudal, rhombencephalic part and in the bilateral wings, situated 
in the mesencephalic part. Only a few serotonin-containing perikarya were located in 
the remaining areas of the nucleus raphe dorsalis. 
Four cell types were observed: small, medium, large and very large. The small 
cells are round, oval or sometimes bipolar with a diameter of 10+3,um. 
The medium-sized perikarya have a fusiform or bipolar shape with a length and a 
diamter of 24+4,um and 18+4.um, respectively. The large neurons have a fusiform 
appearance with a length and a diameter of 31+2.urn and 18+2 .urn, respectively. The 
very large cells are multipolar with a diameter of 39+5.um. The small cells were 
found in the ventromedial part and in the most rostral area of the caudal, 
rhombencephalic part of the nucleus. We observed about five times as many small cell 
bodies as medium-sized somata in the ventromedial region. Only a few small neurons 
were localized rostrally in the caudal, rhombencephalic part, close to the 
ventricular surface. 
The medium-sized perikarya were found uniformly distributed over the nucleus 
with highest concentration in the caudal, rhombencephalic and the dorsomedian, 
mesencephalic part of the nucleus. The cell bodies in the caudal area are mostly 
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oriented in a dorsoventral direction, while the perikarya in the dorsomedian part 
are generally oriented rostrocaudally. 
The large neurons were located in the ventromedial and lateral parts of the 
nucleus. In the ventromedial part of the nucleus the serotoninergic neurons are 
confined to the midline and only few in number. A small percentage of large neurons 
were found in the dorsalmost part of the lateral region of the nucleus raphe 
dorsalis. Here, they are in close proximity to the very large cell elements. 
The very large cells were only localized in the lateral, mesencephalic part 
of the nucleus, where they form the major cell type. 
With regard to size and shape of the cell bodies, our results are in general 
agreement with other studies on the nucleus raphe dorsalis (Dahlström and Fuxe, 69; 
Hubbard and Di Carlo, 132; Taber et al., 300). From our results, it appears that the 
serotonin-immunoreactive neurons corresponds to the medium-sized-fusiform, and the 
large multipolar neurons observed in the normal material. 
Dendrites 
For the sake of clarity the dendritic patterns of the cells occurring in the 
four areas with high cell density will be discussed separately. The dendrites 
belonging to the cell type small serotoninergic neurons show different 
characteristics depending on their position either in the caudal part or the ventro-
medial part of the nucleus raphe dorsalis. The small cells situated in the most 
rostral area of the caudal part of the nucleus give rise to long processes, which 
can be followed over a length of 400-500.urn, and terminate as a part of the supra-
ependymal plexus. Another feature of these processes is that from them, single 
branches originate, which issue close to the perikaryon. The dendrites belonging to 
the small cells situated in the ventromedial part of this nucleus could not be 
investigated, due to the great number of serotonin-immunoreactive perikarya and the 
serotoninergic innervation of this region. 
The dendritic pattern of the medium-sized serotonin-positive neurons differ 
between their two main locations. The dendrites in the caudal, rhombencephalic 
part show different characteristics depending on the position of their perikarya in 
this region. The cells situated in the midline have only very short, rather thick 
dendrites, which in general, are oriented dorsoventrally. These dendrites can be 
followed over a length between 15 and 40,um. The medium-sized cells, situated 
laterally in this area have in general two or three processes. A short, rather 
coarse one, which is directed ventromedially with a length of 20+10,urn. The other 
process(es) extend(s) dorsolatëralward and can be followed parallel to the surface 
of the fourth ventricle over a distance of between 150-250,um. Both the short 
ventromedial and the long dorsolateral dendrites are generally unbranched. There 
have never been observed any processes entering the nucleus tegmentalis dorsalis 
of Gudden. The dendrites of the medium-sized cells in the dorsomedian mesencephalic 
part show different patterns, related to the position of their perikarya. Due to the 
great number of serotonin-immunoreactive neurons in the medial area, it was not 
possible to trace their individual dendrites. However, the direction and length 
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of the dendrites, belonging to the laterally situated neurons could be determined. 
These cells are generally provided with two dendrites, a longer one and a shorter 
one. The longer dendrites shows no special orientation and can be followed over a 
distance of 60,um. The shorter dendrite, with a length of 15,um, is directed 
dorsally, but none of these processes have been observed to actually reach the 
surface (Figs. 23A.B). 
The dendrites belonging to the cell type large, situated either in the 
ventromedial or lateral mesencephalic part of the nucleus raphe dorsalis, show 
different phenomena. The dendrites of the larger cells in the ventromedial part of 
the nucleus could not be determined, due to the dense cell packing in that area. 
The large, fusiform neurons situated in the caudal region of the lateral parts, 
spread out their axons dorsocaudally, reaching the ventricular surface and 
continue caudally as a part of the supra-ependymal plexus. 
The very large multipolar serotonin-immunoreactive cells situated in the lateral, 
mesencephalic parts of the nucleus raphe dorsalis, show generally at their caudal 
side one process, which they rapidly ramifies into two branches. These two branches 
can be followed over a short distance of between 20 and 40,um. At their rostral side 
the serotoninergic cells show very long dorsally directed processes, which sometimes 
can be followed over a length of 100 to 250,um and much shorter ventral processes 
with a length of 80-100,um. However, the former processes do not reach the dorsal 
surface. 
3.1.6 Nucleus centralis superior 
Cytoaroh-iteature 
The nucleus centralis superior is a distinct nucleus situated in the caudal 
part of the tegmentum mesencephali. It extends from level Ρ 1000 to level A 1200 
in our atlas (Figs. 8B; 9A,B; ΙΟΑ,Β; ΙΙΑ,Β). The caudal part of the nucleus is 
situated ventral to the nucleus ventralis tegmenti. Its intermediate and rostral 
parts are located ventral to the pedunculus cerebellaris superior. The caudal part 
of the nucleus is situated dorsal to the nucleus reticularis tegmenti pontis. The 
intermediate part lies dorsally to the lemniscus triangularis and the rostral part 
dorsal to the lemniscus medialis. 
The caudalmost neurons of the nucleus form a narrow band of cells in the median 
plane between the nuclei reticularis tegmenti pontis. More rostrally the nucleus 
shifts to a position dorsally to the nucleus reticularis tegmenti pontis, but it is 
still confined to the median plane. The neurons of its intermediate part are 
diffusely arranged however they do not reach the borders of the tractus tecto-
spinalis. Its most rostral part is difficult to delineate. The nucleus centralis 
superior contains three cell types: small-ellipsoid; medium-sized-ellipsoid and 
medium-sized-fusiform with following dimensions for length and diameter, 
respectively: 13+3.um - 12+2.um; 18+4 .um - 13+4.um and 19+4 .um - 16+4 .um. The cells 
of all of these types are evenly distributed over the nucleus. 
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Serotonin—immunoreaetive perikarya and dendrites 
Perikarya 
Serotoninergic cell bodies are not evenly distributed over the nucleus. Most 
of the immunoreaetive cells were found in the intermediate part, between the 
tectospinal tracts. In addition, some cell bodies were found in the ventrocaudal 
part. Two cell types could be observed: small and medium. The small cells are 
ellipsoid with a length and diameter of 15+3.um and 12+2,urn, respectively. The 
medium-sized cells are fusiform with a length and diameter of 21+4 .um and 17+3.um, 
respectively. The small cell type is mostly found in the medial part of the 
nucleus, while the medium-sized cells are more observed in the lateral areas. 
Comparison of the results obtained from the normal and the immunohistochemical 
material revealed, that the two serotoninergic cell types correspond to the small-
ellipsoid and medium-sized-fusiform perikarya observed in the Nissl-material. 
Dendrites 
The dendrites of the serotoninergic perikarya are in general oriented in a 
rostrocaudal direction. The dendrites of the small-ellipsoid cells are coarse 
and short, 10-20.um. The processes of the medium-sized cells can be followed 
over a much longer distance, 150-250,urn. 
3.1.7 Nucleus linearis oralis 
Cytoarohiteoture 
The nucleus linearis oralis is the most rostral raphe nucleus. This rather 
small, distinct cell mass extends from level A 1100 to level A 1750 in our atlas 
(Figs. IIB; 12A.B). The nucleus is situated dorsal to the nucleus interpeduncularis. 
Rostrally the nucleus extends to the level of the pedunculus corporis mamillaris. 
The most caudal cells of the nucleus linearis oralis were found at the level of the 
rostral pole of the rubrospinal tracts. 
Two types of cell bodies were demonstrated: small and medium. The small cells 
are ellipsoid with a length and diameter of 15+2,um and 12+2 .urn, respectively. The 
medium-sized cells have also an ellipsoid appearance. Their length and diameter 
measure 18+4 ,um - 13+3,um, respectively, the latter being the most frequent. The 
cells of the two types are evenly distributed within the nucleus. 
Serotonin—immmoreactive perikarya and dendrites 
Perikarya 
The serotoninergic cell bodies are unevenly distributed over the nucleus 
linearis oralis. The highest proportion of these elements was found caudally, some 
were observed in its intermediate part, while no serotonin-containing cells were 
demonstrated rostrally (Figs. 15A,C). 
Only one type of serotonin-positive cell body was found: small, piriform cells 
measuring 16+3,urn and 12+3,um, for their length and diameter, respectively. 
This latter cell type resembles the small-ellipsoidal neurons demonstrated in 
the Nissl-material. 
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Dendrites 
The dendrites of the cell bodies, situated in the dorsal part of the nucleus, 
are oriented in a caudorostral direction. They are short and thick, their length 
being 15-25,um. The dendrites of the neurons, located ventrally in the nucleus, 
are exclusively directed ventrally. Hereby, they extend into the dorsal half of the 
nucleus interpeduncularis (Figs. 15A,C). 
3.2 Serotoninergic cell bodies beyond the raphe nuclei 
Besides the serotoninergic neurons situated within the confines of the raphe 
nuclei, we were able with our current procedure to visualize serotonin-immunoreac-
tive cells in several other rhombencephalic and mesencephalic areas. The shape and 
size of these serotonin-immunoreactive perikarya have not been determined ; 
however, it has been observed that the dimensions of the serotoninergic neurons, 
visualized in the proximity of the various raphe nuclei, do not differ 
substantially from the serotonin-positive cells within the boundaries of the 
raphe nuclei itself, see for example Figures 14, 15, which show the cells within 
and beyond the boundaries of the raphe nuclei. Our findings, which have been 
divided into two categories: sparse and substantial, will now be briefly discussed. 
In the medulla oblongata we demonstrated a few cells in the nucleus 
commissuralis, in the area dorsomedially to the nucleus reticularis medullae 
oblongatae, pars ventralis, in the region adjacent to the decussatio pyramidis, 
in the nucleus intercalatus, in the nucleus reticularis lateralis, in the rostral 
part of the nucleus gracilis and in the nucleus reticularis paramedianus. More 
rostrally, at level Ρ 6000,we observed some cells in the midline between both 
fasciculi longitudinale mediale. Around level Ρ 5500 we observed a substantial 
number of serotonin-positive cells ventrolaterally to the inferior olive 
complex . In the rostral part of the medulla oblongata we found a 
large number of neurons in the dorsal part of the lemniscus medialis and in the 
zone between the nucleus raphe magnus and the nucleus nervi facialis. Moreover, 
dorsally at level Ρ 4250, we saw a substantial number of serotoninergic neurons 
ventral and lateral to the nervus facialis, a few cells between the 
nucleus vestibularis medialis and the floor of the fourth ventricle and in the 
dorsal part of the fasciculi longitudinalis medialis. 
In the pons we observed a small number of serotoninergic neurons in the area 
surrounding the nucleus suprageniculatis facialis and at that same level, Ρ 3500, 
within and ventral to the lemniscus medialis and more laterally in the region dorsal 
to the nucleus olivaris superior. More rostrally, at level Ρ 2500, we localized 
a substantial number of serotonin-positive cells dorsal and lateral to the nucleus 
tegmental is dorsalis of Gudden; and some cells between both fasciculi longitudinale 
mediale. A large number of serotonin-immunoreactive cells were demonstrated in the 
area of the lemniscus medialis and a few cells in a zone between the nucleus 
reticularis pontis caudalis and the nucleus corporis trapezoide!. 
In the rostral part of the pons, at level Ρ 1500, we demonstrated a few cells 
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in the ventral part of the locus coeruleus and in the subcoeruleus area; in the 
region under the floor of the fourth ventricle, between the nucleus raphe dorsalis 
and the locus coeruleus, and finally in the region of the lemniscus medialis or 
immediately adjacent to it. 
In the mesencephalon we found caudally, at level Ρ 1000, some serotoninergic 
neurons in the substantia griseum centralis, in the fasciculus 
longitudinal is medialis, and in the rostral part of the nucleus parabrachialis 
ventralis. In addition, some serotonin-positive neurons were observed between the 
rostral pole of the nucleus raphe pontis and the nucleus reticularis tegmenti 
pontis and in a region ventrally to the nucleus raphe pontis. Rostrally, at level 
Ρ 525, we localized serotonin-positive cells in an area dorsally to the tractus 
corticospinalis and medially to the nucleus corporis trapezoidii. In the medial, and 
especially in the rostral part of the mesencephalon we observed that most of the 
serotonin-positive neurons are not confined to the three mesencephalic raphe nuclei, 
although the nucleus raphe dorsalis contains the highest accumulation of 
serotoninergic perikarya in comparison to the other seven raphe nuclei. Cell bodies 
were demonstrated, at level A 775, in the lemniscus medialis, and in the region 
bordered by the fasciculus longitudinal is medialis, the nucleus cuneiformis, the 
lemniscus medialis and the nucleus centralis superior. Some scattered 
cells were visualized within the borders of the nucleus cuneiformis. More rostrally, 
at level A I 100, we observed the highest concentration of extrarapheal 
serotoninergic neurons in the region dorsal to the lemniscus medialis and ventral to 
the nucleus ruber, especially in the lateral parts. A few cells were situated 
within the nucleus ruber. 
The most rostral area in which we demonstrated serotonin-immunoreactive neurons 
in the untreated rat is situated between the pedunculi corporis mamillaris and the 
lemniscus medialis, where a few cells were found. 
Interestingly there exists from caudal to rostral a steady shift of the 
serotoninergic neurons from a dorsal to a ventral position. With our current 
procedure we were also able to visualize serotonin-immunoreactive cells in the 
habenular region (Figs. 16A,B,C,D). These cells, found in the area of the sub­
commissural organ, are of pinealocyte rather than neuronal nature. However, some of 
these cells are provided with processes and differ in this respect from the cells of 
the pineal gland proper. Finally, it should be noted that no serotonin-positive cells 
have been observed in the area of the hypothalamus or in any other diencephalic or 
telencephalic regions, using either a rat which was untreated or pretreated with 
either Nialamide or L-tryptophane. However, in rats pretreated with a combination 
of both drugs, we were able to visualize a number of serotonin-immunoreactive 
neurons in the substantia nigra (Figs. 17A,B) and ventrally in the nucleus dorso-
medialis hypothalami (Figs. 19A.B). 
3.3 Extraencephalic serotoninergic cells 
Three extraencephalic regions reveal the presence of serotoninergic cells. 
Two of these areas contain neurons, which are either situated supraependymal or 
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superficial. One sphere is composed of superficial located, serotonin-immunoreactive 
glia cells. 
Supraependymal serotoninergic neurons 
Within the ventricles we have observed on the roof of the rhombencephalon, the 
basal surface of the fourth ventricle, and in the aquaductus cerebri some 
serotonin-positive neurons. The highest concentration of these neurons is found in 
the rostral part of the bottom of the fourth ventricle. Caudally these neurons are 
only observed at the lateral ventricular walls. All of these cells are medium-sized 
with a fusiform-bipolar appearance. We have not observed a special orientation. 
Their length and diameter measure 25+6 and 18+3.urn, respectively. These elements 
were observed to have two processes, which could be followed over only a very short 
distance. No evidence has been found that these processes enter the ependyma. 
Superficial located serotoninergic neurons 
The second group of extraencephalic serotonin-containing cells, consisting of 
only a sparse number of cells (+20), is located in the region bordered dorsally by 
the area tegmentalis of Tsai and the nucleus mamillaris posterior. The cells are 
situated immediate to the basal brain surface. All of these cells are large and 
tri- or multipolar. The processes of these elements usually show the following 
pattern. One process is running caudally, another is oriented rostrally, and a 
third one extending into the border zone between the nucleus interpeduncularis and 
the area tegmentalis ventralis of Tsai (Figs.15A,B). 
Superficial located serotoninergic glia cells 
The third group of extraencephalic cells was observed adjacent to the 
rhombencephalic part of the tractus corticospinalis and ventrally to the caudal part 
of the inferior olive complex (Fig. 14). Two types of cells are found: 
a) cells which are fusiform, oriented mediolaterally with a length of 24+5 ,um and a 
diameter of 18+3 ,um, and b) cells which are small and round with a diameter of 
17+3,um. The fusiform cell type is demonstrated ventrally to the medial part of the 
tractus corticospinalis. They give rise to short processes some of which enter the 
tractus corticospinalis. Other processes are directed laterally and one particularly 
long process passes rostrally. The round cell type is localized ventrally to the 
lateral aspects of that same tract. These cells are in possession of a thick, short 
process, which is oriented medially and thinner long processes, which are running 
laterally. 
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4. DISCUSSION 
4.1. Specificity of the ínmiunoreaction 
The validity of immunocytochemical methods depends mainly upon the specificity 
of the antibody used. The specificity of the serotonin-aotiserum employed in our 
procedure was tested as follows: 
1) Liquid-phase absorption of the antiserum with increasing concentrations of 
serotonin (5-HT), 5-methoxy-tryptamine (5-MT), tryptamine (TYR), dopamine (DA), 
noradrenaline (ΝΑ), adrenaline (A), octopamine (OCT) and histamine (HIST). This test 
demonstrated a cross-reactivity to DA and 5-MT of less than 2%, the other agents 
showed neglegible binding, see Table I. 
2) Liquid-phase absorption experiments using the conjugates: BSA-5-HT; BSA-DA; 
BSA-NA and BSA-A revealed that the antiserum could only be blocked with the 
BSA-serotonin conjugate. 
3) Intraventricular and intraraphal injections with 5,7-dihydroxytryptamine 
(10 Ug/pl) resulted in an almost complete elimination of 5-HT immunoreactive fibers. 
This finding has been biochemically confirmed by McRae-Degueurce and Pujol (193). 
4) Administration of the serotonin neurotoxin parachloroamphetamine (PCA; 2x10 mg/kg; 
ip) 4 hrs prior to sacrifice (Köhler and Lorens, 154) resulted in a considerable 
decrease of 5-HT immunoreactivity. 
5) Electrolytic lesions of either the nucleus raphe dorsalis or the nucleus centralis 
superior resulted in a complete disappearance of the 5-HT immunoreactivity. 
6) Intraperitoneal injection with reserpine (10 mg/kg bodyweight) 4 hrs before 
sacrifice resulted in a total disappearance of the serotoninergic fibers, although 
the blocking effect on the serotonin-positive perikarya was not complete. 
7) No staining was observed in areas, containing a large amount of possible 
cross-reacting compounds, like noradrenaline in the locus coeruleus or dopamine in 
the substantia nigra. 
With regard to the specificity of our serum the following two additional notes are 
relevant: 
1) Close correlation with the findings of Pickel et al. (235) using an antibody 
to tryptophan hydroxylase (TrH, E.C. 1.14.16.4), the rate limiting enzym in the 
synthesis of serotonin from tryptophan, revealed a good correspondence. However 
TrH-positive staining was often associated with heavily myelinated tracts, i.e., 
the tractus corticospinalis, lemniscus medialis, and the fasciculus longitudinalis 
medialis. 
2) Since our fixation procedure resembles that of the FIF-technique the possibility 
of cross-reactivity of the serotonin-antibody towards ß-carbolines has been 
suggested by Buckholtz (47), Deitrich (72) and Komulainen et al. (155). 
We consider the cross-reactivity mentioned above unlikely, for the following 
two reasons: 
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a) B-carbolines are not water-stable products. The FIF-technique is carried out in 
a completely dry environment after the perfusion, but this is not so in the 
immunocytochemical technique. Thus, it may be expected that all the possibly formed 
ß-carbolines will be washed out of the tissue during our procedure. 
b) High concentrations of B-carbolines have been demonstrated in the nucleus 
arcuatus of the rat, using ultraviolet laser fluorimetry and organic extraction 
(Shoemaker et al., 272). However, in our material this area reveals only a sparse 
to low immunoreactivity. 
In later sections of the present paper some data from the literature obtained 
with antibodies against small neuropeptides are discussed. It should be emphasized 
that these data should be judged with caution, because adequate control experiments 
have sometimes been neglected. It is also worthy of note that in immunocytochemical 
studies with antisera to small peptides cross-reactivity with analogues, fragments 
or sequences of larger peptide should be excluded. The insufficient availability of 
these compounds makes liquid-or solid phase-absorption tests difficult to perform. 
4.2. Ontogenesis of serotoninergic neurons 
Neuroblasts are generally produced in the proliferative zone, near the 
ventricular surface from where they migrate radially to their final position 
where their maturation occurs. From all transmitter-specified neuron populations 
investigated so far the serotonin is the first one to appear. Using the FIF-
technique Olson and Seiger (220) found that indolamine-containing neuronal cell 
bodies can be observed in the rat at day 13 of gestation and in man during the 
seventh week of gestation (Olson et al., 219). 
The immature serotoninergic elements constitute two superficially situated 
columns, which are localized bilaterally at some distance from the median plane, 
in the stretch of the brain stem situated between the pontine and mesencephalic 
flexures. From this finding it may be surmised that the syntheses of serotonin, 
begins after the completion of a ventrally directed, radial migration of the 
prospective serotoninergic elements. At this stage serotonin cannot be designated 
as a neurotransmitter, because the development of synaptic contacts has' yet to be 
started. This raises the question what specific role serotonin might play during 
ontogenesis other than that concerned with chemical neurotransmission. One 
hypothesis is that serotonin acts as a 'differentiation signal' during early 
neurogenesis for those cells which will eventually receive a 5-HT innervation. 
Regulation of the timing of the target cell differentiation by a presumptive 
neurotransmitter substance implies a high degree of specificity in the interaction 
of cells in the neural tube, which is maintained during later developmental 
processes, such as synaptogenesis (Lauder and Krebs, 160; Lauder et al., 161). Thus, 
according to this hypothesis serotonin and other neuroactive principles as well, 
participate in the building of their own circuitry in the developing brain. 
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On the fourteenth day of gestation the existence of three groups of indolaminergic 
neurons was demonstrated in the rat by Cadilhac and Pons (53), using the FIF-
technique. The rostral and most prominent group is situated at the ventral surface 
between the mesencephalic and pontine flexure. The cells in this group showed a 
strong yellow fluorescence, indicating a high amount of indolamines. In addition, 
they observed that these cells are not evenly scattered in this region, but are 
rather arranged in two or three layers. Some rostrally directed axons were seen. 
The second group was localized in the rhombencephalon just behind the pontine 
flexure. It occupied the entire ventral part of the pons. The third group was found 
more caudally at the level of the cervical flexure. Only a few cells in this group 
give rise to some descending axons. The serotoninergic axons grow out later, and 
usually reach their area of termination shortly after birth (Loizou, 177; Olson and 
Steiger, 220). From birth on, the development of the serotoninergic neurons is 
accelerating to reach their mature state in the rat brain at about the sixth postnatal 
week (Agrawal et al., 6). Moreover the study of Hedner and Lundborg (121) showed 
that the rate-limiting step in the development is the availability of tryptophan 
hydroxylase. 
The study in the rat of Levitt and Moore (169), who also have used the FIF-
technique, started at day 18 of gestation and was primarily focused upon the time 
of fusion of the initially bilaterally located prospective raphe cell groups. The 
development of these groups can be seen as a two-step procedure. First, a bilateral, 
ventrally oriented migration of the neuroblasts from the proliferative zone towards 
a region adjacent to the midline and, secondly, a medial migration, bringing about 
the fusion of the bilateral groups of neuronal elemente. Using immunocytochemistry 
in combination with antibodies to serotonin we were able to confirm the findings of 
the authors mentioned above. Preliminary results were achieved in Chinese hamster 
(Cricetulus griseus) embryos of 14 days of gestation (Figs. 13A,B,C,D) and in rats 
on the first postnatal day. According to the work of Gribnau and 
Geijsberts (115) who described a system of staging of mammalian embryos, the 
Chinese hamster embryos studied are comparable with rat embryos aged 14,5 days of 
gestation. Our preparations showed that at that stage the serotonin-immunoreactive 
cell groups are not yet fused (Figs. 13A,B,D). We observed that some of the 
neuroblasts pass the midline (Figs. 13B,D). Observations in the young rats revealed 
that most of the serotonin-positive neurons indeed migrate in the direction of the 
raphe nuclei. However, from a comparison of our material of neonatal rats 
with that of adults it can be inferred that in the ventrorostral part of the 
mesencephalon migration is not directed medially, but rather occurs in the opposite 
direction . These laterally migrating serotoninergic cells will probably 
constitute in the adult rat the B9 cell group, which is equivalent to the serotonin-
positive cells in and around the mesencephalic part of the lemniscus medialis. 
In adult rats all of the seven raphe nuclei fuse except for the rhombencephalic 
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part of the nucleus raphe dorsalis. Our observations warrant the tentative conclusion 
that the serotonin-positive neurons, situated in the reticular formation are neurons 
which during ontogenesis have not completed their migration towards the raphe region. 
4.3. Serotoninergic cells in the adult rat 
In general our results, regarding the distribution of serotonin-immunoreactive 
perikarya, are in confirmity with earlier FIF observations in the rat by Dahlström 
and Fuxe (69), in the cat by Lackner (159), Pin et al. (237), Poitras and Parent 
(238) and Wiklund et al. (337), in the squirrel monkey (Saimirí sciureus) by Hubbard 
and Di Carlo (132), in the pigmy primate (Cebullae pigmae) by Jacobowitz and MacLean 
(135) and in the human fetus brain by Nobin and Björklund (213). However, we observed 
in our material that only a minority of the neurons in the nucleus raphe obscurus, 
the nucleus raphe magnus, the nucleus raphe pontis, the nucleus centralis superior 
and the nucleus linearis oralis are serotonin-immunoreactive. A much higher number 
of serotonin-positive elements was seen in the nucleus raphe pallidus and the nucleus 
raphe dorsalis. Moreover, it has to be mentioned that most of the serotonin-
immunoreactive neurons are not situated within the seven raphe nuclei. It was for 
this reason that Dahlström and Fuxe (69) introduced a new classification of the 
indolamine-containing cells in the rat brain stem: i.e. nine groups, designated as 
В through В . 
Nevertheless, we have not attempted to determine exactly the ratio between 
serotoninergic versus non-serotoninergic neurons in the different raphe nuclei. 
Wiklund et al. (337), who used the FIF-method in combination with the Nissl-stain 
determined this ratio for the raphe nuclei of the cat as follows: nucleus raphe 
obscurus:35%; nucleus raphe pallidus: 50%; nucleus raphe magnus: 15%; nucleus raphe 
pontis: 10%; nucleus raphe dorsalis: 70%; nucleus centralis superior: 35%; and 
nucleus linearis oralis: 25%. The percentage of the serotonin-positive cells in 
the nucleus raphe dorsalis corresponds with the one resulted from the autoradiographic 
study in the rat of Descarries et al. (74). 
So far the most comprehensive mapping of indolaminergic neurons has been carried 
out by Wiklund et al. (337) using the FIF-technique in the brain stem of the cat. 
Two major differences between their results and ours should be mentioned. The first 
is that we remained unable to confirm their observations regarding the presence 
of serotoninergic neurons in the lateral part of the reticular formation. This could 
be a species difference between rat and cat. The second is that we observed a much 
larger number of serotonin-positive neurons within the area of the lemniscus medialis 
in the mesencephalon, than they did. Besides of these two major differences, the 
following two minor controversial points should be mentioned: 
a) We have observed serotoninergic cells at the basal surface of the rhombencepha­
lon in the area ventral to the tractus corticospinalis (Fig. ]4). 
These cells have not been described before. It was not possible to relate them 
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to normal material, since they are hard to demonstrate in 15 ym thick Nissl sections. 
Conceivably, these neurons have been drifted during the early development of the 
pyramidal tract. Since the maturation of the serotoninergic neurons starts ventrally, 
as has been described in section 4.2, these cells may have been precluded from 
migrating dorsomedially. 
b) Indolamine-containing cells in the area of the subcommissural organ of the rat, 
have been described previously by Björklund et al. (31), M^llgard and Wiklund (200) 
and Wiklund (336), who both have used the FIF-method. The latter authors described 
in addition yellow fluorescent cells within the stria medullaris and in the nucleus 
habenularis medialis. Although, we have used the same pharmacological pre-treatments 
as the authors mentioned, we could only confirm the presence of serotonin-containing 
cells in the area of the subcommissural organ (Figs. 16A,B,C,D). 
Finally several authors, who have used autoradiography (Beaudet and Descarries, 
22; Chan-Palay, 61; Kent and Sladek, 149; Parent et al., 225) reported the uptake 
3 
of Η-serotonin in penkarya in several hypothalamic nuclei, among which the nucleus 
ventromedialis hypothalami, the nucleus dorsomedialis hypothalami and the nucleus 
paraventricularis hypothalami. 
As regards our own observations, even after a pretreatment with nialamide or 
L-tryptophane, to enhance the concentration of endogenous serotonin, we remained 
unable to confirm with immunofluorescence, serotonin-positive perikarya in the 
hypothalamus (Figs. 17C,D; 19C.D). However, using the same pharmaca together in 
combination with vibratome sections, which were immunohistochemically stained for 
serotonin we were able to visualize serotoninergic cells in the ventral part of the 
nucleus dorsomedialis hypothalamus (Figs. 19A.B), but also in the substantia nigra, 
pars compacta and the area tegmentalis ventralis of Tsai (Figs. 17A.B). No staining 
was observed in other dopaminergic, noradrenergic or adrenergic neuron populations. 
The immunoreactive cells in the nucleus dorsomedialis hypothalami indeed 
contain serotonin, although their content in vivo is very small. The same cells are 
definitely not dopaminergic, as previously suggested by one of us (Steinbusch, 
284). This appeared from the fact that these cells in immunofluorescence did not 
react with an antibody to tyrosine hydroxylase. Applying this antibody we were 
able to demonstrate dopaminergic cells in neightbouring areas such as the nucleus 
arcuatus and the zona incerta, but none in the nucleus dorsomedialis hypothalami 
itself (Fig. 20 ). Although these cells have not been demonstrated by Pickel et al. 
(235), using immunohistochemistry in combination with an antibody to tryptophan-
hydroxylase, they must contain the enzyme system to convert the applied 
L-tryptophane to serotonin. The neurons under discussion do not contain another 
indolamine than serotonin. The biochemical studies of Green et al. (114) and the 
microspectrofluorometric work of Björklund et al. (26,27,28,29) indicated that other 
indolamines, namely 5-methoxytryptamine or tryptamine are present in the rat 
central nervous system. The latter author stated, that these non 5-HT-indolamines 
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are situated in other brain areas than those where the 5-HT and catecholamine neuron 
populations are located, including the hypothalamus. However, Jonsson et al. (141), 
using a microspectrofluorimetric analysis and Bosin·et al. (40), Nakasimhachari 
et al. (207) and Prozialick et al. (240), using several sensitive gas-chromatographic 
mass spectrophotic methods, remained unable to detect any 5-methoxy-tryptamine in 
the hypothalamus of the rat. 
With regard to the serotonin-immunoreactive cells in the substantia nigra, pars 
compacta and the area tegmentalis ventralis of Tsai, there are three explanations: 
1) It could well be possible that since the substantia nigra and the area 
tegmentalis ventralis of Tsai receive a medium-dense-serotoninergic innervation, the 
released serotonin could be taken up by dopaminergic cells, since the monoamine 
oxydase has been inhibited by nialamide. Subsequently the serotonin taken up 
would be recognized by immunocytochemistry. However, in all other dopaminergic 
as well as noradrenergic neuron populations, which receive an equal or even higher 
serotoninergic innervation we have not demonstrated a serotonin-positive staining 
of their perikarya. 
2) Another possibility could be that L-tryptophane is taken up by serotoninergic 
neurons, in which L-tryptophane is converted to 5-hydroxytryptophan. This 
intermediate product could be released out of the neuron and subsequently be taken 
up by dopaminergic cells. These cells contain the same enzyme, ADDC, to convert 
5-hydroxytryptophan further to serotonin (Fig. 1). However, we have to raise the 
same objections, viz. that in that case we should have to find a serotonin-
positive staining in all catecholaminergic cells. 
3) A further explanation could be that the addition of L-tryptophan will increase 
the activity of the enzyme ADDC which in its turn will result in a build up of 
dopamine. Due to a low amount of cross-reactivity of the serotonin-antibody 
towards dopamine, we would possibly, then, dopaminergic rather than serotoninergic 
structures. However, as has been explained (Steinbusch et al., 291) with the 
applied fixation procedure, we are not able to fix catecholamines. 
4) The last, and in our opinion, the most likely explanation of the phenomena 
observed is that the immunoreactive cells in the substantia nigra, pars compacta 
and in the area tegmentalis ventralis of Tsai contain minute amounts of serotonin, 
which normally cannot be detected. Evidence for this last explanation has been 
obtained from three additional experiments: 
1) No serotonin-immunoreactive cell bodies were observed after the pretreatment 
with the specific 5-HT depletor, 5,7- dihydroxy-tryptamine. 
2) In the substantia nigra immunocytochemically staining of adjacent sections with 
an antibody to tyrosine hydroxylase revealed a striking similarity between the 
serotonin- and catecholamine- immunohistochemistry (Figs. 17A.B; 18). 
3) Electrolytic lesions , in the area immediately rostral to the nucleus raphe 
dorsalis and the nucleus centralis superior resulted in an almost complete 
disappearance of serotoninergic fibres in forebrain areas. However, some fibres 
still remained in the hypothalamus. Thus, those fibres must have an intra-
hypothalamic source, as previously mentioned by Van de Kar and Lorens (317). 
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Finally, three additional observations should be mentioned in this contect 
1) Serotonin-positive cells have been observed in the reptilian homologue area 
of the substantia nigra in the untreated animals (Varanus exanthimaticus) (Wolters , 
personal communication). 
2) Serotonin-immunoreactivity in cells of the area of the substantia nigra is much 
stronger at foetal stages than in the adult material. 
3) It has been proven bij Burnstock (49,50) that sympathetic neurons can 
synthesize and release two different monoamines. 
Conclusion: it might be well possible that we have shown for the first time the 
presence of two monoamines within the same neurons of the central nervous system. 
Moreover it is our impression that these cells produce much higher concentrations 
of serotonin during development than in the adult state and that during maturation 
these cells receive a changing phenotypic expression, so that it can produce instead 
of serotonin the catecholamine dopamine. 
4.4 Comparison of the various raphe nuclei 
4.4.1 Cytoarakiteoture 
The raphe nuclei are all situated in the median and paramedian zone of the 
brain stem. Comparison of these nuclei revealed that they differ not only in cell 
density, but also in the types of cells they contain. On the basis of dimensions 
four cell types can be distinguished: small, medium, large and very large. Each of 
these four cell types can be further divided according to their shape. 
The small cells appear to be present in two forms: a) spherical or ellipsoidal in 
the nucleus raphe obscurus, the nucleus raphe pallidus, the nucleus raphe pontis, 
the nucleus raphe dorsalis, the nucleus centralis superior and the nucleus linearis 
oralis and b) round or oval in the nucleus raphe pallidus. 
The medium-sized cells were present in three forms: a) multipolar in the nucleus 
raphe magnus and the nucleus raphe pontis, b) fusiform in the nucleus raphe dorsalis 
and the nucleus centralis superior and c) ellipsoidal in the nucleus centralis 
superior. 
The large cells can be divided into three types: a) bi- or tripolar in the 
nucleus raphe obscurus, b) fusiform in the nucleus raphe magnus, and c) multipolar 
in the nucleus raphe dorsalis. 
Finally, very large cells,which appeared as fusiform or elongated neurons,were 
demonstrated only in the nucleus raphe dorsalis. 
Our cytoarchitectural analysis of the raphe nuclei of the rat is in general 
agreement with studies in the rabbit (Feiten and Cummings, 89), cat (Taber et al., 
300) and man (Braak, 41). Moreover the raphe nuclei in the rat show with regard to 
their localization a striking resemblance to those of other species. Due to a 
different classification of neurons our results differ somewhat from those of 
Feiten and Cummings (89). The present study confirms the neuronal heterogeneity 
among the various raphe nuclei and shows, that each of these nuclei represents a 
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cytoarchitectonic entity. 
4.4.2 Serotoninergic neurons 
Since the initial description of indolamine-containing neurons in the brain 
stem of the rat (Dahlström and Fuxe, 69), numerous histofluorescence studies in 
several species have appeared as already mentioned in chapter 4.3. The study of 
Wiklund et al. (337) showed that the various raphe nuclei differ not only in the 
total number of serotoninergic cells, but also in the presence of various cell types. 
Four categories of cells were found on the basis of dimensions: small, medium, large 
and very large. Each of these categories can be further divided according to their 
shape. 
Small serotoninergic cells, which were only present in the three mesencephalic 
raphe nuclei, occur in three forms: spherical, ellipsoidal and piriform. The small-
spherical cells were observed in the nucleus raphe dorsalis. The small-ellipsoidal 
cells were found in the nucleus centralis superior and the small-piriform cells 
were demonstrated in the nucleus linearis oralis. 
Medium-sized serotoninergic cells, present in all of the raphe nuclei except 
for the nucleus raphe magnus, occur in two forms: A) spherical and ellipsoidal, and 
B) fusiform or bipolar. Form A was observed in the four rhombencephalic raphe nuclei, 
i.e. nucleus raphe obscurus, the nucleus raphe pallidus, nucleus raphe magnus and 
the nucleus raphe pontis. Form В was found in two of the mesencephalic raphe nuclei, 
i.e. the nucleus raphe dorsalis and the nucleus centralis superior. 
Large serotoninergic cells were found in two forms: A) fusiform and B) multipolar. 
The large-fusiform cell type was demonstrated in the nucleus raphe magnus, the 
nucleus raphe pontis, and the nucleus raphe dorsalis. The large multipolar neurons 
have been found in the nucleus raphe pallidus, and in the nucleus raphe pontis. 
Very large serotoninergic cells finally, were only present in the nucleus raphe 
dorsalis in a multipolar appearance. 
These observations reveal, that the seven raphe nuclei differ considerably 
from each other with regard to both their cytoarchitecture and the typology of 
their constituent serotoninergic cells. However, some similarities were observed 
among the four rhombencephalic raphe nuclei and the three mesencephalic raphe nuclei. 
Summarizing, it may be stated that the raphe nuclei have two features in common: 
a) their position in the midsagittal plane of the brain stem and b) the presence of 
considerable numbers of serotoninergic neurons within their borders. 
However, the considerable differences between these nuclei with regard to 
cytoarchitecture, dendritic patterns, afferent and efferent connections render it 
highly unlikely that these nuclei together constitute a single functional entity. 
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4.5.1. Catecholgmine-containing cellß 
It has been observed that the three mesencephalic raphe nuclei (i.e. the 
nucleus raphe dorsalis, the nucleus centralis superior and the nucleus linearis 
oralis) contain in addition to serotoninergic neurons, catecholaminergic elements 
Table II). In the nucleus raphe dorsalis dopaminergic as well as noradrenergic cells 
have been found. Hökfelt et al. (127) described the presence of small TH-positive 
cell bodies in the area immediately ventral to the aquaductus cerebri. Ochi and 
Shimizu (216), using formaldehyde-induced fluorescence histochemistry demonstrated 
the presence of medium-sized catecholaminergic neurons. Microspectrofluorometry 
identified the catecholamine as dopamine. These dopaminergic perikarya were situated 
in the midline of the ventromedial part. Nagatsu et al. (205) treating sections of 
unperfused tissue with antibodies to tyrosine hydroxylase (TH) of dopamine-ß-hydroxy-
lase (DBH) demonstrated dopaminergic cell bodies in the nucleus raphe dorsalis in the 
part just above and medial to the FLM. The cells were small to medium-sized. Grzanna 
and Molliver (117,118) using a homologous antibody to DBH demonstrated that nor-
adrenaline-immunoreactive cells are present in the lateral parts of the NRD. Yet, 
when we used a primair catecholamine antibody, which visualizes the noradrenergic 
neurons of the locus coeruleus, as well as the dopaminergic neural perikarya in the 
substantia nigra, no immunohistochemical staining was obserned in the ventromedial 
part of the nucleus raphe dorsalis. We were able to confirm the presence of noradre-
nergic cells situated in the lateral part of that nucleus (Steinbusch et al., 287). 
Using the antibody to TH we were able to demonstrate the presence 
of dopaminergic cell bodies in the ventromedial part of the nucleus raphe dorsalis. 
The unability of our procedure with regard to these cells should be seen as a matter 
of sensitivity. 
In the nucleus centralis superior dopaminergic neurons were described by 
Hökfelt et al. (127), Nagatsu et al. (205) and Ochi and Shimizu (216) in the rat 
and recently by Wiklund et al. (337) in the cat. 
In the nucleus linearis oralis dopaminergic cell bodies have been found in the 
rat by Hökfelt et al. (127) and in the cat by Wiklund et al. (337). We have not been 
able to confirm their observations in this nucleus with our primair catecholamine 
antibody. 
Intermingling of serotoninergic and oateaholaminergia neurons beyond the raphe nuclei 
Two areas have been found where serotoninergic and catecholaminergic cell bodies 
coincide: 
1. Some serotonin-immunoreactive perikarya have been found in the locus coeruleus. 
This region, which is often denoted as the A6 group, contains large numbers of 
noradrenergic neurons (Grzanna and Molliver, 118). Similar observations have been 
made previously by Sladek and Walker (275) , who used the FIF-technique in the 
primate (Macaca arctoides) and by Léger et al. (163), who used a combined fluorescence 
histochemical and radioautographic approach in the cat. However, as has been already 
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mentioned hy Sladek and Walker (275), one could argue that the small number of 
serotoninergic neurons situated in the locus coeruleus-subcoeruleus might not exert 
a significant influence upon the noradrenergic coeruleal neurons. 
2. In the region, between the nucleus interpeduncularis and the lemniscus medialis, 
which forms part of the area tegmental is of Tsai, serotonin-immunoreactive cells 
have been observed. This same region is known to contain large numbers of 
dopaminergic neurons and is designated by DahlstrSm and Fuxe (69) as the A - group. 
4.5.2. Amino-aaid-containing celts 
Six aminoacids have been proposed to act as neurotransmitter candidates: i.e. 
GABA, glycine, glutamate, aspartate, proline and taurine. Of these six compounds 
only GABA has been demonstrated in one of the raphe nuclei, see Table II. GABA-
positive cells have been described in the nucleus raphe dorsalis by Belin et al. 
3 
(23,24) and Gamrami et al. (107), using autoradiography with H-GABA, by Nanopoulos 
et al. (208), using immunohistochemistry in combination with antibodies to glutamate 
decarboxylase (GAD), an enzyme involved in the synthesis of glutamate and by Pfister 
et al. (234), using a modified ninhydrine reaction. Interestingly, the area containing 
GABA-accumulating neurons and those containing GAD-positive perikarya did not show 
any overlap. The former were localized caudally, while the GAD-immunoreactive and 
the ninhydrine-positive appeared to be present in the dorsomedian and ventromedial, 
mesencephalic part of the nucleus raphe dorsalis. 
Finally, preliminary results from Pujol and Steinbusch (unpublished) reveal 
the coexistence of GAD and serotonin in neurons of the nucleus raphe dorsalis. 
4.5.3. Peptide-containing cells 
From the results of Wiklund et al. (337) it is obvious that the raphe nuclei 
are not exclusively serotoninergic. Peptidergic neurons have been found within the 
confines of the nucleus raphe obscurus, the nucleus raphe pallidus, the nucleus 
raphe magnus, the nucleus raphe dorsalis and in the nucleus linearis oralis. No 
peptide-containing cell bodies have been demonstrated within the borders of the 
nucleus raphe pontis and the nucleus centralis superior (Table II). 
Within the confines of the nucleus raphe obscurus only substance P-like 
immunoreactive neurons have been described by Ljungdahl et al. (174). No special 
localization has been mentioned. In the nucleus raphe pallidus and the nucleus raphe 
magnus MET-ENK-like-immunoreactive neurons (Hökfelt et al., 123; Uhi et a., 311) as 
well as substance P-positive perikarya (Chan-Palay, 62,63; Ljungdahl et al., 174) have 
been observed. Both cell types were randomly distributed over the two nuclei. Within 
the borders of the nucleus raphe dorsalis of the rat the presence of neurons containing 
one of the following four neuropeptides have been observed. Enkepahlin-like-containing 
cell bodies in the dorsal region of the bilateral wings of the nucleus have been 
described by Glazer et al. (Ill), Hökfelt et al. (123,129,131). Moss et al. (204), and 
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Uhi et al. (311). Vasoactive-Intestinal Polypeptide (VlP)-like-containing neurons have 
been localized by Lorén et al. (182) and Sims et al. (273) in the caudal and the 
dorsomedian part of the nucleus raphe dorsalis. Concerning the exact number of 
VIP-neurons in the central grey no data are available. However, the authors stated 
that the VIP-containing cells in the central grey of the midbrain show a distribution 
similar to that of the enkephalin-positive neurons. Substance P-like immunoreactive 
neurons have been localized in the rostral part of the nucleus raphe dorsalis by 
Ljungdahl et al. (174). 
Cholecystokinine octapeptide- (CCK) like immunoreactive neurons have been 
found by Vanderhaegen et al. (318) in the caudal, rhombencephalic part and in the 
bilateral wings of the nucleus raphe dorsalis. The study of Van der Kooy et al. 
(321) revealed that CCK-like-immunoreactive cell bodies were situated both rostral and 
caudal to the serotonin-positive perikarya in the nucleus raphe dorsalis. Finally in 
the nucleus linearis oralis some CCK-containing neurons were described by Vander-
haegen et al. (318). 
4.5.4. Presence of neuropeptides in serotoninergio neurons 
In several raphe nuclei cells containing serotonin as well as a peptide have 
been found, (Table III). Hökfelt et al. (130) and Chan-Palay et al. (64), although 
using different procedures, observed in the nucleus raphe obscurus, the nucleus 
raphe pallidus and the nucleus raphe magnus, numerous cell bodies containing 
substance Ρ as well as serotonin. The ratio coexistent: non-coexistent has not been 
determined. Chan-Palay (62) postulated a concept of dynamic interrelationships 
between 5-HT and substance Ρ in a single neuron. A neuron with both substances in 
coexistence may have fluctuating levels of one or both substances depending upon 
parameters of time cycle and physiological demands for one or another mediator during 
specific types or phases of activity. Hökfelt et al. (130) pointed out that the two 
different compounds may either be present in different synaptic vesicles or may 
coexist within the samen vesicles. The recent work of Pelletier et al. (233) showed 
that the majority of the vesicles in the serotoninergic neurons, situated in the 
caudal, rhombencephalic raphe area contain serotonin as well as substance P. However, 
no evidence has been reported as yet for a simultaneous release of both neurotrans-
mitters. 
Another coexistence has been described recently by Glazer et al. (Ill), who 
demonstrated the presence of LEU-ENK and serotonin in cells of the nucleus raphe 
magnus and in the nucleus raphe dorsalis. 
4.6. Efferent connections of the raphe nuclei 
The efferente of the raphe nuclei will be divided into transmitter-specified 
and non-transmitter-specified. 
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4.6.1. Transmitter-specified connections 
Of all the transmitter-defined neurons within the various raphe nuclei 
relatively little is known about their efferente. Apart from serotoninergic fibers, 
efferentscontaining other neurotransmitters have been observed to originate from 
the raphe nuclei: i.e. substance P, thyrotropin-releasing-hormone and methionine-
enkephaline. All of these fibers appeared to originate from the medullary raphe 
nuclear group and to descend to lower levels. They project to the dorsal, and ventral 
horn of the spinal cord. The study of Gilbert et al. (110), who combined biochemical 
as well as immunocytochemical results, revealed that especially substance Ρ and TRH 
are present in the same nerve terminals as serotonin in the different regions of the 
spinal cord. Moreover, with chemical detection techniques it was observed that these 
three compounds are released simultaneously after electrical stimulation. This finding 
suggests that the three transmitters mentioned above are present within the same 
terminal. 
The projections of the enkephalin-immunoreactive cells are unknown. It may, 
however, be mentioned that the MET-ENK-positive fibers in the spinal cord do not 
disappear totally after a total transection of the cord (Hökfelt et al., 131). 
Moreover, Hökfelt et al. (123) found MET-ENK cell bodies in the dorsal horn of the 
spinal cord. They considered these enkephalin-containing neurons as local inter-
neurons . 
The areas which receive a high to very high innervation (4+) of serotonin-
immunoreactive fibers have been previously described by Steinbusch (284). A survey 
of literature which was focused upon the correlation of these 4+ density areas with 
the presence of known transmitter-containing neurons in the same areas is summarized 
in Table IV. Some examples are shown in the diencephalon: the medial forebrain 
bundle and the nucleus ventralis corporis geniculati lateralis. 
This survey revealed that serotoninergic neurons populations may influence 
specified-transmitter-containing target neurons by direct innervation either axosoma-
tic or axodendritic. However, the data assembled in this survey have to be taken 
with caution and may lead to erroneous interpretations. As an example we would like 
to discuss the relations in the nucleus suprachiasmaticus. The ventrolateral part 
of that nucleus receives a high to very high innervation of serotonin-immunoreactive 
fibers. According to the work of Sofroniew (277) and Gross et al. (personal 
communication), vasopressin-positive neurons are present in the dorsomedial part of 
the nucleus suprachiasmaticus (Figs. 22A.B). Possibly the dendrites of the vasopressin-
ergic cells are entering the ventrolateral part of the nucleus suprachiasmaticus. But 
it cannot be excluded that the serotoninergic fibers do not make any synaptic contacts 
with the "vasopressinergic" neurons. In addition to vasopressin-immunoreactive neurons 
the nucleus suprachiasmaticus has also been shown to contain VIP-positive perikarya 
(Lorén et al., 182; Sims et al., 273) and peptide-ß-containing cell bodies (Lorën 
et al., 183). However, the latter authors did not describe any special distribution 
of these two transmitter-specified cell types within the nucleus suprachiasmaticus. 
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Because we are at present not able to relate the various areas receiving a high or 
very high serotoninergic innervation specifically to one of the seven raphe nuclei, 
we will have to take all of the serotonin-positive neurons in the raphe nuclei 
together. The results will be discussed from caudal to rostral. 
The serotoninergic raphe nuclei have large efferent connections or output 
mechanisms to several catecholaminergic centers, viz. to the rostral part of the 
dopaminergic substantia nigra, pars compacta (Figs. I7C,D), and to some hypothalamic 
nuclei as the nucleus ventromedialis hypothalami (Fuxe et al., 104), to the 
noradrenergic locus coeruleus (Fuxe et al., 104; Léger et al., 163; Pickel et al., 
235; Sladek and Walker, 275; Steinbusch, 284) and to the adrenergic cells present 
in the caudal part of the nucleus tractus solitarii (Hökfelt et al., 126). A strong 
serotoninergic innervation of two cholinergic centers was demonstrated i.e. to the 
medial part of the nucleus corporis geniculati lateralis as histochemically 
reported by Parent (224), and to the striatum as reported pharmacologically by 
Garattini et al. (108) and Saminin et al. (1978) of histochemically by Parent et al. 
(226). 
In addition we have observed 3+ to 4+ serotoninergic innervation of six peptide-
specified neuron populations, i.e. LEU-ENK, MET-ENK, peptide-B, somatostatin, VIP and 
vasopressin. Two of these, LEU-ENK and MET-ENK, have been visualized in the brain stem, 
the other four are localized in the diencephalon and the telencephalon. Taking into 
consideration that it is the nucleus raphe dorsalis, the nucleus centralis superior 
and the nucleus linearis oralis which have substantial ascending projections to the 
forebrain (Dahlström and Fuxe, 69) we can state that these three mesencephalic raphe 
nuclei project to peptide-B positive cells in the nucleus suprachiasmaticus (Lorén 
et al., 183), to somatostatinergic cells in the ventromedial part of the nucleus 
caudatus and the ventrolateral part of the nucleus accumbens (Dierickx and Vandesande, 
76; Finley et al., 94); to VIP-containing cells in the amygdala complex (Lorén et 
al., 182; Sims et al., 273);to the vasopressin-immunoreactive neurons (Buys, 52; 
Sofroniew and Weindl, 281) and the LH-RH-containing cells (Jennes and Stumpf, 139) 
through an innervation of the nucleus suprachiasmaticus and finally to the CCK-
positive neurons by means of an innervation of the substantia nigra, the nucleus 
mamillaris medialis, the tractus periventricularis thalami, the amygdala complex, 
the nucleus accumbens and the nucleus caudatus (Vanderhaegen et al., 318). 
In the caudal rhombencephalon and in the spinal cord several areas containing 
neurons the transmitters of which are known , .appear to receive a dense to very 
dense serotoninergic innervation. Because it is known that the rhombencephalic 
raphe nuclei project mainly caudally (Dahlström and Fuxe, 69,70), the dense serotoni-
nergic terminal plexus in the following areas presumably have their parent cell 
bodies in these nuclei: a) LEU-ENK as well as MET-ENK-containing neurons situated 
in the nucleus tractus spinalis nervi trigemini and the caudal part of the nucleus 
tractus solitarii, b) numerous MET-ENK- and substance Ρ immunoreactive cell bodies 
were observed by Hökfelt et al. (123, 129) in lamina I to IV of the cornu dorsale 
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of the spinal cord at all levels. However, these findings are not confirmed by Sar 
et al. (258). 
It is now possible to trace efferent connections and to determine their 
transmitter by a combination of immunofluorescence with retrograde transport of 
fluorescent tracers as has been recently described by our laboratory (Steinbusch 
et al., 287, 288; Van der Kooy and Steinbusch, 323). Other approaches 
include the use of retrograde transport of tritiated-transmitters as has been 
mentioned by Streit et al. (294), the combination of retrograde fluorescent tracers 
with the FIF-method (Björklund and Skagerberg, 32), the anterograde transport of 
3 
H-5-HTP (Halaris et al., 119) or immunofluorescence (Hokfelt et al., 131). 
Finally, we would like to reemphasize that we have only discussed the areas 
with a high to very high serotoninergic innervation. If we would assume that 
serotonin-bound transmission or modulation can take place in all regions where we 
have observed serotonin-immunoreactive terminals or varicosities, it would follow 
that the serotoninergic elements in the raphe nuclei together have efferent 
connections with almost all grisea in the brain of the rat. 
4.6.2. Transmitter-non-specified efferent connections 
The ascending as well as descending projections from the raphe nuclei have 
been thoroughly studied with anterograde degeneration techniques (Brodai et al., 43, 
44; Conrad et al., 65; Taber-Pierce et al., 301), autoradiography (Azmitia and 
Segai, 15; Bobillier et al., 36, 37; Conrad et al., 65; Moore et al., 201), 
histofluorescence combined with chemical lesions, i.e. dihydroxytryptamines 
(Aghajanian et al., 5; Anden et al., 9; Fuxe and Jonsson, 105; Ungerstedt, 313), 
retrograde transport of HRP (Kawasaki and Sato, 146; Llamas et al., 175; Martin et 
al., 189; Pasquier and Reinoso-Suarez, 230; Shinnar et al., 271) and finally with 
the retrograde transport of fluorescent tracers (Bentivoglio et al., 25; Björklund 
and Skagerberg, 32; Vanderkooy, 319; Vanderkooy and Kuypers, 322). These studies 
have revealed the presence of ascending as well as descending axons, distributing 
fibers to numerous grisea, as summarized in Figure 21. 
The widespread distribution of the mesencephalic raphe projections suggest 
highly collateralized axon systems. For instance, single neurons in the nucleus 
raphe dorsalis are in a position to exert control over both ends of the massive 
nigro-striatal and striato-nigral pathways (Nauta and Domesick, 210). Using double 
labeling with fluorescent tracers, neurons were demonstrated which send collaterals 
to the caudate-putamen as well as to the substantia nigra (Vanderkooy and Hattori, 
320; Vanderkooy and Kuypers, 322). Moreover, using a triple labeling technique De 
Olson and Heimer (219) demonstrated cells in the nucleus raphe dorsalis which 
project to the medial thalamus, the olfactory cortex as well as to the septum. 
However, these authors showed that whereas the number of double-labeled cells in 
various combinations was relatively large, triple-labeled cells occure more rarely. 
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In addition they observed that dorsal raphe neurone have mostly ipsilateral projec-
tions and to a much smaller extent contralateral projections. 
Five major efferent fibre systems from the raphe nuclei have been described: 1) the 
dorsal ascending or mesostriatal pathway, 2) the medial ascending pathway, 3) the 
ventral ascending or mesolimbic system, 4) a descending projection from the nucleus 
raphe dorsalis to the locus coeruleus and 5) the descending bulbospinal pathway. In 
addition three smaller pathways should be mentioned: 6) the cerebellar pathway, 7) 
the descending propriobulbar pathway and 8) a pathway ascending from some caudal 
raphe nuclei to the dorsal part of the mesencephalon. 
1) The dorsal ascending pathway arises from the medial and rostral parts of the 
nucleus raphe dorsalis. Its fibers do not enter the medial forebrain bundle, but 
are situated dorsolaterally to that bundle. The main area of termination of this 
pathway is the caudatoputamen complex, although some fibers reach the nucleus accumbens 
and the globus pallidus. No fibers enter the substantia nigra. (Devito et al., 75; 
Jacobs et al., 137; Keller et al., 147; Miller et al., 196; Royce, 250; Sato et al., 
259; Steinbusch et al., 287,288 ; Szabo, 298, 299; Vanderkooy, 319; Vanderkooy 
and Kuypers, 322). 
2) The mediai ascending pathway originates from the nucleus raphe dorsalis and 
projects mainly to the substantia nigra (Bobillier et al., 37; Dray et al., 80; 
Fibiger and Miller, 92; Palkovits et al., 222; Pasquier et al., 228). However, the 
parent neurone of this projection have been found to send collaterals to the 
cuadatoputamen complex (Vanderkooy and Hattori, 320). 
3) The ventral ascending pathway arises from the three mesencephalic raphe nuclei. 
Its fibers are directed ventrolateral^ and then curve rostrally to course 
through the ventral tegmentum after which the medial forebrain bundle in the lateral 
hypothalamus is entered (Conrad et al., 65). In the mesencephalon the bundle 
distributee many fibers to the nucleus interpeduncularis and some to the area 
tegmentalis ventralis. The major input to the nucleus interpeduncularis comes 
from the nucleus raphe dorsalis, some fibers originate, however from the nucleus 
centralis superior. The input to the area tegmentalis ventralis arises mainly from 
the nucleus centralis superior (Bobillier et al., 38). Before entering the medial 
forebrain bundle (MFB) some fibers originating from the nucleus raphe dorsalis 
innervate the posterior hypothalamic area. Rostrally, fibers leave the MFB to enter 
the fasciculus retroflexus, to distribute to the nucleus parafascicularis, the 
nucleus dorsomedialis thalami, the nucleus medialis habenulae and the corpus 
geniculatum laterale (Bobillier et al., 36; Conrad et al., 65). The major component 
of this fiber contingent terminates into the nucleus lateralis habenulae (Pasquier 
et al., 227). Further rostrally fibers leave the MFB to enter the corpus marni Hare, 
the nucleus subthalamicus (Conrad et al., 65), the nucleus preopticus (Pasquier 
et al., 229), the nucleus lateralis hypothalami, the nucleus arcuatus, the nucleus 
medialis hypothalami, the nucleus hypothalamicus anterior (Van der Kar and Lorens, 
317), the nucleus suprachiasmaticus (Ajika and Ochi, 8), the septum, the bulbus 
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nlfuctorius (Araneda et al., 10), by way of the striae medulläres the nucleus reuniens 
and the nucleus rhomboideus (Kellar et al., 147; Solomon et al., 282) and the amygdala 
complex by means of the striae terminalis (Jacobs et al., 137; Pasquier et al., 227; 
Wang and Aghajanian, 325, 326). 
A minor input to the head of the nucleus caudatus has been observed by Sato et al. 
(259). Finally, some fibers were demonstrated which via the cingulum bundle (Conrad 
et al., 65) reaching the prefrontal-, frontal-, neo-, entorhinal- and hippocampal 
cortex (Arikuni and Ban, 11; Azmitia , 12; Azmitia et al., 14; Conrad et al., 65; 
Gerten et al., 109; Jacobs et al., 137; Kellar et al., 147; Llamas et al., 175; 
Pasquier and Reinoso-Suarez, 230, 231; Segal, 267; Solomon et al., 282; Toerk et 
al., 304; Tohyama et al., 307). The study of Pasquier et al. (229), who combined 
lesion experiments with quantitative spectrofluorometry for serotonin in the cat, 
demonstrated that the projection from the nucleus centralis superior to the preoptic 
area and the amygdala is stronger than the one arising from the nucleus raphe dorsalis. 
4) A major descending projection has been described from the nucleus raphe dorsalis 
to the locus coeruleus (Cederbaum and Aghajanian, 58; Morgane and Jacobs, 202; 
Palkovits et al., 222; Sakai et al., 255). Some of these fibers continue to the 
nucleus tegmentalis dorsalis (Gudden) and to the nucleus raphe pontis (Sakai et al., 
254). 
5) The descending bulbospinal pathway. The major contribution to this pathway arises 
from the nucleus raphe magnus. During its course the bundle receives fibres from the 
nucleus raphe dorsalis, the nucleus raphe pontis, the nucleus raphe obscurus and the 
nucleus raphe pallidus (Basbaum and Fields, 19; Björklund and Skagerberg, 32; 
Castigliono et al., 57; Kneisley et al., 151; Kuypers and Maisky, 158; Leichnetz 
et al., 165; Martin et al., 189; McCreery et al., 192; Tohyama et al., 305,306; Watkins 
et al., 327). This pathway runs principally in the dorsolateral funiculus to 
innervate the substantia gelatinosa, i.e. lamina I, II, V and VI (Basbaum et al., 
18; Basbaum and Fields, 19; Fields et al., 93), whereas fibers from the nucleus 
raphe pallidus and the nucleus raphe obscurus descend in the lateral and ventral 
funiculi to terminate in the ventral horn (Martin et al., 189). Bobillier et al. 
(37) suggested that the medullary raphe nuclei should be collectivaly considered as an 
extension of the limbic system, modulating sensory input and both somatic and 
autonomic output by way of raphe-spinal projections. 
6) The cerebellar pathway. 
The fibers of this pathway emerge from the nucleus raphe dorsalis, the nucleus 
centralis superior, the nucleus raphe pontis, the nucleus raphe magnus, the nucleus 
raphe obscurus and the nucleus raphe pallidus, pass via the pedunculus cerebellaris 
médius to the cerebellum, where they distribute to the cortex (Shinnar et al., 271). 
Some fibers originating from the caudal part of the nucleus raphe dorsalis innervate 
the flocculus (Kawasaki and Sato, 146). 
7) The descending propriobulbar pathway consists of fibers passing from the nucleus 
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raphe dorsalis and the nucleus centralis superior to the nucleus raphe magnus, the 
nucleus paragigantocellularis, the nucleus prepositus hypoglossi, the nucleus parvo-
cellularis, the nucleus tractus solitarii, the nucleus raphe obscurus, the nucleus 
raphe pallidus and the oliva inferior. 
8) A pathway ascending from some caudal raphe nuclei to the mesencephalon. 
This pathway arises from the nucleus raphe obscurus and the nucleus raphe magnus and 
terminates in the colliculum superior and in the pretectal area. 
If we compare the results obtained with transmitter-non-specifying techniques 
(axon degeneration, autoradiography) with the one revealing the serotoninergic raphe 
efferente, one remarkable discrepance appears, and that is that the fasciculus 
retroflexus and the striae medullaris which do contain labeling following tritiated 
amino acids injections in the mesencephalic raphe nuclei, do not contain any 
serotoninergic fibers. 
The areas which are in continuity with each other, regarding the efferent, non 
transmitter-specified, projection and the serotonin-immunoreactivity are from caudal 
to rostral: the nucleus tractus solitarii, the locus coeruleus, the nucleus raphe 
dorsalis, the substantia nigra, the nucleus subthalamicus, the nucleus corpus 
geniculatum laterale, the nucleus suprachiasmaticus, the nucleus amygdaloideus 
posterior, the nucleus accumbens and the caudateputamen complex. 
Areas, which receive a very high serotonin-innervation, although no connection with 
the raphe system has been demonstrated, using the classical neuroanatomical 
techniques, are the following: the nucleus nervi fascialis, the nucleus motorius 
nervi trigemini, the nucleus reticularis pontis oralis, the nucleus tractus opticus, 
pars medialis, the nucleus mamillaris medialis, the nucleus ventromedialis hypothalami, 
the nucleus periventricularis thaiami, the nucleus amygdaloideus medialis posterior, 
the nucleus amygdaloideus basalis and the nucleus interstitialis commissurae anterioris. 
All other areas in the central nervous system receive to a more or less extent 
(3+ to 1+) a serotoninergic innervation. These findings imply, that the raphe nuclei 
have projections that are more extensive than once was thought. 
Besides of the areas, which receive a serotoninergic innervation from 4+ to 
1+, there were only a small number of regions, which show no serotonin-immuno-
reactivity. These areas consist of coarse, well myelinated fibre tracts: viz. 
cranial nerves, pedunculus cerebellaris inferior and médius, tractus corticospinalis 
(Fig. 14), tractus olivocerebellaris, lemniscus lateralis, fasciculus 
mamillotegmentalis, commi ssura posterior and anterior, tractus opticus, fornix 
(Fig. 19C), chiasma opticum, corpus callosum, ansa lenticularis and the capsula 
interna and externa. 
4.7. The dendritic pattern of serotoninergic raphe cells 
While immunofluorescence and autoradiography have already contributed to a 
comprehensive knowledge concerning the distribution of serotoninergic perikarya 
and their fibers and terminals, little is known about their dendrites. This is an 
important deficit, because it is the size, shape and orientation of the dendrites 
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of a neuron that determine the territory from which it can receive its input. For 
this reason, it would be extremely informative to analyze the dendritic pattern of 
serotoninergic neurons. The latter has been recently attempted by Feiten and 
Harrigan (90), combining results, achieved with the FIF- and with the Golgi-
techniques. However, their study did not reveal whether the dendritic trees of 
serotoninergic neurons differ from those of non-serotoninergic neurons in the 
raphe nuclei. To study specifically the dendritic arborization of serotoninergic 
neurons in the seven raphe nuclei we have applied an immunohistochemical technique 
to visualize these neurons in 100 pm thick vibratome sections of adult rats. This 
approach demonstrates explicitly all serotonin-immunoreactive neurons in their 
entirety, thus yielding a transmitter-specific Golgi-like image. 
The serotoninergic neurons within the raphe nuclei can be considered to belong 
to the category of leptodendritic cells (Ramón-Moliner, 242; Ramón-Moliner and 
Nauta, 243). The leptodendritic neurons are characterized by the presence of only a 
few, although relatively long, dendrites arising from a fusiform perikaryon. 
The results, which were obtained with our immunohistochemical technique 
revealed, that the various raphe nuclei differ in respect to the appearance and 
orientation of their serotoninergic dendrites, i.e. each nucleus displays a typical 
and characteristic dendritic pattern. Possible relations with other transmitter-
specified system have been found in the nucleus raphe ma gnus and in the lateral 
parts of the nucleus raphe dorsalis, where the dendrites of the serotonin-immuno-
reactive cells radiate in areas with a large number of enkephalin-like (Hökfelt 
et al., 123; Sar et al., 258; Uhi et al., 311) and substance P-like containing 
neurons (Hökfelt et al., 129; Ljungdahl et al., 174). 
The function of the dendritic serotonin is at present unclear. It was observed 
by Joh et al. (140), using immunohistochemistry in combination with antibodies to 
tryptophane hydroxylase that firstly at the lightmicroscopical level the dendrites 
of raphe neurons were TrH-positive and secondly at the electronmicroscopical level 
that the enryme within the dendrite was primarily associated with subcellular 
organelles having the characteristics of microtubules. Ultrastructurally Pickel et 
al. (235), using the immunohistochemical visualization of TH, DBH and TrH showed 
that these three monoaminergic enzymes are distributed in an almost identical way. 
These findings suggest that the enzyme, TrH, may be transported from sites of 
synthesis in the cell body to the dendrite. However, the presence of serotonin and 
its synthetizing enzyme in the dendrites does not necessarily imply a release of 
the transmitter in these areas. It is known that neurons in the substantia nigra 
interact by means of dendrodendritic junctions and that dopamine is involved in 
this transmission (Bjorklund and Lindvall, 30), but corresponding contacts among 
dendrites of serotoninergic elements have not been described so far. 
Scheibel et al. (261) reported in an electronmicroscopical study the close 
association of raphe neurons with bloodvessels. However, as already pointed out 
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in section 4.3, especially in the caudal raphe nuclei only a small percentage of 
the total neurons contain serotonin. Cummings and Feiten (67) reported the 
attachment of serotoninergic dendrites to bloodcapillaries or to tanycyten. Their 
lightmicroscopical study was however based upon Golgi- and histofluorescence material 
and by that cannot give evidence for the actual release from - or uptake into 
serotoninergic dendrites. No synaptic contacts have been described for these dendro-
vascular relationships. This could point to a chemoreceptor function of these 
transmitter-specified dendrites. 
Finally, the phenomenon that dendrites may form bundles deserves some comments. 
The existence of dendritic bundles was established by Scheibel and Scheibel (260) in 
a study of the lumbo-sacral spinal cord of the cat and the monkey. Later, 
corresponding structures were described in the reticular formation by Scheibel et 
al. (261). Dendritic bundles are groupings of dendrites, which course along very 
closely together, i.e. from 1 ym apart to direct membrane opposition. However, no 
direct ultrastructural evidence has been obtained that within these bundles 
dendrodendritic contacts are present. Although Roney et al. (248) stated they 
are a general feature in the mammalian brain nevertheless we have found no evidence 
of dendritic bundles other than the monoaminergic mentioned above. No amino-acid 
or peptide-positive dendrite bundling has been demonstrated. 
4.8 Afferent connections to the raphe nuclei 
The studies focused upon the afférents to the raphe have been divided in A) 
transmitter-specified and B) transmitter-non-specified. A summary of these afferent 
system is presented for the four rhombencephalic raphe nuclei in Fig. 34 and for 
the three mesencephalic raphe nuclei in Fig. 25. 
4.8.1. Transmitter-specified connections 
For the description of the transmitter-specified afférents to the raphe nuclei 
we have only used results based upon immunocytochemistry. It is noteworthy, that the 
presence of amines, amino-acid and peptides in the raphe areas has been detected 
with biochemical techniques. However, due to the punch-technique it is not possible 
to relate the biochemical measurements thus obtaines precisely to the defined raphe 
nuclei. Despite of this short coming, the method gives us additional information 
about the presence of various neuroactive compounds. There has been observed a close 
correlation between biochemistry, immunocytochemistry and autoradiography for VIP 
by Lorén et al. (182) and for GABA by Bêlin et al. (23) and Taniyama et al. (302). 
In addition, there have been found some neuroactive compounds which were only 
biochemically detected, i.e. acetylcholine (5-12 ρ mol/ug protein) in all raphe 
nuclei by Kobayashi et al. (1975): glutamate (5-9 mg/kg bodyweight) and aspartate 
(3 mg/kg bodyweight) both in the nucleus raphe dorsalis and the nucleus centralis 
superior by Taniyama et al. (302). The influence of histamine on serotoninergic 
neurons has beeii reported by Pile and Nowak (236). 
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Within the raphe nuclei several transmitter-specified fibres and terminals have been 
described. A summary of the literature is presented in Table V. However, until now 
no systematic attempt has been made to detect the cells of origin of these fibers 
and terminals. Combining immunofluorescence with retrograde transport of fluorescent 
tracers, a technique which has been recently described by Steinbusch et al. (287, 
288) and Vanderkooy and Steinbusch (323), or lesion experiments could solve this 
matter. 
Three kinds of monoaminergic fibers have been demonstrated in all the seven 
raphe nuclei: serotoninergic, noradrenergic and adrenergic. Serotonin-iramunoreactive 
fibers and terminals have been recently described Steinbusch (284) . These fibers 
could play a role in local circuitry within these nuclei or in connecting the 
raphe nuclei with each other. Fuxe et al. (102) using the FIF-method observed a 
high degree of noradrenergic innervation of the 5-HT-positive cell bodies in all 
raphe nuclei, with heaviest concentrations in the nucleus raphe dorsalis. These 
afférents have been demonstrated by histofluorescence, but in addition with 
immunocytochemistry (Grzanna and Molliver, 118) and biochemically (Levitt and Moore, 
170). However, the appearance of some fibers within an area containing serotoninergic 
perikarya does not necessarily imply a direct input. Since the nucleus raphe dorsalis 
contains serotoninergic as well as non-serotoninergic cell bodies, the noradrenergic 
afférents may regulate 5-HT cells directly or indirectly. The study of Baraban and 
Aghajanian (16), using a combination of electron microscopic autoradiography and 
degeneration, adduced evidence that 67% of the noradrenergic terminals make a 
synaptic contact with serotoninergic neurons in the nucleus raphe dorsalis. Finally, 
using an antibody to PNMT, see Figure 1, Hökfelt et al. (126) and Fuxe et al. (101,104) 
have discovered that adrenaline-positive nerve terminals participate in the 
innervation of the serotonin-containing cell bodies within the raphe nuclei, 
suggesting that the raphe nuclei are controlled by both noradrenaline and adrenaline 
nerve terminals. Besides of these three monoaminergic fibre types within the various 
raphe nuclei, fibers containing sixteen other amino-acids or peptides have been 
visualized within the borders of the raphe nuclei, viz: GABA, ACTH, APP, CCK, 
3-endorphin, LH-RH, S-lipotropin, LEU-ENK, MET-ENK, a-MSH, γ-MSH, neurotensin, 
oxytocin, substance P, vasopressin and vasoactive-intestinal-polypeptide. 
Nucleus raphe obsaurus 
Fuxe (100) observed that in this nucleus some dopaminergic fibers occur. 
Besides of the four types of monoaminergic fibers a moderate density of 
vasoactive-intestinal-polypeptide (VlP)-positive fibers were seen by Fuxe et al. 
(103). However, Lorén et al. (182) and Sims et al. (273) were not able to confirm 
this finding. Ljungdahl et al. (174) described the presence of a low density of 
substance P-like immunoreactive fibres in the medial part of this nucleus. Sofroniew 
and Weindl (281) presented evidence indicating that a few oxytocin- and vasopressin-
containing fibers, originating from the nucleus paraventricularis, terminate in the 
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nucleus raphe obscurus (Figs. 24A.B). 
Nucleus raphe pallidus. Within the confines of the nucleus raphe pallidus some 
dopaminergic fibers were described by Fuxe (100). Recent electronmicroscopical 
work of Miyakawa and Usui (198) revealed that the catecholaminergic axon terminals 
in the nucleus were at most 5% of all of the terminals of the neuropil of this region. 
In addition LEU-ENK-containing fibers were observed in the nucleus raphe pallidus by 
Sar et al. (258) and MET-ENK-positive fibers by Hokfelt et al. (123) and Sar et al. 
(258), however Uhi et al. (311) using an antiserum which stains LEU-ENK as well as 
MET-ENK, were not able to confirm their findings. This could be due to a lower 
sensitivity of the antibody used by the latter authors. Ljungdahl et al. (174) 
described a sparse innervation with substance P-iramunoreactive fibers in the medial 
part of the nucleus raphe pallidus. 
Nucleus raphe magnus. Within the area of this nucleus dopaminergic fibers were 
demonstrated by Fuxe (100) besides of fibers containing the three other monoamines. 
A medium density of substance P-like immunoreactive fibers was demonstrated in the 
nucleus raphe magnus by Ljungdahl et al. (174). The presence of S-lipotropin-
positive fibers has been reported by Watson et al. (330). Cholecystokinine (CCK)-
containing fibers are present, according to the work of Vanderhaegen et al. (318). 
Jennes and Stumpf (139) reported the presence of LHRH-fibers, which arise from the 
septum, continue through the fasciculus retroflexus then caudally along the ventral 
border of the nucleus interpeduncularis to terminate in the nucleus raphe magnus. The 
study of Sofroniew and Weindl (281) indicate that in the rat the nucleus contains 
a low density of vasopressinergic fibers arising from the nucleus paraventricularis 
and a medium density of oxytocin-containing fibers, also originating from the 
nucleus paraventricularis. However, these results could not be confirmed by Buys (52). 
Nucleus raphe pontis. Besides containing the three monoamines mentioned above, 
fibers containing the following six peptides have been demonstrated in the nucleus 
raphe pontis. 1) LHRH-fibers originating from the septum (Jennes and Stumpf, 
139). 2) LEU-ENK-positive fibers were demonstrated by Eide et al. (83) and Sar et al. 
(258). 3) MET-ENK-immunoreactive fibers were visualized by Hökfelt et al. (123) 
and Sar et al. (258). These results have been confirmed by Uhi et al. (311), using 
an antibody which stains LEU-ENK as well as MET-ENK. 4) A low density of substance 
P-like immunoreactive fibers has been demonstrated by Ljungdahl et al. (174) in the 
rostral and medial part of the nucleus, while the caudal part receives only single 
fibers. 5,6) Finally a few vasopressin and oxytocin containing fibers, both 
originating from the nucleus paraventricularis, have been localized by Sofroniew 
and Weindl (281). Buys (53) remained unable to confirm these findings. 
Nucleus raphe dorealis. The medium to high serotonergic innervation of this nucleus 
is, according to Mosko et al. (203) partly originating from neurons within the 
nucleus itself. Dopaminergic and/or noradrenergic fibers have been described by 
Hokfelt et al. (127) using an antibody to tyrosine hydroxylase. The varicose 
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appearance of these fibers was observed in the midline. In the nucleus 
raphe dorsalis the presence of a particularly large number of peptides has been 
demonstrated. LEU-ENK fibers have been described by Eide et al. (83) and Sar et al. 
(258). MET-ENK-containing fibers have been visualized by Hökfelt et al. (123) and 
Sar et al. (258). Uhi et al. (311) confirmed their results, using an antibody 
which stains both LEU-ENK and MET-ENK. Dubé et al. (81), Jacobowitz and O'Donohue 
(136) and Watson et al. (328) adduced evidence for the presence of a-MSH-immunoreactive 
fibers in the nucleus. Bloom et al. (34) demonstrated a low to medium innervation of 
it with (3-endorphin-positive fibers. The same author reported in 1980 the existence 
of a low reactivity of γ-MSH-positive fibers in the same area. Ljungdahl et al. 
(174) showed a medium density of substance P-like immunoreactive fibers. According 
to the work of Neckers et al. (211) these peptidergic fibers are originating from 
the nucleus habenularis medialis. The study of Ljungdahl et al. (174) showed that 
in the latter area indeed a high proportion of substance P-like-immunoreactive 
neurons were present. A moderate dens innervation with VIF-positive fibers was 
mentioned in the studies of Lorén et al. (182) and Sims et al. (273). In the earlier 
work of Fuxe et al. (103) these fibers have not been described.Pelletier and 
Ledere (232), Sofroniew (277) and Watson et al. (331) visualized a large number 
ACTH-containing fibers in this region. The presence of CCK-positive 
fibers was reported by Vanderhaegen (318). Uhi et al. (312) mentioned the presence 
of neurotensin-immunoreactive fibers. Watson et al. (330) adduced evidence for the 
presence of ß-lipotropin-positive fibers. The study of Sofroniew (278) and Sofroniew 
and Weindl (280, 281) revealed that the nucleus under discussion receives a low 
innervation of vasopressinergic fibers originating from the nucleus suprachiasmaticus. 
In addition a few vasopressin- and oxytocin-positive fibers arising from the nucleus 
paraventricularis were observed. These results are in conformity 
with work of Buys (51). Belin et al. (23), using autoradiography, mentioned the 
presence of GABA-labeled fibers throughout the whole nucleus. However, according to 
the work of Forchetti and Meek (95) , who have measured biochemically the 5-HT 
turnover, the GABAergic influences might be from afférents arising outside the raphe; 
for example, a GABAergic habenulo-raphe tract was proposed (Aghajanian and Wang, 
4), but not confirmed by Gottesfeld et al. (113). Alternatively, GABA interneurons 
in the nucleus raphe dorsalis might mediate extrinsic influences on serotoninergic 
cells. Finally, Jennes and Stumpf (139) found that LH-RH-positive fibers originating 
from the septum, terminate in the nucleus raphe dorsalis. 
Nucleus centralis superior 
Massari et al. (191) reported on the basis of lesion experiments, that the 
nucleus centralis superior receives a strong input from noradrenergic as well as 
adrenergic fibers. These fibers appeared to originate partly from the A. and A. 
group, according to the designations of Dahlström and Fuxe (69), and partly from 
the locus coeruleus. Hökfelt et al. (127) reported the presence of TH-positive 
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fibers in the nucleus centralis superior. Such fibers may either be dopaminergic, 
noradrenergic or adrenergic. However, in earlier studies Hökfelt et al. (126) 
remained unable to observe any PNMT-positive terminals in this nucleus. Thus, it 
may be stated that the results of Hökfelt et al. (126) tally only partially with 
those of Massari et al. (191). 
Eight peptide-specific afférents to the nucleus centralis superior have been 
described: LH-RH-positive fibers, with their cell bodies situated in the septum, 
were found by Jennes and Stumpf (139). Watson et al. (330) visualized (3-lipotropin-
containing fibers. LE'J-ENKand MET-ENK-immunoreactive fibers and terminals were 
observed by Sar et al. (258). Uhi et al. (311) showed the presence of neurotensin-
positive fibers. Oxytocin and vasopressin-containing fibers were mentioned by Buys 
(51, 52), Sofroniew (278) and Sofroniew and Weindl (280, 281). Ljungdahl et al. 
(174) reported a medium density of substance P-like immunoreactive fibers in the 
nucleus. However, according to the study of Neckers et al. (211) these substance 
P-positive fibers contrary to those terminating in the nucleus raphe dorsalis, 
do not originate from the habenular nuclei. 
Nucleus linearis oralis. Besides of 5-HT, NA and A-positive fibers within the 
borders of this nucleus (Fig. I5C) the presence of dopaminergic fibers was mentioned 
by Hökfelt et al. (127). The presence of the following peptides has been reported 
for the nucleus linearis oralis. A high density of substance P-positive fibers 
have been described by Ljungdahl et al. (174). Uhi et al. (312) described neuro-
tensin-containing fibers. The existence of 8-lipotropin fibers was mentioned by 
Watson et al. (330). Uhi et al. (311) localized enkephalin-fibers. However this 
finding is not in accordance with the work of Hökfelt et al. (123) and Sar et al. 
(258). The study of Vanderhaegen et al. (318) showed the presence of CCK-immuno-
reactive fibers in the nucleus. Finally LHRH-positive fibers, arising from the 
septum, were recently observed by Jennes and Stumpf (139). 
4.8.2. Transmitter-поп specified connections 
The afférents to the raphe nuclei have been investigated with axon degeneration 
techniques and with the retrograde tracer technique, using HRP (Brodai et al., 45; 
Gallager and Pert, 106; Mosko et al., 203; Sakai et al., 253, 255; Usunoff 
et al., 314). The results will be discussed separately for the various raphe 
nuclei. 
The nucleus raphe pallidas receives a prominent input from the substantia grísea 
centralis, the area tegmentalis ventralis and the nucleus tegmentalis dorsalis 
(Gallager and Pert, 106). Other afférents arise from: a) spinal cord neurons (Brodai 
et al., 45); b) the nucleus vestibularis medialis, the nucleus reticularis pontis 
oralis, the colliculi superioris and inferioris (Gallager and Pert, 106); с the 
nucleus raphe dorsalis, the nucleus centralis superior, the preoptic region and 
the prefrontal cortex (Brodai et al., 45). 
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The nucleus raphe obscurus receives a substantial amount of afferent fibers from 
the substantia grísea centralis, the area tegmentalis ventralis and the dorsal 
tegmental region (Gallager and Pert, 106). In addition some afférents originate 
from the colliculus superior and inferior, the nucleus reticularis pontis oralis, 
the nucleus venstibularis medialis, the nucleus raphe dorsalis and the nucleus 
centralis superior (Gallager and Pert, 106). 
The nucleus raphe magnus receives three major and four minor projections. 
1) A major ascending projection comes from spinal cord neurons (Brodai et al., 45). 
According to the latter authors the number of fibers coming from lumbar and sacral 
segments is apparently small. 
2) Another major input is derived from the fastigial nucleus in the cerebellum and 
the nucleus tegmentalis dorsalis of Gudden (Brodai et al., 45). This projection also 
receives some fibers from the nucleus vestibularis medialis (Gallager and Pert, 106). 
3) Finally, the third major afferent projection to the nucleus raphe magnus consists 
of fibers descending from the area tegmentalis ventralis (Gallager and Pert, 106; 
Shah and Dostrovsky, 270) and the substantia grísea centralis. This projection receives 
in addition some fibers from the colliculus superior and inferior and the nucleus 
reticularis pontis oralis (Gallager and Pert, 106). 
Minor afferent projections to the nucleus raphe magnus originate from (a) the 
nucleus raphe dorsalis and the nucleus centralis superior, (b) the nucleus paragiganto-
cellularis, (c) the prefrontal cortex (Brodai et al., 45) and the preoptic region 
and (d) the head of the caudatoputamen. The latter projection has been described 
by Usunoff et al. (314). According to these authors the nucleus raphe magnus is the 
only nucleus of the raphe complex showing degenerating fibers following a selective 
lesion in the caudatoputamen. 
The nucleus raphe pontis receives a major and a minor input. The major input arises 
from the fastigial nucleus (Brodai et al., 45). A smaller projection to this nucleus 
originates from the nucleus raphe dorsalis. 
The nucleus raphe dorsalis receives a major ascending projection from the rostral 
part of the nucleus tractus solitarii (Aghajanian and Wang, 4). In addition, there 
has been reported a major input from the nucleus habenulae lateralis. This projection 
also receives some fibers from the nucleus parafascicularis (Aghajanian and Wang, 
4; Pasquier et al., 227, 228, 229; Sakai et al., 253). Another major source of 
fibers terminating in the nucleus raphe dorsalis is arising from the prefrontal 
cortex and the hippocampus (Nauta, 209). These fibers reach the nucleus raphe dorsalis 
by way of the medial forebrain bundle. Other fibers which reach the nucleus raphe 
dorsalis also via the medial forebrain bundle originate from the nucleus dorsalis 
and lateralis hypothalami and from the preoptic region (AGhajanian and Wang, 4; 
Sakai et al., 255). 
Finally, a considerable numer of afferent fibers to the nucleus has been found 
to originate from the area dorsolateral to the inferior olivary complex (Sakai et al., 
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(253). This same area has been designated by Dahlström and Fuxe (69) as the nor-
adrenergic A -region. 
Smaller projections to the dorsal raphe have been observed starting from the 
area tegmentalis ventralis (Sakai et al., 255), the substantia nigra (Aghajanian and 
Wang, 4; Pasquier et al., 228; Sakai et al., 253), the substantia grisea centralis 
(Sakai et al., 253), the nucleus tegmentalis dorsalis (Sakai et al., 253, 255), the 
locus coeruleus subcoeruleus and the nucleus tractus solitarii (Aghajanian and 
Wang, 4; Sakai et al., 254, 255), the nucleus centralis superior (Aghajanian and 
Wang, 4; Mosko et al., 203), the nucleus raphe magnus (Sakai et al., 253, 255) and 
the nucleus raphe pontis and linearis oralis (Mosko et al., 203; Sakai et al., 253, 
255). 
Finally, Mosko et al. (203) observed some HRP labeled cells in the nucleus raphe 
dorsalis after injection of HRP into the nucleus raphe dorsalis. 
The nucleus centralis superior receives its most prominent input from the nucleus 
habenulae lateralis, the nucleus parafascicularis (Aghajanian and Wang, 4; Pasquier 
et al., 229; Sakai et al., 255), from the nucleus linearis oralis (Aghajanian and 
Wang, 4; Sakai et al., 255) and from the prefrontal cortex. In addition some fibers 
originating from the nucleus dorsalis and lateralis hypothalami and the preoptic region 
enter the medial forebrain bundle and terminate in the nucleus centralis superior 
(Sakai et al., 255). Some other fibers terminating in this nucleus are derived 
from the nucleus periventricularis, the nucleus raphe dorsalis, the substantia 
grisea centralis (Sakai et al., 255), the fastigial nucleus (Brodai et al., 45), the 
nucleus parabrachialis dorsalis, locus coeruleus and subcoeruleus (Sakai et al., 255) 
and the nucleus tractus solitarii (Aghajanian and Wang, 4). 
The nucleus linearis oralis receives most of its afferent fibers from the adjacent 
nucleus centralis superior. Moreover, several other areas were observed to give 
rise to afférents to this nucleus, these include the nucleus raphe dorsalis (Sakai 
et al., 255), the nucleus tegmentalis dorsalis, the nucleus parabrachialis 
dorsalis, the locus coeruleus and subcoeruleus, the nucleus reticularis pontis 
oralis, the substantia grisea centralis, the nucleus dorsalis and lateralis 
hypothalami, and the nucleus habenulae lateralis (Sakai et al., 255). 
4.9. The relationship between the raphe nuclei and the reticular formation. 
The central parts of the brain stem are occupied by cell populations of diverse 
morphology, etunenshed in a complex network of axons, which branches in all 
directions. In this chapter we will discuss the topography and fibre connections 
of the grisea present in the central core of the brainstem, with emphasis on the 
transmitter-specified cell groups. 
4.9.1. Topography 
The architecture of the central parts of the brain stem and the morphology of its 
neurons have previously been studied with Nissl-, Golgi-, and silver stains 
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(Brodai, 43; Valverde, 316), Due to the highly reticular structure, discrete sets 
of neurons and fiber pathways are not readily delineated by means of these classical 
neurohistological methods. The term reticular formation refers to the fact that the 
dendrites of the cells in this area are arranged in bundles that together form a 
net-like pattern. The reticular formation can be divided in three longitudinal zones: 
a) a median zone, which comprises the raphe nuclei, b) a medial zone which contains 
many large cells and c) a lateral zone. The median zone, constituted by the raphe 
nuclei, have been already discussed in previous chapters. 
The medial zone can be subdivided in three areas according to their caudorostral 
localization. 1) the medullary medial reticular formation comprising the nucleus 
reticularis gigantocellularis and the nucleus reticularis paramedianus, 2) the pontine 
medial reticular formation, consisting of the nucleus reticularis pontis caudalis 
and the nucleus reticularis pontis oralis and 3) the tegmental medial reticular 
formation, including the nucleus reticularis tegmenti pontis and the nucleus 
cuneiformis. 
The lateral zone of the reticular formation can also be divided into three 
areas: 1) the medullary lateral area, comprising the nucleus reticularis medullae 
oblongatae, pars dorsalis and ventralis; 2) the pontine lateral area containing 
the nucleus reticularis parvocellularis and 3) the lateral tegmental reticular 
formation. 
4.9.2. Transmitter-specified celts in the reticular formation 
Immunocytochemistry provides us with a tool to characterize neurons on the 
principle of their chemical individuality and by that classify them in morphologically 
and chemically distinct groups. 
Firstly, we observed a substantial number of serotoninergic neurons interspersed 
through the medial and lateral parts of the reticular formation. Moreover, these 
observations showed us, that these serotonin-containing cells do not constitute 
recognizable cytoarchitectonic sub-units (Figs. 14; 15A). 
However, the entities within the confines of which serotoninergic cells do occur may 
be briefly mentioned. A few 5-HT-positive cells have been found in the nucleus 
reticularis paramedianus,the nucleus reticularis tegmenti pontis and the nucleus 
cuneiformis. A substantial number of serotoninergic neurons was demonstrated in the 
lateral tegmental reticular formation (Fig. I5A). 
Besides of serotoninergic neurons, cells containing one of the following eight 
transmitters have been demonstrated in the reticular formation: dopamine, noradrena-
line, histamine, avian-pancreatic polypeptide (APP), MET-ENK, LEU-ENK, CCK and 
substance P. 
Dopamine-containing cell bodies were described by Hökfelt et al. (127), using 
an antibody to TH, in the ventrolateral part of the mesencephalic reticular 
formation. This cell group was previously designated by DahlstrSm and Fuxe (69) as 
the A8-cell group. 
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Noradrenaline-positive cell bodies have been described by histofluorescence 
(Dahlström and Fuxe, 69) and hy immunofluorescence, using an antibody to DBH 
(Swanson and Hartman, 297). Some of these are situated within the medullary and 
pontine reticular formation, i.e., the A5-cell group which is partly situated in 
the nucleus reticularis parvocellularis and the A7-cell group which is situated 
in the lateral mesencephalic reticular formation. The caudal part of this latter 
group is identical to the subcoeruleus NA-cell group (Lindvall and Björklund, 172). 
APP-like immunoreactive cell bodies were shown in the lateral medullary 
reticular formation, especially in the noradrenergic Al and A3 regions (Hunt et al., 
134). Double staining experiments demonstrated that 63% of the APP-positive perikarya 
in the Al region and 43% in the A3 region are also immunoreactive with a TH-antiserum. 
MET-ENK-like as well as LEU-ENK-like immunoreactive cell bodies were found 
scattered throughout the reticular formation, with highest concentrations in the 
nucleus reticularis parvocellularis and the nucleus reticularis medullae oblongatae, 
pars dorsalis (Sar et al., 258). These results have not been confirmed by Hökfelt 
et al., (123,129), who demonstrated MET-ENK-like immunoreactive neurons only in the 
area medial to the nucleus reticularis lateralis overlying the inferior olive, in 
the ventromedial parts of the nucleus reticularis gigantocellularis and in the nucleus 
reticularis paramedianus. 
A few CCK-like immunoreactive neurons have been demonstrated by Vanderhaegen 
et al. (318) in the nucleus reticularis medullae onblongatae, pars medialis and 
ventralis. 
A substantial number of substance P-containing cell bodies were found by 
Ljungdahl et al. (174) in the nucleus reticularis gigantocellularis and in the 
mesencephalic reticular formation, particularly the nucleus cuneiformis. 
Finally, the study of Brownstein (46), who analysed biochemically lesion data, 
showed that histaminergic axons, projecting to the cerebral cortex might emanate 
mainly from neurons situated in the mesencephalic reticular formation. These 
findings have been confirmed by Barbin et al. (17), Pollard et al. (239) and 
Schwartz et al. (263). 
It isworthlyof note that, judging from their localization, the groups of 
neurons containing a transmitter other than serotonin, may all enter into dendro-
dendritic or dendrosomatic contact with serotoninergic elements. 
4.9.3. Fiber oonneatione 
In this subchapter we will describe the afferent and efferent connections of 
the serotonin-containing neurons situated beyond the raphe nuclei. Because the 
majority of these outlying serotonin-positive neurons are situated in the lateral 
tegmental reticular formation, we will mainly focus upon this area. The serotoninergic 
neurons outside the raphe nuclei do not form discrete nuclei and therefore have 
resisted neuroanatomical studies, involving degeneration experiments or axonal 
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transport techniques. A short review of the efferente from the reticular formation 
has been presented by Nieuwenhuys et al (212). 
4.9.3.1. Transmitter-non-specified efferente from the reticular formation 
The lateral tegmental reticular formation give rise to ascending as well as 
descending fibres, the latter being the much numerous. 
3 
The study of Conrad et al. (65), who injected Η-proline laterally and ventrally 
in the tegmental reticular formation, revealed that the ascending projections from 
this area were ipsilateral. These fibers enter the medial forebrain bundle. They 
diminish rapidly in number as they continue rostrally. No fibers were seen further 
rostrally than the level of the anterior hypothalamus. Another major ascending 
projection spreads rostrally through the anterior mesencephalic reticular formation 
into the posterior thalamus. Some label also appeared in the zona incerta, a region 
rich in dopaminergic neurons, and in the subthalamus. Fibers were also observed 
to project to the nucleus parafascicularis, the nucleus centralis lateralis and the 
nucleus dorsomedialis of the thalamus. The studies of Cederbaum and Aghajanian 
(58) and Morgane and Jacobs (202), who have applied HRP-injections into the locus 
coeruleus, demonstrated some labeled cells in the lateral reticular areas of the 
nucleus reticularis pontis caudalis and oralis. 
The descending fibers from the lateral tegmental reticular formation were more 
dense than the ones emanating from the raphe nuclei. Most of these fibres pass to 
the medial part of the reticular formation, i.e. the nucleus reticularis pontis 
oralis, the nucleus reticularis pontis caudalis and the nucleus reticularis 
gigantocellularis. However, this same area also gives rise to a substantial number 
of fibres, which descend in the dorsolateral funiculus throughout the spinal cord 
(Basbaum et al., 18; Basbaum and Fields, 19; Huisman et al., 133; Kuypers and 
Maisky, 158; Martin et al., 189). 
The study of Tohyama et al. (306), who have applied HRP injections in the 
spinal cord, demonstrated a significant number of HRP labeled cells in an area 
ventral to the nucleus cuneiformis. This area has often been mentioned as the 
mesencephalic locomotor region (Steeves et al., 283). The pontine reticulospinal 
tracts originates mainly from the nucleus reticularis gigantocellularis, although 
the nucleus reticularis pontis oralis, the nucleus reticularis pontis caudalis, the 
nucleus reticularis parvocellularis, the nucleus reticularis paramediamus and the 
nucleus reticularis dorsalis and ventralis also constitute fibers to these tracts. 
These results were confirmed by Goode et al. (112), who have used HRP tracing as well 
as autoradiography. They also showed that the nucleus reticularis gigantocellularis 
and the nucleus reticularis pontis oralis innervate only laminae I and II of the 
spinal cord. However, in addition to the reticulospinal system originating at this 
level, there exists a major reticulospinal pathway which arises bilaterally from 
cells located in the caudal reticular formation, just laterally to the decussatio 
pyramidis (Coulter et al., 66). 
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4.9.3.2. Afférents to the reticular formation 
4.9.3.2.1. Transmitter-specified afferente to the serotoninergic reticular nuclei-
have been described by several authors. It is known that all of the reticular nuclei 
receive a sparse to moderate innervation with serotoninergic fibers (Steinbusch, 
284).The same holds true for the catecholamines. The major part of the pontine 
reticular formation contains a low density of uniformly distributed noradrenergic 
terminals, whereas only a small number of such fibers was found in the mesencephalic 
reticular formation. A dense terminal field of catecholaminergic axons is present 
in the area dorsally and dorsolaterally to the lemniscus medialis, i.e. the area 
of the Bq-cell group (Lindvall and Bjorklund, 172; Swanson and Hartman, 297). 
Levitt and Moore (170) who studied the catecholamine innervation of the brainstem, 
using a biochemical assay as well as glyoxylic-histofluorescence, found that the 
entire reticular formation received a moderate to dense innervation with 
catecholaminergic fibers, with highest concentrations in the nucleus reticularis 
tegmenti pontis. Their study showed in addition that these fibers arise from the 
locus coeruleus (Α.), as well as from the lateral tegmental cell populations, i.e. b 
the A,, A, and A cell groups. Adrenergic fibers have not been described by Hökfelt 
et al. (125). 
Besides of these catecholaminergic terminals, fibers containing one of the 
following seven transmitters, could be recognized, i.e. MET-ENK, LEU-ENK, a-MSH, 
substance P, CCK, VIP and ACTH. 
MET-ENK-like and LEU-ENK-like immunoreactive fibers have been demonstrated 
by Sar et al. (258) throughout the reticular formation, i.e. with law densities 
in the nucleus reticularis tegmenti pontis and the nucleus cuneiformis. 
α-MSH-positive fibers were demonstrated by Dubé et al. (81) in the dorsolateral 
part of the mesencephalic formatio reticularis, in the nucleus reticularis tegmenti 
pontis and in the nucleus reticularis pontis oralis. A large number of a-MSH-
containing fibers were observed by Jacobowitz and O'Donohue (136) in the nucleus 
cuneiformis. According to them in the rest of the reticular formation only a few 
a-MSH-innnunoreactive fibers were present. 
Substance P-containing fibers have been found by Ljungdahl et al. (174) in 
many of the reticular nuclei, although their number was relatively small. A moderately 
dense plexus was present in the nucleus cuneiformis. The ventrolateral mesencephalic 
reticular formation contained only sparse or low densities of substance P-positive 
nerve terminals. 
Vanderhaegen et al. (318) described thick beaded CCK-positive fibers in the 
lateral part of the reticular formation. 
Some VIP-containing axons were demonstrated by Sims et al. (273) in the nucleus 
reticularis pontis oralis and a sparse number dorsally in the mesencephalic reticular 
formation. 
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Finally, a moderate density of ACTH-immunoreactive fibers were detected 
throughout the reticular formation (Pelletier and Ledere, 232). 
None of the following peptide-containing fibers were observed: APP (Hunt et al., 
134), vasopressin or oxytocin (Buys, 51; Sofroniew and Weindl, 281), LH-RH (Jennes 
and Stumpf, 139), γ-MSH (Bloom et al., 35) and ß-endorphin (Bloom et al., 34). 
Thus, whereas the catecholaminergic fibers were uniformly distributed over 
the reticular formation, it was observed that the peptide containing fibers were 
preferentially located laterally. 
4,9.3.2.2. Transmitter-non-speeified afférents to the serotoninergic reticular 
nuclei have been described by several authors. First of all it was observed that 
the reticular formation receives a strong input from the raphe nuclei. Bobillier 
et al. (36) described that mesencephalic reticular nuclei received some fibers 
from the nucleus raphe dorsalis and the nucleus centralis superior. Moreover the 
autoradiographic study of Bobillier et al. (37,38) revealed that the medullary 
reticular nuclei, i.e. the nucleus reticularis gigantocellularis, the nucleus 
reticularis medullae oblongatae and the nucleus reticularis paramedianus receive 
a major input from the nucleus centralis superior, although some fibers were also 
deriving from the nucleus raphe magnus and the nucleus raphe pontis. The pontine 
reticular nuclei receive fibers mainly from the nucleus raphe magnus and the nucleus 
raphe pontis. Some fibers were deriving from the nucleus centralis superior. Whereas 
the mesencephalic reticular formation was observed to receive a substantial number 
of fibers from the nucleus centralis superior, only a moderate number of fibers from 
the nucleus raphe magnus and pontis and just a few from the nucleus raphe dorsalis. 
The study of Kawamura and Chiba (145), employing the retrograde transport of 
HRP, showed the pontine reticular formation receiving fibers from layer V of the 
ipsilateral cerebral cortex. 
The study of Sofroniew and Schrell (279) who have applied immunoperoxidase 
staining of retrogradely transported HRP revealed that there are no hypothalamic 
neurons projecting to the reticular formation. This is in contrary to the work of 
Wright and Arbuthnott (339), who pretreating rats with 6-hydroxydopamine, observed 
the presence of non-dopamine efferent connections of the substantia nigra to the 
dorsolateral pontine reticular formation. The study of Loewy and Saper (176), 
using autoradiographic anterograde axonal tracing, showed that the ventral parts 
of the mesencephalic and pontine reticular formation receive a substantial number 
of fibers from the nucleus Edinger-Westphal. 
Finally, the study of Coulter et al. (66) revealed that the nucleus reticularis 
gigantocellularis and the neurons adjacent to the decussatio pyramidum receive 
an ascending spinal input and extensive descending inputs from some rostral 
structures, i.e. the contralateral tectum and the head and face region of the 
sensorimotor cerebral cortex. 
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4.10. The relation between serotonin and the glia 
Glia cells are elements, which belong to the central nervous system although 
their function is not directly related to neurotransmission, rather they have to be 
considered as supporting cells in the brain. Glia cells are like neurons of an 
ectodermal origin but they differ from them in having only one type of process. 
They can be divided in macro- en microglia. The macroglia comprise the astrocytes, 
the oligodendrocytes and the tanycytes. In this chapter we will focus upon three 
areas in which we observed glia-cells, which are serotonin-immunoreactive them-
selves and on one region in which neurons are in close proximity to glia elements. 
4.10.1. Serotoninergia glia oells 
Serotonin-positive glia cells were demonstrated in the following areas: a) the 
area postrema, b) the infundibular stalk and c) the extraencephalic are situated 
immediately ventral to the rhombencephalon (cf. section 3.3). 
a) A compact group of relatively small, monopolar serotonin-immunoreactive glia cells 
was found in the area postrema. This observation confirms work from Falck and 
Owman (86), who have used the FIF-method and from Dow et al. (78,79), who have 
employed uptake studies of serotonin. However, all of these authors did not 
observe serotoninergic glia cells beyond the boundaries of this region. 
b) As already mentioned in section 3.2 specific serotonin-immunostaining of glia 
cells was found in the infundibular stalk. These findings have not been confirmed 
by other authors. In the medial part of that area we observed some weakly fluorescent 
tanycytes with elongated cell bodies, which are situated in the vicinity of the 
ventricular space. Their radially arranged processes extend into the external zone 
of the median eminence. These observations are in keeping with those of Sladek 
and Sladek (274). These authors demonstrated by means of microspectrofluorometry 
the presence of serotonin within tanycytes of the median eminence, although they 
•were unable to show the serotonin-positive glia cells in the infundibular stalk. 
According to the work of Wittkovski (338) tanycytes are characterized by having 
only one single process, which either participates in the formation of the membrana 
limitans gliae externa or extends into the perivascular region (Scott and Pauli, 
266). Tanycytes in mammals have been encountered mainly in the walls of the third 
ventricle, particularly ventrally. Each tanycyte can be regarded as consisting 
of a soma, a neck and a tail portion. The light microscopical investigations of 
Kobayashi et al. (153) and Rodriguez (247) demonstrated the substantial uptake and 
transependymal transport of HRP by "basilar ependymal cells", following injection 
of that enzyme into the third ventricle and subsequently transferring them to 
capillaries in the surrounding periventricular neuropil or to the portal capillaries. 
The observations of serotonin within tanycytes of the median eminence by 
Sladek and Sladek (274), which was confirmed by us, and the additional finding 
of the presence of dopaminergic nerve terminal endings in linear profiles arranged 
parallel to tanycytes, described by Sladek and Sladek (274) and previously by 
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Hoffman and Sladek (122), brought up the hypothesis that tanycytes may regulate 
the storage of regulating hormones originating from the cerebrospinal fluid in the 
third ventricle and their release into the portal vasculature by an intracellular 
mechanism affecting some point along the way from uptake to release. This latter 
phenomenon, then could be mediated by a catecholaminergic input. 
c) As previously described in section 3.3 superficial serotonin-immunoreactive glia 
cells were demonstrated in the region adjacent to the rhombencephalic part of the 
tractus corticospinalis and ventrally to the caudal part of the inferior olive 
complex (Fig. 14). With regard to localization, distribution and 
shape these cells corresponds to those recently described by Ross et al. (249). 
These authors observed that the cells in question give rise to axons which project 
to the thoracic and lumbar spinal cord. Although these authors marked these cells 
as neurons, an immunoelectronmicroscopical survey, using antibodies to serotonin, 
revealed that these cells actually represent çlia cells defined on the basis of 
their morphological appearance, such as the lack of cellorganelles other then 
mitochondria in their processes, or the bundeling of fibrous elements, consisting 
of 8-9 nm thick filaments in their processes (Leenen, personal communication). 
It is known that the ventrolateral surface of the brainstem is an important 
area for the regulation of respiration and cardiovascular activity and moreover, it 
is accepted that serotonin can lead to changes in cardiovascular function. However, 
combining the results of Ross et al. (249) with ours, we can state that their 
neurons are not serotoninergic. While our serotonin-immunoreactive cells are glia 
cells. Moreover, as described in section 3.3. these glia cells are in possession 
of processes which enter the tractus corticospinalis or the area laterally of it. 
By entering this latter region these cells could be involved in autonomic and 
respiratory regulation (Riche et al., 246; Saper et al., 257). 
4.10.2. Serotoninergic neurons contacting glia cells 
Several areas in the rhombencephalon and mesencephalon have been described 
where dendrites of serotonin-immunoreactive neurons are in close proximity to 
tanycyte-like glia cells, i.e. elements with cell bodies forming part of the 
ependymal ventricular lining and provided with one or a few long, peripherally 
extending processes (Figs. 26A.B ; Cummings and Feiten, 67; Feiten and Harrigan, 
90; Feiten et al., 91). These areas, containing high proportions of serotonin-
positive neurons, correspond with the nucleus raphe pallidus, the nucleus raphe 
obscurus, the nucleus raphe dorsalis and the nucleus centralis superior. The glia 
cells, under discussion, are non-serotoninergic. However, there has been found no 
direct proof on the ultrastructural level for a direct apposition between sero-
toninergic dendrites and glia processes. Circumstantial evidence has been presented 
by Cummings and Feiten (67), who used in different rat brains either the Golgi-Cox-
or the histofluorescence method. Our findings are in keeping with theirs, but we 
remained unable to visualize simultaneously serotoninergic dendrites and Golgi-
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impregnated tanycytes. 
Assuming a direct apposition of serotoninergic dendrites with tanycytes in the 
medial plane of the brainstem, what functional implications could did lead to? 
As already pointed out in section 4.7. the dendrites could release serotonin or 
take up compounds which influences the intraneuronal serotonin levels. Cummings and 
Feiten (67) and Feiten et al. (91) suggested that the tanycytes represent a 
communication channel between the cerebrospinal fluid of the fourth ventricle and 
the raphe nuclei, by which a change in the composition of the cerebrospinal fluid 
could either activate or depress the excitability of the medullary raphe neurons. 
They suggested further more that the raphe neurons in that way might influence 
blood pressure regulating centra. 
4.11. Serotonin and neuronal-liquor- and neuronal-vascular relationships 
This chapter will be divided into four parts: A) supra-ependymal neuronal-
liquor relationships, B) arachnoidal neuronal-liquor relationships, C) intra-
encephalic neuronal-vascular relationships and D) extra-encephalic neuronal-vascular 
relationships. 
4.11.1. Supra-ependymal neuronal-liquor relationships 
The presence of supra-ependymal cells was first reported by Leonhardt and 
Lindemann (167), using scanning- and transmission electronmicroscopy on the 
floor of the fourth ventricle. Using the same technique Jennes et al. (138) and 
Scott et al. (265) observed a large number of supra-ependymal cells in the third 
as well as fourth ventricle. However, the majority of these elements appeared to 
be glia cells. Jennes et al. (138) reported that the supra-ependymally situated 
are of two types: small and large. 
The presence of supra-ependymal serotoninergic neuronal elements has been 
reported by Lorez and Richards (184) using histofluorescence and by Chan-Palay (61) 
3 
and Parent et al. (225), applying intra-ventricular injections of H-serotonin. 
However, all these authors were only been able to visualize serotoninergic fibers. 
We were able to confirm their findings and in addition demonstrate the existence 
of supra-ependymal serotoninergic neurons on the lateral walls of the fourth 
ventricle and in the aquaductus cerebri. These neurons rememble in dimension as well 
as in number, the large neurons described by Jennes et al. (138) 
The presence of cerebrospinal fluid contacting serotonin-immunoreactive nerve 
fibres projecting through or lying on the cerebral ventricular ependyma was 
observed in all ventricles, although with local differences in intensities. This 
plexus can be divided into two parts: a) a dense serotoninergic plexus on the 
ventricular surface of the rhombencephalon, in the aquaductus cerebri and 
in the lateral ventricles, b) a moderately dense serotonin-positive plexus 
in the dorsal part of the third ventricle (Fig. 19C). No serotonincontaining axons 
were demonstrated in the ventral part of the third ventricle, i.e. 
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in the zone adjacent to the hypothalamus. The plexus itself consists of thin, 
varicose fibers. The difference of the plexus mentioned above are not related to 
disparities in varicosities or intervaricose connections, bus has to be seen as 
differences in the absolute number of fibers. Apparently no correlation exists 
between the density of these fibers and the density of the serotoninergic innervation 
in the adjacent brain areas or nuclei. 
The appearance of the serotoninergic supra-ependymal plexus must be later than 
postnatal day one in the rat, since we remained unable to visualize that plexus 
before or at that time. These results have been confirmed by Lauder 
(personal communication). The observations, which we have made in the adult rat 
resemble those of Aghajanian et al. (1); Aghajanian and Gallager (2); Calas et al. 
(55) and Chan-Palay (59), but these authors did not report local differences in 
density of the plexus. Moreover, Chan-Palay (59) found a positive reaction in the 
ventral part of the third ventricle. However, our findings are fully in keeping 
with those of Lorez and Richards (184,185), who have studied the 5-HT innervation 
of the ventricles with fluorescence histochemistry, and those of Cupédo and de 
Weerd (68), who demonstrated intraventricular axons in the habenular region, using 
both intraventricular injections of 5,7-dihydroxytryptamine and electrolytical 
midbrain-raphe lesions. Besides of serotoninergic fibers on the ventricle walls, 
only one other type of transmitter-specified supraependymal fiber has been 
described, i.e. luteinizing hormone-releasing hormone (LH-RH)-like immunoreactive 
fibers in the rat by Burchanowski et al. (48) and in the brain of the golden 
hamster by Jennes and Stumpf (139). 
The question arises, whether it is possible to determine the site of origin 
of the supraependymal plexus. Using lesion experiments, Aghajanian and Gallager (2) 
were able to determine that the serotonin-containing nerve terminals in the cerebral 
ventricular system are derived from the nucleus raphe dorsalis and the nucleus 
centralis superior. These results are confirmed by Parent et al. (225), who, using 
autoradiography, described this periventricular system as one of the two major 
ascending projections, issuing mainly from the rostral pole of the nucleus raphe 
dorsalis. Cupédo and de Weerd (68), using degeneration experiments, adduced 
evidence that the supra-ependymal habenular serotoninergic axons originates from 
the nucleus centralis superior and the nucleus raphe dorsalis. However, the 
possibility must be considered that some lesion effects could be due to damage of 
serotoninergic axons, ascending from rhombencephalic raphe nuclei. 
Concerning the role of the serotoninergic intraventricular cell bodies and neuronal 
processes the following suggestions have been made: a) secretion of serotonin into 
the cerebrospinal fluid; b) regulation of pendymal secretion; c) absoprtion of other 
bioactive compounds from the cerebrospinal fluid; and d) regulation of ciliary 
activity. 
a) Secretion in terms of modifying the CSF composition has been suggested by 
Chan-Palay (59), Leonhardt and Lindeman (167), and Scott et al. (266). Moreover, 
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Leonhardt and Lindeman (167) and Scott et al. (265), who all used electronmicroscopy, 
observed that most axons are unmyelinated. Secretion of 5-HT into the CSF is, may be, 
important since it is not possible for serotonin, synthesized outside the brain, to 
reach the ventricular system by way of the choroid plexus (Lindvall et al., 173). 
b) The penetration of the ependyma by neuronal processes is a consistent 
characteristic of supraependymal neurons as shown in the electron microscopic 
study of Mitchell and Card (197). Leonhardt and Prien (168), who have studied 
electronmicroscopically intraventricular axonal endings in the fourth ventricle 
of the rat brain, found that the plasmalemma of the bulbs is in synapse-like contact 
with the ependyma. It has been mentioned already that the ependymal layer contributes 
directly or indirectly to a significant production of CSF and hormones (Ribas, 
245). Taken these findings and our own observations together, we might hypothetize 
that serotoninergic supraependymal neurons may modulate ependymal activity. It would 
be interestin«» to investigate whether there are local differences in the composition 
of the ependyma, mainly in the ventral part of the third ventricle, an area in which 
serotoninergic supraependymal fibers are lacking but in which the ependyma is in 
close apposition to a large number of neuropeptide secreting endocrine cells. 
c) No direct evidence has been presented for the absorption of compounds from 
the CSF into the intraventricular axons. However, with regard to this absorption 
Westergaard (334) hypothesized, solely on the basis of morphological data, that 
these axons may be receptors for the registration of CSF composition. 
d) The last function of the serotoninergic supra-ependymal plexus suggested 
is the regulation of the flow of the CSF, by modulating the ciliary acitivity 
of ependymal cells . Interestingly a regulatory role for 5-HT in ciliary 
movement has been observed on the molluscan epithelium (Quay, 241). 
Calas et al. (55) reported in their autoradiographic study that in the third 
ventricle and the subcommissural region of the rat the density of cilia is 
positively correlated with the density of the supraependymally situated serotoniner-
gic fibres. However, according to the study of Ribas (245) in the intracommissural 
and suprahabenular recesses of the rat epithalamus, a dense serotoninergic inner-
vation was demonstrated in a non-ciliated area. 
4.11.2. Suprapial neuronal-liquor relationships 
Extra-encephalic serotonin-immunoreactive fibers were not only observed on 
the ventricular walls, but also on the entire pial surface of the brain, forming 
there a suprapial plexus. Highest densities were found in adjacent cortical areas, 
whereas only a few 5-HT positive fibers could be demonstrated on the cerebellum and 
on the basal surface of the brain. It was observed that, in the suprapial fibers 
the intervaricose distances are much longer than in the supraependymal fibers. There 
appeared to be no correlation between the density of the suprapial serotoninergic 
fibers and those present in the adjacent brain areas. 
- 219 -
The function of the suprapial serotoninergic fibers is at present unclear. 
Some fibers are related to the extraencephalic vascularization and will be discussed 
in the next section. The neuronal-liquor relationships resemble the ones which we 
have described previously: i.e. secretion of serotonin into the CSF and absorption 
of compounds from the CSF. 
4.11.3. Intra-enaephalio neuronal-vascular relationships 
Serotoninergic neurons are strategically located near areas of cardiovascular 
control. For example the 5-HT afférents to the sympathetic preganglionic neurons 
are arising from the raphe nuclei (Dahlström and Fuxe, 69). The lightmicroscopical 
study of Scheibel and Scheibel (261) suggested that serotoninergic perikarya and 
dendrites of the nucleus raphe pontis and the nucleus linearis oralis border on 
midline blood vessels, however an electron microscopic survey did not reveal a 
direct contact between neural- and vascular elements in the nucleus raphe pontis. 
A recent study at the lightmicroscopical level of the nucleus raphe obscurus and 
the nucleus raphe pallidus (Cummings and Feiten, 67) revealed a direct neuronal-
vascural contact between serotoninergic perikarya and dendrites and blood vessels 
situated within these nuclei. However, it is not possible to demonstrate conclusively 
a functional neuron-vascular relationship at the lightmicroscopic level. Only 
electronmicroscopy can reveal the presence of direct appositions between neurons and 
blood vessels. Feiten and Crutcher (88), using fluorescence histochemistry and 
electronmicroscopy, found perikarya and dendrites abutting on the basement membrane 
of capillaries and small arteries ranging from 8-50 ym in diameter, without 
evidence of glial interposition. Taking it for granted that all neurons in the nucleus 
raphe dorsalis are serotoninergic, they considered the neuroactive principle involved 
in the contacts categorically as serotonin. However, as already described in sections 
4.3 and 4.5 neurons, containing another transmitter than serotonin are not only 
present in the nucleus raphe dorsalis but in all the other raphe nuclei as well. 
Hardebo and Owman (120) mentioned that the brain microvascular endothelium contained 
a large concentration of monoamine-oxidase (MAO). The presence of MAO has to be seen 
as two-folded: a) providing the enzymatic breakdown of amines and by that fulfilling 
a simple barrier function against the entrance of circulating monoamines. 
It is known, that cerebral blood vessels are richly innervated by noradrenergic 
neurons whose cell bodies are either located within the superior cervical ganglia 
(Verhofstad et al., 324) or in the brain stem locus coeruleus. The ultrastructural 
study of Swanson et al. (296) revealed that within the nucleus paraventricularis 
direct appositions between the noradrenergic terminals and the blood vessels occur. 
They showed in addition that no astrocytic processes were interposed between the 
noradrenergic varicositie and the basal laminae of the endothelial cells. The 
direct noradrenergic innervation of the endothelial cells of blood vessels in the 
nucleus paraventricularis hypothalami and the presence of amine uptake and enzymatic 
mechanisms within these cells may influence the activity of these cells. 
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Circumstantial evidence suggesting the presence of similar links between serotoniner-
gic neurons and blood vessels was obtained from pharmacological and biochemical 
studies (78,79,157). 
The question arises whether the neuronal-vascular connections are afferent, 
efferent or both. Feiten and Crutcher (88) suggested that the neuronal-vascular 
relationship of serotoninergic raphe nuclei represents an afferent vascular channel 
for conveying blood-borne substances to receptors on the serotoninergic neurons. 
However, Reinhard et al. (244), using electric lesions in combination with 
radioenzymatic micro-assays for serotonin, adduced evidence that serotoninergic 
dendrites can release serotonin into small blood vessels. It was measured that 
lesions of the nucleus raphe dorsalis and the nucleus linearis oralis resulted in a 
70% reduction in microvessel serotonin concentration as compared to controls. 
Ganglionectomy failed to reduce microvessel serotonin concentrations. 
Edvinsson et al. (82) brought up the possibility that serotonin present in small 
brain capillaries originates from mast cells. However, we don't expect that the mast 
cells are contributing substantially to the blood serotonin, because serotonin-
immunoreactive mast cells appeared to be confined to the area of the median eminence 
(Steinbusch, 284). 
Smits et al. (276) demonstrated that in rats electric stimulation of either the 
nucleus raphe dorsalis or the nucleus centralis superior leads to an increased 
blood pressure. This effect in the nucleus centralis superior was abolished it the 
rats were pretreated with the serotonin-depletor, para-chlorophenylalamine. 
Presumably, raphe stimulation leads to the release of 5-HT, which activates 
postsynaptic 5-HT receptors, leading to the observed pressor effect. These results 
have been confirmed by Kuhn et al. (157) and Fuller (96). 
Finally, Reinhard et al. (244) brought up the possibility that other raphe nuclei 
are also in close proximity to blood vessels, suggesting that serotoninergic neurons 
receive afferences by way of chemoreceptors who detect changes in blood composition. 
On the basis of this afference they may regulate blood flow and vascular permeability 
and thereby provide the brain with a mechanism for controlling its own microcircula-
tion. However, direct evidence for a release of serotonin from raphe neurons into 
the blood is unconvincing. Scheibel and Scheibel (261) and Feiten and Crutcher (88) 
were not able to show synapses or dense core vesicles within monoaminergic 
perikarya or dendrites abutting blood vessels. 
Summarizing: There is only some circumstantial evidence for the presence of direct 
appesitimi of serotoninergic neuron· end the neurovascular system. However, 
pharmacological and electophyeiologieal experiment« have conclusively shown that 
seFPlPnin is involved in the regulation of blood pressure. For this reason, serotonin 
has frequently been suggested to be implicated in the pathogenesis of a number of 
vaeeula? disorders, including migraine and ischemia (Chan-Palay, 60; Welch et al. 
332). 
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4.11.4. Suprapial neuronal-vasaular relationship ε 
The work of Chan-Palay (60), who has used autoradiography, histofluorescence 
and immunocytochemistry, revealed that the cerebral bloodvessels are not only 
innervated by serotonin-positive fibers, but in addition by noradrenaline-, 
substance P-like and neurotensin-like positive fibers. A clearly positive reaction 
with Η-serotonin was not only seen within the brain parenchyma, but also in the 
arachnoidial, particularly in the vicinity of the superficial cerebral blood 
vessels. We were able to confirm these findings and to show in addition that this 
plexus is much more extensive than was thought before. The functional significance 
of this neuronal-vascular relationship may resemble that of the one we have 
described under the preceeding subsection. Thus, release of serotonin from this 
plexus could cause elevation of the concentration of serotonin in the CSF surrounding 
the blood vessel and may be even within the vessel itself. This could lead in its 
term to vasoconstriction, resulting in changes in cerebral blood flow (Chan-Palay, 
59). 
5. CONCLUSION 
Cytoarchitectonic and immunohistochemical studies revealed that the seven 
raphe nuclei, which contain the bulk of the serotoninergic cell bodies represent 
separate entities. Moreover, it was observed that serotoninergic neurons within 
the raphe nuclei have no special structural characteristics. Thus, it is not 
possible to recognize serotonin-positive cells in Nissl or Golgi material. 
We consider it likely, that the serotoninergic neurons situated within the 
raphe nuclei differ with regard to both their afferent and efferent connections 
from those situated beyond these nuclei. In this context it would be interesting 
•to extend the ontogenitical studies with an analysis of a series of representative 
vertebrate species. 
Because the raphe nuclei are by no means exclusively serotoninergic, their 
efferents are not exclusively serotoninergic either. 
Serotoninergic neurons have been shown to be involved in a number of widely 
different functions, hence it is not likely to denote the total population of the 
neurons containing this transmitter as forming a single functional system. 
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+++ 
+++ 
++ 
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-
+ 
+++ 
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++ 
TABLE I Results of blocking experiments. 
Fluorescence intensity in comparable cryostat sections of the rat medulla 
oblongata stained with samples of an antiserum to serotonin-immunogen 
purified from BSA-antibodies. These samples were incubated with different 
concentrations of substances as indicated. 
+++ : normal fluorescence; ++ : some inhibition; + : strong inhibition and 
- : no fluorescence. 5-HT : serotonin; 5-MT : 5-methoxy-tryptamine; DA: dopamine; 
NA: noradrenaline; OCT: octopamine; A: adrenaline; SYN: synephrine and 
HIST: histamine. 
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Table II: Transmitter-specified perikarya within the raphe nuclei. 
nucleus nucleus nucleus nucleus nucleus nucleus nucleus 
raphe raphe raphe raphe raphe centralis linearis 
obscurus pallidus magnus pontis dorsalis superior oralis 
. 284 
serotonin 
127,205,218,337 
117,118 
dopamine 
noradrenaline' 
GABA / GAD 2 3 ^ 2 0 S 
318 
CCK 
LEU-ENK 
111,204,111 
MET-ENK 
123, 311 
Substance-P 
и р
 182,273,321 
63,174 
Table I I I : Cell bodies in raphe nuclei containing two neurotransmitters. 
serotonin +
 с л
 nn 
, -p4,läU 
substance-P 
serotonin..*-
LEU-ENK 
nucleus 
raphe 
obscurus 
+ 
nucleus 
raphe 
pallidus 
+ 
nucleus 
raphe 
magnus 
+ 
+ 
nucleus 
raphe 
pontis 
nucleus 
raphe 
dorsalis 
+ 
nucleus 
centralis 
superior 
nucleus 
linearis 
oralis 
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Table У: Transmitter-specified fibres and terminals within the raphe nuclei. 
I nucleus nucleus nucleus nucleus nucleus nucleus nucleus 
raphe raphe raphe raphe raphe centralis linearis 
л Ь с л п п і е п ч П ί / I n o т п ч г т т і с T l í - i«* - - íc І І Л Г О З І І О Q l i n O f l Г» Τ" П Г Э І І С 
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Tryptophan ^]Г~\[СИтТ~ННг H O ^ _ j H C H r Ç H - N H 2 
Tryptophan Hydroxylase I | Tyrosine Hydroxylase 
I ΓΗ) 
НО. 
но 
XAjJ1 ¿ООН HO-<^J>-CHjÇH-NH 2 D O P A 
1 н — соон DOPA Decarboxylase (DDO I 
с L. " " У ^ T-O-bCH^NH, HO 
5-Hydroxytryptamine H 2 2 2 \ 
н HOH^bCHj-CHj-NHj Dopamine 
Dopamine ^-Hydroxylase 
i IDBH ) 
HO 
но-( У-снюн)-сн
г
мн2 Noradrenaline 
Phenylethanolamme 
I N-Methyl Transféras! s e e 
IPNMT I 
HO 
HO
 \ / CH<OHbCH2NH_CH3 Adrenaline 
Fig. 1 Biosynthet ic pathways of serotonin ( l e f t ) and dopamine, noradrenal ine and 
adrenaline ( r i g h t ) . Note tha t the enzyme DOPA-decarboxylse (DDC, aromatic L-amino-
acid decarboxylase) i s involved in both pathways. 
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Fig . 2-12 Atlas of serotonin-iimnunoreactive neurons in the brainstem and pons of the 
rat. Every cell at a certain level in a 50 .urn thick Vibratone section has been 
plotted. Note that the majority of the serotoninergic perikarya are not strictly 
confined to the raphe nuclei. Abbrevations used in the figures: atv: area tegmentalis 
ventralis Tsai; CC: crus cerebri; ct: nucleus corporis trapezoidei; CX: corpus 
trapezoidei; DP: decussatio pyramidis; DT: decussationes tegmenti; FC: fasciculus 
cuneatus; FG: fasciculus gracilis; FL: fasciculus longitudinalis; FLDG: fasciculus 
longitudinalis dorsalis, pars tegmentalis; FLM: fasciculus longitudinalis medialis; 
FOR: formatio reticularis; gr: nucleus gracilis; io: nucleus olivaris inferior; iom: 
nucleus accessorius olivaris medialis; ip: nucleus interpeduncularis; LC: locus 
coeruleus; LM: lemniscus medialis; lo: nucleus linearis oralis ; nbi: nucleus 
basilaris internus Cajal; nes: nucleus centralis superior; neu: nucleus cuneiformis; 
nE: nucleus Edinger-Westphal; np: nucleus parabrachialis ventralis; nrp: nucleus 
reticularis paramedianus; nrv: nucleus reticularis medullae oblongatae, pars 
ventralis; ntd: nucleus tegmenti dorsalis; ntdl: nucleus tegmenti dorsalis lateralis; 
ntm: nucleus tractus mesencephali; nts: nucleus tractus solitarius; nt V: nucleus 
tractus spinalis nervi trigemini; nlll: nucleus motorius nervi oculomotorii; nIV: 
nucleus nervi trochlearis; nV: nucleus motorius nervi trigemini; ηVI: nucleus nervi 
abducentis; nVII: nucleus nervi facialis; nXII: nucleus nervi hypoglossi; os: 
nucleus olivaris superior; Ρ: tractus corticospinalis; PCI: pedunculus cerebellaris 
inferior; PCM: pedunculus cerebellaris médius; PCMA: pedunculus corporis mamillaris; 
PCS: pedunculus cerebellaris superior; ph: nucleus prepositus hypoglossi; po: nucleus 
pontis; r: nucleus ruber; rgi: nucleus reticularis gigantocellularis; ri: nucleus 
reticularis lateralis; rm: nucleus raphe magnus; ro: nucleus raphe obscurus; rp: 
nucleus raphe pallidus; rpc: nucleus reticularis parvocellularis; rpo: nucleus raphe 
pontis; rpoс: nucleus reticularis pontis caudalis; rpoo: nucleus reticularis pontis 
oralis; rtp: nucleus reticularis tegmenti pontis; sg: nucleus suprageniculatis 
facialis; SGCl: substantia grísea centralis lateralis; SGCv: substantia grísea 
centralis ventralis; SGv: substantia grisea ventralis; SN: substantia nigra; tmV: 
nucleus tractus mesencephali nervi trigemini; TRS: tractus rubrospinalis; TSV: 
tractus spinalis nervi trigemini; TTS: tractus tectospinalis; vm: nucleus 
vestibularis medialis; vt: nucleus tegmenti ventralis and VII: nervus facialis. 
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Fig. 13 Photomicrographs of t r a n s v e r s a l immunoperoxidase-paraffin sec t ions through 
the bvain stem of a chinese hamster embryo of 14 days of g e s t a t i o n , a f t e r incubation 
with serotonin-ant i serum, at the l eve l between the p o n t i n e - and mesencephalic 
f lexure; (A,B) in the median p l a n e , (C) v e n t r o l a t e r a l ^ and (D) j u s t caudally to the 
pontine f lexure . Note in В and D t h a t a t t h i s s tage the s e r o t o n i n e r g i c c e l l groups 
are not y e t fused. (Bars: 75,um). 
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Fig. 14 Photomicrograph of a midsagittal section through the caudal brainstem after 
incubation with serotonin-antiserum. Serotonin-immunoreactive neurons are 
demonstrated in the nucleus raphe pallidus (rp) and the nucleus raphe obscurus (ro). 
Some serotonin-positive cells are shown in the reticular formation dorsally to the 
tractus corticospinalis (P) and ventrally to the fibrae corticospinalis (FCS) ; Some 
serotoninergic fibers are seen in the area dorsocaudally to the pyramidal tract (P). 
Ventrally to this same tractus a few superficial situated serotoninergic glia-cells 
are demonstrated (LM: lemniscus medialis; Bar: 75 ,um). 
?66 -
\ 
G 
Fig. 15 Photomicrographs of a horizontal section through the ventral part of the 
mesencephalon after incubation with serotonin-antiserum. Note in (A) the serotonin-
immunoreactive cells in the area of the lemniscus medialis. These cells were 
designated by Dahlström and Fuxe (1964), as the B9- cell group. (B) Serotonin-
positive neuron ventrally in the area tegmentalis ventralis of Tsai. (C) Perikarya 
in the nucleus linearis oralis (Bars: 75,um). 
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Fig. 16 Photomicrographs of a horizontal (A,B) and transversal (C,D) section through 
the epithalamic lamina intercalaris after incubation with serotonin-antiserum. A 
large number of serotonin-positive pinealocyte-like elements are observed. (D) In 
addition a strong serotoninergic innervation of the ventricular walls is shown (Bars: 
75 ,um) . 
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Fig. 17 Photomicrographs of transversal immunoperoxidase-stained Vibratome sections 
through the substantia nigra after incubation with serotonin-antiserum of (A,B) a rat, 
pretreated with nialamide and L-tryptophan and (C,D) a rat, pretreated with nialamide. 
Note (A,B) the appearance of serotonin-immunoreactive cell bodies in the substantia 
nigra, pars compacta. Note (A,B,C,D) the presence of a dense serotoninergic 
innervation of the substantia nigra, pars reticulata (Bars: 75,um). 
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Fig. 18 Photomicrograph of a transversal cryostat-stained section through the 
substantia nigra after incubation with an antibody to tyrosine-hydroxylase. A large 
number of dopaminergic cells are found in the substantia nigra, pars compacta and in 
the area tegmentalis ventralis of Tsai (atv) (CC: crus cerebri; FR: fasciculus 
retroflexus; LM: lemniscus medialis; PCMA: pedunculus cerebellaris mamillaris 
anterior; snr: substantia nigra, pars reticulata; TOB: tractus opticus basalis, 
Bar: 75 ,um) . 
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Fig. 19 Photomicrographs of transversal Vibratome-stained sections through the 
hypothalamus after incubation with serotonin-antiserum of (A,B) a rat, pretreated 
with nialamide and L-tryptophan and (C,D) a rat, pretreated with L-tryptophan. 
Note in (A,B) the appearance of serotonin-immunoreactive cell bodies in the ventral 
part of the nucleus dorsomedialis hypothalami (ndm). Note in (B) the serotoninergic 
supra-ependymal plexus in the third ventricle (na: nucleus arcuatus; Bars: 75,urn). 
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Fig. 20 Photomicrograph of transversal cryostat-stained sections through the 
hypothalamus after incubation with an antibody to tyrosine-hydroxylase. Dopaminergic 
neurons can be visualized in the nucleus arcuatus (na) and in the zona incerta (zi). 
A very dense innervation with catecholaminergic fibers has been found in the median 
eminence (ME), a large number of serotoninergic fibers is passing through the medial 
forebrain bundle (MFB). No dopaminergic neurons are visualized in the nucleus dorso-
medialis hypothalami (ndm). (nvm: nucleus ventromedialis hypothalami; F: fornix; 
IIIv: third ventricle; Bar: 75,um). 
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Fig. 21 Ascending and descending projections from the raphe nuclei. List of 
abbreviations: a: nucleus accumbens; ahp: area hypothalami posterior; al: nucleus 
amygdaloideus lateralis; am: nucleus amygdaloideus medialis; ap: area pretectalis; 
apol: area preopticus lateralis; BO: bulbus olfactorius; ce: cortex entorhinalis; 
cm: nucleus centromedianus thalami; cp: nucleus caudatus putamen; CS: colliculus 
superior; FR: fasciculus retroflexus; gp: globus pallidus; HI: hippocampus; hi: 
nucleus habenulae lateralis; hm: nucleus habenulae medialis; io: nucleus olivaris 
inferior; ip: nucleus interpeduncularis; na: nucleus arcuatus; nc: neocortex; 
ncs: nucleus centralis superior; ndh: nucleus dorsalis hypothalami; nf: nucleus 
fastiguus; nha: nucleus hypothalami anterior; nlh: nucleus lateralis hypothalami; 
nlo: nucleus lineari", oralis; nmh: nucleus medialis hypothalami; npd: nucleus 
parabrachialis dorsalis; npm: nucleus premamillaris; npv: nucleus paraventricularis 
hypothalami; nsc: nucleus suprachiasmaticus; ntd: nucleus tegmentalis dorsalis; nts: 
nucleus tractus solitarius; nlll: nucleus motorius nervi oculomotorii; pf: nucleus 
parafascicularis; PF: cortex prefrontalis ; ph: nucleus prepositus hypoglossi; po: 
nucleus pontis; pv: nucleus periventricularis thalami; rd: nucleus raphe dorsalis; 
re: nucleus reuniens; rgi: nucleus reticularis gigantocellularis; rh: nucleus 
rhomboideus; rm: nucleus raphe magnus ; ro: nucleus raphe obscurus; rp: nucleus raphe 
pallidus; rpo: nucleus raphe pontis; rpoo: nucleus reticularis pontis oralis; 
SGC: substantia grísea centralis; si: nucleus lateralis septi; sm: striae medialis; 
sn: substantia nigra; sut: nucleus subthalamicus; tdm: nucleus dorsomedialis thalami; 
vgcl: nucleus ventralis corporis peniculati lateralis and vm: nucleus vestibularis 
medialis. 
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Fig. 22 Serial transverse semithin sections of the rat suprachiasmatic nucleus, 
immunohistochemically stained with (A) anti-serotonin and (B) anti-vasopressin 
serum. Note that whereas the serotonin-immunoreactive perikarya are situated 
dorsomedially, the vasopressinergic fibers are located in the ventral part of the 
nucleus suprachiasmaticus (IIIv: third ventricle; CO: chiasma opticum; Bars: 75,um.) 
Photomicrographs are kindly supplied by Gross and van Leeuwen. 
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Fig. 23 Afferent connections to the rhombencephalic raphe nuclei. Included are the 
transmitter-specified afférents (LH-RH, vas: Vasopressine; oxy: Oxytocine; DA. 
dopamine; NA: noradrenaline.) For abbreviations see Fig. 21. 
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Fig. 24 Photomicrographs of a transversal section through the nucleus raphe 
obscurus after incubation with neurophysin-antiserum. Neurophysin-like immunoreactive 
fibers are demonstrated in the nucleus raphe obscurus (ro), the nucleus tractus 
solitarius (nts) and in the griseum centralis. Some fibers are even distributed close 
to the fourth ventricle (Bar: 75,um). Photomicrographs are reproduced by courtesy 
from Sofroniew. 
Fig. 25 Afferent connections to the mesencephalic raphe nuclei. Included are the 
transmitter-specified afférents (LH-RH, vas: Vasopressine; oxy: Oxytocine; S-P: 
substance P; DA: do-amine; NA: noradrenaline; A: adrenaline; GABA). For abbreviations 
see Fig. 21 . 
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Fig. 26 Transversal section through the medulla oblongatae after staining with the 
Golgi-Сох method. Long tanycyte shafts are seen in the midline with their soma 
situated near the ventricular walls (Bars: 75 .urn). 
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CHAPTER Vili 
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2. Hypothalamic control of pituitary function 
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C. Conclusion 
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Chapter VIII Functional Implications 
There is a vast literature of the function of serotoninergic neurons in physio-
logical and behavioral events. However, most of these studies are based upon a) 
anatomical findings, in which the oversimplifying assumption has been made that all 
of the neurons located in the raphe nuclei are strictly serotoninergic or b) pharma-
cological observations in which the endogeneous levels of serotonin were changed 
and the related effects were registrated; however, the manipulations of the sero-
toninergic neurons employed in these experiments are generally not specific, e.g. 
treatment with 5,6-dihydroxytryptamine has also an effect upon the endogeneous levels 
of noradrenergic neurons. 
Thus for most of the implications only indirect evidence can be presented and 
by that linkage to our own observations is only vague. More direct connections 
between the work presented in this thesis and behavioral implications can be shown 
in relation to the innervation of the spinal cord. Serotoninergic fibres arising 
from the raphe nuclei innervate specific functional regions of the spinal cord, i.e. 
the dorsal horn or sensory region (important in pain sensitivity), the zona intermedia 
or autonomic region (important for thermoregulation) and the ventral horn or somatic 
motor region (important for locomotor activity). 
A.l. Central regulation of cardiovascular function 
Anatomical observations. 
A function of serotoninergic neurons in the regulation of the cardiovascular 
system can be inferred from morphological relations found in both the brain and 
the spinal cord. The intraencephalic relationship of serotoninergic neurons with 
bloodvessels has been discussed in depth in chapter VII of this thesis, in which 
we have described the strong vascularization of the raphe nuclei. It has been 
demonstrated that serotoninergic neurons in the raphe nuclei with their somata and 
dendrites directly contact bloodvessels. 
At the spinal level it has been found that the neurons situated in the inter-
mediolateral column of the thoracic part of the spinal cord are densely innervated 
by serotoninergic fibers. It is known that at least part of the sympathetic pre-
ganglionic neurons which make up the nucleus intermediolateralis play a role in the 
regulation of the cardiovascular system. 
Pharmacological observations. 
Antonaccio (1977) and Blatt et al. (1979), using the central serotoninergic 
agent MK-122, demonstrated that an increase of the central serotoninergic activity 
inhibits the activity of preganglionic sympathetic neurons in the intermediolateral 
cell column and by that has an inhibitory function on the heart rate. Recently, 
Loewy and Neil (1981) devoted a review to the role of descending serotoninergic 
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fibres in the central control of bloodpressure. 
A.2. The raphe-hypothalamus-pltuitary connection 
Anatomical observations. 
Three areas, with a medium to dense serotoninergic innervation, are involved 
in regulating the release of pituitary hormones 
A) A direct serotoninergic innervation of the pars intermedia of the pituitary has 
been described by the present author in chapter V. The fibres are not terminating upon 
known hormone-producing cells, but it may well be possible that serotonin stimulates 
cells, which release compounds to the portal system, and by that will have an effect 
in the pars distalis of the pituitary. 
B) A medium dense serotoninergic innervation has been observed in the ventromedial 
part of the hypothalamus. Cells in this area give rise to fibres, which contact 
bloodvessels of the portal system. 
C) A third and more suggestive involvement of serotoninergic neurons in regulating 
pituitary function can be found in the eminentia mediana. Immunohistochemical 
studies at the lightmicroscopical level revealed that numerous transmitter-specified 
fibres are passing through this region, i.e. serotonin-, dopamine-, LH-RH-containing 
fibres. Since these diverse fibres are very densely packed, it is conceivable that 
axo-axonic contacts are made. These contacts do not necessarily have to be synaptic. 
Pharmacological and endocrinological observations. 
The role of serotoninergic neurons in pituitary-adrenal function can be 
related to an enhanced serotonin production, resulting in an increase of the plasma 
corticosterone level (Lissák and Telegdy, 197Θ; Meyer, 1978; Meyer et al., 1978). 
Several reports showed that intracerebrally injected p-chlorophenylalanine (PCPA), 
a serotomn-depletor, abolishes or attenuates the normal diurnal rhythm in the 
level of circulating corticosterone. Following administration of this substance the 
concentration of corticosterone appears to be elevated during the time when levels 
are normally low and decreased during the time at which corticosterone levels 
ordinarily are highest (Rotszte]n et al., 1977; Vernikos-Daniellis et al., 1973, 
1977). These findings have been interpreted as supporting the idea that central 
serotoninergic neurons are involved in regulating the diurnal adrenal rhythm by 
exerting an inhibition on the hypothalamo-pituitary-adrenal axis (Fuller, 1981; 
Meyer et al., 1978). A decrease in this inhibition results in an increased basal 
corticosterone level. However, it should be mentioned that PCPA has to be given at 
high doses to deplete serotonin and probably influences other neurotransmitters in 
the brain as well. A diminished serotonin level in the brain is accompanied by a 
prolonged activation of the adrenal cortex which facilitates stress response 
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(Fuller, 1981). 
It has been shown by Jones and Hlllhouse (1977) that there is no direct effect 
of serotonin upon serum corticosterone levels. Elevation of serum corticosterone, 
following enhanced serotonin function is presumably Initiated by increased release 
of corticotropin-releasing factor from the hypothalamus. There are similar kinds 
of evidence for this role of serotoninergic neurons towards the release of growth 
hormone, thyrotrophin and luteinizing hormone (Héry et al., 1978; Lissák and 
Telegdy, 1978; Mess, 1977; Weiner and Ganong, 1978) or prolactin and ACTH (Clemens 
et al., 1978; Krieger, 1977; Pavasuthipaisit et al., 1980). Most of the studies are 
based upon the administration of 5-hydroxytryptophan (5-HTP) after PCPA treatment, 
which restored the rhythmic changes in plasma ACTH, that had been abolished, 
suggesting that serotonin depletion did contribute to the observed changes 
(Szafarczyk et al., 1979). However, the serotonin precursor, 5-HTP, may enter 
cerebral dopaminergic neuronal terminals, undergo decarboxylation to 5-HT, and then 
replace the endogenous catecholamine from vesicular stores (Ng et al., 1972). 
A role of serotonin in ovulation control has been suggested by Marko and 
Fluckinger (1980). Using 5-HT antagonists who inhibit the secretion of luteinizing 
hormone, these authors elicited ovulation in rats. The newly produced serotonin by 
itself will have a time dependent inhibitory action on the enzyme aromatic-L-amino 
acid decarboxylase (Voltattorni and Minelli, 1980). Summarizing, more extensive 
studies are needed to demonstrate unequivocally that serotoninergic neurons play an 
inhibitory role in controlling the pituitary-adrenocortical rhythm. 
B. The possible role of serotoninergic neurons in some clinical disorders. 
B.l. Depression 
A relation between a malfunction of serotoninergic neurons and depression is 
suggested by the fact that at least in a number of patients suffering from this 
mental disorder the concentrations of serotonin and its major metabolite 
(5-hydroxyindolacetic acid) in the cerebrospinal fluid appear to be reduced. 
Anatomical observations. 
We are presently unable to unveil which raphe nuclei are responsible for the 
disorder under discussion. However, we consider it likely that the nucleus raphe 
dorsalis is mostly involved in the etiology of depression. The reasons for this 
assumption are as follows: 1) the disorder is related to changes in levels of 
serotonin and 5-HIAA in the cerebrospinal fluid (CSF), 2) the serotoninergic 
supraependymal plexus, which originates from the nucleus raphe dorsalis, can release 
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Serotonin into the CSF, (cf. Chapter VII). 
Pharmacological observations. 
Currently, the most prevalent idea about the nature of depression is that it 
involves a functional deficiency of serotonin as well noradrenaline. This holds for 
both types of depression, i.e. the endogenous unipolar as well as the manic-bipolar 
depression (Schildkraut, 1977; Murphy et al., 1978). Arguments have been presented 
that a disturbance in the central 5-HT transmission is a cause of the symptoms of 
depression in a proportion of patients suffering from endogenous 5-HT depression. 
That serotonin release from brain neurons might be inadequate in some patients 
with depression is suggested by reported reductions in the levels of 5-HIAA within 
the liquor (van Praag and Korf, 1974) and in brain serotonin levels in people who 
committed suicide (Shaw et al., 1967). However, van Praag and Korf (1974) mentioned 
in their study that only a subgroup of patients suffering from depression has a 
deficiency or a hypofunction of their serotoninergic neurons. Thus, the role of 
serotonin in depression should not be generalized. 
Because serotonin cannot pass the blood-brain barrier, therapies have been 
introduced to raise the endogenous levels of brain serotonin. Coppen (1967) and 
Mendels et al. (1975) showed that the treatment with the serotonin-precursor, 
L-tryptophan, improved depression in patients with a reduction in the 5-HIAA levels 
in their CSF. 
One of the more convincing arguments that enhanced serotonin function accounts 
for or contributed to an antidepressant effect came from studies in which tryciclyc 
antidepressant (TCA) drugs, e.g. Imipramine, serotonin reuptake inhibitors, e.g. 
zimelidine, monoamine oxidase inhibitors and serotonin receptor antagonists, e,g, 
L.S.D., were applied, see for review Fuller (1980). L-tryptophan, clinically active 
in the mental disorder under discussion, increases the synthesis of 5-HT and is 
found to depress markedly the firing rate of 5-HT cells. MAO-inhibitors also reduce 
the firing of these cells as do tryciclyc antidepressants, which inhibit the 
reuptake of 5-HT. Contrary, noradrenaline reuptake blockers, such as desipramine, 
when admlnistrered, failed to produce a reduction of the firing rate of serotoniner-
gic neurons. However, the long delay of the therapeutic effect of tryciclyc anti-
depressant drugs is difficult to reconcile with a meohanisms of blocking serotonin 
reuptake. Uptake inhibition can take place within minutes, whereas the clinical 
response requires a minimum of eight days. In contrary, Baumgarten et al. (1979) 
considered it unjustified to draw conclusions concerning the physiological importance 
of reduced serotonin levels in depression from therapeutic effects of antidepressant 
drugs that have blocking activity on serotonin reuptake, since tricyclic drugs with 
little or no inhibitory effect on 5-HT reuptake are equally potent antidepressant 
and moreover, since drugs of this class show other effects. 
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In summary, it is my impression that despite the intense research endeavour 
put forth in the last decade, direct unequivocal evidence of consistent malfunctioning 
of the serotoninergic neurons in the depressive disorders under discussion is still 
lacking. It were Lapin and Oxenkrug (1969), who proposed that "intensification of 
serotoninergic processes plays a leading part in the therapeutic effect of the 
various antidepressant treatments". This proposal might still be valid. 
Thus, although we are presently unable to unveil the exact role of serotoninergic 
neurons in the etiology of this particular form of depression, pharmacology has shown 
us that raising endogeneous levels of serotonin has an antidepressant effect upon 
patient with this specific depressive syndrome. By that, the proposal of Lapin and 
Oxenkrug (1969) grated above might still be valid. 
B.2. The involvement of serotoninergic neurons in Parkinson's disease. 
Parkinson's disease, one of the best characterized diseases of the basal 
ganglia, is accompanied by 1) a rhythmical tremor at rest, 2) a unique kind of 
rigidity and 3) a slowness in the initiation of movement as well as in the execution 
of movement. The main reason for discussing this disease within the framework of 
this chapter is the finding of Celesia and Wanamaker (1972), that a considerable 
number of patients (37%), who are suffering from Parkinson's disease, had in 
addition depressive symptoms. 
Anatomical observations. 
Neuropathological studies show a degeneration of the nigrostriatal pathway due 
to a marked loss of pigmented neurons with a replacement by astrocytic gliosis and 
the presence of Lewy bodies in the substantia nigra (Earle, 196Θ). Besides of 
these observations, Lewy bodies have also been found, although to a lesser extent, 
in the raphe nuclei, the locus coeruleus and the motor nucleus of the vagus (Ohama 
and Ikuta, 1976). 
It has been shown by the present author that the caudatoputamen receives a 
medium to dense innervation with serotoninergic fibres and terminals, (cf. Chapter IV). 
These fibres have their parent cell bodies in the nucleus raphe dorsalis (cf. 
Chapter VI). 
It is presently not clear whether the raphestriatal pathway is showing degenera­
tion in patients suffering from Parkinson's disease. This may well be possible because 
Lewy bodies were observed to be present in the raphe nuclei of these patients. 
Pharmacological observations. 
In Parkinson's disease degeneration of dopamine-containing cells in the sub­
stantia nigra and a resultant decrease of the dopamine concentration in the basal 
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ganglia are common findings (Fahn et al., 1971). Curzon (1972) showed in his biochemical 
study, that the serotonin concentrations were similar in both caudate nuclei, where-
as that of dopamine was reduced on the contralateral side in a patient with unilateral 
Parkinsonism. 
However, it was observed by Lloyd and Hornkiewicz (1974) that serotonin and its 
major metabolite 5-hydroxyindoleacetic acid measured in patients suffering from 
Parkinson's disease are unevenly reduced throughout the neostriatum. This reduction 
may result from impaired synthesis of serotonin in the mesencephalic serotonin-con-
taining neurons, where a reduction in the aromatic-L-amino acid decarboxylase 
activity was observed in Parkinson's disease (Lloyd, 1977). 
Disturbance of serotonin metabolism is additionally reflected by a reduction 
of the major metabolite of serotonin, 5-HIAA, in the cerebrospinal fluid. Moreover, 
Parkinson's disease patients with low 5-HIAA concentrations in their liquor respond 
only weak to dopamine replacement therapy with L-DOPA, suggesting that intact 
serotonin neurotransmission may be important in the therapeutic response to L-DOPA. 
Finally, it has been postulated by Ng et al. (1972) that serotoninergic 
nerve terminals in the caudatoputamen are involved in mediating the therapeutic 
effect of L-DOPA. Thus, in vitro studies have shown that L-DOPA can be taken up, 
decarboxylated and released as dopamine by serotoninergic nerve terminals. However, 
this hypothesis is not in harmony with the findings of Melamed et al. (1980). They 
examined the decarboxylation of exogenous L-DOPA in rats with unilateral nigrostriatal 
lesions (Ungerstedt, 1971). In their experiments firstly, electrolytic lesions were 
made in the nucleus raphe dorsalis and the nucleus centralis superior, secondly, one 
month later unilateral lesions were made into the right substantia nigra by injecting 
6-hydroxydopamine into that center and finally, two weeks later the rats were injected 
with L-DOPA and decapitated after 45 minutes. The study revealed that striatal ADDC 
activity did not decrease despite marked reductions in serotonin, thus the decarboxy-
lase contained within serotoninergic neurons contributes insignificantly to the 
total ADDC activity in the striatum. 
The problem which we are encountering here resembles the one which we have 
discussed already previously in Chapter VII. Under normal conditions L-DOPA is 
decarboxylated to dopamine in DA-containing terminals in the striatum. Although 
L-DOPA has been widely used to treat Parkinson's disease, the site of its 
decarboxylation to dopamine in the Parkinsonian striatum is unknown. However, 
since exogenous DOPA might also be taken up, decarboxylated and released as dopamine 
by serotoninergic terminals, it may well be that non-dopaminergic neurons mediate 
some of L-DOPA's therapeutic effects. 
B.3. Serotoninergic neurons and myoclonus. 
Myoclonus is defined by abrupt, shocklike contractions of muscles, irregular 
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in rhyth and amplitude and usually asynchronous or asymmetrical in distribution. 
Myoclonus occurs in a wide variety of neurological diseases. A specific myoclonic 
syndrome in which central serotoninergic neurons seem to be involved is post-
hypoxic intention myoclonus. This syndrome results from transient brain anoxia, 
such as occurs during a cardiorespiratory arrest (Lance and Adams, 1963). Its 
association with reduced HIAA levels in the CSF and the tendency of some patients 
to respond therapeutically to the administration of 5-HTP or L-tryptophan, alone or 
in combination with a MAO-inhibitor, resulting in a surpression of the myoclonic 
movements in some patients, suggests that the syndrome may arise from a deficiency 
of serotoninergic neurons in the same sense as Parkinson's disease is a result of 
dopamine deficiency (Van Woerth and Sethy, 1975; Chadwick et al., 1977; Growdon, 
1978). One difficulty in studying myoclonus in the laboratory has been the lack 
of a specific animal model. The results of several laboratory experiments are not in 
harmony with the observations made in humans. Thus, in rats, repetitive myoclinic 
jerking movements have been produced by serotonin precursors, such as L-tryptophan 
(Brown and Growdon, 1980), or 5-HTP (Klawans et al., 1975), and by serotonin 
receptor agonists, such as methylated-tryptamines, e.g. 5-methoxy-N, N-dimethyl-
tryptamine (5-MEDDMT) (Fuxe et al., 1962; Squires, 1975). 
Stewart et al. (1976) and Trulson and Jacobs (1976) found independently and 
concurrently that in rats who had previously received the serotoninneurotoxin 
5,7-dihydroxytryptamine, myoclonus can be produced by administering small doses 
of 5-HTP. This myoclonus could be blocked again by the administration of serotonin 
antagonists. From these experiments it appears that increase in the level of 
serotonin in the brain, or potentiation of its post-synaptic effects, can produce 
myoclonus in experimental animals. However, there are no animal models of post-
hypoxic intention myoclonus and the extent to which myoclonic syndromes in animals 
correlate with this specific syndrome in humans remain unknown. 
B.4. Serotoninergic neurons and the state of sleep. 
Sleep is a transient, reversible and periodic state of rest in which there is 
diminution of physiologic activity and of consciousness. The human sleep cycle 
generally progresses through four stages from the lightest (stage 1) to the deepest 
(stage 4), followed by an interlude of REM or paradoxial sleep and four to seven 
repetitions of the cycle during one night. 
Paradoxial or REM (rapid eye movement) sleep is characterized by burts of rapid eye 
movements (REMs), loss of tonic activity of the facial muscles, and desynchronization 
of the electroencephalogram. 
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Anatomical observations. 
Four brain areas have been suggested to be implicated in the involvement of 
serotoninergic neurons in sleep: the raphe nuclei, the caudoventral part of the 
striatum, the preoptic region and the nucleus suprachiasmaticus. As already shown 
in Chapter IV the nucleus raphe dorsalis gives rise to serotoninergic fibres, which 
innervate with a medium-to dense density the caudoventral part of the striatum. In 
addition, we were able to demonstrate that the preoptic region also receives a 
number of serotoninergic fibres. These fibres arise from neurons in the nucleus 
raphe dorsalis and the nucleus centralis superior, and pass through the medial 
forebrain bundle to reach their target area (Puizillout et al., 1981). 
Pharmacological observations. 
A link between the serotoninergic neurons of the raphe nuclei and sleep was 
brought up firstly by Jouvet (1967; 1969; 1972), who demonstrated that in cats 
electrolytic lesioning of the raphe nuclei simultaneously induces a reduction in 
endogenous brain serotonin and total insommia for 10 days. His hypothesis was that 
the raphe nuclei and their projections play a dominant role by releasing serotonin, 
resulting in the induction of slow wave sleep, while noradrenergic neurons are 
involved in the initiation of REM sleep. This model stood at the basis of a great 
deal of research. 
The following discussion will be divided into A) experimental evidence 
supporting this model and B) results being not in harmony with it. 
A. Four types of supporting experiments should be mentioned: 
1) The inhibition of the rate-limiting enzyme of catecholamine-synthesis, tyrosine 
hydroxylase, by a-methyl-para-tyrosine, leads firstly to a diminishing of cate-
cholaminergic containing nerve terminals and secondly, induces an increased turnover 
in 5-HT cells, due to the decreased inhibition of serotoninergic raphe neurons by 
catecholaminergic neurons (Loizou, 1969). In keeping with the results of this 
experiment it was shown by Puizillout et al. (1981) that a selective bilateral 
lesion of the dorsal noradrenergic bundle at the level of the isthmus induces 
hypersomnia. 
2) Jouvet and Pujol (1974) showed that an intraventricular injection of 5,6-di-
hydroxytryptamine, a serotonin depletor, results in a significant decrease of 
slow wave sleep and to some extent of REM-sleep. 
3) Laguzzi and Adrien (1980) obtained in cats, after pretreatment with the 
tryptophan hydroxylase inhibitor, parachlorophenylalanine, a severe insomnia. This 
effect could be reversed by additional administration of 5-hydroxytryptophan. 
However, as pointed out previously, this amine is not solely converted in serotoni­
nergic neurons. Moreover, even prolonged PCPA administration cannot lead to a 
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100% blockade of 5-HT synthesis. 
4) Electrolytic lesions of the pontine and mesencephalic raphe nuclei induce 
insomnia, which is not reversed by 5-HT treatment, (Puizillout et al., 1981). 
However, not alle raphe neurons are serotomnergic and, more importantly, only 
75% of all serotomnergic neurons are located within the raphe nuclei. The other 
somata are scattered in non-raphe structures, as e.g. the locus coeruleus, the 
formatio reticularis, the nucleus ruber and the area tegmentalis ventralis of Tsai. 
B. Numerous experimental studies have yielded data which are not in harmony with 
studies which present the serotonin-sleep hypothesis of Jouvet (1972). Some of 
these will now be briefly discussed. 
1) The study of Aghajanian and Wang (1978) showed that noradrenergic fibres from 
the locus coeruleus have a minor and possibly indirect influence on 5-HT cells 
in the nucleus raphe dorsalis because stimulation of the locus coeruleus does not 
have a marked inhibitory effect on 5-HT cells and microiontophoretic application 
of noradrenaline directly into the nucleus raphe dorsalis does not consistently 
produce inhibition. This same study showed in addition that the nucleus raphe 
dorsalis receives an important input from the pontine reticular formation. Moreover, 
stimulation of the latter area markedly suppresses the activity of 5-HT cells in 
the nucleus raphe dorsalis (Héry et al., 1978). 
2) Hartman (1977) found that oral administration of high doses of L-tryptophan 
in rats significantly reduces sleep latency and increases subjective sleepiness 
in animals with long sleep latencies. Moreover, Wojcik et al. (1980) reported that 
injection of a low dose of tryptophan decreases sleep latency, but that a larger 
dose not only failed to affect sleep latency but also increases wakefulness. 
3) Lesions of raphe nuclei in rats have no effect, or only a transient effect, 
upon sleep (Adrien, 1978; Mouret and Coindet, 1980). Likewise, massive destruction 
of cerebral serotomnergic terminals by intraventricular injections of 5,7-dihy-
droxytryptamine in the rat does not change the amount of slow wave sleep, but 
increases the REM-sleep percentage slightly after the first week (Ross and Trulson, 
1976). 
The 5-HT control of the sleep circadian rhythm may in fact involve a 
neurohumoral mechanism. Serotonin is released into the ventricles from supraependymal 
varicosities. It has been shown by Lanoir et al. (1981) that neurons of the nucleus 
suprachiasmaticus are particularly sensitive to circadian variations of the con-
centrations of serotonin in the cerebrospinal fluid. The authors suggested that 
after tryptophan-depnvation a delayed and drastic reduction in the release of 
5-HT to the liquor could result in a disappearance of the sleep circadian rhythm. 
In summary it seems likely that release of serotonin from raphe nuclei plays 
a role in slow wave sleep. However, since serotoninergic neurons are also involved 
in a wide variety of other behavioral and physiological functions, I consider it 
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unlikely that serotonin is the only slow wave sleep inducing substance. It should 
be considered as a more general deactivating effector on the waking state, rather 
than a specific sleep-producing substrate. 
B.5. Thermoregulation. 
Anatomical observations. 
Two areas in the central nervous system are important for thermoregulation, 
a) the anterior hypothalamus and the preoptic region and b) the nucleus intermedio 
medialis and -lateralis at thoracic levels of the spinal cord (Feldberg and Myers, 
1965; Cronin and Baker, 1977; Myers and Waller, 1978; Petrovicky et al., 1981). 
Both areas receive a medium - to very dense serotoninergic innervation (cf Chapter 
IV) and thus connect them with serotoninergic cell bodies. However, as shown in 
chapter VII the serotonin-positive fibres and terminals innervating both regions 
have their parent cell bodies in different raphe nuclei. The area of the anterior 
hypothalamus and the preoptic region receives afférents via the medial forebrain 
bundle from the nucleus raphe dorsalis and the nucleus centralis superior, as shown 
by the study of Petrovicky et al. (1981). These authors applied anterograde 
degeneration and tracing of retrograde transported HRP. The same study revealed 
mutual connections between the two mesencephalic raphe nuclei and the ditelencephalic 
thermoregulatory field. In that same study, the authors brought up the hypothesis 
that both the ascending as well as the descending connections between the raphe 
nuclei and the hypothalamus were involved in thermoregulation, and moreover, that 
the raphe nuclei may be integrated in these circuits not only as relay station, but 
also as centers of thermosensitivity. 
The nucleus intermediolateralis and -medialis receive serotoninergic fibres 
via the dorsolateral funiculus of the spinal cord from the three caudally situated 
raphe nuclei, i.e. the nucleus raphe magnus, the nucleus raphe pallidus and the 
nucleus raphe obscurus (Bowker et al., 1981a,b; and chapter IV of this thesis). 
Pharmacological observations. 
It were Feldberg and Myers (1964; 1965) who first showed that bodytemperature 
is controlled by a balance of opposing actions due to the relative rates of a 
catecholamine, probably noradrenaline, and serotonin released in the hypothalamus. 
Injected into the cerebral ventricles 5-HT was found to have a hyper-thermic effect, 
adrenaline and noradrenaline a hypo-thermic effect. One action might be associated 
with heat-producing responses, the other with dissipating responses (Helion and 
Mitchell, 1975). Feldberg and Myers (1965) demonstrated further that by injecting 
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minute amounts of serotonin 12 pg in 1 yl) throughout the hypothalamus of unanaesthe-
tized cats the region most sensitive to 5-HT was localized to be a thermosensitive 
zone dorsal to the chiasma opticum and ventral to the commissura anterior, i.e. the 
anterior hypothalamic and the preoptic area. The changes in bodytemperature were 
recorded rectally. Borsook et al. (1977) found that low doses of 5-HT infused 
directly into the anterior hypothalamus produce hyperthermia, whereas the depletion 
of 5-HT in the forebrain by treatment with PCPA impairs the capacity to thermoregulate 
against a cold stressor. However, when 5-HT or 5-HTP is given systemically either 
a sharp rise or fall in the animal's body temperature can occur, which depending 
on the dose and route of administration, as well as on the ambient temperature 
of the test situation. Chai and Lin (1972) observed that thermosensitive neurons 
are also present in the brain stem raphe nuclei. Moreover, Dickenson (1977) found 
that there are two populations of thermosensitive neurons in the raphe nuclei, cells 
responding to warming the skin and coldresponse neurons. These results are in 
accordance with the work of Murakami and Sakata (1980), who injected LSD intravenous-
ly or locally in the nucleus raphe dorsalis or in the nucleus raphe magnus, and 
showed opposite temperature effects, i.e., an increase in the rectal temperature and 
a fall in the ear skin temperature, although both effects were concentration depen-
dent. These experiments revealed in addition that only the serotoninergic neurons 
of the heterogeneous cell populations of the raphe nuclei are responsible for the 
effect under discussion. Although the field from which thermoregulation can be 
influenced does largely coincide with the cytoarchitectonic boundaries of the 
raphe nuclei, it has been found, that some of the heat responding neurons are 
situated more laterally in the reticular formation. In this context it is presently 
unclear why after an interruption of the medial forebrain bundle or destruction of 
the mesencephalic raphe nuclei, no alterations in the daily temperature rhythm have 
been observed as mentioned by Dunn et al. (1978). 
In summary, we were able to demonstrate that serotoninergic fibres originating from 
raphe areas are innervating regions which are involved in thermoregulation. The 
serotoninergic neurons of the nucleus raphe dorsalis and the nucleus centralis 
superior seem to play a vital role in the hypothalamic control mechanism which 
underlies thermoregulation. Moreover, they are reacting upon internal temperature 
fluctuations in two ways, either by descending efferente to the rhombencephalic 
raphe nuclei or ascending efferents via the medial forebrain bundle to the anterior 
hypothalamic and preoptic region. 
The three caudal rhombencephalic raphe nuclei are responding to external 
temperature variations by means of efferents to the autonomic system in the nucleus 
intermediolateralis and -medialis at thoracic levels of the spinal cord. 
Finally, neurons situated in the thermosensitive preoptico-hypothalamic area 
give rise to descending fibres to all of the raphe nuclei. 
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В.6. The involvement of serotoninergic neurons in pain. 
Current interest in the mechanisms of analgesia and the modulation of nociception 
has focussed attention of many investigators onto a possible role of serotoninergic 
neurons and the raphe nuclei. 
Anatomical observations. 
Anatomically two descending pathways are involved in mediating pain transmission. 
Leu-enkephalin-positive neurons situated in the periventricular central gray of the 
mesencephalon send their axons to the nucleus raphe magnus and the adjacent nucleus 
reticularis paragigantocellularis. The latter two regions project upon the dorsal 
horn of the spinal cord. 
It has been described by the present author, that only a minority of the neurons 
in the rhombencephalic nuclei is serotoninergic (chapter VII). The serotoninergic 
innervation of the spinal cord is derived mainly from the expanded portion of the 
nucleus raphe magnus, and from the nucleus raphe pallidus, and passes via the 
dorsolateral funiculus to the substantia gelatinosa of the dorsal horn (Basbaum and 
Fields, 1979; Bowker et al., 1981a,b). Some serotoninergic fibres have their parent 
cell bodies in the caudal part of the nucleus raphe dorsalis and the area dorsally 
to the mesencephalic part of the lemniscus medialis (Basbaum et al., 1978,· Leichnetz 
et al., 1978). The nucleus centralis superior does not appear to project to the 
spinal cord (Björklund and Skagerberg, 1979; Fields et al., 1977). 
Since the serotoninergic neurons in the nucleus raphe magnus form only a 
minority within the total cell group, the question arises whether there are non-
serotoninergic raphe spinal components involved in the regulation of pain? The 
study of Bowker et al. (1981b), using the retrogradely transported cell marker 
horseradish peroxidase and immunocytochemistry with antibodies to serotonin, 
indicated that most (55%) of the rhombencephalic raphespinal projecting neurons in 
the nucleus raphe magnus are non-serotoninergic while no less than 90% of the cells 
situated in the mesencephalic tegmental area adjacent to the nucleus centralis 
superior and dorsal to the lemniscus medialis, which project upon the dorsal horn 
of the spinal cord, are serotoninergic. 
Pharmacological observations. 
It was Vogt (1974) who made a link between serotonin and nociception. Using 
pharmacological lesions of the raphe nuclei, resulting in a depletion of the 
serotoninergic innervation of the spinal cord, she observed a reduction of analgesia 
produced by morphine. It was demonstrated by Messing and Lytle (1977) that pain 
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sensitivity is increased in rats consuming tryptophan-poor diets and is restored 
to normal by the addition of tryptophan to the diet. The study of West and Wolsten-
corft (1977), which was based upon extracellular recordings from raphespinal neurons 
identified by stimulation of their axons in the cornu dorsale of the lumbar spinal 
cord, revealed that their parent cell bodies are mainly localized in the nucleus 
raphe magnus. Direct evidence for the regulation of nociception by serotoninergic 
neurons has been provided by the demonstration that direct application of serotonin 
into the spinal subarachnoidal space produces a dose-dependent decrease in respon-
siveness to noxious peripheral stimulation (Yaksh and Wilson, 1979). Electric stimu-
lation of the nucleus raphe magnus and the nucleus raphe pallidus can produce anal-
gesia and a lesion of the latter nuclei in the rat has been reported to reduce or 
abolish analgesia produced by morphine. These studies were based upon measuring the 
lesion-induced changes in content of serotonin in the spinal cord and the differen-
ces in serotonin levels in the spinal cord after morphine induced analgesia (Proud-
fit. 1980). 
Summarizing, the serotoninergic neurons of the nucleus raphe magnus and the 
nucleus reticularis paragigantocellularis form an important chain in producing 
analgesia. The activation of bulbospinal 5-HT containing neurons by electrical 
Stimulation of the periaquaductal central gray or by intracerebral injections of 
morphine in the same area results in release of 5-HT in the substantia gelatinosa 
of the spinal cord. In this spinal region 5-HT exerts an inhibitory influence on 
neurons which play a role in pain-transmission. 
Since the serotoninergic neurons form only a minority of the total number of 
cells in the raphe nuclei, it seems most likely that non-serotoninergic fibres 
may also play a role in mediating analgesia. It has been shown by Hökfelt et al. 
(1979) in an immunohistochemical study, that LEU-ENK- and substance-P positive 
neurons in the nucleus raphe magnus and adjacent reticular formation send their 
axons also to the dorsal horn of the spinal cord. Moreover, it has been demonstrated 
that serotonin and substance-P (Hökfelt et al., 1978; Chan-Palay et al., 1978) and 
serotonin and LEU-ENK (Glazer et al., 1981) can be present within the same cells of 
the nucleus raphe dorsalis, the nucleus raphe magnus and the nucleus reticularis 
paragigantocellularis. In this respect it is understandable why drugs which deplete 
endogeneous levels of 5-HT, reduce rather than abolish the analgesic effects of 
serotonin. Thus, it is not clear, whether the particular peptide synthetized by 
these serotonin neurons synergizes with or antagonizes the actions of serotonin. 
For example, serotonin and substance-P have opposite effects on spinal nociceptive 
elements; the former is inhibitory, the latter excitatory. In contrast, 5-HT and 
LEU-ENK are thought to be both inhibitory (Sanders et al., 1980). 
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В.7. The role of serotoninerglc neurons In somatic motor function. 
Anatomical observations. 
Several descending spinal pathways are involved in controlling locomotion 
activity. Prominent among these are the corticospinal, rubrospinal, vestibulo­
spinal and reticulospinal tracts. Two transmitterspecified pathways both monoaminer-
gic, i.e. noradrenergic fibres from the locus coeruleus and serotoninergic fibres 
from the caudal raphe nuclei (Commissiong, 1981) have also been shown to be involved 
in locomotor activity. It has been demonstrated by the present author (chapter IV), 
that a dense plexus of serotoninergic fibres and terminals can be visualized within 
the area of the motoneurons in the ventral horn of the spinal cord, i.e. lamina IX 
of Rexed. It was known from studies which applied the retrogradely transported 
substance HRP by injecting into the ventral horn of the spinal cord that the parent 
cell bodies of the fibres terminating in the ventral horn are located in the 
nucleus raphe magnus, the nucleus raphe pallidus and the nucleus raphe obscurus 
(Bowker et al., 1981a,b,- Björklund and Skagerberg, 19B0) . Moreover, a direct 
innervation of these neurons by serotoninergic fibres and their terminals has been 
shown, although only at the llghtmloroscopie level (see fig. 2B, pag. 21 of this 
thesis). 
Pharmacological observations. 
Indirect evidence for an involvement of serotoninergic neurons in controlling 
locomotor activity was obtained by electrophysiological and pharmacological studies. 
Viala and Buser (1969), showed for the first time that injection of DOPA and 5-HTP 
in the ventral horn of the spinal cord, facilitates spontaneous rhythmic activity 
in the antagonistic muscles of the ankle joint of the rabbit, i.e. DOPA largely 
in extensors and 5-HTP in flexors. 
Pharmacological evidence came from the work of Mabry and Campbell (1973) and 
Fibiger and Campbell (1971) which showed an increased locomotor activity after 
inhibiting serotonin synthesis by PCPA or after electrolytical lesione placed in 
the mesencephalic raphe nuclei. Pompeiano and Hoshino (1976) reported in their 
electrophysiological study two groupings of pontine neurons, which show reciprocal 
changes in their discharge rate during the suppression of decerebrate rigidity. 
One of these cell groups showed a decrease in firing rate during the induced 
cataplectic episode and was, moreover, confined to the caudal rhombencephalic 
nuclei. However, these experiments do not show whether or not it are the sero-
toninergic neurons in the raphe nuclei which are reponsible for the phenomenon 
described. Orlovsky (1972) found that most reticulospinal neurons have a weak 
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background activity at rest, but that during locomotion their activity increases 
greatly. However, the conclusion made by Mori et al. (1980), that serotoninergic 
neurons elevate the background excitability of the brain stem and the spinal cord 
is premature, because the raphe nuclei contain large numbers of non-serotoninergic 
neurons. 
Recently a study of Steeves et al. (1980) brought up data militating against 
the hypothesis that stimulation of the mesencephalic locomotor region, c.q. the 
nucleus cuneiformis, can give rise to locomotion, due to the activation of 
descending monoaminergic fibres to the spinal cord and moreover, that these fibres 
comprise the only pathways which control the initiation of locomotion. The lattei 
authors reported in addition that after depletion of serotonin by intraventricular 
injections of 5,6-dihydroxytryptamine and intraperitoneal injections of PCPA and 
depletion of noradrenaline by intraventricular injections of 6-hydroxydopamine and 
alpha-methyl-parai-tyrosine did not abolish locomotion. Therefore, they concluded 
that descending monoaminergic fibre tracts are not essential for locomotion evoked 
by brain stem stimulation. 
Schlosberg and Harvey (1979) demonstrated an increase of locomotor activity 
after lesioning the mesencephalic raphe nuclei, while Salles and Salles (1980) 
observed a permanent decrease in locomotor activity after electrolytic lesioning 
of the nucleus centralis superior. The latter results are in accordance with previous 
work of Lorens (1978), which showed a decrease in motor activity after intrarapheal 
injections of 5,7-dihydroxytryptamine. 
Conclusion: Several pieces of evidence point toward an involvement of serotoninergic 
neurons of the raphe nuclei in the control of somatic motor function. It is at 
present not clear whether the serotoninergic neurons situated beyond the raphe 
nuclei, e.g in the nucleus reticularis gigantocellularis, also project to the 
ventral horn of the spinal cord. 
C. Conclusion 
It seems reasonable to assume that some basic role is served by neurons whose 
cell bodies are localized in the lower, phylogenetically older parts of the brain 
and whose axonal ramifications are distributed throughout the entire central 
nervous system. However, the diversification of true synaptic contacts (Chan-Palay, 
1975) and the possibility that many of these contacts are established with inter-
neurons rather than with efferent neurons in a given local circuit, and the occurrence 
of ηαη-synaptic serotoninergic transmission, especially in cortical areas (Chiba, 
1980) renders it unlikely that the population of serotoninergic neurons subserves 
one single, discrete function. The study of Jacobs et al. (1974) indicated the 
weakness in the assumption that alle serotoninergic neurons act as one system to 
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produce behavioral or physiological changes. For instance, lesions of the nucleus 
centralis superior resulted in a disturbance of somatic motor activity, while 
lesions of the nucleus raphe dorsalis did not show such an effect. However, it is 
important to not that lesioning of a raphe nucleus will never include all seroto-
ninergic neurons within a certain area. Moreover, it should be kept in mind that 
none of the raphe nuclei consists exclusively of serotoninergic neurons. 
A full explanation of the functional significance of the serotoninergic neurons 
cannot be given as yet. However, the following notes and suggestions may well be 
conducive to an elucidation of the wide variety of physiological and behavioral 
effects ascribed to the action of these neurons. A) In most brain areas serotoniner-
gic neurons modulate rather than determine the neuronal activity. B) Due to inner-
vation density differences the effects produced by the release of serotonin may 
vary regionally. C) The slowness and clocklike regularity of the electrical 
activity of serotoninergic neurons denotes a tonic neuronal function, in contrary 
to the rapid and variable activity of peptidergic neurons, which could transfer 
more information and by that subserve a more dynamic function. 
Viewed in this light it is my impression that the populations of serotoniner-
gic and noradrenergic neurons, have to be seen as two opposing but connected sets 
of neurons regulating various brain functions. It has been shown by Dray et al. 
(1976) that 5-HT inhibits catecholamlnergic neurons. In considering its action on 
dopaminergic neurons, the neurophysiological evidence is overwhelming that in 
regions with a dense to very dense innervation of serotoninergic fibres and 
terminals, e.g. the substantia nigra, serotonin applied locally by iontophoresis 
invariably produces inhibition of neural firing. Stimulation of the raphe nuclei 
produces the same effect (Dray et al., 1976). 
The work of Ennis et al. (1981) indicated that dopaminergic neurons may have 
inhibitory 5-HT receptors on their terminals, which diminish the release of 
dopamine. 
In general, serotonin plays an inhibitory role with respect to a variety 
of behavioral and physiological processes. Blockade of serotonin neurotransmission, 
inhibition of its synthesis, or blockade of its receptors, consistently produces 
an animal which is hypersensitive to all stimuli. Thus, through a general inhibitory 
function, serotoninergic neurons are responsible for limitation of behaviors, 
maintain them within narrow specified limits and prevent that they become repetitive. 
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SUMMARY 
The present thesis describes the development and application of a lightmicros-
copical immunohistochemical staining procedure for the study of serotoninergic neurons, 
including their dendritic and axonal processes, and their terminals. 
In Chapter II a detailed description is given of the production of antibodies 
to serotonin. This antiserum could be used after an appropriate tissue fixation in 
an immunofluorescence technique on cryostat sections for the localization of 
serotonin in the central nervous system of the rat. The specificity of the antiserum 
was examined by liquid-phase absorption experiments. From these tests it was 
estimated that under our experimental conditions there is a cross-reactivity of 
approximately 2% to 5-methoxytryptamine and dopamine and less than 1% to noradrena-
line and adrenaline. 
In Chapter III we extend the application of our antiserum to the îmmunoperoxi-
dase staining of Vibratome sections. These were especially suited for examining 
the dendrites of serotoninergic neurons. In addition we have applied three different 
conjugai-es to serotonin two of which could be used for raising antibodies. Both 
antisera gave a similar distribution of immunoreactivity, although there were some 
sensitivity differences. This finding proved that antibodies to the currently used 
immunogen, were demonstrating serotonin rather than its 0-carboline derivate, which 
is normally be visualized with the formaldehyde-induced fluorescence method. 
Finally, the presence of serotonin-immunoreactivity could be demonstrated in three 
species examined, namely the lamprey (Lampetra fluviatilis), the trout (Salmo 
gairdneri) and the rat. Thus, it was shown that these antibodies have a much wider 
applicability than those directed against synthetizing enzymes. 
In Chapter IV an extensive mapping of serotoninergic cell bodies, fibres and 
terminals throughout the central nervous system of the rat has been presented. 
It was found that almost the entire central nervous system received a serotoninergic 
innervation, although there were local differences in density. Only a few areas 
could be found with no serotonin-immunoreactivity. Most of these represent areas 
containing compact myelinated fibre tracts as e.g. the tractus corticospinalis. 
In Chapter V we have investigated in detail the serotoninergic innervation 
of the hypothalamus and pituitary. The hypothalamus is one of the brain regions with 
a very dense serotoninergic innervation. This holds in particular for the lateral 
hypothalamic area; the nucleus suprachiasmaticus and the nucleus ventromedialis 
hypothalami. In the pituitary 5-HT-immunoreactivity has been found in the pars 
nervosa. Finally, no serotonin-positive cell bodies have been encountered in the 
hypothalamus, neither in untreated nor in colchicine-pretreated rats. 
In Chapter VI we have focussed upon the nucleus raphe dorsalis and its ascending 
projections to the caudatoputamen. A cytoarchitectonic analysis showed that three 
cell types are present within the confines of the nucleus raphe dorsalis; small, 
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medium and large. Serotonin-immunoreactive perikarya in the same nucleus were 
categorized as medium and large neurons. 
Our analysis revealed that serotoninergic neurons are not distributed homogeneously 
within the nucleus and are not strictly confined within its border. Since the 
immunofluorescence technique enabled us only to visualize serotoninergic fibres and 
their terminals, but not the cell bodies from which they arise, we had to develop 
a new method for tracing serotoninergic fibres from their parent cell bodies. This 
technique was based upon combining serotonin-immunofluorescence with the fluorescent 
retrogradely transported tracer, propidium iodide,for the simultaneous demonstration 
of both serotoninergic and non-serotoninergic perikarya in the same section. It was 
observed that the nucleus raphe dorsalis contains serotoninergic as well as non-
serotoninergic perikarya, projecting mostly ipsilaterally to the caudate-putamen 
complex. Approximately one third of the serotonin-positive neurons in the nucleus 
raphe dorsalis appeared to project to the caudatoputamen. 
In Chapter VII we have widened our observations to all of the seven raphe 
nuclei. Cytoarchitectonic and immunohistochemical studies revealed that the seven 
raphe nuclei, which contain the bulk of the serotoninergic cell bodies, represent 
separate entities. Moreover, it appeared that in the raphe nuclei serotoninergic 
neurons cannot be distinguished on the basis of cytoarchitectonic criteria. 
Because a variety of different transmitter-specified cells are present within 
the raphe nuclei, their efferents are by no means exclusively serotoninergic. Thus 
the observations made with the retrograde transport of HRP, amino-acid autoradio-
graphy or degeneration experiments related to the raphe nuclei, cannot be directly 
linked to serotonin. Thus, afférents towards the raphe nuclei cannot be interpreted 
as input channels to serotoninergic neurons. 
In the same chapter we have also presented evidence suggesting that serotonin may 
act as neurohormone. The extensive supraependymal, serotoninergic plexus formed by 
raphe neurons presumably release serotonin in the cerebrospinal fluid. In the raphe 
serotonin may be directly released in the bloodvessels abundantly present in that 
area. 
Finally in Chapter VIII we have attempted to relate our neuroanatomical 
findings on the group of serotoninergic neurons to pathophysiological and behavioural 
observations. During our exploration of the literature two major difficulties were 
encountered: 1) In most neuroanatomical studies all of the neurons present in the 
raphe nuclei were considered as serotoninergic. Hence, lesions in these nuclei were 
considered as specific lesions of the serotoninergic "system". 2) In many pharmacolo-
gical studies attempts have been made to influence the group of serotoninergic neurons 
by various drugs, i.e. precursors or depletors. However, it is of paramount importance 
that none of these drugs are specific for serotonin. Moreover, a pharmacological 
pretreatment has never a local effect. Thus such a pretreatment cannot give us 
information concerning specific question, as e.g. the involvement of the nucleus 
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raphe magnus in nociceptive transmission. Despite these difficulties and limitations 
it may be tentatively concluded that serotoninerqic neurons are involved in the 
central regulation of cardiovascular function; the hypothalamic control of pituitary 
function, sleep, thermoregulation, pain and locomotor activity. 
In conclusion it may be stated that the technique developed for the visualiza-
tion of serotoninergic neurons, described in the present thesis, has enabled us to 
analyze these neurons and their processes in great detail. A major task to be 
carried out in the future is the determination of the serotoninergic output of the 
various raphe nuclei separately and the determination of specific input to the 
serotoninergic neurons contained within the seven raphe nuclei. Such studies will 
provide a sound basis for a further exploration of the functional significance of 
the serotoninergic set of neurons. 
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SAMENVATTING 
Het in dit proefschrift beschreven onderzoek handelt over de ontwikkeling en 
toepassing van een lichtmikroskopische en immunohistochemische kleuringsmethode 
voor serotonine-bevattende neuronen, inclusief hun dendrieten, axonen en axon-
eindigingen. 
Hoofdstuk I laat zien dat serotonine niet alleen binnen het centrale zenuw-
stelsel gevonden wordt, maar ook aanwezig is in de mucosa van het maagdarmkanaal en 
in bloedplaatjes. 
In Hoofdstuk II wordt een gedetailleerde beschrijving gegeven van de produktie 
van antilichamen tegen serotonine gebaseerd op het koppelen van serotonin aan het 
drager eiwit rund serum albumine. Het ontwikkelde antiserum kan gebruikt worden voor 
de lokalisatie van serotonine in het centrale zenuwstelsel van de rat, na een 
geschikte weef self ïxatie m.b.v. een immunofluorescentie techniek op dunne, 10 μπι, 
cryostaat koupes. De specificiteit van het antiserum is onderzocht door middel van 
"liquid-phase" absorptie experimenten. Hieruit bleek dat er onder de geldende 
experimentele omstandigheden, een kruisreaktiviteit bestaat van ongeveer 2% ten 
opzichte van 5-methoxy-tryptamine en dopamine, en van minder dan 1% ten opzichte 
van noradrenaline en adrenaline. 
In Hoofdstuk III wordt het antiserum toegepast op dikke, 100 ym vibratoom koupes 
in kombinatie met de immunoperoxidase methode. Deze techniek is speciaal geschikt om 
de dendrieten van serotoninerge neuronen te onderzoeken. 
In dit hoofdstuk is verder gekeken naar de toepasbaarheid van drie andere 
serotomne-immunogenen voor het opwekken van antilichamen in konijnen. Een van deze 
drie immunogenen is een modificatie van het konjugaat, de bereiding waarvan reeds in 
Hoofdstuk II werd besproken. Slechts twee van de drie immunogenen geven na verloop 
van tijd een positieve respons. Deze beide antisera vertonen een identieke verdeling 
van hun immunoreaktiviteit. Ze zijn echter verschillend in gevoeligheid. Dit resultaat 
toont aan dat antilichamen, opgewekt tot het nu toegepaste immunogeen inderdaad 
serotonine en niet zijn 3-carboline derivaat localiseert. Deze laatste verbinding 
wordt zichtbaar gemaakt met de veel toegepaste formaldehyde-geinduceerde fluorescentie 
methode. 
Tenslotte wordt in Hoofdstuk III de aanwezigheid van serotonine-immunoreaktivi-
teit aangetoond in drie diersoorten, namelijk de prik (Lampetra fluviatilis), 
de forel (Salmo gairdneri) en de rat. Hieruit blijkt, dat het toegepaste antiserum 
tegen serotonine een veel bredere toepasbaarheid heeft dan antilichamen tegen de 
enzymen, die deze stof synthetiseren. 
In Hoofdstuk IV wordt een uitgebreide atlas gepresenteerd van serotoninerge 
cellichamen, vezels en terminalia in het centrale zenuwstelsel van de rat. Bijna 
alle delen van het centrale zenuwstelsel blijken een serotoninerge innervatle te 
ontvangen, waarbij echter aanzienlijke verschillen in intensiteit worden geconstateerd. 
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Slechts enkele gebieden vertonen geen serotonine-immunoreaktiviteit. Deze laatste 
gebieden bevatten in het algemeen kompakte, gemyeliniseerde vezelbanen, zoals 
bijvoorbeeld de pyramidebaan. 
In Hoofdstuk V is de serotoninerge innervatie van de hypothalamus en hypofyse 
in detail onderzocht. De hypothalamus is een van de hersengebieden met een zeer 
dichte serotoninerge innervatie en dat geldt in het bijzonder voor de laterale 
hypothalamus, de nucleus suprachiasmaticus en de nucleus ventromedials hypothalamus. 
In de hypofyse wordt serotonine-immunoreaktiviteit gevonden en wel in de pars 
nervosa. Er werden geen serotonine-positieve cellichamen gevonden in de hypothalamus, 
noch bij onbehandelde ratten, noch bij ratten die met colchicine behandeld zijn. Deze 
laatste behandeling heeft tot doel om het axonale transport van vezels stop te zetten, 
waardoor er een ophoping van de neurotransmitter in het cellichaam plaatsvindt. 
Hoofdstuk VI is gewijd aan de nucleus raphe dorsalls en zijn ascenderende 
projekties naar het caudatoputamen komplex. Een cytoarchitektonische analyse laat 
zien, dat er drie celtypen aanwezig zijn binnen de begrenzingen van de nucleus raphe 
dorsalis: kleine, middelgrote en grote cellen. Serotonine-immunoreaktieve cellichamen 
in deze kern behoren tot de middelgrote en grote neuronen. De analyse onthult verder, 
dat serotoninerge neuronen niet homogeen binnen de nucleus verspreid liggen en dat 
zij bovendien niet uitsluitend binnen zijn begrenzingen zijn gelegen. 
Door serotonine-immunofluorescentie te combineren met de resultaten verkregen uit 
experimenten waarbij de retrograad getransporteerde tracer, propidium jodide in het 
striatum werd ingespoten, kan vastgesteld worden dat de nucleus raphe dorsalis zowel 
serotoninerge als niet-serotoninerge cellichamen, die naar het ipsilaterale 
caudatoputamen komplex projekteren, bevat. Voorts werd gevonden dat de serotoninerge 
neuronen, die met hun ascenderende axonen naar het caudatoputamen projecteren, slechts 
een derde deel van de totale populatie van serotonine-positieve neuronen in de nucleus 
raphe dorsalis vormen. 
In Hoofdstuk VII was de aandacht gericht op alle zeven te onderscheiden raphe 
kernen, die tesamen het grootste gedeelte van alle serotoninerge cellichamen bevatten. 
Cytoarchitektonische en immunohistochemische studies lieten zien dat elk van de zeven 
raphe kernen een aparte eenheid vormt, en dat binnen de raphe kernen de serotoninerge 
neuronen niet op basis van cytoarchitektonische kriteria onderscheiden kunnen worden 
van niet-serotoninerge neuronen. 
Het voorkomen van een groot aantal verschillende transmitter-gespecificeerde 
cellen binnen de raphe kernen, betekent dat de efferenten van de raphe kernen zeker 
niet exclusief serotomnerg zijn, en dat tracer experimenten met betrekking tot de 
efferenten van de raphe kernen, m e t direkt in verband kunnen worden gebracht met 
serotonine. Evenmin mogen afferenten naar de raphe kernen uitsluitend als op 
serotoninerge neuronen eindigend worden beschreven. 
In hetzelfde hoofdstuk VII wordt ook aangetoond dat serotonine behalve een rol 
als neurotransmitter, ook een funktie als neurohormoon kan hebben. De uitgebreide 
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supra-ependymale serotoninerge plexus, gevormd door axonen van de nucleus raphe 
dorsalis, geeft waarschijnlijk serotonine af in de liquor cerebrospinalis. Bovendien 
kan serotonine in de raphe rechtstreeks afgegeven worden aan de bloedvaten die hier 
in ruime mate voorhanden zi]n. 
Tenslotte is in Hoofdstuk VIII getracht om de neuroanatomische bevindingen over 
de groep van serotoninerge neuronen in verband te brengen met fysiologische en 
ethologische observaties. 
Bi] het literatuuronderzoek zijn we op twee belangrijke problemen gestuit: 
1. In de meeste neuroanatomische studies wordt verondersteld, dat alle neuronen in 
de raphe kernen serotomnerg zijn. Vandaar dat lesies van deze kerngebieden veelal 
beschouwd worden als specifieke lesies van het serotoninerge "systeem". 2. In 
farmakologische experimenten wordt getracht om de serotoninerge groep neuronen te 
beïnvloeden met verschillende pharmaca, zoals precursors of depletors. Een precursor 
is een stof die na orale of intraperitoneale toediening de mogelijkheid heeft om 
de bloed-hersen barrière te passeren en die aan het begin staat van de synthese weg 
van een transmitter. In het geval van serotonine kunnen zowel L-tryptophan als 
L-5-hydroxytryptofaan een precursor funktie vervullen. Een depletor is een ver-
binding, die meestal intrathecaal wordt toegediend en die tot doel heeft de endogene 
gehalte's van de neurotransmitter te verlagen. Een depletor voor serotoninerge 
neuronen kan 5,6-dihydroxytryptamine zijn. Echter noch de genoemde precursors, noch 
de genoemde depletors zijn 100% specifiek voor serotoninerge neuronen. Bovendien 
heeft een farmacologische behandeling nooit een uitsluitend lokaal effect. Behande-
ling met een depletor verschaft ons dus geen informatie betreffende specifieke 
vragen, zoals welke rol speelt de nucleus raphe magnus in de nociceptieve transmissie 
of in de kontrole van de motoriek. Ondanks deze problemen en beperkingen mag 
voorzichtig gekonkludeerd worden dat serotoninerge neuronen zijn betrokken bij de 
centrale regulatie van het cardiovasculaire systeem, bij de hypothalamische kontrole 
van de hypofyse, bij de regulatie van de slaap, bij pijnperceptie, bij het in stand 
houden van de lichaamstemperatuur binnen bepaalde grenzen en bij de regulatie van 
het voortbewegen. 
Konkluderend kan worden gesteld, dat de in dit proefschrift beschreven techniek 
voor het lokaliseren van serotoninerge neuronen de mogelijkheid biedt om deze 
neuronen en hun uitlopers in detail te bestuderen. Deze studie vormt de basis voor 
verder onderzoek naar het funktionele belang van serotoninerge neuronen. Toekomstig 
onderzoek zal zich dienen te richten op het bepalen van de specifieke serotoninerge 
efferenten van de verschillende raphe kernen en op het bestuderen van de afferenten 
naar de serotoninerge neuronen binnen iedere raphe kern. 
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Stellingen. 
I. 
De morfologie van een bepaald neuron Is niet gerelateerd aan de voor dat 
neuron karakteristieke transmitter. 
II. 
Cytoarchitektonische grenzen van kerngebieden zijn in het algemeen geen 
funktionele grenzen. 
III. 
De fysiologische betekenis van een transmitter-specifieke innervatie van 
een bepaald weefsel is primair afhankelijk van het al of niet voorkomen 
van receptoren voor deze transmitter in dit weefsel. 
IV. 
Het gebruik van het aanhangsel "-like" bij immunocytochemische karakteri-
sering dient beperkt te worden tot die groep van neurotransmitters, die 
farmakologisch niet nader gespecificeerd kunnen worden. 
V. 
Het gebruik van monoklonale antilichamen biedt niet de_ oplossing voor het 
probleem van de specificiteit. 
VI. 
Het voorkomen van gemyeliniseerde descenderende serotoninerge vezels vanuit 
de nucleus raphe magnus ontkracht de algemeen aanvaarde opvatting dat 
serotonine binnen het centrale zenuwstelsel uitsluitend in niet-gemyelini-
seerde vezels aanwezig is. 
Rivot et al. J.Neurophysiol. 44, (1980), 1039. 
VII. 
De neurobiologische betekenis van het vóórkomen van meerdere transmitters 
binnen eenzelfde neuron is vooralsnog onbekend. 
Vili. 
Flexibiliteit en mobiliteit met betrekking tot· wetenschappelijk onderzoek . 
dienen juist voor wetenschappelijk personeel in vaste dienst te worden 
gestimuleerd. 
IX. 
Het zogenaamd gekontroleerd storten van verontreinigd slib uit de Rotterdamse 
haven langs de kust van Zuid-Holland zal binnen afzienbare tijd gifschandalen 
zoals die bij Lekkerkerk in de schaduw stellen. 
X. 
Het gebruik van auto's voorzien van dieselmotoren dient, zowel in het kader 
van de energie- als de snelheidsproblematiek, gestimuleerd te worden en 
niet via een extra-verzwaring in de belastingsfeer geremd te worden. 
XI. 
Een autonoom bestuurd Zuid-Limburg zou, niet alleen gezien zijn rijk kuituur-
historisch verleden maar ook door zijn grote energievoorraden, beter af zijn 
dan een regio die ekonomisch en maatschappelijk gekluisterd is aan een 
centraal overheidsapparaat. 
XII. 
Het promoveren op 1 april dient de geloofwaardigheid van het in deze 
dissertatie beschreven onderzoek niet aan te tasten. 
H.W.M.Steinbusch 
Nijmegen, 1 april 1982. 


